data_2jn7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jn7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.431 ' NH2' ' HG1' ' A' ' 37' ' ' THR . 35.9 ptt180 . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 110.647 -0.131 . . . . 1.0 110.647 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tt -113.35 133.52 55.1 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.059 -0.719 . . . . 1.0 109.059 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -136.01 -171.17 12.24 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 109.76 -1.336 . . . . 1.0 109.76 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.41 71.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.446 ' O ' ' NH1' ' A' ' 33' ' ' ARG . 16.8 ptm180 -75.33 123.85 26.07 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.083 0.468 . . . . 1.0 110.417 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.48 152.66 18.41 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.1 m -102.99 134.84 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.852 -0.796 . . . . 1.0 108.852 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -78.24 140.33 38.9 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.779 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -174.45 113.72 0.17 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.038 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.02 -147.82 45.21 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 109.228 -1.549 . . . . 1.0 109.228 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -99.25 10.99 40.33 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.067 0.434 . . . . 1.0 110.662 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -134.81 157.97 45.4 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.465 -0.568 . . . . 1.0 109.465 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mp -109.63 133.07 53.54 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.496 ' HD1' ' N ' ' A' ' 29' ' ' TYR . 2.0 t-80 -86.23 115.98 24.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.524 -0.307 . . . . 1.0 111.112 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.496 ' N ' ' HD1' ' A' ' 28' ' ' HIS . 87.7 t80 -100.55 110.53 22.7 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.321 -0.992 . . . . 1.0 108.321 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 mt -96.04 114.48 26.19 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.21 0.604 . . . . 1.0 110.022 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.02 91.94 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.826 0.346 . . . . 1.0 111.408 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.39 -8.67 27.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.029 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 19' ' ' ARG . 52.6 ttp85 -110.4 67.82 0.65 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.16 0.505 . . . . 1.0 110.585 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -171.14 175.48 4.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.046 -0.724 . . . . 1.0 109.046 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.8 t -135.94 145.38 46.17 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.8 mt -107.46 141.24 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.955 -0.758 . . . . 1.0 108.955 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.431 ' HG1' ' NH2' ' A' ' 15' ' ' ARG . 7.8 t -126.89 148.12 50.03 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.29 -134.89 29.12 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -170.64 135.33 1.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.307 0.575 . . . . 1.0 110.277 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -112.66 124.26 52.14 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.719 0.808 . . . . 1.0 109.284 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.2 t -65.27 169.62 5.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.086 0.47 . . . . 1.0 110.625 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.47 -21.19 65.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.639 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.61 -10.58 36.92 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 117.721 0.237 . . . . 1.0 110.74 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -105.57 -31.78 8.79 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.789 0.435 . . . . 1.0 110.703 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -60.58 10.05 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.718 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -58.85 -43.98 39.46 Favored 'Trans proline' 0 N--CA 1.506 2.23 0 C-N-CA 122.148 1.899 . . . . 1.0 111.688 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -61.85 -36.89 82.52 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.735 -0.212 . . . . 1.0 110.909 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.8 tp -78.33 -36.71 45.96 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 122.095 -0.378 . . . . 1.0 110.429 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.01 -35.34 78.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.14 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -77.35 -20.49 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 110.261 -0.274 . . . . 1.0 110.261 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.48 -25.61 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -55.3 -57.5 20.0 Favored Pre-proline 0 CA--C 1.555 1.149 0 CA-C-O 119.325 -0.369 . . . . 1.0 111.38 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -57.46 -28.13 79.24 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 121.823 1.682 . . . . 1.0 112.101 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -61.4 -49.58 76.29 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.358 -0.537 . . . . 1.0 109.921 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.436 ' CD1' ' SG ' ' A' ' 85' ' ' CYS . 37.3 m-85 -67.35 -41.48 85.1 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.815 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.3 mt -67.25 -37.98 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 118.293 0.497 . . . . 1.0 109.74 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 m -53.17 -27.93 23.8 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.609 0.243 . . . . 1.0 110.663 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -83.14 -40.44 19.76 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.657 -0.247 . . . . 1.0 111.083 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mm -57.9 -48.55 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 120.781 -0.368 . . . . 1.0 110.383 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -53.42 -31.48 45.44 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.571 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.5 m -84.84 -33.9 22.79 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.019 0.378 . . . . 1.0 112.019 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.9 mmt -54.27 -42.86 70.44 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 122.352 -0.218 . . . . 1.0 111.009 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 pp -63.19 -31.2 72.28 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.819 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -90.18 -62.34 1.48 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.986 0.422 . . . . 1.0 110.758 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.4 m -66.12 -40.55 90.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.129 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.23 0.97 72.15 Favored Glycine 0 N--CA 1.467 0.767 0 N-CA-C 109.528 -1.429 . . . . 1.0 109.528 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 54.39 99.34 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.271 -0.464 . . . . 1.0 110.607 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.0 tp -79.21 132.89 36.66 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -160.92 90.76 1.59 Allowed Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.892 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -47.4 98.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.506 2.23 0 C-N-CA 121.763 1.642 . . . . 1.0 111.47 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -137.37 -47.05 0.56 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.287 0.565 . . . . 1.0 110.931 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -165.7 154.19 11.38 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.148 -0.933 . . . . 1.0 110.713 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.4 144.7 56.37 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.156 -0.929 . . . . 1.0 110.544 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -151.31 104.37 3.09 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.857 0.36 . . . . 1.0 110.044 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 76.2 m -77.72 131.79 37.84 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.525 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.45 134.88 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 109.078 -0.712 . . . . 1.0 109.078 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.4 p -113.15 111.55 22.29 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.8 mt -97.79 155.24 17.13 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.4 ' O ' ' CG ' ' A' ' 80' ' ' HIS . 39.9 p90 -141.69 124.85 16.36 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 110.083 -0.339 . . . . 1.0 110.083 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 79' ' ' TYR . 99.4 m-70 -156.6 139.33 15.13 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.832 -0.432 . . . . 1.0 109.832 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.405 ' C ' ' H ' ' A' ' 83' ' ' PHE . 72.3 m-80 54.33 34.55 20.89 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.926 0.393 . . . . 1.0 111.069 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.36 -29.55 1.68 Allowed Glycine 0 N--CA 1.468 0.768 0 N-CA-C 111.474 -0.65 . . . . 1.0 111.474 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.405 ' H ' ' C ' ' A' ' 81' ' ' ASN . 82.2 m-85 -77.97 149.17 34.16 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.765 -0.457 . . . . 1.0 109.765 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.9 p -134.64 122.18 21.9 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.948 -0.389 . . . . 1.0 109.948 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.436 ' SG ' ' CD1' ' A' ' 55' ' ' PHE . 69.6 m -106.61 142.06 36.87 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -106.71 137.73 44.19 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.706 0.684 . . . . 1.0 109.173 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.38 151.81 47.84 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 120.53 0.205 . . . . 1.0 110.696 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -163.74 149.06 10.9 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 91' ' ' GLY . 68.2 p -91.31 -15.46 29.07 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 110.537 -0.171 . . . . 1.0 110.537 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.8 mp 58.43 5.63 0.46 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 110.136 -0.32 . . . . 1.0 110.136 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 89' ' ' THR . . . 77.27 12.93 84.13 Favored Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.19 -1.164 . . . . 1.0 110.19 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.0 t -77.18 148.78 35.72 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.009 0.433 . . . . 1.0 111.052 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 60.9 m -90.69 111.84 23.36 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.78 -0.645 . . . . 1.0 111.685 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . 69.72 39.8 76.82 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.113 -0.395 . . . . 1.0 112.113 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.431 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 79.4 m-85 -158.27 138.54 12.51 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.1 112.46 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -90.05 126.77 35.89 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.99 -0.744 . . . . 1.0 108.99 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.1 pt -130.15 157.11 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-O 120.947 0.403 . . . . 1.0 110.529 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.48 147.2 26.55 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.119 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.6 p -123.2 133.16 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.021 -0.991 . . . . 1.0 110.125 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -136.24 90.29 18.3 Favored Pre-proline 0 N--CA 1.47 0.562 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.82 140.98 67.15 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.439 1.426 . . . . 1.0 111.962 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.9 p -69.2 132.17 46.1 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.627 -0.508 . . . . 1.0 109.627 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 120.841 0.353 . . . . 1.0 110.452 -179.718 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.491 ' CG ' ' H ' ' A' ' 16' ' ' LEU . 41.1 ttm180 . . . . . 0 N--CA 1.463 0.192 0 N-CA-C 107.983 -1.117 . . . . 1.0 107.983 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.491 ' H ' ' CG ' ' A' ' 15' ' ' ARG . 6.0 tt -100.96 121.97 42.69 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.78 167.1 21.78 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.521 -1.032 . . . . 1.0 110.521 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.2 86.44 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.276 -0.639 . . . . 1.0 109.276 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.439 ' NH2' ' CD1' ' A' ' 95' ' ' TYR . 70.2 ttt-85 -85.34 114.7 22.61 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.91 146.75 24.73 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.144 -0.688 . . . . 1.0 109.144 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.45 136.78 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -78.95 131.74 36.45 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.657 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -170.23 113.27 0.46 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.75 -163.02 53.7 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -89.79 13.01 15.46 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 117.085 0.442 . . . . 1.0 110.096 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -131.64 148.72 52.62 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.827 -0.435 . . . . 1.0 109.827 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.3 mt -97.54 122.87 41.11 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -83.64 118.77 24.07 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.142 0.577 . . . . 1.0 111.044 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -103.78 110.69 22.89 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.06 114.95 27.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.259 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.46 -34.78 72.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.953 0.406 . . . . 1.0 111.079 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -66.7 -10.44 46.71 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.308 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -112.34 56.52 0.66 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.215 0.531 . . . . 1.0 110.465 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.97 176.97 4.51 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.803 -0.635 . . . . 1.0 109.364 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 92.0 p -149.42 159.81 43.97 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.1 pt -98.64 144.71 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.9 p -133.89 149.22 51.31 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.082 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.24 -129.3 20.24 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -168.44 127.28 1.15 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.608 0.718 . . . . 1.0 110.28 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -113.79 120.1 39.62 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.628 -0.878 . . . . 1.0 108.628 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.0 p -68.43 167.78 14.05 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.102 0.477 . . . . 1.0 110.592 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -63.44 -19.81 65.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.491 -0.777 . . . . 1.0 110.605 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.96 -12.18 36.74 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.698 0.285 . . . . 1.0 110.725 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -104.84 -38.34 6.69 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.121 0.568 . . . . 1.0 110.827 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.67 -61.98 3.25 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 119.894 -0.098 . . . . 1.0 110.958 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -57.91 -41.83 64.92 Favored 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 122.501 2.134 . . . . 1.0 112.583 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -62.88 -46.07 89.57 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.904 -0.318 . . . . 1.0 110.875 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.3 mt -63.06 -37.6 87.86 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.763 0.316 . . . . 1.0 110.209 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -59.51 -27.36 66.09 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.924 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.6 t -86.0 -30.6 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 81.9 t -78.89 -18.41 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 121.124 0.488 . . . . 1.0 109.788 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.5 -60.63 9.95 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.57 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -57.11 -22.09 45.92 Favored 'Trans proline' 0 N--CA 1.507 2.314 0 C-N-CA 122.098 1.865 . . . . 1.0 112.728 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -59.49 -45.2 92.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 120.448 -0.501 . . . . 1.0 110.151 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -65.76 -42.97 90.24 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.626 -0.429 . . . . 1.0 110.722 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.66 -41.88 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 120.993 -0.283 . . . . 1.0 110.355 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.8 p -58.18 -36.84 73.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.202 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -81.48 -28.65 33.99 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 119.712 -0.185 . . . . 1.0 111.462 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.8 mm -62.23 -44.2 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -58.69 -39.63 81.28 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.916 0.389 . . . . 1.0 110.608 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.1 m -61.09 -44.72 96.93 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.168 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 23.4 mmt -54.18 -40.79 67.87 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.574 0.226 . . . . 1.0 110.869 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.5 mt -62.01 -33.39 74.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.628 -0.508 . . . . 1.0 109.628 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -81.32 -57.2 3.6 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.199 0.444 . . . . 1.0 112.199 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.9 t -86.96 -38.69 16.41 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.08 0.4 . . . . 1.0 112.08 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.54 -8.22 62.57 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.161 -1.175 . . . . 1.0 110.161 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 43.83 81.3 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.491 0.317 . . . . 1.0 110.787 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.5 tp -80.63 137.12 36.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.662 -0.495 . . . . 1.0 109.662 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -127.48 78.34 74.81 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 123.122 0.569 . . . . 1.0 109.949 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -48.68 99.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 122.051 1.834 . . . . 1.0 112.458 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -169.6 -18.37 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.844 0.355 . . . . 1.0 110.797 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -150.12 147.56 27.91 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.109 0.48 . . . . 1.0 110.875 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.66 142.08 50.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.65 -0.704 . . . . 1.0 111.132 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -160.02 103.35 1.48 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 63.4 m -84.65 143.35 29.29 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.791 -0.641 . . . . 1.0 110.3 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.1 p -140.64 146.91 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.2 p -128.68 104.12 7.47 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.58 0.352 . . . . 1.0 110.098 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.0 mt -82.9 148.71 27.52 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.068 -0.715 . . . . 1.0 109.068 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -139.87 125.22 18.96 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.455 ' CD2' ' N ' ' A' ' 80' ' ' HIS . 0.1 OUTLIER -170.67 146.4 2.66 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.18 0.514 . . . . 1.0 110.168 -179.715 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' A' ' 83' ' ' PHE . 59.6 t30 53.82 31.14 12.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.979 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.18 -27.86 1.18 Allowed Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.783 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.423 ' H ' ' C ' ' A' ' 81' ' ' ASN . 65.7 m-85 -83.19 154.01 24.46 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 117.081 0.44 . . . . 1.0 110.384 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 t -151.02 133.56 15.57 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.068 0.461 . . . . 1.0 110.85 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 68.4 m -106.89 142.5 36.41 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.008 -0.738 . . . . 1.0 109.008 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -106.39 141.97 36.84 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.441 0.564 . . . . 1.0 109.572 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.11 147.71 31.84 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 110.646 -0.131 . . . . 1.0 110.646 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -145.64 140.88 27.65 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.9 m -94.14 -22.43 18.47 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.43 15.85 0.24 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.752 0.821 . . . . 1.0 111.837 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.64 14.98 74.56 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 109.373 -1.491 . . . . 1.0 109.373 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.42 ' O ' ' SG ' ' A' ' 93' ' ' CYS . 13.4 t -50.19 -22.04 1.56 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.113 -0.544 . . . . 1.0 111.798 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 92' ' ' SER . 27.9 p 36.67 34.14 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 177.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.81 -48.47 0.08 OUTLIER Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.505 -0.855 . . . . 1.0 112.13 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.439 ' CD1' ' NH2' ' A' ' 19' ' ' ARG . 99.1 m-85 -107.09 145.43 32.43 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.752 -0.462 . . . . 1.0 109.752 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.79 140.5 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.634 0.773 . . . . 1.0 109.199 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -139.22 162.25 35.45 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.311 0.577 . . . . 1.0 109.683 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 42.4 pt -137.41 165.18 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 114.92 -1.036 . . . . 1.0 110.523 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.65 146.34 27.22 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.631 -0.713 . . . . 1.0 109.56 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 p -122.59 133.29 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 115.299 -0.864 . . . . 1.0 109.86 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -140.55 93.65 8.64 Favored Pre-proline 0 N--CA 1.471 0.601 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -51.19 139.35 43.77 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 121.33 1.353 . . . . 1.0 112.337 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 75.3 p -74.29 136.06 42.61 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 120.789 0.328 . . . . 1.0 110.272 179.703 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.9 ttt85 . . . . . 0 C--O 1.232 0.181 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.5 tt -122.53 140.07 53.18 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.177 0.591 . . . . 1.0 109.646 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.37 176.3 16.17 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.59 100.09 0.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -75.95 134.22 40.26 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.964 -0.754 . . . . 1.0 108.964 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.4 mt -127.21 146.03 50.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.363 -0.835 . . . . 1.0 109.941 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.2 137.2 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -71.61 136.13 47.25 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -166.91 100.64 0.55 Allowed 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.78 -165.65 54.56 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -84.84 26.98 0.78 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.77 0.319 . . . . 1.0 110.237 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -145.23 139.56 27.26 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.608 -0.516 . . . . 1.0 109.608 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.0 mt -91.55 131.64 36.84 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -82.29 114.95 21.12 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.217 -0.29 . . . . 1.0 110.217 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -100.07 105.69 17.36 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.62 141.0 28.96 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.54 -0.755 . . . . 1.0 109.598 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.46 -40.97 17.07 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.674 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 23.5 p-10 -72.28 -8.26 53.9 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.237 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -114.77 49.3 1.05 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 120.896 0.379 . . . . 1.0 110.211 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.82 127.23 1.57 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.905 0.383 . . . . 1.0 110.185 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.4 p -76.49 166.86 22.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 pt -125.37 153.79 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.0 p -137.1 136.64 38.49 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.47 102.46 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.16 -0.776 . . . . 1.0 111.16 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -58.36 123.6 16.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.001 0.429 . . . . 1.0 110.276 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -90.27 137.88 31.99 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.364 0.602 . . . . 1.0 109.663 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.7 m -69.21 169.38 12.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.239 -0.891 . . . . 1.0 110.6 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -65.63 -20.35 66.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.402 -0.817 . . . . 1.0 110.166 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.93 -10.05 40.9 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 120.827 0.346 . . . . 1.0 110.544 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -107.88 -26.49 10.71 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.258 0.623 . . . . 1.0 111.416 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -68.45 -45.37 36.65 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.393 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 35.1 Cg_exo -62.57 -53.31 1.85 Allowed 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 122.317 2.012 . . . . 1.0 112.477 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -54.01 -36.84 63.41 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.649 -0.705 . . . . 1.0 110.994 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.5 tp -76.27 -36.87 58.23 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.93 0.395 . . . . 1.0 110.204 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.41 -20.42 65.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.852 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.7 m -97.02 -8.99 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 110.107 -0.331 . . . . 1.0 110.107 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.5 t -92.77 -26.5 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.415 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -63.36 -47.78 83.54 Favored Pre-proline 0 CA--C 1.551 0.988 0 O-C-N 122.243 -0.286 . . . . 1.0 110.809 -178.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 52' ' ' PHE . 69.7 Cg_exo -54.53 -39.31 88.81 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.336 2.024 . . . . 1.0 111.88 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -62.32 -42.89 99.75 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.096 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -64.25 -42.42 96.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.619 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.18 -29.93 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.84 -0.43 . . . . 1.0 109.84 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.8 m -60.88 -43.62 98.2 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.885 -0.326 . . . . 1.0 111.061 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -68.76 -33.4 73.82 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.27 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.2 mm -62.78 -45.13 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.16 -40.02 80.34 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.828 0.347 . . . . 1.0 110.429 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.9 m -76.6 -27.92 55.94 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.597 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 66' ' ' GLY . 59.4 ttm -60.16 -40.05 88.56 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 110.052 -0.351 . . . . 1.0 110.052 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 mt -62.11 -32.4 72.96 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.9 p -87.29 -59.75 2.17 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.982 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.5 p -78.39 -39.62 38.54 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.441 0.534 . . . . 1.0 112.441 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -80.86 -16.71 74.42 Favored Glycine 0 N--CA 1.474 1.195 0 N-CA-C 111.238 -0.745 . . . . 1.0 111.238 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 40.74 79.11 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.078 0.551 . . . . 1.0 111.621 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.13 157.94 27.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.108 0.48 . . . . 1.0 109.812 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -135.67 79.37 47.02 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.237 -0.892 . . . . 1.0 110.141 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -51.47 -13.32 1.29 Allowed 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 122.365 2.043 . . . . 1.0 111.939 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -73.26 -14.27 61.29 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.089 0.471 . . . . 1.0 110.04 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -138.73 144.95 39.72 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.431 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.06 141.01 47.43 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.277 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -160.64 140.04 10.73 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.3 m -131.97 144.46 50.82 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.639 0.375 . . . . 1.0 110.017 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.1 p -147.03 147.97 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.9 p -125.32 115.6 20.6 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 67.9 mt -98.33 158.22 15.71 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -139.6 123.01 17.15 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -154.94 133.49 11.97 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 53.73 24.2 4.19 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.814 0.34 . . . . 1.0 111.324 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.59 -25.79 7.03 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 111.23 -0.748 . . . . 1.0 111.23 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -65.13 146.39 55.04 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.1 m -139.23 107.07 5.65 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.589 -0.522 . . . . 1.0 109.589 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 54.1 t -98.23 137.55 36.81 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -95.56 134.05 38.88 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.23 133.28 38.85 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -148.4 140.94 24.39 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.576 -0.527 . . . . 1.0 109.576 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 74.9 p -92.38 -38.14 12.18 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 120.757 0.313 . . . . 1.0 111.332 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.0 mp 55.46 23.11 5.56 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.002 0.429 . . . . 1.0 110.119 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 93' ' ' CYS . . . 83.34 12.05 79.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.995 -1.242 . . . . 1.0 109.995 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.9 p -57.43 83.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.848 0.356 . . . . 1.0 110.995 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 91' ' ' GLY . 81.8 m -63.12 119.83 10.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.615 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.43 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . 64.21 31.43 80.81 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.43 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 41.9 m-85 -162.62 153.03 16.67 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.2 p -148.78 140.17 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.337 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -119.49 136.66 54.22 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.1 pt -137.12 160.89 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 120.944 0.402 . . . . 1.0 110.037 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.49 119.84 7.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.597 0.713 . . . . 1.0 110.1 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.7 t -93.36 130.83 41.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-N 114.643 -1.162 . . . . 1.0 108.719 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -137.95 115.84 9.55 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-O 118.689 -0.672 . . . . 1.0 109.69 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.49 145.95 38.6 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.371 1.381 . . . . 1.0 110.813 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.7 t -99.09 148.81 23.67 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 110.192 -0.299 . . . . 1.0 110.192 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 . . . . . 0 CA--C 1.513 -0.455 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 tp -121.59 128.57 52.09 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.232 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.81 153.99 33.51 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.142 -1.183 . . . . 1.0 110.142 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.23 62.67 0.05 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.141 0.496 . . . . 1.0 109.94 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -72.94 132.87 44.0 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.092 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.9 mt -112.92 153.15 28.42 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.469 -0.567 . . . . 1.0 109.469 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.8 m -96.5 136.06 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.442 -0.947 . . . . 1.0 108.442 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -78.11 135.65 37.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -168.1 113.68 0.67 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.181 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.48 -159.0 53.21 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 109.727 -1.349 . . . . 1.0 109.727 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -92.96 10.03 33.08 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 110.362 -0.236 . . . . 1.0 110.362 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -130.61 137.33 49.59 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.138 -0.483 . . . . 1.0 109.954 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.1 mp -89.83 135.98 33.31 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.537 ' HD1' ' N ' ' A' ' 29' ' ' TYR . 0.9 OUTLIER -89.86 115.94 27.56 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.076 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.537 ' N ' ' HD1' ' A' ' 28' ' ' HIS . 56.1 t80 -98.24 104.56 16.61 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.883 -0.784 . . . . 1.0 108.883 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 mt -93.06 115.23 27.9 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.339 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.86 -30.4 70.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.749 -0.659 . . . . 1.0 110.128 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -70.77 -9.58 57.68 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.951 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -112.25 56.84 0.65 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.538 0.685 . . . . 1.0 110.555 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.85 175.28 6.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.58 -0.736 . . . . 1.0 109.432 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.7 m -145.67 163.63 34.3 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.8 mt -107.0 141.37 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.4 m -127.71 138.66 52.86 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.93 -135.06 14.81 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.567 -1.013 . . . . 1.0 110.567 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -168.57 132.96 1.58 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.651 -0.499 . . . . 1.0 109.651 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -115.75 126.89 54.64 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.176 -0.676 . . . . 1.0 109.176 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.8 m -67.88 161.11 27.05 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -56.29 -21.85 26.56 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.729 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.72 -12.58 33.57 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.66 0.267 . . . . 1.0 110.528 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.27 -27.78 8.93 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.025 0.53 . . . . 1.0 111.062 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.495 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -61.66 -46.57 93.55 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 45.7 Cg_exo -57.71 -47.77 19.77 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.043 1.829 . . . . 1.0 112.522 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -54.63 -51.96 63.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.981 -0.554 . . . . 1.0 111.793 -177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.69 -41.16 97.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.852 0.358 . . . . 1.0 110.995 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -66.09 -16.64 64.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.103 -0.498 . . . . 1.0 110.227 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.3 t -101.93 -14.72 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 110.168 -0.308 . . . . 1.0 110.168 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.51 -18.71 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.48 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -61.85 -47.23 92.15 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 110.141 -0.318 . . . . 1.0 110.141 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 52' ' ' PHE . 52.9 Cg_exo -56.56 -33.3 92.55 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.273 1.982 . . . . 1.0 111.037 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.521 ' NE2' ' NE2' ' A' ' 58' ' ' GLN . 48.6 t60 -59.29 -42.77 92.09 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.7 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -64.94 -42.1 94.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.143 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.1 mm -72.23 -26.71 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.376 -0.529 . . . . 1.0 109.63 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -70.1 -42.89 72.09 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.745 -0.382 . . . . 1.0 111.046 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.521 ' NE2' ' NE2' ' A' ' 54' ' ' HIS . 48.5 mt-30 -81.8 -50.4 9.28 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.377 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.8 mt -53.17 -46.24 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -55.58 -33.96 64.38 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.519 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m -76.11 -32.9 59.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.734 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.451 ' O ' ' N ' ' A' ' 66' ' ' GLY . 81.1 mmm -59.59 -29.16 67.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.937 0.399 . . . . 1.0 110.328 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.9 mt -60.01 -41.59 92.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.849 0.357 . . . . 1.0 110.125 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.9 m -85.4 -55.02 4.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.242 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.4 m -65.01 -42.05 94.81 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.696 -0.402 . . . . 1.0 111.339 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -86.11 -7.84 79.67 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 50.29 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.662 0.268 . . . . 1.0 110.393 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.4 tp -78.91 143.13 36.14 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -135.41 80.4 45.84 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.814 -0.63 . . . . 1.0 109.77 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.32 88.77 0.83 Allowed 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.11 1.873 . . . . 1.0 110.677 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -171.43 -9.47 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.927 0.394 . . . . 1.0 111.006 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -146.28 147.15 31.09 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.155 0.502 . . . . 1.0 110.867 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.22 131.2 47.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.63 -0.714 . . . . 1.0 109.944 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -162.4 139.22 7.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.431 -0.951 . . . . 1.0 108.431 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 58.3 m -129.88 140.88 50.89 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.6 t -132.94 134.49 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.488 -0.93 . . . . 1.0 108.488 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.2 m -109.7 119.92 40.89 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.54 142.49 40.53 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.122 -0.696 . . . . 1.0 109.122 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 42.3 p90 -133.75 126.47 30.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -156.25 139.42 15.56 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.421 ' C ' ' H ' ' A' ' 83' ' ' PHE . 17.2 t-20 54.45 34.31 20.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.928 0.394 . . . . 1.0 111.576 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.99 -28.63 1.62 Allowed Glycine 0 N--CA 1.467 0.725 0 N-CA-C 111.269 -0.732 . . . . 1.0 111.269 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 81' ' ' ASN . 69.8 m-85 -70.81 150.46 45.82 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.7 m -138.65 112.77 8.61 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 62.1 m -100.73 143.27 31.09 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -106.38 143.09 35.0 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.12 151.05 40.28 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -162.21 137.67 7.31 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.117 -0.698 . . . . 1.0 109.117 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' ' 91' ' ' GLY . 67.1 p -87.3 -16.11 36.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.977 -0.101 . . . . 1.0 110.729 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.2 mt 59.19 8.05 1.0 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.162 0.506 . . . . 1.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 89' ' ' THR . . . 71.73 20.22 78.49 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 110.614 -0.995 . . . . 1.0 110.614 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.9 t -61.9 -145.91 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.782 0.325 . . . . 1.0 110.161 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.3 p -164.8 107.86 0.87 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.19 28.27 68.52 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.483 -1.047 . . . . 1.0 110.483 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -151.96 146.98 26.01 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.1 m -139.71 140.16 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.325 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 8.0 m-85 -125.51 131.92 52.72 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.811 -0.811 . . . . 1.0 108.811 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.4 pt -138.95 163.57 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.73 145.74 25.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.717 -0.845 . . . . 1.0 108.717 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.56 135.54 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.247 -0.888 . . . . 1.0 109.388 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -145.91 143.67 20.13 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.123 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.82 139.88 44.83 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.681 1.587 . . . . 1.0 111.57 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.3 p -81.16 141.85 33.82 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 . . . . . 0 N--CA 1.464 0.264 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 179.809 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 109.554 -0.536 . . . . 1.0 109.554 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 tt -121.82 131.45 54.06 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.733 -0.469 . . . . 1.0 109.733 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.54 164.36 25.46 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.174 -1.171 . . . . 1.0 110.174 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.08 135.82 0.61 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -136.98 130.59 31.73 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.1 mt -111.16 152.77 26.66 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.69 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.49 137.75 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -73.45 138.9 45.45 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.002 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -169.55 107.6 0.4 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.93 -169.94 44.71 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 109.824 -1.31 . . . . 1.0 109.824 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -84.81 23.76 1.14 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 122.717 -0.284 . . . . 1.0 110.32 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -143.65 143.01 31.27 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.748 -0.464 . . . . 1.0 109.748 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.7 mt -95.13 134.63 37.65 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -92.97 117.81 30.47 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.44 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -98.51 104.96 17.04 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.58 112.65 24.67 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.614 -0.721 . . . . 1.0 109.553 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.35 79.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.611 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -69.04 -11.99 61.28 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.567 -0.742 . . . . 1.0 110.583 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -107.97 55.36 0.65 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.879 0.371 . . . . 1.0 111.105 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.41 126.27 0.52 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.206 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -82.48 139.95 33.64 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.229 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.4 mt -85.71 141.33 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 76.9 p -130.9 147.7 52.57 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.001 0.52 . . . . 1.0 109.617 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.89 -150.32 50.34 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.823 -0.911 . . . . 1.0 110.823 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -158.49 130.36 6.72 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -111.53 125.68 54.17 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.609 0.764 . . . . 1.0 109.153 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -65.75 168.57 7.6 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.212 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.79 -22.16 66.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.68 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.42 -9.73 40.58 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 120.667 0.27 . . . . 1.0 110.602 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -108.26 -26.17 10.68 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.845 0.458 . . . . 1.0 111.421 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -67.59 -44.8 45.41 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 110.169 -0.308 . . . . 1.0 110.169 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 45.1 Cg_exo -59.43 -50.9 7.26 Favored 'Trans proline' 0 N--CA 1.503 2.062 0 C-N-CA 122.22 1.946 . . . . 1.0 112.23 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -55.99 -27.44 52.79 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.898 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -39.87 92.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -68.16 -24.93 65.04 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.927 -0.579 . . . . 1.0 111.053 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.64 -44.63 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.308 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.7 t -84.21 -15.1 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 121.205 0.526 . . . . 1.0 110.506 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -55.92 -53.15 66.28 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-O 118.658 -0.687 . . . . 1.0 111.804 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -68.04 -22.04 42.16 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 CA-C-N 121.443 1.551 . . . . 1.0 111.431 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.511 ' NE2' ' ND1' ' A' ' 80' ' ' HIS . 62.0 t-80 -59.24 -46.74 87.67 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.516 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.66 -42.61 91.14 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.87 -0.332 . . . . 1.0 110.531 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.4 mt -71.6 -42.52 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 120.729 -0.389 . . . . 1.0 110.076 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -57.75 -39.11 76.62 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.836 -0.345 . . . . 1.0 111.283 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.31 -46.55 13.48 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 110.565 -0.161 . . . . 1.0 110.565 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.9 mt -63.08 -43.98 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -58.41 -41.51 85.11 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.693 -0.403 . . . . 1.0 110.42 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.1 p -69.15 -31.82 70.75 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 121.018 -0.273 . . . . 1.0 110.359 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 66' ' ' GLY . 42.8 tpp -60.75 -40.9 94.14 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.59 -35.7 78.59 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.015 -0.365 . . . . 1.0 110.015 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.1 p -86.37 -58.84 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.76 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -63.54 -41.13 98.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.777 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -117.1 70.77 0.29 Allowed Glycine 0 N--CA 1.476 1.325 0 N-CA-C 111.448 -0.661 . . . . 1.0 111.448 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -47.2 86.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.006 0.403 . . . . 1.0 111.174 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 66' ' ' GLY . 4.5 tp -82.23 145.75 29.87 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.569 -0.9 . . . . 1.0 108.569 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -134.64 144.01 48.95 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 72' ' ' HIS . 82.1 Cg_exo -38.23 -87.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 122.485 2.123 . . . . 1.0 113.057 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.438 ' O ' ' CG ' ' A' ' 72' ' ' HIS . 81.6 mtp180 58.36 -56.62 0.04 OUTLIER 'General case' 0 C--N 1.346 0.447 0 C-N-CA 123.744 0.817 . . . . 1.0 112.689 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 70' ' ' PRO . 74.2 m80 -158.66 149.14 19.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.751 -0.658 . . . . 1.0 110.023 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.51 144.13 54.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.504 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.51 102.77 1.37 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.038 0.447 . . . . 1.0 110.122 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.37 137.17 39.63 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.804 -0.635 . . . . 1.0 110.655 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.9 t -125.91 134.87 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.0 p -113.18 111.18 21.64 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.344 -0.613 . . . . 1.0 109.344 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.3 mt -95.67 151.47 19.32 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.42 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 50.0 p90 -146.86 127.3 14.05 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.649 0.261 . . . . 1.0 110.308 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.511 ' ND1' ' NE2' ' A' ' 54' ' ' HIS . 58.6 t-80 -159.63 4.11 0.09 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.597 0.237 . . . . 1.0 110.472 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -165.71 22.03 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.156 0.503 . . . . 1.0 110.252 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.89 -29.39 5.06 Favored Glycine 0 N--CA 1.468 0.815 0 N-CA-C 111.087 -0.805 . . . . 1.0 111.087 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -72.74 143.56 47.96 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.422 ' O ' ' CZ ' ' A' ' 101' ' ' TYR . 60.6 p -134.1 107.46 7.75 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.8 t -90.52 140.37 29.8 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -97.88 138.31 35.42 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.133 -0.692 . . . . 1.0 109.133 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.06 149.08 39.46 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 110.013 -0.366 . . . . 1.0 110.013 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -168.51 141.45 2.97 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.0 p -86.03 -29.38 23.5 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.804 0.335 . . . . 1.0 110.285 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.6 mt 59.2 17.7 5.9 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.613 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.74 10.42 76.49 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 109.979 -1.248 . . . . 1.0 109.979 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.411 ' O ' ' SG ' ' A' ' 93' ' ' CYS . 35.4 t -49.59 -22.21 1.22 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 118.927 -0.559 . . . . 1.0 111.944 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 92' ' ' SER . 26.2 p 36.76 34.41 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.354 0.872 . . . . 1.0 113.354 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.36 -55.24 0.02 OUTLIER Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.849 -0.5 . . . . 1.0 111.849 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.23 139.13 54.22 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.72 0.408 . . . . 1.0 110.387 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.9 t -106.1 115.71 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -97.97 137.02 37.42 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.883 -0.784 . . . . 1.0 108.883 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.2 pt -138.31 161.19 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.29 147.76 27.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.942 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.05 131.21 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.082 -0.963 . . . . 1.0 109.357 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 11.3 p90 -131.71 94.25 25.94 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 108.734 -0.839 . . . . 1.0 108.734 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.79 137.64 34.49 Favored 'Trans proline' 0 N--CA 1.503 2.056 0 C-N-CA 121.524 1.483 . . . . 1.0 111.742 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 t -96.07 148.72 22.38 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 120.948 0.404 . . . . 1.0 110.219 -179.77 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.08 149.24 51.88 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.56 0.695 . . . . 1.0 110.481 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.82 138.24 20.54 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.639 -1.384 . . . . 1.0 109.639 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.29 53.81 0.22 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.455 0.645 . . . . 1.0 109.438 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -76.41 128.91 35.76 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.847 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.6 mt -92.63 150.0 20.98 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.891 -0.411 . . . . 1.0 109.891 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.5 p -104.24 136.49 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -76.12 130.74 38.77 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.358 -0.383 . . . . 1.0 109.998 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -170.29 109.7 0.38 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.45 -165.67 54.76 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 109.685 -1.366 . . . . 1.0 109.685 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -87.21 10.91 15.45 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.896 -0.409 . . . . 1.0 109.896 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -129.76 141.06 50.93 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.736 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 54.8 mt -90.55 124.99 35.46 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -82.85 116.01 21.98 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.637 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -101.05 107.33 18.75 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.04 118.36 31.72 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.649 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.47 80.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.034 0.445 . . . . 1.0 110.739 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -67.83 -11.2 58.07 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.905 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -111.3 58.62 0.62 Allowed 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.041 0.448 . . . . 1.0 110.508 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.09 176.35 4.67 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.978 -0.556 . . . . 1.0 109.626 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -133.19 127.91 34.83 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.587 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 pt -85.32 147.73 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 82.5 p -133.21 134.76 44.47 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.8 102.66 0.01 OUTLIER Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -58.75 129.79 43.79 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.995 0.426 . . . . 1.0 110.113 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -96.02 136.33 36.61 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.745 -0.662 . . . . 1.0 109.853 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -67.1 167.43 11.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.381 -0.827 . . . . 1.0 110.709 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -64.46 -20.58 66.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.605 -0.725 . . . . 1.0 110.616 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.57 -11.01 38.48 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.006 0.432 . . . . 1.0 110.517 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -107.72 -24.28 11.78 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.283 0.633 . . . . 1.0 111.812 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.47 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -70.68 -45.36 17.27 Favored Pre-proline 0 CA--C 1.551 0.995 0 O-C-N 122.093 -0.38 . . . . 1.0 110.27 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 52.5 Cg_exo -58.15 -50.58 9.61 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 122.328 2.019 . . . . 1.0 113.167 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -60.2 -43.93 95.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.303 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.47 -39.64 91.62 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.34 -10.59 11.64 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.088 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 81.2 t -101.42 -15.34 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 109.557 -0.535 . . . . 1.0 109.557 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.93 -28.39 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 110.52 -0.178 . . . . 1.0 110.52 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.423 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -67.06 -46.65 52.92 Favored Pre-proline 0 N--CA 1.483 1.223 0 O-C-N 122.393 -0.192 . . . . 1.0 111.156 -178.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 52' ' ' PHE . 54.6 Cg_exo -56.59 -36.35 97.88 Favored 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 122.494 2.129 . . . . 1.0 111.885 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -65.31 -40.51 93.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 1.0 109.954 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.21 -41.62 96.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.502 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.5 mm -69.43 -36.91 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.4 t -59.13 -45.57 90.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.625 -0.261 . . . . 1.0 111.392 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.436 ' O ' ' SD ' ' A' ' 62' ' ' MET . 29.1 mm100 -67.85 -37.81 82.35 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.852 -0.158 . . . . 1.0 110.846 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.0 mt -59.08 -43.67 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.915 -0.491 . . . . 1.0 109.815 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -58.13 -39.48 78.84 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.815 0.34 . . . . 1.0 110.275 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -65.34 -39.59 92.59 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.459 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -60.3 -40.71 91.45 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 110.348 -0.241 . . . . 1.0 110.348 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.69 -34.93 76.63 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.546 -0.539 . . . . 1.0 109.546 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.3 p -86.02 -62.41 1.53 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.309 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.471 ' HG1' ' N ' ' A' ' 66' ' ' GLY . 70.8 p -74.72 -39.64 61.77 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.042 0.386 . . . . 1.0 112.042 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.471 ' N ' ' HG1' ' A' ' 65' ' ' THR . . . -81.29 -4.7 90.41 Favored Glycine 0 N--CA 1.47 0.961 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 31.79 78.6 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.699 0.8 . . . . 1.0 112.113 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.63 151.43 32.3 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.247 0.546 . . . . 1.0 109.657 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -141.29 74.84 23.97 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.154 -0.93 . . . . 1.0 110.013 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -48.2 105.97 0.1 OUTLIER 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 122.332 2.022 . . . . 1.0 111.648 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -171.02 -16.08 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.663 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -142.53 142.37 32.22 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.931 0.396 . . . . 1.0 110.999 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.3 125.73 24.51 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.768 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -162.01 103.99 1.16 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 27.7 p -90.29 148.13 23.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.433 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.58 152.27 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.8 p -128.01 110.27 12.35 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.801 -0.444 . . . . 1.0 109.801 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.5 mp -91.94 158.87 16.03 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.828 -0.805 . . . . 1.0 108.828 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -140.94 122.63 15.24 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -157.81 134.6 9.89 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 53.92 27.5 7.38 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.104 0.478 . . . . 1.0 111.406 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.63 -24.91 4.12 Favored Glycine 0 N--CA 1.469 0.85 0 N-CA-C 111.532 -0.627 . . . . 1.0 111.532 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -67.61 140.85 56.9 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 67.8 m -129.27 109.19 10.91 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 39.8 t -95.53 140.74 29.93 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -106.0 130.2 53.97 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.85 140.2 45.64 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -145.05 133.56 21.96 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.771 -0.825 . . . . 1.0 108.771 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.8 p -92.69 -32.2 14.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.012 0.434 . . . . 1.0 110.712 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.46 12.69 1.56 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.526 -0.546 . . . . 1.0 109.526 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.81 18.28 77.4 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 109.179 -1.568 . . . . 1.0 109.179 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.429 ' C ' ' H ' ' A' ' 94' ' ' GLY . 69.8 m -67.49 75.6 0.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.111 0.482 . . . . 1.0 111.668 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 43.6 t -65.69 48.96 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.773 -1.103 . . . . 1.0 110.559 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 92' ' ' SER . . . -166.38 -21.16 0.02 OUTLIER Glycine 0 CA--C 1.531 1.087 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.412 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 87.0 m-85 -158.41 170.78 21.45 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.938 0.369 . . . . 1.0 110.284 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.67 113.22 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -86.93 133.53 33.59 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.985 -0.376 . . . . 1.0 109.985 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.1 pt -143.33 161.85 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-N 118.221 0.464 . . . . 1.0 110.625 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.5 148.0 26.88 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.315 0.578 . . . . 1.0 110.4 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.18 137.18 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.028 -0.987 . . . . 1.0 110.508 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -151.55 148.16 21.58 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.1 141.75 71.24 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 121.361 1.374 . . . . 1.0 111.257 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.0 m -74.48 136.96 42.25 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 . . . . . 0 N--CA 1.464 0.237 0 CA-C-O 120.775 0.322 . . . . 1.0 110.201 -179.826 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 108.364 -0.976 . . . . 1.0 108.364 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.2 tt -109.54 116.24 31.41 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.36 161.99 27.93 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 110.254 -1.139 . . . . 1.0 110.254 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.12 72.75 0.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 1.0 110.433 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -83.72 125.85 32.31 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.28 153.94 20.92 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.232 0.613 . . . . 1.0 109.445 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.14 140.87 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 108.817 -0.808 . . . . 1.0 108.817 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -81.38 108.34 14.91 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -65.0 -51.95 58.82 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.288 0.566 . . . . 1.0 109.676 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.95 -77.6 0.1 Allowed Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.058 -1.217 . . . . 1.0 110.058 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -100.28 8.06 43.99 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.892 0.477 . . . . 1.0 110.317 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -155.99 156.24 34.12 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.015 -0.365 . . . . 1.0 110.015 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.43 121.65 40.63 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.082 -0.71 . . . . 1.0 109.082 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.451 ' HD1' ' N ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -90.96 119.74 31.39 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.297 0.239 . . . . 1.0 110.6 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.451 ' N ' ' HD1' ' A' ' 28' ' ' HIS . 42.4 t80 -99.84 101.99 13.29 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.82 109.12 19.06 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.848 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.81 -28.02 68.47 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.132 0.491 . . . . 1.0 110.708 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -68.33 -11.62 59.81 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.573 -0.739 . . . . 1.0 111.046 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -109.37 45.77 1.04 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 120.869 0.366 . . . . 1.0 110.118 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.71 127.4 0.91 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.759 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.5 m -95.24 167.74 11.16 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.3 tp -94.9 141.16 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.5 m -128.25 125.3 38.64 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.99 153.53 8.59 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.809 -0.916 . . . . 1.0 110.809 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -92.81 125.95 37.66 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.825 0.345 . . . . 1.0 110.271 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -112.1 129.47 56.21 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 m -71.3 164.32 25.94 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.969 0.414 . . . . 1.0 110.382 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -63.98 -20.25 65.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.459 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.95 -11.92 34.82 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.88 0.371 . . . . 1.0 110.284 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -107.19 -25.85 11.34 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.08 0.552 . . . . 1.0 111.452 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -67.8 -45.39 43.92 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 120.904 -0.319 . . . . 1.0 110.391 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 51.9 Cg_exo -56.65 -46.86 26.75 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 122.345 2.03 . . . . 1.0 112.527 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.67 -32.67 69.32 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.595 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tp -63.28 -37.75 88.46 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.13 0.491 . . . . 1.0 110.095 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -68.96 -11.06 60.34 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.462 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.9 t -82.76 -48.49 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 110.35 -0.241 . . . . 1.0 110.35 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.18 -26.79 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 120.622 0.249 . . . . 1.0 111.497 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -54.89 -61.83 5.17 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-O 119.51 -0.281 . . . . 1.0 111.373 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -60.85 -30.48 90.2 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.636 1.557 . . . . 1.0 111.288 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -61.89 -44.78 96.09 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.735 -0.468 . . . . 1.0 109.735 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -65.62 -41.94 92.13 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.529 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.5 mt -72.58 -36.83 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.143 0.497 . . . . 1.0 109.795 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 t -68.83 -40.23 79.56 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.316 0.858 . . . . 1.0 113.316 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -81.7 -46.19 14.65 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 122.113 -0.367 . . . . 1.0 111.57 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 tt -54.88 -36.03 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.777 0.322 . . . . 1.0 110.515 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -54.97 -46.22 75.05 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.605 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 m -70.87 -32.44 69.44 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.149 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.8 ttm -59.72 -31.64 69.8 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.316 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.05 -41.75 93.0 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.681 -0.489 . . . . 1.0 109.681 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.6 m -85.61 -55.57 3.93 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.381 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.6 p -66.47 -39.12 88.63 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 121.114 -0.235 . . . . 1.0 111.476 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.4 1.03 78.48 Favored Glycine 0 N--CA 1.472 1.064 0 N-CA-C 110.341 -1.104 . . . . 1.0 110.341 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 41.85 71.23 0.22 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.054 0.542 . . . . 1.0 111.069 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.0 144.99 29.58 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.201 0.524 . . . . 1.0 110.096 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -129.77 79.86 72.6 Favored Pre-proline 0 N--CA 1.471 0.589 0 CA-C-N 115.237 -0.892 . . . . 1.0 109.186 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -45.54 98.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.942 1.762 . . . . 1.0 112.406 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -170.19 -63.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.837 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -94.39 137.55 33.4 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 116.475 -0.329 . . . . 1.0 110.264 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.0 142.61 58.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.47 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -161.1 104.88 1.31 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 43.0 m -74.91 139.64 43.22 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.197 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.9 t -134.22 139.05 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.1 p -115.28 115.01 25.96 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.602 0.361 . . . . 1.0 110.261 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tt -102.58 143.07 32.74 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.857 0.463 . . . . 1.0 109.941 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.59 127.98 17.86 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 110.184 -0.302 . . . . 1.0 110.184 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -159.16 9.51 0.12 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.463 0.173 . . . . 1.0 111.032 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -166.11 34.3 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.255 0.55 . . . . 1.0 110.373 179.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.15 -28.07 1.43 Allowed Glycine 0 N--CA 1.465 0.595 0 N-CA-C 111.235 -0.746 . . . . 1.0 111.235 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' A' ' 81' ' ' ASN . 58.6 m-85 -83.36 146.26 28.58 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.8 p -132.49 108.17 8.95 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 96.1 m -87.13 132.9 33.7 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -91.58 135.99 33.46 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.67 0.668 . . . . 1.0 109.32 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.83 137.04 39.33 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -146.1 139.71 26.2 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.438 ' C ' ' H ' ' A' ' 91' ' ' GLY . 39.3 m -90.12 -11.64 40.67 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.82 0.343 . . . . 1.0 110.592 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.49 9.08 0.71 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 89' ' ' THR . . . 78.49 25.84 60.29 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.2 p -66.68 -140.32 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 53.0 t -167.67 -39.14 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.651 0.262 . . . . 1.0 110.307 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.418 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . -133.29 36.26 2.16 Favored Glycine 0 N--CA 1.477 1.385 0 N-CA-C 110.525 -1.03 . . . . 1.0 110.525 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.418 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 95.7 m-85 -157.22 145.62 19.48 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 45.0 t -134.44 134.82 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -122.51 133.04 54.59 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.5 pt -138.83 159.67 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-O 120.965 0.412 . . . . 1.0 110.303 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.68 124.5 10.56 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.532 0.682 . . . . 1.0 109.658 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.36 131.7 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.093 -0.958 . . . . 1.0 109.779 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -135.92 105.0 9.69 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 108.706 -0.849 . . . . 1.0 108.706 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -69.96 142.05 46.02 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 CA-C-N 121.223 1.473 . . . . 1.0 111.426 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 63.7 p -90.63 146.65 23.87 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.847 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 120.729 0.299 . . . . 1.0 110.238 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 121.088 0.47 . . . . 1.0 110.253 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 pp -41.88 148.62 0.16 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.92 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.38 179.66 16.06 Favored Glycine 0 N--CA 1.477 1.379 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.39 146.57 18.5 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -100.96 120.64 40.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.672 -0.695 . . . . 1.0 111.081 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.3 mt -131.34 131.81 44.02 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.83 140.97 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -71.47 132.22 44.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.994 -0.372 . . . . 1.0 109.994 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -157.69 105.05 2.0 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.04 -165.64 50.84 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 109.724 -1.35 . . . . 1.0 109.724 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -84.4 29.05 0.61 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.014 0.435 . . . . 1.0 109.868 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -148.27 143.86 27.24 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.339 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -96.45 130.15 43.66 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -85.91 115.79 23.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.057 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -96.41 109.11 21.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.482 -0.932 . . . . 1.0 108.482 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.01 115.86 28.24 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.936 -0.574 . . . . 1.0 109.67 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.03 -37.85 88.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.144 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -66.26 -9.44 32.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.737 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.48 67.59 0.67 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.327 0.584 . . . . 1.0 110.179 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.69 172.35 6.89 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.4 m -139.84 138.33 35.67 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 tp -93.83 145.01 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.4 p -129.72 148.1 51.57 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.59 -146.57 26.0 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 111.076 -0.809 . . . . 1.0 111.076 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -166.64 75.7 0.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.316 0.579 . . . . 1.0 110.519 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -61.49 138.19 58.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.248 0.546 . . . . 1.0 110.171 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 87.1 p -71.7 167.86 18.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.44 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -65.53 -20.9 66.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.379 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.59 -9.32 44.58 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.878 0.37 . . . . 1.0 110.551 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -109.32 -30.54 7.94 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.213 0.605 . . . . 1.0 111.288 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.473 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -61.58 -45.32 93.67 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 120.781 -0.367 . . . . 1.0 110.189 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 44.8 Cg_exo -59.15 -50.21 9.21 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 122.392 2.062 . . . . 1.0 112.664 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.38 -46.42 88.72 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.335 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.66 -39.01 86.81 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.097 0.475 . . . . 1.0 109.98 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -60.62 -12.48 10.28 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.2 t -104.22 -18.48 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.8 t -90.28 -33.37 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.408 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 65.8 t80 -62.75 -49.67 81.36 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 118.534 -0.746 . . . . 1.0 111.248 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 52' ' ' PHE . 44.3 Cg_endo -58.83 -26.26 79.75 Favored 'Trans proline' 0 N--CA 1.511 2.507 0 CA-C-N 121.323 1.508 . . . . 1.0 112.132 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 80' ' ' HIS . 17.6 t60 -60.48 -43.39 97.02 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.839 0.352 . . . . 1.0 110.175 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -64.48 -40.57 95.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.094 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.7 mt -65.47 -43.86 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 120.064 -0.654 . . . . 1.0 109.286 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.6 t -58.7 -46.08 88.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.104 -0.238 . . . . 1.0 111.239 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -70.48 -38.67 74.42 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.846 -0.161 . . . . 1.0 111.028 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.2 mt -61.08 -45.63 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 109.999 -0.371 . . . . 1.0 109.999 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -52.98 -41.93 65.07 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.544 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.7 p -75.99 -29.82 58.34 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.649 -0.25 . . . . 1.0 110.463 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 66' ' ' GLY . 12.1 tmm? -61.66 -33.32 73.75 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 110.251 -0.277 . . . . 1.0 110.251 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.74 -40.61 97.77 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.452 ' HG1' ' H ' ' A' ' 65' ' ' THR . 60.8 p -75.17 -56.22 4.94 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.389 -0.368 . . . . 1.0 111.268 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.452 ' H ' ' HG1' ' A' ' 64' ' ' THR . 63.1 p -68.65 -39.07 80.84 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.68 0.276 . . . . 1.0 111.255 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -80.96 -14.91 78.64 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 52.06 84.77 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.6 tp -81.35 142.88 32.62 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.763 -0.829 . . . . 1.0 108.763 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -151.95 131.24 6.69 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 119.221 -0.419 . . . . 1.0 110.355 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.18 102.2 1.58 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.361 1.374 . . . . 1.0 110.408 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -146.23 -34.24 0.3 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.257 0.551 . . . . 1.0 111.391 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -166.26 155.53 11.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.048 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.35 146.64 50.66 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.428 -0.806 . . . . 1.0 110.308 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -159.66 102.95 1.53 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.322 0.582 . . . . 1.0 109.759 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.1 t -83.16 137.29 34.12 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.181 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.36 153.09 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -131.85 103.18 6.18 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.8 mp -90.87 143.8 26.35 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.368 -0.975 . . . . 1.0 108.368 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -125.44 127.75 47.0 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 54' ' ' HIS . 79.6 t60 -163.04 139.67 7.36 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.4 m120 53.34 26.1 5.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.981 0.42 . . . . 1.0 111.311 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.79 -28.42 3.19 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -70.27 149.13 47.75 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.511 -0.552 . . . . 1.0 109.511 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.5 m -135.7 120.85 18.9 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.473 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 65.5 m -107.05 139.65 41.11 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.296 -1.001 . . . . 1.0 108.296 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -104.7 140.83 37.49 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 108.807 -0.812 . . . . 1.0 108.807 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.91 151.26 38.41 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 110.011 -0.366 . . . . 1.0 110.011 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -166.56 139.76 3.89 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.4 m -76.33 -20.04 57.63 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 110.468 -0.197 . . . . 1.0 110.468 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.0 mt 62.67 10.42 4.15 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.986 0.422 . . . . 1.0 110.202 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.61 13.46 83.46 Favored Glycine 0 N--CA 1.466 0.642 0 N-CA-C 110.546 -1.021 . . . . 1.0 110.546 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.6 p -62.13 -143.34 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.564 0.221 . . . . 1.0 110.473 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 23.7 p -170.64 107.39 0.3 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.78 0.324 . . . . 1.0 110.351 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.02 -9.64 37.74 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 111.216 -0.753 . . . . 1.0 111.216 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -113.94 141.95 46.74 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.039 0.536 . . . . 1.0 109.582 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.2 136.81 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 108.901 -0.777 . . . . 1.0 108.901 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -125.65 138.59 53.91 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.213 -1.032 . . . . 1.0 108.213 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.8 pt -137.38 165.2 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.982 0.42 . . . . 1.0 109.952 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.92 108.47 3.82 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.73 139.36 17.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 114.745 -1.116 . . . . 1.0 108.744 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -147.54 129.3 7.41 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.29 143.52 43.81 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 CA-C-N 120.539 1.228 . . . . 1.0 111.692 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 t -87.24 147.38 25.58 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.079 -0.51 . . . . 1.0 109.633 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 . . . . . 0 CA--C 1.532 0.265 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.236 -179.938 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 . . . . . 0 N--CA 1.469 0.483 0 N-CA-C 109.832 -0.432 . . . . 1.0 109.832 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 tt -119.93 114.86 22.69 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.45 156.77 43.47 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 109.822 -1.311 . . . . 1.0 109.822 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -165.34 71.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -73.91 128.99 36.99 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.0 mt -116.67 153.5 32.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.905 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.85 137.08 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.375 -0.972 . . . . 1.0 108.375 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -81.45 130.46 35.05 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -160.52 124.05 3.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.258 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.18 -147.53 50.82 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 109.953 -1.259 . . . . 1.0 109.953 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -105.18 15.42 27.5 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 110.171 -0.307 . . . . 1.0 110.171 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.411 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 17.8 mp0 -135.8 143.46 45.21 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.052 0.453 . . . . 1.0 110.122 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 50.8 mt -91.85 131.03 37.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -88.26 116.87 26.78 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -100.07 106.71 18.48 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -91.24 111.8 23.43 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.52 -35.1 73.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.237 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -71.62 -8.33 53.41 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.656 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -110.56 63.11 0.61 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.133 0.492 . . . . 1.0 110.378 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.9 175.09 4.56 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 t -141.43 138.06 32.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.957 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.0 mm -82.6 141.81 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.12 -0.326 . . . . 1.0 110.12 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.466 ' C ' ' H ' ' A' ' 39' ' ' LYS . 73.8 p -132.81 146.48 51.86 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.675 0.39 . . . . 1.0 110.035 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.99 -9.31 2.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.466 ' H ' ' C ' ' A' ' 37' ' ' THR . 48.5 mtmt 50.77 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 O-C-N 122.462 -0.434 . . . . 1.0 111.25 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -69.36 139.91 54.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.299 0.571 . . . . 1.0 110.572 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.3 p -72.69 171.09 13.19 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.386 -0.825 . . . . 1.0 110.125 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.28 -19.28 65.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.434 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.98 -10.73 38.25 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 120.816 0.341 . . . . 1.0 110.544 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -109.27 -24.42 11.1 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.645 0.778 . . . . 1.0 111.227 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -67.27 -46.27 50.35 Favored Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.119 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 28.5 Cg_exo -63.75 -55.08 0.74 Allowed 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.22 1.947 . . . . 1.0 112.398 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -56.85 -45.22 82.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.254 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.16 -39.67 87.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.291 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -62.24 -20.23 64.01 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.384 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.4 t -92.55 -21.99 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.1 t -85.78 -13.45 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 110.094 -0.335 . . . . 1.0 110.094 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.42 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -65.49 -59.39 9.59 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 122.286 -0.259 . . . . 1.0 110.512 178.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 55' ' ' PHE . 30.8 Cg_endo -55.65 -24.66 46.63 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.642 1.561 . . . . 1.0 112.089 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -66.17 3.86 0.8 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.751 0.31 . . . . 1.0 110.988 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.46 ' H ' ' C ' ' A' ' 53' ' ' PRO . 44.5 m-85 -131.95 -40.96 1.04 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.751 0.421 . . . . 1.0 110.424 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.13 -42.5 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.3 p -57.1 -41.98 79.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.977 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -67.05 -56.47 9.93 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.666 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.15 -45.71 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -52.37 -37.91 57.5 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.74 -0.384 . . . . 1.0 111.011 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.5 p -76.77 -32.33 57.65 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.125 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 78.0 mmm -56.43 -31.17 63.67 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.282 -0.266 . . . . 1.0 110.282 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.2 mt -61.51 -37.13 82.59 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.6 m -92.05 -58.8 2.28 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.161 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.5 m -66.58 -43.07 85.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.648 -0.421 . . . . 1.0 111.864 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.66 -10.54 81.33 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 110.544 -1.023 . . . . 1.0 110.544 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 47.46 77.29 0.09 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 110.183 -0.303 . . . . 1.0 110.183 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.57 126.91 34.8 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -145.64 151.07 45.6 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.572 -0.285 . . . . 1.0 110.523 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.36 87.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.503 2.046 0 C-N-CA 121.86 1.707 . . . . 1.0 111.688 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -133.09 -60.2 0.86 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 120.868 0.366 . . . . 1.0 110.571 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -153.56 140.01 18.7 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.952 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.74 126.14 28.78 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.689 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -138.39 103.77 4.99 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.4 t -78.59 136.01 37.41 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.819 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.5 t -125.62 136.26 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.9 p -116.97 110.96 18.94 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 68.1 mt -89.91 160.65 16.32 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 50.0 p90 -143.57 130.56 20.57 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.047 -0.353 . . . . 1.0 110.047 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.517 ' C ' ' H ' ' A' ' 82' ' ' GLY . 74.1 t60 -157.75 -96.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.442 ' C ' ' H ' ' A' ' 83' ' ' PHE . 59.0 t30 -70.02 35.43 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.87 0.366 . . . . 1.0 111.503 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . 77.53 -28.83 1.76 Allowed Glycine 0 N--CA 1.466 0.657 0 N-CA-C 110.735 -0.946 . . . . 1.0 110.735 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 84' ' ' THR . 6.9 t80 -78.52 147.23 33.92 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.487 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 35.6 p -134.08 116.24 15.22 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.958 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 45.6 t -87.51 142.16 28.07 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -102.01 136.89 41.07 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.325 -0.621 . . . . 1.0 109.325 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.64 151.64 41.65 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -168.72 152.49 5.54 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.2 m -98.58 -18.18 18.27 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.667 0.27 . . . . 1.0 110.67 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.7 mp 59.41 8.97 1.29 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.07 15.37 76.48 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.101 -1.199 . . . . 1.0 110.101 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.1 m -65.62 -134.95 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.01 -0.367 . . . . 1.0 110.01 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 20.8 p -170.61 105.97 0.28 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.865 0.364 . . . . 1.0 110.054 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.37 33.9 78.61 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.652 -0.979 . . . . 1.0 110.652 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -151.25 137.16 18.14 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 m -142.3 138.33 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.307 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.429 ' N ' ' CD1' ' A' ' 97' ' ' TYR . 21.5 m-85 -116.69 120.39 38.45 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 156.8 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.296 -1.001 . . . . 1.0 108.296 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.43 150.8 30.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.18 -0.918 . . . . 1.0 109.328 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.7 p -123.38 135.66 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 115.115 -0.948 . . . . 1.0 109.568 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 13.4 p90 -149.03 97.33 3.64 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.135 -0.938 . . . . 1.0 108.971 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -51.63 144.84 32.05 Favored 'Trans proline' 0 N--CA 1.507 2.279 0 C-N-CA 121.922 1.748 . . . . 1.0 112.058 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 80.7 p -63.29 134.04 55.17 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.348 -0.387 . . . . 1.0 109.98 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.747 0.308 . . . . 1.0 110.323 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 . . . . . 0 CA--C 1.52 -0.206 0 CA-C-O 120.784 0.326 . . . . 1.0 110.839 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.0 tp -116.39 118.32 32.4 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.388 -1.338 . . . . 1.0 107.388 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.34 161.9 33.02 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 108.73 -1.748 . . . . 1.0 108.73 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.39 67.6 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -73.31 122.17 21.58 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.295 -0.632 . . . . 1.0 109.295 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.6 mt -90.06 144.91 25.47 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.702 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -102.99 136.79 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -75.75 133.61 40.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.942 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -172.25 109.18 0.23 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.016 -0.735 . . . . 1.0 109.016 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.66 -161.48 53.76 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 109.759 -1.337 . . . . 1.0 109.759 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -87.14 5.87 35.7 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.732 0.301 . . . . 1.0 110.389 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -127.79 136.36 51.37 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.09 0.471 . . . . 1.0 110.054 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.07 127.73 35.71 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.941 -0.762 . . . . 1.0 108.941 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -83.9 116.31 22.71 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.664 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -97.67 103.65 15.6 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.847 -1.168 . . . . 1.0 107.847 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.5 mp -86.68 134.62 33.59 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.052 -0.722 . . . . 1.0 109.052 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.05 -24.58 30.38 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.883 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -73.93 -10.44 59.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.028 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -108.41 16.64 22.9 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.537 0.335 . . . . 1.0 110.473 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.22 127.67 10.0 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.2 m -86.92 170.27 11.77 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.853 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.4 pt -97.4 155.07 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 82.0 p -134.45 128.64 33.88 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.48 99.16 0.01 OUTLIER Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.102 -0.799 . . . . 1.0 111.102 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -56.07 99.64 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.789 0.328 . . . . 1.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -69.23 140.08 54.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.007 -0.542 . . . . 1.0 109.544 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -69.46 171.07 9.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.276 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -64.28 -21.18 66.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.58 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.32 -22.51 20.5 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 120.825 0.345 . . . . 1.0 110.103 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -96.87 -26.36 15.11 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.904 0.482 . . . . 1.0 110.717 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -60.36 -57.59 25.53 Favored Pre-proline 0 CA--C 1.555 1.135 0 O-C-N 122.089 -0.382 . . . . 1.0 110.127 177.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 45' ' ' CYS . 35.0 Cg_endo -56.22 -41.91 71.69 Favored 'Trans proline' 0 N--CA 1.51 2.478 0 C-N-CA 122.497 2.131 . . . . 1.0 112.688 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -56.74 -37.31 70.84 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.951 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.55 -31.11 47.25 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.047 0.451 . . . . 1.0 110.091 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.13 -40.82 86.84 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.629 -0.669 . . . . 1.0 110.685 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.2 m -75.12 -20.56 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -86.01 -20.54 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.184 0.516 . . . . 1.0 110.045 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.79 -57.06 26.53 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.063 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.41 ' C ' ' H ' ' A' ' 55' ' ' PHE . 36.2 Cg_endo -56.6 -26.92 67.14 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.161 1.241 . . . . 1.0 111.72 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -77.35 16.08 0.66 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.749 0.309 . . . . 1.0 110.97 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.41 ' H ' ' C ' ' A' ' 53' ' ' PRO . 55.1 t80 -131.32 -37.33 1.24 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.12 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.7 mm -74.74 -30.78 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.8 m -60.82 -43.92 97.6 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.844 0.354 . . . . 1.0 111.132 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -65.42 -42.5 92.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.91 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.14 -46.94 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.37 -45.9 90.15 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.5 t -65.81 -40.67 92.09 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.495 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.428 ' O ' ' N ' ' A' ' 66' ' ' GLY . 45.6 ttm -50.67 -44.05 57.58 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.863 0.363 . . . . 1.0 110.925 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.37 -37.33 86.86 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.283 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -68.77 -61.72 1.69 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.756 0.312 . . . . 1.0 111.616 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.4 t -72.4 -39.47 67.92 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.067 0.46 . . . . 1.0 110.781 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -98.51 73.4 0.57 Allowed Glycine 0 N--CA 1.462 0.396 0 N-CA-C 109.073 -1.611 . . . . 1.0 109.073 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.25 88.82 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -82.72 123.67 29.51 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.774 -1.195 . . . . 1.0 107.774 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -122.68 147.03 49.51 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-O 119.286 -0.388 . . . . 1.0 110.727 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.28 88.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.506 2.233 0 C-N-CA 121.419 1.412 . . . . 1.0 112.159 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -131.67 -50.83 0.98 Allowed 'General case' 0 N--CA 1.48 1.065 0 O-C-N 121.999 -0.438 . . . . 1.0 109.9 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -163.36 151.72 13.78 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.767 -178.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.85 150.31 20.5 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.717 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -155.4 139.64 16.61 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.2 t -130.55 143.63 50.88 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.628 -0.508 . . . . 1.0 109.628 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.86 144.88 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.597 -0.52 . . . . 1.0 109.597 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.6 p -115.36 116.36 28.14 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 67.4 mt -99.79 134.76 42.22 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.52 -0.919 . . . . 1.0 108.52 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.414 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 47.2 p90 -115.03 127.58 55.73 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -156.72 141.2 16.72 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.456 ' ND2' ' CD1' ' A' ' 83' ' ' PHE . 5.7 p-10 43.91 29.5 0.32 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.237 0.458 . . . . 1.0 112.237 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.21 -27.25 4.61 Favored Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.876 -0.89 . . . . 1.0 110.876 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.456 ' CD1' ' ND2' ' A' ' 81' ' ' ASN . 6.5 m-85 -68.78 150.02 48.34 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.0 m -142.29 108.11 5.14 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.139 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.5 m -93.63 143.04 26.68 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -99.36 140.75 33.08 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.61 150.27 37.15 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 110.288 -0.264 . . . . 1.0 110.288 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -164.54 134.18 3.82 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.8 m -77.21 -42.59 36.84 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.991 0.424 . . . . 1.0 110.729 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.433 ' C ' ' H ' ' A' ' 92' ' ' SER . 57.5 mt 58.01 37.09 26.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.118 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.41 5.93 1.99 Allowed Glycine 0 CA--C 1.533 1.209 0 N-CA-C 111.386 -0.686 . . . . 1.0 111.386 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 90' ' ' LEU . 28.7 t -104.36 57.47 0.71 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.7 p -58.41 -23.41 57.18 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 119.954 -0.698 . . . . 1.0 110.386 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.66 -12.82 48.77 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.907 -0.877 . . . . 1.0 110.907 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -155.18 119.57 4.7 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 t -101.59 113.68 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -90.49 131.01 36.48 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.163 -0.68 . . . . 1.0 109.163 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.9 pt -139.03 161.55 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.1 111.57 3.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.402 0.62 . . . . 1.0 109.397 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.1 t -91.49 136.07 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 114.845 -1.071 . . . . 1.0 108.658 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -145.38 128.19 8.21 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 119.029 -0.51 . . . . 1.0 109.761 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.27 145.74 39.22 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.374 1.383 . . . . 1.0 111.243 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.2 p -83.58 138.67 33.27 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 . . . . . 0 C--N 1.332 -0.172 0 CA-C-O 120.783 0.325 . . . . 1.0 110.343 -179.692 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -153.26 149.3 27.78 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.913 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -62.78 -45.96 90.23 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.711 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.3 m -124.55 130.83 53.19 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.093 0.557 . . . . 1.0 109.998 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.5 m -139.83 126.38 20.38 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -53.43 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.523 0.201 . . . . 1.0 110.766 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.01 -169.15 0.54 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.224 -0.75 . . . . 1.0 111.224 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 mt -56.71 146.36 25.99 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.155 0.502 . . . . 1.0 110.285 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -71.56 88.47 0.94 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.513 -0.767 . . . . 1.0 110.08 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -140.38 134.91 31.53 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -124.37 14.57 8.93 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.127 0.489 . . . . 1.0 109.985 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.4 mt -71.88 -173.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 107.067 -1.457 . . . . 1.0 107.067 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -43.97 -60.81 2.4 Favored Pre-proline 0 N--CA 1.483 1.214 0 CA-C-N 118.936 0.789 . . . . 1.0 110.893 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -70.46 74.73 1.57 Allowed 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.756 1.638 . . . . 1.0 109.821 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.431 ' NH2' ' HG1' ' A' ' 37' ' ' THR . 35.9 ptt180 -88.55 1.36 55.08 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.19 -0.319 . . . . 1.0 110.647 -177.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tt -113.35 133.52 55.1 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.059 -0.719 . . . . 1.0 109.059 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -136.01 -171.17 12.24 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 109.76 -1.336 . . . . 1.0 109.76 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.41 71.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.446 ' O ' ' NH1' ' A' ' 33' ' ' ARG . 16.8 ptm180 -75.33 123.85 26.07 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.083 0.468 . . . . 1.0 110.417 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.48 152.66 18.41 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.1 m -102.99 134.84 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.852 -0.796 . . . . 1.0 108.852 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -78.24 140.33 38.9 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.779 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -174.45 113.72 0.17 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.038 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.02 -147.82 45.21 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 109.228 -1.549 . . . . 1.0 109.228 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -99.25 10.99 40.33 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.067 0.434 . . . . 1.0 110.662 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -134.81 157.97 45.4 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.465 -0.568 . . . . 1.0 109.465 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mp -109.63 133.07 53.54 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.496 ' HD1' ' N ' ' A' ' 29' ' ' TYR . 2.0 t-80 -86.23 115.98 24.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.524 -0.307 . . . . 1.0 111.112 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.496 ' N ' ' HD1' ' A' ' 28' ' ' HIS . 87.7 t80 -100.55 110.53 22.7 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.321 -0.992 . . . . 1.0 108.321 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 mt -96.04 114.48 26.19 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.21 0.604 . . . . 1.0 110.022 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.02 91.94 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.826 0.346 . . . . 1.0 111.408 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.39 -8.67 27.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.029 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 19' ' ' ARG . 52.6 ttp85 -110.4 67.82 0.65 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.16 0.505 . . . . 1.0 110.585 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -171.14 175.48 4.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.046 -0.724 . . . . 1.0 109.046 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.8 t -135.94 145.38 46.17 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.8 mt -107.46 141.24 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.955 -0.758 . . . . 1.0 108.955 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.431 ' HG1' ' NH2' ' A' ' 15' ' ' ARG . 7.8 t -126.89 148.12 50.03 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.29 -134.89 29.12 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -170.64 135.33 1.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.307 0.575 . . . . 1.0 110.277 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -112.66 124.26 52.14 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.719 0.808 . . . . 1.0 109.284 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.2 t -65.27 169.62 5.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.086 0.47 . . . . 1.0 110.625 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.47 -21.19 65.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.639 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.61 -10.58 36.92 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 117.721 0.237 . . . . 1.0 110.74 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -105.57 -31.78 8.79 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.789 0.435 . . . . 1.0 110.703 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -60.58 10.05 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.718 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -58.85 -43.98 39.46 Favored 'Trans proline' 0 N--CA 1.506 2.23 0 C-N-CA 122.148 1.899 . . . . 1.0 111.688 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -61.85 -36.89 82.52 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.735 -0.212 . . . . 1.0 110.909 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.8 tp -78.33 -36.71 45.96 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 122.095 -0.378 . . . . 1.0 110.429 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.01 -35.34 78.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.14 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -77.35 -20.49 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 110.261 -0.274 . . . . 1.0 110.261 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.48 -25.61 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -55.3 -57.5 20.0 Favored Pre-proline 0 CA--C 1.555 1.149 0 CA-C-O 119.325 -0.369 . . . . 1.0 111.38 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -57.46 -28.13 79.24 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 121.823 1.682 . . . . 1.0 112.101 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -61.4 -49.58 76.29 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.358 -0.537 . . . . 1.0 109.921 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.436 ' CD1' ' SG ' ' A' ' 85' ' ' CYS . 37.3 m-85 -67.35 -41.48 85.1 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.815 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.3 mt -67.25 -37.98 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 118.293 0.497 . . . . 1.0 109.74 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 m -53.17 -27.93 23.8 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.609 0.243 . . . . 1.0 110.663 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -83.14 -40.44 19.76 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.657 -0.247 . . . . 1.0 111.083 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mm -57.9 -48.55 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 120.781 -0.368 . . . . 1.0 110.383 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -53.42 -31.48 45.44 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.571 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.5 m -84.84 -33.9 22.79 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.019 0.378 . . . . 1.0 112.019 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.9 mmt -54.27 -42.86 70.44 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 122.352 -0.218 . . . . 1.0 111.009 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 pp -63.19 -31.2 72.28 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.819 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -90.18 -62.34 1.48 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.986 0.422 . . . . 1.0 110.758 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.4 m -66.12 -40.55 90.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.129 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.23 0.97 72.15 Favored Glycine 0 N--CA 1.467 0.767 0 N-CA-C 109.528 -1.429 . . . . 1.0 109.528 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 54.39 99.34 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.271 -0.464 . . . . 1.0 110.607 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.0 tp -79.21 132.89 36.66 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -160.92 90.76 1.59 Allowed Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.892 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -47.4 98.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.506 2.23 0 C-N-CA 121.763 1.642 . . . . 1.0 111.47 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -137.37 -47.05 0.56 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.287 0.565 . . . . 1.0 110.931 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -165.7 154.19 11.38 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.148 -0.933 . . . . 1.0 110.713 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.4 144.7 56.37 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.156 -0.929 . . . . 1.0 110.544 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -151.31 104.37 3.09 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.857 0.36 . . . . 1.0 110.044 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 76.2 m -77.72 131.79 37.84 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.525 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.45 134.88 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 109.078 -0.712 . . . . 1.0 109.078 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.4 p -113.15 111.55 22.29 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.8 mt -97.79 155.24 17.13 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.4 ' O ' ' CG ' ' A' ' 80' ' ' HIS . 39.9 p90 -141.69 124.85 16.36 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 110.083 -0.339 . . . . 1.0 110.083 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 79' ' ' TYR . 99.4 m-70 -156.6 139.33 15.13 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.832 -0.432 . . . . 1.0 109.832 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.405 ' C ' ' H ' ' A' ' 83' ' ' PHE . 72.3 m-80 54.33 34.55 20.89 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.926 0.393 . . . . 1.0 111.069 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.36 -29.55 1.68 Allowed Glycine 0 N--CA 1.468 0.768 0 N-CA-C 111.474 -0.65 . . . . 1.0 111.474 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.405 ' H ' ' C ' ' A' ' 81' ' ' ASN . 82.2 m-85 -77.97 149.17 34.16 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.765 -0.457 . . . . 1.0 109.765 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.9 p -134.64 122.18 21.9 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.948 -0.389 . . . . 1.0 109.948 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.436 ' SG ' ' CD1' ' A' ' 55' ' ' PHE . 69.6 m -106.61 142.06 36.87 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -106.71 137.73 44.19 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.706 0.684 . . . . 1.0 109.173 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.38 151.81 47.84 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 120.53 0.205 . . . . 1.0 110.696 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -163.74 149.06 10.9 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 91' ' ' GLY . 68.2 p -91.31 -15.46 29.07 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 110.537 -0.171 . . . . 1.0 110.537 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.8 mp 58.43 5.63 0.46 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 110.136 -0.32 . . . . 1.0 110.136 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 89' ' ' THR . . . 77.27 12.93 84.13 Favored Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.19 -1.164 . . . . 1.0 110.19 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.0 t -77.18 148.78 35.72 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.009 0.433 . . . . 1.0 111.052 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 60.9 m -90.69 111.84 23.36 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.78 -0.645 . . . . 1.0 111.685 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . 69.72 39.8 76.82 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.113 -0.395 . . . . 1.0 112.113 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.431 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 79.4 m-85 -158.27 138.54 12.51 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.1 112.46 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -90.05 126.77 35.89 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.99 -0.744 . . . . 1.0 108.99 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.1 pt -130.15 157.11 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-O 120.947 0.403 . . . . 1.0 110.529 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.48 147.2 26.55 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.119 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.6 p -123.2 133.16 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.021 -0.991 . . . . 1.0 110.125 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -136.24 90.29 18.3 Favored Pre-proline 0 N--CA 1.47 0.562 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.82 140.98 67.15 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.439 1.426 . . . . 1.0 111.962 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.9 p -69.2 132.17 46.1 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.627 -0.508 . . . . 1.0 109.627 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -75.24 -60.5 2.27 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.841 0.353 . . . . 1.0 110.452 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 118.055 -0.974 . . . . 1.0 110.398 -179.588 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mtp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.052 -0.722 . . . . 1.0 109.052 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.0 p -61.84 -39.5 92.04 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.562 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -166.81 115.83 0.87 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.986 -0.552 . . . . 1.0 109.606 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.2 m -117.07 86.77 2.57 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.031 0.532 . . . . 1.0 110.19 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 58.1 p -127.93 123.92 36.11 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -90.16 44.78 1.22 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.966 0.413 . . . . 1.0 110.308 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -148.89 155.71 26.49 Favored Glycine 0 N--CA 1.47 0.916 0 N-CA-C 110.553 -1.019 . . . . 1.0 110.553 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -68.09 157.92 34.18 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -92.13 133.61 35.62 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.427 -0.582 . . . . 1.0 109.427 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.416 HH21 ' HD2' ' A' ' 15' ' ' ARG . 11.5 ptt-85 -152.17 -169.4 3.34 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 110.022 -0.362 . . . . 1.0 110.022 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -53.35 -52.93 57.63 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.67 -0.241 . . . . 1.0 110.923 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 92.1 mt -82.4 129.2 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.17 -57.64 0.49 Allowed Pre-proline 0 N--CA 1.47 0.558 0 CA-C-O 119.078 -0.487 . . . . 1.0 110.833 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.41 132.93 16.86 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 CA-C-N 120.187 1.102 . . . . 1.0 110.107 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.491 ' CG ' ' H ' ' A' ' 16' ' ' LEU . 41.1 ttm180 -175.79 172.64 2.48 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.983 -1.117 . . . . 1.0 107.983 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.491 ' H ' ' CG ' ' A' ' 15' ' ' ARG . 6.0 tt -100.96 121.97 42.69 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.78 167.1 21.78 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.521 -1.032 . . . . 1.0 110.521 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.2 86.44 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.276 -0.639 . . . . 1.0 109.276 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.439 ' NH2' ' CD1' ' A' ' 95' ' ' TYR . 70.2 ttt-85 -85.34 114.7 22.61 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.91 146.75 24.73 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.144 -0.688 . . . . 1.0 109.144 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.45 136.78 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -78.95 131.74 36.45 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.657 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -170.23 113.27 0.46 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.75 -163.02 53.7 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -89.79 13.01 15.46 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 117.085 0.442 . . . . 1.0 110.096 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -131.64 148.72 52.62 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.827 -0.435 . . . . 1.0 109.827 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.3 mt -97.54 122.87 41.11 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -83.64 118.77 24.07 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.142 0.577 . . . . 1.0 111.044 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -103.78 110.69 22.89 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.06 114.95 27.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.259 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.46 -34.78 72.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.953 0.406 . . . . 1.0 111.079 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -66.7 -10.44 46.71 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.308 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -112.34 56.52 0.66 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.215 0.531 . . . . 1.0 110.465 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.97 176.97 4.51 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.803 -0.635 . . . . 1.0 109.364 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 92.0 p -149.42 159.81 43.97 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.1 pt -98.64 144.71 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.9 p -133.89 149.22 51.31 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.082 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.24 -129.3 20.24 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -168.44 127.28 1.15 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.608 0.718 . . . . 1.0 110.28 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -113.79 120.1 39.62 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.628 -0.878 . . . . 1.0 108.628 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.0 p -68.43 167.78 14.05 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.102 0.477 . . . . 1.0 110.592 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -63.44 -19.81 65.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.491 -0.777 . . . . 1.0 110.605 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.96 -12.18 36.74 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.698 0.285 . . . . 1.0 110.725 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -104.84 -38.34 6.69 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.121 0.568 . . . . 1.0 110.827 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.67 -61.98 3.25 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 119.894 -0.098 . . . . 1.0 110.958 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -57.91 -41.83 64.92 Favored 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 122.501 2.134 . . . . 1.0 112.583 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -62.88 -46.07 89.57 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.904 -0.318 . . . . 1.0 110.875 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.3 mt -63.06 -37.6 87.86 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.763 0.316 . . . . 1.0 110.209 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -59.51 -27.36 66.09 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.924 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.6 t -86.0 -30.6 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 81.9 t -78.89 -18.41 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 121.124 0.488 . . . . 1.0 109.788 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.5 -60.63 9.95 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.57 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -57.11 -22.09 45.92 Favored 'Trans proline' 0 N--CA 1.507 2.314 0 C-N-CA 122.098 1.865 . . . . 1.0 112.728 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -59.49 -45.2 92.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 120.448 -0.501 . . . . 1.0 110.151 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -65.76 -42.97 90.24 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.626 -0.429 . . . . 1.0 110.722 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.66 -41.88 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 120.993 -0.283 . . . . 1.0 110.355 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.8 p -58.18 -36.84 73.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.202 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -81.48 -28.65 33.99 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 119.712 -0.185 . . . . 1.0 111.462 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.8 mm -62.23 -44.2 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -58.69 -39.63 81.28 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.916 0.389 . . . . 1.0 110.608 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.1 m -61.09 -44.72 96.93 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.168 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 23.4 mmt -54.18 -40.79 67.87 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.574 0.226 . . . . 1.0 110.869 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.5 mt -62.01 -33.39 74.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.628 -0.508 . . . . 1.0 109.628 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -81.32 -57.2 3.6 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.199 0.444 . . . . 1.0 112.199 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.9 t -86.96 -38.69 16.41 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.08 0.4 . . . . 1.0 112.08 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.54 -8.22 62.57 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.161 -1.175 . . . . 1.0 110.161 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 43.83 81.3 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.491 0.317 . . . . 1.0 110.787 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.5 tp -80.63 137.12 36.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.662 -0.495 . . . . 1.0 109.662 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -127.48 78.34 74.81 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 123.122 0.569 . . . . 1.0 109.949 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -48.68 99.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 122.051 1.834 . . . . 1.0 112.458 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -169.6 -18.37 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.844 0.355 . . . . 1.0 110.797 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -150.12 147.56 27.91 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.109 0.48 . . . . 1.0 110.875 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.66 142.08 50.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.65 -0.704 . . . . 1.0 111.132 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -160.02 103.35 1.48 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 63.4 m -84.65 143.35 29.29 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.791 -0.641 . . . . 1.0 110.3 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.1 p -140.64 146.91 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.2 p -128.68 104.12 7.47 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.58 0.352 . . . . 1.0 110.098 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.0 mt -82.9 148.71 27.52 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.068 -0.715 . . . . 1.0 109.068 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -139.87 125.22 18.96 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.455 ' CD2' ' N ' ' A' ' 80' ' ' HIS . 0.1 OUTLIER -170.67 146.4 2.66 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.18 0.514 . . . . 1.0 110.168 -179.715 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' A' ' 83' ' ' PHE . 59.6 t30 53.82 31.14 12.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.979 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.18 -27.86 1.18 Allowed Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.783 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.423 ' H ' ' C ' ' A' ' 81' ' ' ASN . 65.7 m-85 -83.19 154.01 24.46 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 117.081 0.44 . . . . 1.0 110.384 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 t -151.02 133.56 15.57 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.068 0.461 . . . . 1.0 110.85 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 68.4 m -106.89 142.5 36.41 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.008 -0.738 . . . . 1.0 109.008 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -106.39 141.97 36.84 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.441 0.564 . . . . 1.0 109.572 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.11 147.71 31.84 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 110.646 -0.131 . . . . 1.0 110.646 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -145.64 140.88 27.65 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.9 m -94.14 -22.43 18.47 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.43 15.85 0.24 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.752 0.821 . . . . 1.0 111.837 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.64 14.98 74.56 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 109.373 -1.491 . . . . 1.0 109.373 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.42 ' O ' ' SG ' ' A' ' 93' ' ' CYS . 13.4 t -50.19 -22.04 1.56 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.113 -0.544 . . . . 1.0 111.798 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 92' ' ' SER . 27.9 p 36.67 34.14 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 177.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.81 -48.47 0.08 OUTLIER Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.505 -0.855 . . . . 1.0 112.13 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.439 ' CD1' ' NH2' ' A' ' 19' ' ' ARG . 99.1 m-85 -107.09 145.43 32.43 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.752 -0.462 . . . . 1.0 109.752 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.79 140.5 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.634 0.773 . . . . 1.0 109.199 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -139.22 162.25 35.45 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.311 0.577 . . . . 1.0 109.683 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 42.4 pt -137.41 165.18 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 114.92 -1.036 . . . . 1.0 110.523 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.65 146.34 27.22 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.631 -0.713 . . . . 1.0 109.56 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 p -122.59 133.29 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 115.299 -0.864 . . . . 1.0 109.86 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -140.55 93.65 8.64 Favored Pre-proline 0 N--CA 1.471 0.601 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -51.19 139.35 43.77 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 121.33 1.353 . . . . 1.0 112.337 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 75.3 p -74.29 136.06 42.61 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -77.22 -38.34 51.53 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.789 0.328 . . . . 1.0 110.272 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.136 -0.935 . . . . 1.0 110.222 -179.793 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.4 t 52.81 89.84 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.264 -0.425 . . . . 1.0 111.054 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -59.97 -48.05 83.28 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.998 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.6 t -126.69 146.0 50.37 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.926 0.49 . . . . 1.0 110.11 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.54 127.18 15.19 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 120.929 0.395 . . . . 1.0 110.291 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -63.27 133.7 54.64 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.081 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.43 -162.35 36.31 Favored Glycine 0 N--CA 1.465 0.603 0 N-CA-C 110.2 -1.16 . . . . 1.0 110.2 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.64 150.9 22.0 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.495 0.664 . . . . 1.0 110.462 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -88.05 108.45 19.24 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.986 -1.007 . . . . 1.0 109.799 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -137.63 135.11 36.25 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.47 -44.68 93.75 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.807 0.813 . . . . 1.0 111.357 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.0 pt -57.22 128.22 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 113.944 -1.48 . . . . 1.0 111.941 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.567 ' C ' ' H ' ' A' ' 15' ' ' ARG . 3.1 m -85.31 -34.34 0.51 Allowed Pre-proline 0 CA--C 1.549 0.908 0 CA-C-O 118.805 -0.617 . . . . 1.0 109.366 177.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 13' ' ' THR . 47.4 Cg_exo -52.28 21.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.525 3.326 0 C-N-CA 123.544 2.83 . . . . 1.0 114.172 175.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.567 ' H ' ' C ' ' A' ' 13' ' ' THR . 57.9 ttt85 -148.41 140.14 23.73 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.5 tt -122.53 140.07 53.18 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.177 0.591 . . . . 1.0 109.646 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.37 176.3 16.17 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.59 100.09 0.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -75.95 134.22 40.26 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.964 -0.754 . . . . 1.0 108.964 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.4 mt -127.21 146.03 50.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.363 -0.835 . . . . 1.0 109.941 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.2 137.2 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -71.61 136.13 47.25 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -166.91 100.64 0.55 Allowed 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.78 -165.65 54.56 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -84.84 26.98 0.78 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.77 0.319 . . . . 1.0 110.237 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -145.23 139.56 27.26 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.608 -0.516 . . . . 1.0 109.608 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.0 mt -91.55 131.64 36.84 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -82.29 114.95 21.12 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.217 -0.29 . . . . 1.0 110.217 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -100.07 105.69 17.36 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.62 141.0 28.96 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.54 -0.755 . . . . 1.0 109.598 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.46 -40.97 17.07 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.674 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 23.5 p-10 -72.28 -8.26 53.9 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.237 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -114.77 49.3 1.05 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 120.896 0.379 . . . . 1.0 110.211 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.82 127.23 1.57 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.905 0.383 . . . . 1.0 110.185 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.4 p -76.49 166.86 22.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 pt -125.37 153.79 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.0 p -137.1 136.64 38.49 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.47 102.46 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.16 -0.776 . . . . 1.0 111.16 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -58.36 123.6 16.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.001 0.429 . . . . 1.0 110.276 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -90.27 137.88 31.99 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.364 0.602 . . . . 1.0 109.663 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.7 m -69.21 169.38 12.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.239 -0.891 . . . . 1.0 110.6 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -65.63 -20.35 66.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.402 -0.817 . . . . 1.0 110.166 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.93 -10.05 40.9 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 120.827 0.346 . . . . 1.0 110.544 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -107.88 -26.49 10.71 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.258 0.623 . . . . 1.0 111.416 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -68.45 -45.37 36.65 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.393 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 35.1 Cg_exo -62.57 -53.31 1.85 Allowed 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 122.317 2.012 . . . . 1.0 112.477 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -54.01 -36.84 63.41 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.649 -0.705 . . . . 1.0 110.994 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.5 tp -76.27 -36.87 58.23 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.93 0.395 . . . . 1.0 110.204 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.41 -20.42 65.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.852 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.7 m -97.02 -8.99 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 110.107 -0.331 . . . . 1.0 110.107 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.5 t -92.77 -26.5 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.415 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -63.36 -47.78 83.54 Favored Pre-proline 0 CA--C 1.551 0.988 0 O-C-N 122.243 -0.286 . . . . 1.0 110.809 -178.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 52' ' ' PHE . 69.7 Cg_exo -54.53 -39.31 88.81 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.336 2.024 . . . . 1.0 111.88 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -62.32 -42.89 99.75 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.096 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -64.25 -42.42 96.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.619 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.18 -29.93 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.84 -0.43 . . . . 1.0 109.84 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.8 m -60.88 -43.62 98.2 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.885 -0.326 . . . . 1.0 111.061 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -68.76 -33.4 73.82 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.27 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.2 mm -62.78 -45.13 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.16 -40.02 80.34 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.828 0.347 . . . . 1.0 110.429 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.9 m -76.6 -27.92 55.94 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.597 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 66' ' ' GLY . 59.4 ttm -60.16 -40.05 88.56 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 110.052 -0.351 . . . . 1.0 110.052 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 mt -62.11 -32.4 72.96 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.9 p -87.29 -59.75 2.17 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.982 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.5 p -78.39 -39.62 38.54 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.441 0.534 . . . . 1.0 112.441 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -80.86 -16.71 74.42 Favored Glycine 0 N--CA 1.474 1.195 0 N-CA-C 111.238 -0.745 . . . . 1.0 111.238 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 40.74 79.11 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.078 0.551 . . . . 1.0 111.621 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.13 157.94 27.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.108 0.48 . . . . 1.0 109.812 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -135.67 79.37 47.02 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.237 -0.892 . . . . 1.0 110.141 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -51.47 -13.32 1.29 Allowed 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 122.365 2.043 . . . . 1.0 111.939 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -73.26 -14.27 61.29 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.089 0.471 . . . . 1.0 110.04 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -138.73 144.95 39.72 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.431 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.06 141.01 47.43 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.277 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -160.64 140.04 10.73 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.3 m -131.97 144.46 50.82 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.639 0.375 . . . . 1.0 110.017 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.1 p -147.03 147.97 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.9 p -125.32 115.6 20.6 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 67.9 mt -98.33 158.22 15.71 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -139.6 123.01 17.15 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -154.94 133.49 11.97 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 53.73 24.2 4.19 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.814 0.34 . . . . 1.0 111.324 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.59 -25.79 7.03 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 111.23 -0.748 . . . . 1.0 111.23 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -65.13 146.39 55.04 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.1 m -139.23 107.07 5.65 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.589 -0.522 . . . . 1.0 109.589 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 54.1 t -98.23 137.55 36.81 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -95.56 134.05 38.88 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.23 133.28 38.85 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -148.4 140.94 24.39 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.576 -0.527 . . . . 1.0 109.576 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 74.9 p -92.38 -38.14 12.18 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 120.757 0.313 . . . . 1.0 111.332 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.0 mp 55.46 23.11 5.56 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.002 0.429 . . . . 1.0 110.119 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 93' ' ' CYS . . . 83.34 12.05 79.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.995 -1.242 . . . . 1.0 109.995 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.9 p -57.43 83.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.848 0.356 . . . . 1.0 110.995 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 91' ' ' GLY . 81.8 m -63.12 119.83 10.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.615 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.43 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . 64.21 31.43 80.81 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.43 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 41.9 m-85 -162.62 153.03 16.67 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.2 p -148.78 140.17 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.337 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -119.49 136.66 54.22 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.1 pt -137.12 160.89 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 120.944 0.402 . . . . 1.0 110.037 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.49 119.84 7.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.597 0.713 . . . . 1.0 110.1 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.7 t -93.36 130.83 41.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-N 114.643 -1.162 . . . . 1.0 108.719 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -137.95 115.84 9.55 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-O 118.689 -0.672 . . . . 1.0 109.69 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.49 145.95 38.6 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.371 1.381 . . . . 1.0 110.813 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.7 t -99.09 148.81 23.67 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -77.84 115.86 17.91 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 110.192 -0.299 . . . . 1.0 110.192 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.981 -1.009 . . . . 1.0 109.474 179.732 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtp . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 t -169.21 89.97 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.262 -0.426 . . . . 1.0 109.986 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -66.72 118.61 10.51 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.1 m -118.47 116.48 26.77 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.9 m -145.47 129.34 17.32 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -52.73 -77.0 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.918 0.39 . . . . 1.0 110.698 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.21 -162.12 0.24 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 111.022 -0.831 . . . . 1.0 111.022 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.467 ' O ' ' NH1' ' A' ' 10' ' ' ARG . 4.2 mm? -59.26 154.65 15.95 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 121.382 0.611 . . . . 1.0 110.359 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -93.84 127.81 39.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.193 -0.912 . . . . 1.0 109.871 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.467 ' NH1' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -150.62 174.79 12.59 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -100.98 -49.13 4.21 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.435 0.636 . . . . 1.0 110.408 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.2 pt -64.48 132.07 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 114.498 -1.228 . . . . 1.0 109.855 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.525 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -74.82 -47.23 5.05 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 114.921 -1.036 . . . . 1.0 110.339 177.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 13' ' ' THR . 26.8 Cg_exo -29.97 -35.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.511 2.557 0 C-N-CA 123.201 2.601 . . . . 1.0 113.886 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 13' ' ' THR . 83.2 mtp180 -96.76 138.69 33.94 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.452 -0.794 . . . . 1.0 109.759 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 tp -121.59 128.57 52.09 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.232 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.81 153.99 33.51 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.142 -1.183 . . . . 1.0 110.142 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.23 62.67 0.05 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.141 0.496 . . . . 1.0 109.94 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -72.94 132.87 44.0 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.092 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.9 mt -112.92 153.15 28.42 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.469 -0.567 . . . . 1.0 109.469 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.8 m -96.5 136.06 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.442 -0.947 . . . . 1.0 108.442 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -78.11 135.65 37.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -168.1 113.68 0.67 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.181 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.48 -159.0 53.21 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 109.727 -1.349 . . . . 1.0 109.727 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -92.96 10.03 33.08 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 110.362 -0.236 . . . . 1.0 110.362 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -130.61 137.33 49.59 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.138 -0.483 . . . . 1.0 109.954 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.1 mp -89.83 135.98 33.31 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.537 ' HD1' ' N ' ' A' ' 29' ' ' TYR . 0.9 OUTLIER -89.86 115.94 27.56 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.076 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.537 ' N ' ' HD1' ' A' ' 28' ' ' HIS . 56.1 t80 -98.24 104.56 16.61 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.883 -0.784 . . . . 1.0 108.883 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 mt -93.06 115.23 27.9 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.339 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.86 -30.4 70.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.749 -0.659 . . . . 1.0 110.128 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -70.77 -9.58 57.68 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.951 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -112.25 56.84 0.65 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.538 0.685 . . . . 1.0 110.555 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.85 175.28 6.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.58 -0.736 . . . . 1.0 109.432 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.7 m -145.67 163.63 34.3 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.8 mt -107.0 141.37 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.4 m -127.71 138.66 52.86 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.93 -135.06 14.81 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.567 -1.013 . . . . 1.0 110.567 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -168.57 132.96 1.58 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.651 -0.499 . . . . 1.0 109.651 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -115.75 126.89 54.64 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.176 -0.676 . . . . 1.0 109.176 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.8 m -67.88 161.11 27.05 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -56.29 -21.85 26.56 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.729 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.72 -12.58 33.57 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.66 0.267 . . . . 1.0 110.528 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.27 -27.78 8.93 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.025 0.53 . . . . 1.0 111.062 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.495 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -61.66 -46.57 93.55 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 45.7 Cg_exo -57.71 -47.77 19.77 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.043 1.829 . . . . 1.0 112.522 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -54.63 -51.96 63.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.981 -0.554 . . . . 1.0 111.793 -177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.69 -41.16 97.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.852 0.358 . . . . 1.0 110.995 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -66.09 -16.64 64.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.103 -0.498 . . . . 1.0 110.227 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.3 t -101.93 -14.72 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 110.168 -0.308 . . . . 1.0 110.168 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.51 -18.71 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.48 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -61.85 -47.23 92.15 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 110.141 -0.318 . . . . 1.0 110.141 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 52' ' ' PHE . 52.9 Cg_exo -56.56 -33.3 92.55 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.273 1.982 . . . . 1.0 111.037 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.521 ' NE2' ' NE2' ' A' ' 58' ' ' GLN . 48.6 t60 -59.29 -42.77 92.09 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.7 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -64.94 -42.1 94.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.143 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.1 mm -72.23 -26.71 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.376 -0.529 . . . . 1.0 109.63 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -70.1 -42.89 72.09 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.745 -0.382 . . . . 1.0 111.046 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.521 ' NE2' ' NE2' ' A' ' 54' ' ' HIS . 48.5 mt-30 -81.8 -50.4 9.28 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.377 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.8 mt -53.17 -46.24 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -55.58 -33.96 64.38 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.519 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m -76.11 -32.9 59.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.734 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.451 ' O ' ' N ' ' A' ' 66' ' ' GLY . 81.1 mmm -59.59 -29.16 67.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.937 0.399 . . . . 1.0 110.328 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.9 mt -60.01 -41.59 92.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.849 0.357 . . . . 1.0 110.125 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.9 m -85.4 -55.02 4.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.242 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.4 m -65.01 -42.05 94.81 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.696 -0.402 . . . . 1.0 111.339 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -86.11 -7.84 79.67 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 50.29 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.662 0.268 . . . . 1.0 110.393 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.4 tp -78.91 143.13 36.14 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -135.41 80.4 45.84 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.814 -0.63 . . . . 1.0 109.77 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.32 88.77 0.83 Allowed 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.11 1.873 . . . . 1.0 110.677 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -171.43 -9.47 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.927 0.394 . . . . 1.0 111.006 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -146.28 147.15 31.09 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.155 0.502 . . . . 1.0 110.867 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.22 131.2 47.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.63 -0.714 . . . . 1.0 109.944 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -162.4 139.22 7.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.431 -0.951 . . . . 1.0 108.431 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 58.3 m -129.88 140.88 50.89 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.6 t -132.94 134.49 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.488 -0.93 . . . . 1.0 108.488 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.2 m -109.7 119.92 40.89 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.54 142.49 40.53 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.122 -0.696 . . . . 1.0 109.122 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 42.3 p90 -133.75 126.47 30.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -156.25 139.42 15.56 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.421 ' C ' ' H ' ' A' ' 83' ' ' PHE . 17.2 t-20 54.45 34.31 20.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.928 0.394 . . . . 1.0 111.576 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.99 -28.63 1.62 Allowed Glycine 0 N--CA 1.467 0.725 0 N-CA-C 111.269 -0.732 . . . . 1.0 111.269 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 81' ' ' ASN . 69.8 m-85 -70.81 150.46 45.82 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.7 m -138.65 112.77 8.61 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 62.1 m -100.73 143.27 31.09 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -106.38 143.09 35.0 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.12 151.05 40.28 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -162.21 137.67 7.31 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.117 -0.698 . . . . 1.0 109.117 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' ' 91' ' ' GLY . 67.1 p -87.3 -16.11 36.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.977 -0.101 . . . . 1.0 110.729 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.2 mt 59.19 8.05 1.0 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.162 0.506 . . . . 1.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 89' ' ' THR . . . 71.73 20.22 78.49 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 110.614 -0.995 . . . . 1.0 110.614 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.9 t -61.9 -145.91 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.782 0.325 . . . . 1.0 110.161 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.3 p -164.8 107.86 0.87 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.19 28.27 68.52 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.483 -1.047 . . . . 1.0 110.483 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -151.96 146.98 26.01 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.1 m -139.71 140.16 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.325 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 8.0 m-85 -125.51 131.92 52.72 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.811 -0.811 . . . . 1.0 108.811 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.4 pt -138.95 163.57 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.73 145.74 25.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.717 -0.845 . . . . 1.0 108.717 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.56 135.54 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.247 -0.888 . . . . 1.0 109.388 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -145.91 143.67 20.13 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.123 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.82 139.88 44.83 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.681 1.587 . . . . 1.0 111.57 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.3 p -81.16 141.85 33.82 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -88.82 96.57 10.74 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.736 -1.126 . . . . 1.0 110.495 179.454 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.1 mtp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 108.728 -0.841 . . . . 1.0 108.728 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.1 p -61.95 -40.63 96.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.677 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -88.36 51.04 2.09 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.423 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.9 m -58.52 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.879 -0.328 . . . . 1.0 110.369 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.9 p -136.65 129.26 30.43 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.889 0.376 . . . . 1.0 110.608 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -82.4 152.83 26.0 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.747 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.35 176.76 45.99 Favored Glycine 0 N--CA 1.465 0.572 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.6 mp -60.68 143.05 55.03 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -87.79 121.74 30.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.049 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' NH1' ' NE ' ' A' ' 15' ' ' ARG . 98.2 mtt180 -145.59 133.91 21.79 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.79 -38.69 86.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.41 0.624 . . . . 1.0 111.163 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.447 ' H ' ' CD1' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -75.55 129.8 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.006 -0.997 . . . . 1.0 111.163 -178.267 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.457 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -72.18 -44.06 10.47 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.517 177.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 13' ' ' THR . 0.2 OUTLIER -34.35 -37.51 0.12 Allowed 'Trans proline' 0 N--CA 1.509 2.385 0 C-N-CA 123.08 2.52 . . . . 1.0 113.863 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.481 ' NE ' ' NH1' ' A' ' 10' ' ' ARG . 78.9 mtp180 -96.09 137.52 35.04 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.554 -0.536 . . . . 1.0 109.554 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 tt -121.82 131.45 54.06 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.733 -0.469 . . . . 1.0 109.733 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.54 164.36 25.46 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.174 -1.171 . . . . 1.0 110.174 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.08 135.82 0.61 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -136.98 130.59 31.73 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.1 mt -111.16 152.77 26.66 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.69 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.49 137.75 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -73.45 138.9 45.45 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.002 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -169.55 107.6 0.4 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.93 -169.94 44.71 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 109.824 -1.31 . . . . 1.0 109.824 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -84.81 23.76 1.14 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 122.717 -0.284 . . . . 1.0 110.32 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -143.65 143.01 31.27 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.748 -0.464 . . . . 1.0 109.748 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.7 mt -95.13 134.63 37.65 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -92.97 117.81 30.47 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.44 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -98.51 104.96 17.04 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.58 112.65 24.67 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.614 -0.721 . . . . 1.0 109.553 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.35 79.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.611 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -69.04 -11.99 61.28 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.567 -0.742 . . . . 1.0 110.583 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -107.97 55.36 0.65 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.879 0.371 . . . . 1.0 111.105 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.41 126.27 0.52 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.206 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -82.48 139.95 33.64 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.229 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.4 mt -85.71 141.33 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 76.9 p -130.9 147.7 52.57 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.001 0.52 . . . . 1.0 109.617 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.89 -150.32 50.34 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.823 -0.911 . . . . 1.0 110.823 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -158.49 130.36 6.72 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -111.53 125.68 54.17 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.609 0.764 . . . . 1.0 109.153 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -65.75 168.57 7.6 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.212 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.79 -22.16 66.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.68 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.42 -9.73 40.58 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 120.667 0.27 . . . . 1.0 110.602 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -108.26 -26.17 10.68 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.845 0.458 . . . . 1.0 111.421 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -67.59 -44.8 45.41 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 110.169 -0.308 . . . . 1.0 110.169 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 45.1 Cg_exo -59.43 -50.9 7.26 Favored 'Trans proline' 0 N--CA 1.503 2.062 0 C-N-CA 122.22 1.946 . . . . 1.0 112.23 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -55.99 -27.44 52.79 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.898 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -39.87 92.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -68.16 -24.93 65.04 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.927 -0.579 . . . . 1.0 111.053 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.64 -44.63 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.308 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.7 t -84.21 -15.1 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 121.205 0.526 . . . . 1.0 110.506 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -55.92 -53.15 66.28 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-O 118.658 -0.687 . . . . 1.0 111.804 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -68.04 -22.04 42.16 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 CA-C-N 121.443 1.551 . . . . 1.0 111.431 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.511 ' NE2' ' ND1' ' A' ' 80' ' ' HIS . 62.0 t-80 -59.24 -46.74 87.67 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.516 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.66 -42.61 91.14 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.87 -0.332 . . . . 1.0 110.531 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.4 mt -71.6 -42.52 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 120.729 -0.389 . . . . 1.0 110.076 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -57.75 -39.11 76.62 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.836 -0.345 . . . . 1.0 111.283 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.31 -46.55 13.48 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 110.565 -0.161 . . . . 1.0 110.565 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.9 mt -63.08 -43.98 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -58.41 -41.51 85.11 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.693 -0.403 . . . . 1.0 110.42 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.1 p -69.15 -31.82 70.75 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 121.018 -0.273 . . . . 1.0 110.359 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 66' ' ' GLY . 42.8 tpp -60.75 -40.9 94.14 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.59 -35.7 78.59 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.015 -0.365 . . . . 1.0 110.015 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.1 p -86.37 -58.84 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.76 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -63.54 -41.13 98.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.777 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -117.1 70.77 0.29 Allowed Glycine 0 N--CA 1.476 1.325 0 N-CA-C 111.448 -0.661 . . . . 1.0 111.448 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -47.2 86.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.006 0.403 . . . . 1.0 111.174 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 66' ' ' GLY . 4.5 tp -82.23 145.75 29.87 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.569 -0.9 . . . . 1.0 108.569 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -134.64 144.01 48.95 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 72' ' ' HIS . 82.1 Cg_exo -38.23 -87.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 122.485 2.123 . . . . 1.0 113.057 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.438 ' O ' ' CG ' ' A' ' 72' ' ' HIS . 81.6 mtp180 58.36 -56.62 0.04 OUTLIER 'General case' 0 C--N 1.346 0.447 0 C-N-CA 123.744 0.817 . . . . 1.0 112.689 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 70' ' ' PRO . 74.2 m80 -158.66 149.14 19.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.751 -0.658 . . . . 1.0 110.023 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.51 144.13 54.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.504 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.51 102.77 1.37 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.038 0.447 . . . . 1.0 110.122 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.37 137.17 39.63 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.804 -0.635 . . . . 1.0 110.655 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.9 t -125.91 134.87 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.0 p -113.18 111.18 21.64 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.344 -0.613 . . . . 1.0 109.344 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.3 mt -95.67 151.47 19.32 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.42 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 50.0 p90 -146.86 127.3 14.05 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.649 0.261 . . . . 1.0 110.308 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.511 ' ND1' ' NE2' ' A' ' 54' ' ' HIS . 58.6 t-80 -159.63 4.11 0.09 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.597 0.237 . . . . 1.0 110.472 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -165.71 22.03 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.156 0.503 . . . . 1.0 110.252 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.89 -29.39 5.06 Favored Glycine 0 N--CA 1.468 0.815 0 N-CA-C 111.087 -0.805 . . . . 1.0 111.087 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -72.74 143.56 47.96 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.422 ' O ' ' CZ ' ' A' ' 101' ' ' TYR . 60.6 p -134.1 107.46 7.75 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.8 t -90.52 140.37 29.8 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -97.88 138.31 35.42 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.133 -0.692 . . . . 1.0 109.133 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.06 149.08 39.46 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 110.013 -0.366 . . . . 1.0 110.013 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -168.51 141.45 2.97 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.0 p -86.03 -29.38 23.5 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.804 0.335 . . . . 1.0 110.285 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.6 mt 59.2 17.7 5.9 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.613 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.74 10.42 76.49 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 109.979 -1.248 . . . . 1.0 109.979 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.411 ' O ' ' SG ' ' A' ' 93' ' ' CYS . 35.4 t -49.59 -22.21 1.22 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 118.927 -0.559 . . . . 1.0 111.944 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 92' ' ' SER . 26.2 p 36.76 34.41 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.354 0.872 . . . . 1.0 113.354 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.36 -55.24 0.02 OUTLIER Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.849 -0.5 . . . . 1.0 111.849 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.23 139.13 54.22 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.72 0.408 . . . . 1.0 110.387 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.9 t -106.1 115.71 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -97.97 137.02 37.42 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.883 -0.784 . . . . 1.0 108.883 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.2 pt -138.31 161.19 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.29 147.76 27.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.942 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.05 131.21 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.082 -0.963 . . . . 1.0 109.357 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 11.3 p90 -131.71 94.25 25.94 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 108.734 -0.839 . . . . 1.0 108.734 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.79 137.64 34.49 Favored 'Trans proline' 0 N--CA 1.503 2.056 0 C-N-CA 121.524 1.483 . . . . 1.0 111.742 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 105' ' ' ARG . 1.9 t -96.07 148.72 22.38 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -64.92 77.27 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.948 0.404 . . . . 1.0 110.219 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 103' ' ' THR . 47.1 ptt85 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.914 -1.041 . . . . 1.0 110.722 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ptt? . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -70.64 -5.89 32.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.619 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.62 -53.89 0.55 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.467 0.48 . . . . 1.0 110.986 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.7 p -119.4 95.16 4.68 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.997 0.519 . . . . 1.0 109.716 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.09 122.63 33.24 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.424 ' CD1' ' NH1' ' A' ' 33' ' ' ARG . 3.8 m-90 -79.34 144.81 33.86 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.982 0.42 . . . . 1.0 110.9 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.64 -172.74 55.04 Favored Glycine 0 N--CA 1.465 0.608 0 N-CA-C 110.361 -1.096 . . . . 1.0 110.361 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.8 mt -59.11 143.17 49.5 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.098 0.475 . . . . 1.0 110.062 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -90.34 104.11 16.72 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.133 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -133.17 135.74 45.31 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -64.17 -20.29 65.9 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.954 0.883 . . . . 1.0 110.087 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 77.0 mt -65.73 129.51 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 113.92 -1.491 . . . . 1.0 110.858 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -55.18 1.12 Allowed Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 176.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -31.39 -34.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.505 2.152 0 C-N-CA 123.258 2.639 . . . . 1.0 114.311 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -99.4 141.64 31.92 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.08 149.24 51.88 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.56 0.695 . . . . 1.0 110.481 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.82 138.24 20.54 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.639 -1.384 . . . . 1.0 109.639 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.29 53.81 0.22 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.455 0.645 . . . . 1.0 109.438 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -76.41 128.91 35.76 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.847 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.6 mt -92.63 150.0 20.98 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.891 -0.411 . . . . 1.0 109.891 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.5 p -104.24 136.49 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -76.12 130.74 38.77 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.358 -0.383 . . . . 1.0 109.998 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -170.29 109.7 0.38 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.45 -165.67 54.76 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 109.685 -1.366 . . . . 1.0 109.685 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -87.21 10.91 15.45 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.896 -0.409 . . . . 1.0 109.896 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -129.76 141.06 50.93 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.736 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 54.8 mt -90.55 124.99 35.46 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -82.85 116.01 21.98 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.637 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -101.05 107.33 18.75 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.04 118.36 31.72 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.649 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.47 80.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.034 0.445 . . . . 1.0 110.739 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -67.83 -11.2 58.07 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.905 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.424 ' NH1' ' CD1' ' A' ' 6' ' ' TRP . 23.8 mmm180 -111.3 58.62 0.62 Allowed 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.041 0.448 . . . . 1.0 110.508 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.09 176.35 4.67 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.978 -0.556 . . . . 1.0 109.626 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -133.19 127.91 34.83 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.587 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 pt -85.32 147.73 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 82.5 p -133.21 134.76 44.47 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.8 102.66 0.01 OUTLIER Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -58.75 129.79 43.79 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.995 0.426 . . . . 1.0 110.113 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -96.02 136.33 36.61 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.745 -0.662 . . . . 1.0 109.853 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -67.1 167.43 11.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.381 -0.827 . . . . 1.0 110.709 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -64.46 -20.58 66.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.605 -0.725 . . . . 1.0 110.616 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.57 -11.01 38.48 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.006 0.432 . . . . 1.0 110.517 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -107.72 -24.28 11.78 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.283 0.633 . . . . 1.0 111.812 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.47 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -70.68 -45.36 17.27 Favored Pre-proline 0 CA--C 1.551 0.995 0 O-C-N 122.093 -0.38 . . . . 1.0 110.27 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 52.5 Cg_exo -58.15 -50.58 9.61 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 122.328 2.019 . . . . 1.0 113.167 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -60.2 -43.93 95.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.303 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.47 -39.64 91.62 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.34 -10.59 11.64 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.088 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 81.2 t -101.42 -15.34 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 109.557 -0.535 . . . . 1.0 109.557 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.93 -28.39 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 110.52 -0.178 . . . . 1.0 110.52 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.423 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -67.06 -46.65 52.92 Favored Pre-proline 0 N--CA 1.483 1.223 0 O-C-N 122.393 -0.192 . . . . 1.0 111.156 -178.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 52' ' ' PHE . 54.6 Cg_exo -56.59 -36.35 97.88 Favored 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 122.494 2.129 . . . . 1.0 111.885 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -65.31 -40.51 93.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 1.0 109.954 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.21 -41.62 96.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.502 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.5 mm -69.43 -36.91 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.4 t -59.13 -45.57 90.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.625 -0.261 . . . . 1.0 111.392 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.436 ' O ' ' SD ' ' A' ' 62' ' ' MET . 29.1 mm100 -67.85 -37.81 82.35 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.852 -0.158 . . . . 1.0 110.846 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.0 mt -59.08 -43.67 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.915 -0.491 . . . . 1.0 109.815 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -58.13 -39.48 78.84 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.815 0.34 . . . . 1.0 110.275 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -65.34 -39.59 92.59 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.459 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -60.3 -40.71 91.45 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 110.348 -0.241 . . . . 1.0 110.348 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.69 -34.93 76.63 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.546 -0.539 . . . . 1.0 109.546 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.3 p -86.02 -62.41 1.53 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.309 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.471 ' HG1' ' N ' ' A' ' 66' ' ' GLY . 70.8 p -74.72 -39.64 61.77 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.042 0.386 . . . . 1.0 112.042 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.471 ' N ' ' HG1' ' A' ' 65' ' ' THR . . . -81.29 -4.7 90.41 Favored Glycine 0 N--CA 1.47 0.961 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 31.79 78.6 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.699 0.8 . . . . 1.0 112.113 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.63 151.43 32.3 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.247 0.546 . . . . 1.0 109.657 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -141.29 74.84 23.97 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.154 -0.93 . . . . 1.0 110.013 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -48.2 105.97 0.1 OUTLIER 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 122.332 2.022 . . . . 1.0 111.648 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -171.02 -16.08 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.663 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -142.53 142.37 32.22 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.931 0.396 . . . . 1.0 110.999 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.3 125.73 24.51 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.768 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -162.01 103.99 1.16 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 27.7 p -90.29 148.13 23.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.433 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.58 152.27 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.8 p -128.01 110.27 12.35 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.801 -0.444 . . . . 1.0 109.801 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.5 mp -91.94 158.87 16.03 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.828 -0.805 . . . . 1.0 108.828 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -140.94 122.63 15.24 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -157.81 134.6 9.89 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 53.92 27.5 7.38 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.104 0.478 . . . . 1.0 111.406 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.63 -24.91 4.12 Favored Glycine 0 N--CA 1.469 0.85 0 N-CA-C 111.532 -0.627 . . . . 1.0 111.532 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -67.61 140.85 56.9 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 67.8 m -129.27 109.19 10.91 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 39.8 t -95.53 140.74 29.93 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -106.0 130.2 53.97 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.85 140.2 45.64 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -145.05 133.56 21.96 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.771 -0.825 . . . . 1.0 108.771 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.8 p -92.69 -32.2 14.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.012 0.434 . . . . 1.0 110.712 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.46 12.69 1.56 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.526 -0.546 . . . . 1.0 109.526 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.81 18.28 77.4 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 109.179 -1.568 . . . . 1.0 109.179 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.429 ' C ' ' H ' ' A' ' 94' ' ' GLY . 69.8 m -67.49 75.6 0.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.111 0.482 . . . . 1.0 111.668 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 43.6 t -65.69 48.96 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.773 -1.103 . . . . 1.0 110.559 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 92' ' ' SER . . . -166.38 -21.16 0.02 OUTLIER Glycine 0 CA--C 1.531 1.087 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.412 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 87.0 m-85 -158.41 170.78 21.45 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.938 0.369 . . . . 1.0 110.284 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.67 113.22 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -86.93 133.53 33.59 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.985 -0.376 . . . . 1.0 109.985 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.1 pt -143.33 161.85 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-N 118.221 0.464 . . . . 1.0 110.625 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.5 148.0 26.88 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.315 0.578 . . . . 1.0 110.4 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.18 137.18 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.028 -0.987 . . . . 1.0 110.508 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -151.55 148.16 21.58 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.1 141.75 71.24 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 121.361 1.374 . . . . 1.0 111.257 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.0 m -74.48 136.96 42.25 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -65.31 -39.53 92.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.775 0.322 . . . . 1.0 110.201 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.997 -1.001 . . . . 1.0 110.733 -179.756 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.9 t -64.53 147.76 52.14 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.162 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -161.77 135.97 6.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.37 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 t -59.71 144.34 48.35 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.671 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.0 m -135.07 125.09 25.78 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -91.73 142.09 27.97 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.803 -0.443 . . . . 1.0 109.803 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 123.31 147.03 7.23 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.558 ' H ' ' NH2' ' A' ' 15' ' ' ARG . 2.9 mp -68.12 157.02 36.23 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.719 0.295 . . . . 1.0 110.385 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -91.6 128.99 37.64 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.623 ' H ' ' NE ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -152.25 -166.57 2.52 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.594 0.235 . . . . 1.0 110.71 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 18.6 p-10 -53.01 -56.07 18.8 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.203 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.6 pt -69.41 130.92 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 109.209 -0.664 . . . . 1.0 109.209 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.19 -48.21 3.4 Favored Pre-proline 0 N--CA 1.473 0.716 0 O-C-N 122.123 -0.361 . . . . 1.0 110.205 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -89.85 142.61 4.01 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.845 1.697 . . . . 1.0 110.494 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.558 ' NH2' ' H ' ' A' ' 8' ' ' LEU . 52.4 ttp180 -168.34 166.94 12.3 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.364 -0.976 . . . . 1.0 108.364 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.2 tt -109.54 116.24 31.41 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.36 161.99 27.93 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 110.254 -1.139 . . . . 1.0 110.254 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.12 72.75 0.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 1.0 110.433 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -83.72 125.85 32.31 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.28 153.94 20.92 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.232 0.613 . . . . 1.0 109.445 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.14 140.87 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 108.817 -0.808 . . . . 1.0 108.817 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -81.38 108.34 14.91 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -65.0 -51.95 58.82 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.288 0.566 . . . . 1.0 109.676 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.95 -77.6 0.1 Allowed Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.058 -1.217 . . . . 1.0 110.058 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -100.28 8.06 43.99 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.892 0.477 . . . . 1.0 110.317 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -155.99 156.24 34.12 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.015 -0.365 . . . . 1.0 110.015 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.43 121.65 40.63 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.082 -0.71 . . . . 1.0 109.082 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.451 ' HD1' ' N ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -90.96 119.74 31.39 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.297 0.239 . . . . 1.0 110.6 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.451 ' N ' ' HD1' ' A' ' 28' ' ' HIS . 42.4 t80 -99.84 101.99 13.29 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.82 109.12 19.06 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.848 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.81 -28.02 68.47 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.132 0.491 . . . . 1.0 110.708 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -68.33 -11.62 59.81 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.573 -0.739 . . . . 1.0 111.046 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -109.37 45.77 1.04 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 120.869 0.366 . . . . 1.0 110.118 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.71 127.4 0.91 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.759 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.5 m -95.24 167.74 11.16 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.3 tp -94.9 141.16 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.5 m -128.25 125.3 38.64 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.99 153.53 8.59 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.809 -0.916 . . . . 1.0 110.809 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -92.81 125.95 37.66 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.825 0.345 . . . . 1.0 110.271 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -112.1 129.47 56.21 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 m -71.3 164.32 25.94 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.969 0.414 . . . . 1.0 110.382 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -63.98 -20.25 65.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.459 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.95 -11.92 34.82 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.88 0.371 . . . . 1.0 110.284 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -107.19 -25.85 11.34 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.08 0.552 . . . . 1.0 111.452 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -67.8 -45.39 43.92 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 120.904 -0.319 . . . . 1.0 110.391 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 51.9 Cg_exo -56.65 -46.86 26.75 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 122.345 2.03 . . . . 1.0 112.527 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.67 -32.67 69.32 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.595 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tp -63.28 -37.75 88.46 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.13 0.491 . . . . 1.0 110.095 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -68.96 -11.06 60.34 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.462 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.9 t -82.76 -48.49 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 110.35 -0.241 . . . . 1.0 110.35 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.18 -26.79 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 120.622 0.249 . . . . 1.0 111.497 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -54.89 -61.83 5.17 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-O 119.51 -0.281 . . . . 1.0 111.373 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -60.85 -30.48 90.2 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.636 1.557 . . . . 1.0 111.288 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -61.89 -44.78 96.09 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.735 -0.468 . . . . 1.0 109.735 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -65.62 -41.94 92.13 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.529 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.5 mt -72.58 -36.83 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.143 0.497 . . . . 1.0 109.795 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 t -68.83 -40.23 79.56 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.316 0.858 . . . . 1.0 113.316 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -81.7 -46.19 14.65 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 122.113 -0.367 . . . . 1.0 111.57 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 tt -54.88 -36.03 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.777 0.322 . . . . 1.0 110.515 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -54.97 -46.22 75.05 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.605 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 m -70.87 -32.44 69.44 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.149 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.8 ttm -59.72 -31.64 69.8 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.316 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.05 -41.75 93.0 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.681 -0.489 . . . . 1.0 109.681 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.6 m -85.61 -55.57 3.93 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.381 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.6 p -66.47 -39.12 88.63 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 121.114 -0.235 . . . . 1.0 111.476 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.4 1.03 78.48 Favored Glycine 0 N--CA 1.472 1.064 0 N-CA-C 110.341 -1.104 . . . . 1.0 110.341 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 41.85 71.23 0.22 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.054 0.542 . . . . 1.0 111.069 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.0 144.99 29.58 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.201 0.524 . . . . 1.0 110.096 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -129.77 79.86 72.6 Favored Pre-proline 0 N--CA 1.471 0.589 0 CA-C-N 115.237 -0.892 . . . . 1.0 109.186 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -45.54 98.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.942 1.762 . . . . 1.0 112.406 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -170.19 -63.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.837 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -94.39 137.55 33.4 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 116.475 -0.329 . . . . 1.0 110.264 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.0 142.61 58.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.47 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -161.1 104.88 1.31 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 43.0 m -74.91 139.64 43.22 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.197 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.9 t -134.22 139.05 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.1 p -115.28 115.01 25.96 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.602 0.361 . . . . 1.0 110.261 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tt -102.58 143.07 32.74 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.857 0.463 . . . . 1.0 109.941 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.59 127.98 17.86 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 110.184 -0.302 . . . . 1.0 110.184 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -159.16 9.51 0.12 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.463 0.173 . . . . 1.0 111.032 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -166.11 34.3 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.255 0.55 . . . . 1.0 110.373 179.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.15 -28.07 1.43 Allowed Glycine 0 N--CA 1.465 0.595 0 N-CA-C 111.235 -0.746 . . . . 1.0 111.235 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' A' ' 81' ' ' ASN . 58.6 m-85 -83.36 146.26 28.58 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.8 p -132.49 108.17 8.95 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 96.1 m -87.13 132.9 33.7 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -91.58 135.99 33.46 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.67 0.668 . . . . 1.0 109.32 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.83 137.04 39.33 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -146.1 139.71 26.2 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.438 ' C ' ' H ' ' A' ' 91' ' ' GLY . 39.3 m -90.12 -11.64 40.67 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.82 0.343 . . . . 1.0 110.592 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.49 9.08 0.71 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 89' ' ' THR . . . 78.49 25.84 60.29 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.2 p -66.68 -140.32 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 53.0 t -167.67 -39.14 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.651 0.262 . . . . 1.0 110.307 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.418 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . -133.29 36.26 2.16 Favored Glycine 0 N--CA 1.477 1.385 0 N-CA-C 110.525 -1.03 . . . . 1.0 110.525 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.418 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 95.7 m-85 -157.22 145.62 19.48 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 45.0 t -134.44 134.82 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -122.51 133.04 54.59 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.5 pt -138.83 159.67 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-O 120.965 0.412 . . . . 1.0 110.303 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.68 124.5 10.56 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.532 0.682 . . . . 1.0 109.658 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.36 131.7 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.093 -0.958 . . . . 1.0 109.779 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -135.92 105.0 9.69 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 108.706 -0.849 . . . . 1.0 108.706 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -69.96 142.05 46.02 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 CA-C-N 121.223 1.473 . . . . 1.0 111.426 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 63.7 p -90.63 146.65 23.87 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.847 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -68.86 79.4 0.3 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.729 0.299 . . . . 1.0 110.238 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.125 -0.941 . . . . 1.0 111.168 179.851 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 ptm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -64.29 157.78 25.11 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.312 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 54.29 51.14 14.86 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.819 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.2 m -58.44 129.21 40.99 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.212 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.4 m -133.84 126.77 31.2 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 109.677 -0.49 . . . . 1.0 109.677 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 8.8 m-90 -47.92 -65.24 0.6 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.813 0.34 . . . . 1.0 110.826 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.43 -176.55 0.12 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.502 -0.639 . . . . 1.0 111.502 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.442 ' O ' ' NH1' ' A' ' 10' ' ' ARG . 64.2 mt -56.79 144.92 31.07 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.579 0.704 . . . . 1.0 110.045 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -64.28 121.98 15.58 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.807 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.631 ' NH2' ' H ' ' A' ' 17' ' ' GLY . 27.5 ptt-85 -149.25 137.29 20.61 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 25.2 p-10 -70.16 -43.09 71.58 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.89 0.852 . . . . 1.0 109.84 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 27.1 pt -78.77 130.75 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 114.216 -1.357 . . . . 1.0 112.128 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.586 ' C ' ' H ' ' A' ' 15' ' ' ARG . 0.1 OUTLIER -82.6 -39.14 0.83 Allowed Pre-proline 0 CA--C 1.553 1.071 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 177.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 13' ' ' THR . 74.1 Cg_exo -52.22 11.89 0.02 OUTLIER 'Trans proline' 0 N--CA 1.512 2.607 0 C-N-CA 123.11 2.54 . . . . 1.0 113.886 175.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.586 ' H ' ' C ' ' A' ' 13' ' ' THR . 51.5 ttt85 -139.65 44.24 1.96 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.088 0.47 . . . . 1.0 110.253 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 pp -41.88 148.62 0.16 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.92 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.631 ' H ' ' NH2' ' A' ' 10' ' ' ARG . . . -124.38 179.66 16.06 Favored Glycine 0 N--CA 1.477 1.379 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.39 146.57 18.5 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -100.96 120.64 40.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.672 -0.695 . . . . 1.0 111.081 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.3 mt -131.34 131.81 44.02 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.83 140.97 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -71.47 132.22 44.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.994 -0.372 . . . . 1.0 109.994 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -157.69 105.05 2.0 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.04 -165.64 50.84 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 109.724 -1.35 . . . . 1.0 109.724 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -84.4 29.05 0.61 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.014 0.435 . . . . 1.0 109.868 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -148.27 143.86 27.24 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.339 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -96.45 130.15 43.66 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -85.91 115.79 23.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.057 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -96.41 109.11 21.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.482 -0.932 . . . . 1.0 108.482 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.01 115.86 28.24 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.936 -0.574 . . . . 1.0 109.67 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.03 -37.85 88.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.144 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -66.26 -9.44 32.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.737 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.48 67.59 0.67 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.327 0.584 . . . . 1.0 110.179 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.69 172.35 6.89 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.4 m -139.84 138.33 35.67 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 tp -93.83 145.01 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.4 p -129.72 148.1 51.57 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.59 -146.57 26.0 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 111.076 -0.809 . . . . 1.0 111.076 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -166.64 75.7 0.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.316 0.579 . . . . 1.0 110.519 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -61.49 138.19 58.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.248 0.546 . . . . 1.0 110.171 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 87.1 p -71.7 167.86 18.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.44 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -65.53 -20.9 66.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.379 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.59 -9.32 44.58 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.878 0.37 . . . . 1.0 110.551 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -109.32 -30.54 7.94 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.213 0.605 . . . . 1.0 111.288 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.473 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -61.58 -45.32 93.67 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 120.781 -0.367 . . . . 1.0 110.189 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 44.8 Cg_exo -59.15 -50.21 9.21 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 122.392 2.062 . . . . 1.0 112.664 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.38 -46.42 88.72 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.335 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.66 -39.01 86.81 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.097 0.475 . . . . 1.0 109.98 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -60.62 -12.48 10.28 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.2 t -104.22 -18.48 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.8 t -90.28 -33.37 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.408 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 65.8 t80 -62.75 -49.67 81.36 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 118.534 -0.746 . . . . 1.0 111.248 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 52' ' ' PHE . 44.3 Cg_endo -58.83 -26.26 79.75 Favored 'Trans proline' 0 N--CA 1.511 2.507 0 CA-C-N 121.323 1.508 . . . . 1.0 112.132 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 80' ' ' HIS . 17.6 t60 -60.48 -43.39 97.02 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.839 0.352 . . . . 1.0 110.175 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -64.48 -40.57 95.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.094 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.7 mt -65.47 -43.86 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 120.064 -0.654 . . . . 1.0 109.286 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.6 t -58.7 -46.08 88.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.104 -0.238 . . . . 1.0 111.239 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -70.48 -38.67 74.42 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.846 -0.161 . . . . 1.0 111.028 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.2 mt -61.08 -45.63 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 109.999 -0.371 . . . . 1.0 109.999 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -52.98 -41.93 65.07 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.544 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.7 p -75.99 -29.82 58.34 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.649 -0.25 . . . . 1.0 110.463 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 66' ' ' GLY . 12.1 tmm? -61.66 -33.32 73.75 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 110.251 -0.277 . . . . 1.0 110.251 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.74 -40.61 97.77 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.452 ' HG1' ' H ' ' A' ' 65' ' ' THR . 60.8 p -75.17 -56.22 4.94 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.389 -0.368 . . . . 1.0 111.268 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.452 ' H ' ' HG1' ' A' ' 64' ' ' THR . 63.1 p -68.65 -39.07 80.84 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.68 0.276 . . . . 1.0 111.255 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -80.96 -14.91 78.64 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 52.06 84.77 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.6 tp -81.35 142.88 32.62 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.763 -0.829 . . . . 1.0 108.763 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -151.95 131.24 6.69 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 119.221 -0.419 . . . . 1.0 110.355 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.18 102.2 1.58 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.361 1.374 . . . . 1.0 110.408 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -146.23 -34.24 0.3 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.257 0.551 . . . . 1.0 111.391 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -166.26 155.53 11.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.048 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.35 146.64 50.66 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.428 -0.806 . . . . 1.0 110.308 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -159.66 102.95 1.53 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.322 0.582 . . . . 1.0 109.759 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.1 t -83.16 137.29 34.12 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.181 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.36 153.09 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -131.85 103.18 6.18 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.8 mp -90.87 143.8 26.35 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.368 -0.975 . . . . 1.0 108.368 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -125.44 127.75 47.0 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 54' ' ' HIS . 79.6 t60 -163.04 139.67 7.36 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.4 m120 53.34 26.1 5.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.981 0.42 . . . . 1.0 111.311 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.79 -28.42 3.19 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -70.27 149.13 47.75 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.511 -0.552 . . . . 1.0 109.511 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.5 m -135.7 120.85 18.9 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.473 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 65.5 m -107.05 139.65 41.11 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.296 -1.001 . . . . 1.0 108.296 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -104.7 140.83 37.49 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 108.807 -0.812 . . . . 1.0 108.807 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.91 151.26 38.41 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 110.011 -0.366 . . . . 1.0 110.011 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -166.56 139.76 3.89 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.4 m -76.33 -20.04 57.63 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 110.468 -0.197 . . . . 1.0 110.468 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.0 mt 62.67 10.42 4.15 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.986 0.422 . . . . 1.0 110.202 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.61 13.46 83.46 Favored Glycine 0 N--CA 1.466 0.642 0 N-CA-C 110.546 -1.021 . . . . 1.0 110.546 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.6 p -62.13 -143.34 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.564 0.221 . . . . 1.0 110.473 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 23.7 p -170.64 107.39 0.3 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.78 0.324 . . . . 1.0 110.351 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.02 -9.64 37.74 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 111.216 -0.753 . . . . 1.0 111.216 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -113.94 141.95 46.74 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.039 0.536 . . . . 1.0 109.582 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.2 136.81 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 108.901 -0.777 . . . . 1.0 108.901 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -125.65 138.59 53.91 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.213 -1.032 . . . . 1.0 108.213 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.8 pt -137.38 165.2 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.982 0.42 . . . . 1.0 109.952 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.92 108.47 3.82 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.73 139.36 17.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 114.745 -1.116 . . . . 1.0 108.744 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -147.54 129.3 7.41 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.29 143.52 43.81 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 CA-C-N 120.539 1.228 . . . . 1.0 111.692 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 t -87.24 147.38 25.58 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.079 -0.51 . . . . 1.0 109.633 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -72.29 110.38 6.69 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.236 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 . . . . . 0 C--O 1.218 -0.597 0 CA-C-O 118.114 -0.946 . . . . 1.0 109.777 179.651 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtm . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 4' ' ' THR . 20.9 m 53.93 38.85 29.67 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.064 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 58.5 t30 68.83 -45.85 0.55 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.148 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.426 ' H ' ' C ' ' A' ' 2' ' ' SER . 40.3 m -58.87 93.38 0.02 OUTLIER 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.165 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.4 m -102.84 125.33 49.54 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.543 -0.539 . . . . 1.0 109.543 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -50.37 -79.12 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.708 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.79 -157.84 0.28 Allowed Glycine 0 C--N 1.329 0.157 0 N-CA-C 110.663 -0.975 . . . . 1.0 110.663 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.5 mt -58.82 148.57 29.41 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.873 -0.418 . . . . 1.0 109.873 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -88.39 110.38 20.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.114 -0.493 . . . . 1.0 109.866 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.534 ' NH1' ' NH2' ' A' ' 15' ' ' ARG . 99.2 mtt180 -137.78 133.53 34.15 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -65.98 -35.55 80.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.502 0.668 . . . . 1.0 110.349 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 69.5 mt -59.71 125.65 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 114.397 -1.274 . . . . 1.0 110.012 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.46 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -81.09 -49.88 1.0 Allowed Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 107.938 -1.134 . . . . 1.0 107.938 177.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 13' ' ' THR . 33.0 Cg_exo -32.76 -33.95 0.05 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.631 2.221 . . . . 1.0 113.565 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.534 ' NH2' ' NH1' ' A' ' 10' ' ' ARG . 75.0 mtp180 -93.79 138.19 32.23 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.832 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 tt -119.93 114.86 22.69 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.45 156.77 43.47 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 109.822 -1.311 . . . . 1.0 109.822 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -165.34 71.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -73.91 128.99 36.99 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.0 mt -116.67 153.5 32.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.905 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.85 137.08 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.375 -0.972 . . . . 1.0 108.375 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -81.45 130.46 35.05 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -160.52 124.05 3.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.258 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.18 -147.53 50.82 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 109.953 -1.259 . . . . 1.0 109.953 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -105.18 15.42 27.5 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 110.171 -0.307 . . . . 1.0 110.171 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.411 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 17.8 mp0 -135.8 143.46 45.21 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.052 0.453 . . . . 1.0 110.122 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 50.8 mt -91.85 131.03 37.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -88.26 116.87 26.78 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -100.07 106.71 18.48 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -91.24 111.8 23.43 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.52 -35.1 73.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.237 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -71.62 -8.33 53.41 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.656 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -110.56 63.11 0.61 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.133 0.492 . . . . 1.0 110.378 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.9 175.09 4.56 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 t -141.43 138.06 32.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.957 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.0 mm -82.6 141.81 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.12 -0.326 . . . . 1.0 110.12 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.466 ' C ' ' H ' ' A' ' 39' ' ' LYS . 73.8 p -132.81 146.48 51.86 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.675 0.39 . . . . 1.0 110.035 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.99 -9.31 2.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.466 ' H ' ' C ' ' A' ' 37' ' ' THR . 48.5 mtmt 50.77 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 O-C-N 122.462 -0.434 . . . . 1.0 111.25 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -69.36 139.91 54.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.299 0.571 . . . . 1.0 110.572 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.3 p -72.69 171.09 13.19 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.386 -0.825 . . . . 1.0 110.125 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.28 -19.28 65.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.434 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.98 -10.73 38.25 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 120.816 0.341 . . . . 1.0 110.544 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -109.27 -24.42 11.1 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.645 0.778 . . . . 1.0 111.227 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -67.27 -46.27 50.35 Favored Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.119 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 28.5 Cg_exo -63.75 -55.08 0.74 Allowed 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.22 1.947 . . . . 1.0 112.398 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -56.85 -45.22 82.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.254 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.16 -39.67 87.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.291 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -62.24 -20.23 64.01 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.384 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.4 t -92.55 -21.99 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.1 t -85.78 -13.45 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 110.094 -0.335 . . . . 1.0 110.094 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.42 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -65.49 -59.39 9.59 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 122.286 -0.259 . . . . 1.0 110.512 178.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 55' ' ' PHE . 30.8 Cg_endo -55.65 -24.66 46.63 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.642 1.561 . . . . 1.0 112.089 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -66.17 3.86 0.8 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.751 0.31 . . . . 1.0 110.988 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.46 ' H ' ' C ' ' A' ' 53' ' ' PRO . 44.5 m-85 -131.95 -40.96 1.04 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.751 0.421 . . . . 1.0 110.424 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.13 -42.5 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.3 p -57.1 -41.98 79.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.977 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -67.05 -56.47 9.93 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.666 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.15 -45.71 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -52.37 -37.91 57.5 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.74 -0.384 . . . . 1.0 111.011 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.5 p -76.77 -32.33 57.65 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.125 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 78.0 mmm -56.43 -31.17 63.67 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.282 -0.266 . . . . 1.0 110.282 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.2 mt -61.51 -37.13 82.59 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.6 m -92.05 -58.8 2.28 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.161 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.5 m -66.58 -43.07 85.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.648 -0.421 . . . . 1.0 111.864 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.66 -10.54 81.33 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 110.544 -1.023 . . . . 1.0 110.544 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 47.46 77.29 0.09 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 110.183 -0.303 . . . . 1.0 110.183 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.57 126.91 34.8 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -145.64 151.07 45.6 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.572 -0.285 . . . . 1.0 110.523 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.36 87.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.503 2.046 0 C-N-CA 121.86 1.707 . . . . 1.0 111.688 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -133.09 -60.2 0.86 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 120.868 0.366 . . . . 1.0 110.571 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -153.56 140.01 18.7 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.952 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.74 126.14 28.78 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.689 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -138.39 103.77 4.99 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.4 t -78.59 136.01 37.41 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.819 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.5 t -125.62 136.26 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.9 p -116.97 110.96 18.94 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 68.1 mt -89.91 160.65 16.32 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 50.0 p90 -143.57 130.56 20.57 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.047 -0.353 . . . . 1.0 110.047 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.517 ' C ' ' H ' ' A' ' 82' ' ' GLY . 74.1 t60 -157.75 -96.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.442 ' C ' ' H ' ' A' ' 83' ' ' PHE . 59.0 t30 -70.02 35.43 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.87 0.366 . . . . 1.0 111.503 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . 77.53 -28.83 1.76 Allowed Glycine 0 N--CA 1.466 0.657 0 N-CA-C 110.735 -0.946 . . . . 1.0 110.735 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 84' ' ' THR . 6.9 t80 -78.52 147.23 33.92 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.487 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 35.6 p -134.08 116.24 15.22 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.958 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 45.6 t -87.51 142.16 28.07 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -102.01 136.89 41.07 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.325 -0.621 . . . . 1.0 109.325 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.64 151.64 41.65 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -168.72 152.49 5.54 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.2 m -98.58 -18.18 18.27 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.667 0.27 . . . . 1.0 110.67 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.7 mp 59.41 8.97 1.29 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.07 15.37 76.48 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.101 -1.199 . . . . 1.0 110.101 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.1 m -65.62 -134.95 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.01 -0.367 . . . . 1.0 110.01 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 20.8 p -170.61 105.97 0.28 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.865 0.364 . . . . 1.0 110.054 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.37 33.9 78.61 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.652 -0.979 . . . . 1.0 110.652 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -151.25 137.16 18.14 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 m -142.3 138.33 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.307 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.429 ' N ' ' CD1' ' A' ' 97' ' ' TYR . 21.5 m-85 -116.69 120.39 38.45 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 156.8 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.296 -1.001 . . . . 1.0 108.296 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.43 150.8 30.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.18 -0.918 . . . . 1.0 109.328 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.7 p -123.38 135.66 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 115.115 -0.948 . . . . 1.0 109.568 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 13.4 p90 -149.03 97.33 3.64 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.135 -0.938 . . . . 1.0 108.971 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -51.63 144.84 32.05 Favored 'Trans proline' 0 N--CA 1.507 2.279 0 C-N-CA 121.922 1.748 . . . . 1.0 112.058 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 80.7 p -63.29 134.04 55.17 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.348 -0.387 . . . . 1.0 109.98 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -68.78 -41.1 79.22 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.747 0.308 . . . . 1.0 110.323 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 . . . . . 0 C--O 1.222 -0.389 0 CA-C-O 118.143 -0.932 . . . . 1.0 110.115 -179.224 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 mmt . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.1 t -63.29 -19.81 64.92 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.391 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -63.71 -37.08 86.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.025 -0.534 . . . . 1.0 109.61 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 m -57.55 102.16 0.09 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.411 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.9 p -133.89 125.82 29.11 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -96.1 163.69 13.01 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.88 160.21 22.72 Favored Glycine 0 N--CA 1.471 0.991 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.2 mt -69.84 153.99 42.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.185 -0.507 . . . . 1.0 109.992 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -102.51 118.15 36.23 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.897 0.479 . . . . 1.0 109.785 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.454 ' C ' ' H ' ' A' ' 12' ' ' ILE . 79.8 mtp180 -143.15 -168.17 2.73 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.744 -0.836 . . . . 1.0 108.744 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -57.83 -5.26 0.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.651 -0.249 . . . . 1.0 111.216 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.454 ' H ' ' C ' ' A' ' 10' ' ' ARG . 79.7 mt -96.79 128.88 47.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.295 -1.002 . . . . 1.0 108.295 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -56.08 0.44 Allowed Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 108.295 -1.002 . . . . 1.0 108.295 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.01 126.38 5.69 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 121.228 1.285 . . . . 1.0 110.743 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -152.18 153.12 33.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.839 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.0 tp -116.39 118.32 32.4 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.388 -1.338 . . . . 1.0 107.388 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.34 161.9 33.02 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 108.73 -1.748 . . . . 1.0 108.73 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.39 67.6 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -73.31 122.17 21.58 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.295 -0.632 . . . . 1.0 109.295 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.6 mt -90.06 144.91 25.47 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.702 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -102.99 136.79 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -75.75 133.61 40.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.942 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -172.25 109.18 0.23 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.016 -0.735 . . . . 1.0 109.016 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.66 -161.48 53.76 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 109.759 -1.337 . . . . 1.0 109.759 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -87.14 5.87 35.7 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.732 0.301 . . . . 1.0 110.389 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -127.79 136.36 51.37 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.09 0.471 . . . . 1.0 110.054 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.07 127.73 35.71 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.941 -0.762 . . . . 1.0 108.941 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -83.9 116.31 22.71 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.664 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -97.67 103.65 15.6 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.847 -1.168 . . . . 1.0 107.847 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.5 mp -86.68 134.62 33.59 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.052 -0.722 . . . . 1.0 109.052 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.05 -24.58 30.38 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.883 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -73.93 -10.44 59.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.028 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -108.41 16.64 22.9 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.537 0.335 . . . . 1.0 110.473 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.22 127.67 10.0 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.2 m -86.92 170.27 11.77 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.853 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.4 pt -97.4 155.07 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 82.0 p -134.45 128.64 33.88 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.48 99.16 0.01 OUTLIER Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.102 -0.799 . . . . 1.0 111.102 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -56.07 99.64 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.789 0.328 . . . . 1.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -69.23 140.08 54.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.007 -0.542 . . . . 1.0 109.544 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -69.46 171.07 9.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.276 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -64.28 -21.18 66.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.58 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.32 -22.51 20.5 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 120.825 0.345 . . . . 1.0 110.103 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -96.87 -26.36 15.11 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.904 0.482 . . . . 1.0 110.717 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -60.36 -57.59 25.53 Favored Pre-proline 0 CA--C 1.555 1.135 0 O-C-N 122.089 -0.382 . . . . 1.0 110.127 177.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 45' ' ' CYS . 35.0 Cg_endo -56.22 -41.91 71.69 Favored 'Trans proline' 0 N--CA 1.51 2.478 0 C-N-CA 122.497 2.131 . . . . 1.0 112.688 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -56.74 -37.31 70.84 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.951 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.55 -31.11 47.25 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.047 0.451 . . . . 1.0 110.091 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.13 -40.82 86.84 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.629 -0.669 . . . . 1.0 110.685 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.2 m -75.12 -20.56 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -86.01 -20.54 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.184 0.516 . . . . 1.0 110.045 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.79 -57.06 26.53 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.063 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.41 ' C ' ' H ' ' A' ' 55' ' ' PHE . 36.2 Cg_endo -56.6 -26.92 67.14 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.161 1.241 . . . . 1.0 111.72 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -77.35 16.08 0.66 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.749 0.309 . . . . 1.0 110.97 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.41 ' H ' ' C ' ' A' ' 53' ' ' PRO . 55.1 t80 -131.32 -37.33 1.24 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.12 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.7 mm -74.74 -30.78 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.8 m -60.82 -43.92 97.6 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.844 0.354 . . . . 1.0 111.132 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -65.42 -42.5 92.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.91 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.14 -46.94 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.37 -45.9 90.15 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.5 t -65.81 -40.67 92.09 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.495 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.428 ' O ' ' N ' ' A' ' 66' ' ' GLY . 45.6 ttm -50.67 -44.05 57.58 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.863 0.363 . . . . 1.0 110.925 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.37 -37.33 86.86 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.283 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -68.77 -61.72 1.69 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.756 0.312 . . . . 1.0 111.616 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.4 t -72.4 -39.47 67.92 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.067 0.46 . . . . 1.0 110.781 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -98.51 73.4 0.57 Allowed Glycine 0 N--CA 1.462 0.396 0 N-CA-C 109.073 -1.611 . . . . 1.0 109.073 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.25 88.82 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -82.72 123.67 29.51 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.774 -1.195 . . . . 1.0 107.774 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -122.68 147.03 49.51 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-O 119.286 -0.388 . . . . 1.0 110.727 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.28 88.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.506 2.233 0 C-N-CA 121.419 1.412 . . . . 1.0 112.159 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -131.67 -50.83 0.98 Allowed 'General case' 0 N--CA 1.48 1.065 0 O-C-N 121.999 -0.438 . . . . 1.0 109.9 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -163.36 151.72 13.78 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.767 -178.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.85 150.31 20.5 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.717 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -155.4 139.64 16.61 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.2 t -130.55 143.63 50.88 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.628 -0.508 . . . . 1.0 109.628 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.86 144.88 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.597 -0.52 . . . . 1.0 109.597 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.6 p -115.36 116.36 28.14 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 67.4 mt -99.79 134.76 42.22 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.52 -0.919 . . . . 1.0 108.52 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.414 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 47.2 p90 -115.03 127.58 55.73 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -156.72 141.2 16.72 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.456 ' ND2' ' CD1' ' A' ' 83' ' ' PHE . 5.7 p-10 43.91 29.5 0.32 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.237 0.458 . . . . 1.0 112.237 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.21 -27.25 4.61 Favored Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.876 -0.89 . . . . 1.0 110.876 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.456 ' CD1' ' ND2' ' A' ' 81' ' ' ASN . 6.5 m-85 -68.78 150.02 48.34 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.0 m -142.29 108.11 5.14 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.139 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.5 m -93.63 143.04 26.68 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -99.36 140.75 33.08 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.61 150.27 37.15 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 110.288 -0.264 . . . . 1.0 110.288 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -164.54 134.18 3.82 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.8 m -77.21 -42.59 36.84 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.991 0.424 . . . . 1.0 110.729 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.433 ' C ' ' H ' ' A' ' 92' ' ' SER . 57.5 mt 58.01 37.09 26.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.118 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.41 5.93 1.99 Allowed Glycine 0 CA--C 1.533 1.209 0 N-CA-C 111.386 -0.686 . . . . 1.0 111.386 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 90' ' ' LEU . 28.7 t -104.36 57.47 0.71 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.7 p -58.41 -23.41 57.18 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 119.954 -0.698 . . . . 1.0 110.386 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.66 -12.82 48.77 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.907 -0.877 . . . . 1.0 110.907 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -155.18 119.57 4.7 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 t -101.59 113.68 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -90.49 131.01 36.48 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.163 -0.68 . . . . 1.0 109.163 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.9 pt -139.03 161.55 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.1 111.57 3.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.402 0.62 . . . . 1.0 109.397 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.1 t -91.49 136.07 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 114.845 -1.071 . . . . 1.0 108.658 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -145.38 128.19 8.21 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 119.029 -0.51 . . . . 1.0 109.761 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.27 145.74 39.22 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.374 1.383 . . . . 1.0 111.243 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.2 p -83.58 138.67 33.27 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -64.87 -47.08 79.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.783 0.325 . . . . 1.0 110.343 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.067 -0.968 . . . . 1.0 110.397 -179.303 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 110.647 -0.131 . . . . 1.0 110.647 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tt -113.35 133.52 55.1 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.059 -0.719 . . . . 1.0 109.059 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -136.01 -171.17 12.24 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 109.76 -1.336 . . . . 1.0 109.76 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.41 71.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.446 ' O ' ' NH1' ' A' ' 33' ' ' ARG . 16.8 ptm180 -75.33 123.85 26.07 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.083 0.468 . . . . 1.0 110.417 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.48 152.66 18.41 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.1 m -102.99 134.84 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.852 -0.796 . . . . 1.0 108.852 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -78.24 140.33 38.9 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.779 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -174.45 113.72 0.17 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.038 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.02 -147.82 45.21 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 109.228 -1.549 . . . . 1.0 109.228 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -99.25 10.99 40.33 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.067 0.434 . . . . 1.0 110.662 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -134.81 157.97 45.4 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.465 -0.568 . . . . 1.0 109.465 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mp -109.63 133.07 53.54 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -86.23 115.98 24.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.524 -0.307 . . . . 1.0 111.112 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -100.55 110.53 22.7 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.321 -0.992 . . . . 1.0 108.321 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 mt -96.04 114.48 26.19 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.21 0.604 . . . . 1.0 110.022 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.02 91.94 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.826 0.346 . . . . 1.0 111.408 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.39 -8.67 27.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.029 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 19' ' ' ARG . 52.6 ttp85 -110.4 67.82 0.65 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.16 0.505 . . . . 1.0 110.585 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -171.14 175.48 4.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.046 -0.724 . . . . 1.0 109.046 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.8 t -135.94 145.38 46.17 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.8 mt -107.46 141.24 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.955 -0.758 . . . . 1.0 108.955 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.8 t -126.89 148.12 50.03 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.29 -134.89 29.12 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -170.64 135.33 1.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.307 0.575 . . . . 1.0 110.277 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -112.66 124.26 52.14 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.719 0.808 . . . . 1.0 109.284 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.2 t -65.27 169.62 5.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.086 0.47 . . . . 1.0 110.625 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.47 -21.19 65.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.639 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.61 -10.58 36.92 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 117.721 0.237 . . . . 1.0 110.74 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -105.57 -31.78 8.79 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.789 0.435 . . . . 1.0 110.703 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -60.58 10.05 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.718 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -58.85 -43.98 39.46 Favored 'Trans proline' 0 N--CA 1.506 2.23 0 C-N-CA 122.148 1.899 . . . . 1.0 111.688 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -61.85 -36.89 82.52 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.735 -0.212 . . . . 1.0 110.909 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.8 tp -78.33 -36.71 45.96 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 122.095 -0.378 . . . . 1.0 110.429 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.01 -35.34 78.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.14 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -77.35 -20.49 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 110.261 -0.274 . . . . 1.0 110.261 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.48 -25.61 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.404 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.3 m-85 -55.3 -57.5 20.0 Favored Pre-proline 0 CA--C 1.555 1.149 0 CA-C-O 119.325 -0.369 . . . . 1.0 111.38 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 52' ' ' PHE . 35.4 Cg_endo -57.46 -28.13 79.24 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 121.823 1.682 . . . . 1.0 112.101 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -61.4 -49.58 76.29 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.358 -0.537 . . . . 1.0 109.921 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -67.35 -41.48 85.1 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.815 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.3 mt -67.25 -37.98 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 118.293 0.497 . . . . 1.0 109.74 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 m -53.17 -27.93 23.8 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.609 0.243 . . . . 1.0 110.663 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -83.14 -40.44 19.76 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.657 -0.247 . . . . 1.0 111.083 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mm -57.9 -48.55 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 120.781 -0.368 . . . . 1.0 110.383 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -53.42 -31.48 45.44 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.571 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.5 m -84.84 -33.9 22.79 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.019 0.378 . . . . 1.0 112.019 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.9 mmt -54.27 -42.86 70.44 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 122.352 -0.218 . . . . 1.0 111.009 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 pp -63.19 -31.2 72.28 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.819 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -90.18 -62.34 1.48 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.986 0.422 . . . . 1.0 110.758 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.4 m -66.12 -40.55 90.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.129 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.23 0.97 72.15 Favored Glycine 0 N--CA 1.467 0.767 0 N-CA-C 109.528 -1.429 . . . . 1.0 109.528 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 54.39 99.34 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.271 -0.464 . . . . 1.0 110.607 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.0 tp -79.21 132.89 36.66 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -160.92 90.76 1.59 Allowed Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.892 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -47.4 98.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.506 2.23 0 C-N-CA 121.763 1.642 . . . . 1.0 111.47 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -137.37 -47.05 0.56 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.287 0.565 . . . . 1.0 110.931 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -165.7 154.19 11.38 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.148 -0.933 . . . . 1.0 110.713 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.4 144.7 56.37 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.156 -0.929 . . . . 1.0 110.544 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -151.31 104.37 3.09 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.857 0.36 . . . . 1.0 110.044 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 76.2 m -77.72 131.79 37.84 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.525 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.45 134.88 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 109.078 -0.712 . . . . 1.0 109.078 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.4 p -113.15 111.55 22.29 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.8 mt -97.79 155.24 17.13 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.4 ' O ' ' CG ' ' A' ' 80' ' ' HIS . 39.9 p90 -141.69 124.85 16.36 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 110.083 -0.339 . . . . 1.0 110.083 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 79' ' ' TYR . 99.4 m-70 -156.6 139.33 15.13 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.832 -0.432 . . . . 1.0 109.832 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 54.33 34.55 20.89 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.926 0.393 . . . . 1.0 111.069 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.36 -29.55 1.68 Allowed Glycine 0 N--CA 1.468 0.768 0 N-CA-C 111.474 -0.65 . . . . 1.0 111.474 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -77.97 149.17 34.16 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.765 -0.457 . . . . 1.0 109.765 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.9 p -134.64 122.18 21.9 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.948 -0.389 . . . . 1.0 109.948 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 69.6 m -106.61 142.06 36.87 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -106.71 137.73 44.19 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.706 0.684 . . . . 1.0 109.173 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.38 151.81 47.84 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 120.53 0.205 . . . . 1.0 110.696 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -163.74 149.06 10.9 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 91' ' ' GLY . 68.2 p -91.31 -15.46 29.07 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 110.537 -0.171 . . . . 1.0 110.537 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.8 mp 58.43 5.63 0.46 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 110.136 -0.32 . . . . 1.0 110.136 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 89' ' ' THR . . . 77.27 12.93 84.13 Favored Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.19 -1.164 . . . . 1.0 110.19 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.0 t -77.18 148.78 35.72 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.009 0.433 . . . . 1.0 111.052 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 60.9 m -90.69 111.84 23.36 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.78 -0.645 . . . . 1.0 111.685 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . 69.72 39.8 76.82 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.113 -0.395 . . . . 1.0 112.113 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.431 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 79.4 m-85 -158.27 138.54 12.51 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.1 112.46 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -90.05 126.77 35.89 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.99 -0.744 . . . . 1.0 108.99 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.1 pt -130.15 157.11 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-O 120.947 0.403 . . . . 1.0 110.529 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.48 147.2 26.55 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.119 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.6 p -123.2 133.16 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.021 -0.991 . . . . 1.0 110.125 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -136.24 90.29 18.3 Favored Pre-proline 0 N--CA 1.47 0.562 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.82 140.98 67.15 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.439 1.426 . . . . 1.0 111.962 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.9 p -69.2 132.17 46.1 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.627 -0.508 . . . . 1.0 109.627 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 120.841 0.353 . . . . 1.0 110.452 -179.718 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.423 ' CG ' ' N ' ' A' ' 16' ' ' LEU . 41.1 ttm180 . . . . . 0 N--CA 1.463 0.192 0 N-CA-C 107.983 -1.117 . . . . 1.0 107.983 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.423 ' N ' ' CG ' ' A' ' 15' ' ' ARG . 6.0 tt -100.96 121.97 42.69 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.78 167.1 21.78 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.521 -1.032 . . . . 1.0 110.521 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.2 86.44 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.276 -0.639 . . . . 1.0 109.276 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.439 ' NH2' ' CD1' ' A' ' 95' ' ' TYR . 70.2 ttt-85 -85.34 114.7 22.61 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.8 mm? -88.91 146.75 24.73 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.144 -0.688 . . . . 1.0 109.144 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.45 136.78 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -78.95 131.74 36.45 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.657 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -170.23 113.27 0.46 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.75 -163.02 53.7 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -89.79 13.01 15.46 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 117.085 0.442 . . . . 1.0 110.096 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -131.64 148.72 52.62 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.827 -0.435 . . . . 1.0 109.827 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.3 mt -97.54 122.87 41.11 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -83.64 118.77 24.07 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.142 0.577 . . . . 1.0 111.044 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -103.78 110.69 22.89 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.06 114.95 27.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.259 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.46 -34.78 72.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.953 0.406 . . . . 1.0 111.079 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -66.7 -10.44 46.71 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.308 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -112.34 56.52 0.66 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.215 0.531 . . . . 1.0 110.465 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.97 176.97 4.51 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.803 -0.635 . . . . 1.0 109.364 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 92.0 p -149.42 159.81 43.97 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.1 pt -98.64 144.71 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.9 p -133.89 149.22 51.31 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.082 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.24 -129.3 20.24 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -168.44 127.28 1.15 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.608 0.718 . . . . 1.0 110.28 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -113.79 120.1 39.62 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.628 -0.878 . . . . 1.0 108.628 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.0 p -68.43 167.78 14.05 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.102 0.477 . . . . 1.0 110.592 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -63.44 -19.81 65.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.491 -0.777 . . . . 1.0 110.605 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.96 -12.18 36.74 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.698 0.285 . . . . 1.0 110.725 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -104.84 -38.34 6.69 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.121 0.568 . . . . 1.0 110.827 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.67 -61.98 3.25 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 119.894 -0.098 . . . . 1.0 110.958 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -57.91 -41.83 64.92 Favored 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 122.501 2.134 . . . . 1.0 112.583 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -62.88 -46.07 89.57 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.904 -0.318 . . . . 1.0 110.875 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.3 mt -63.06 -37.6 87.86 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.763 0.316 . . . . 1.0 110.209 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -59.51 -27.36 66.09 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.924 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.6 t -86.0 -30.6 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 81.9 t -78.89 -18.41 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 121.124 0.488 . . . . 1.0 109.788 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.5 -60.63 9.95 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.57 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -57.11 -22.09 45.92 Favored 'Trans proline' 0 N--CA 1.507 2.314 0 C-N-CA 122.098 1.865 . . . . 1.0 112.728 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -59.49 -45.2 92.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 120.448 -0.501 . . . . 1.0 110.151 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -65.76 -42.97 90.24 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.626 -0.429 . . . . 1.0 110.722 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.66 -41.88 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 120.993 -0.283 . . . . 1.0 110.355 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.8 p -58.18 -36.84 73.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.202 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -81.48 -28.65 33.99 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 119.712 -0.185 . . . . 1.0 111.462 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.8 mm -62.23 -44.2 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -58.69 -39.63 81.28 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.916 0.389 . . . . 1.0 110.608 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.1 m -61.09 -44.72 96.93 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.168 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 23.4 mmt -54.18 -40.79 67.87 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.574 0.226 . . . . 1.0 110.869 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.5 mt -62.01 -33.39 74.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.628 -0.508 . . . . 1.0 109.628 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -81.32 -57.2 3.6 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.199 0.444 . . . . 1.0 112.199 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.9 t -86.96 -38.69 16.41 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.08 0.4 . . . . 1.0 112.08 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.54 -8.22 62.57 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.161 -1.175 . . . . 1.0 110.161 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 43.83 81.3 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.491 0.317 . . . . 1.0 110.787 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.5 tp -80.63 137.12 36.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.662 -0.495 . . . . 1.0 109.662 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -127.48 78.34 74.81 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 123.122 0.569 . . . . 1.0 109.949 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -48.68 99.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 122.051 1.834 . . . . 1.0 112.458 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -169.6 -18.37 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.844 0.355 . . . . 1.0 110.797 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -150.12 147.56 27.91 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.109 0.48 . . . . 1.0 110.875 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.66 142.08 50.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.65 -0.704 . . . . 1.0 111.132 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -160.02 103.35 1.48 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 63.4 m -84.65 143.35 29.29 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.791 -0.641 . . . . 1.0 110.3 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.1 p -140.64 146.91 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.2 p -128.68 104.12 7.47 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.58 0.352 . . . . 1.0 110.098 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.0 mt -82.9 148.71 27.52 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.068 -0.715 . . . . 1.0 109.068 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -139.87 125.22 18.96 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.455 ' CD2' ' N ' ' A' ' 80' ' ' HIS . 0.1 OUTLIER -170.67 146.4 2.66 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.18 0.514 . . . . 1.0 110.168 -179.715 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 83' ' ' PHE . 59.6 t30 53.82 31.14 12.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.979 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.18 -27.86 1.18 Allowed Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.783 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.4 ' H ' ' C ' ' A' ' 81' ' ' ASN . 65.7 m-85 -83.19 154.01 24.46 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 117.081 0.44 . . . . 1.0 110.384 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 t -151.02 133.56 15.57 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.068 0.461 . . . . 1.0 110.85 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 68.4 m -106.89 142.5 36.41 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.008 -0.738 . . . . 1.0 109.008 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -106.39 141.97 36.84 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.441 0.564 . . . . 1.0 109.572 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.11 147.71 31.84 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 110.646 -0.131 . . . . 1.0 110.646 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -145.64 140.88 27.65 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.9 m -94.14 -22.43 18.47 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.43 15.85 0.24 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.752 0.821 . . . . 1.0 111.837 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.64 14.98 74.56 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 109.373 -1.491 . . . . 1.0 109.373 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.407 ' O ' ' SG ' ' A' ' 93' ' ' CYS . 13.4 t -50.19 -22.04 1.56 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.113 -0.544 . . . . 1.0 111.798 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 92' ' ' SER . 27.9 p 36.67 34.14 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 177.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.81 -48.47 0.08 OUTLIER Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.505 -0.855 . . . . 1.0 112.13 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.439 ' CD1' ' NH2' ' A' ' 19' ' ' ARG . 99.1 m-85 -107.09 145.43 32.43 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.752 -0.462 . . . . 1.0 109.752 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.79 140.5 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.634 0.773 . . . . 1.0 109.199 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -139.22 162.25 35.45 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.311 0.577 . . . . 1.0 109.683 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 42.4 pt -137.41 165.18 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 114.92 -1.036 . . . . 1.0 110.523 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.65 146.34 27.22 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.631 -0.713 . . . . 1.0 109.56 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 p -122.59 133.29 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 115.299 -0.864 . . . . 1.0 109.86 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -140.55 93.65 8.64 Favored Pre-proline 0 N--CA 1.471 0.601 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -51.19 139.35 43.77 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 121.33 1.353 . . . . 1.0 112.337 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 75.3 p -74.29 136.06 42.61 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 120.789 0.328 . . . . 1.0 110.272 179.703 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.9 ttt85 . . . . . 0 C--O 1.232 0.181 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.5 tt -122.53 140.07 53.18 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.177 0.591 . . . . 1.0 109.646 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.37 176.3 16.17 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.59 100.09 0.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -75.95 134.22 40.26 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.964 -0.754 . . . . 1.0 108.964 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.4 mt -127.21 146.03 50.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.363 -0.835 . . . . 1.0 109.941 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.2 137.2 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -71.61 136.13 47.25 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -166.91 100.64 0.55 Allowed 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.78 -165.65 54.56 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -84.84 26.98 0.78 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.77 0.319 . . . . 1.0 110.237 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -145.23 139.56 27.26 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.608 -0.516 . . . . 1.0 109.608 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.0 mt -91.55 131.64 36.84 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -82.29 114.95 21.12 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.217 -0.29 . . . . 1.0 110.217 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -100.07 105.69 17.36 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.62 141.0 28.96 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.54 -0.755 . . . . 1.0 109.598 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.46 -40.97 17.07 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.674 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 23.5 p-10 -72.28 -8.26 53.9 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.237 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -114.77 49.3 1.05 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 120.896 0.379 . . . . 1.0 110.211 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.82 127.23 1.57 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.905 0.383 . . . . 1.0 110.185 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.4 p -76.49 166.86 22.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 pt -125.37 153.79 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.0 p -137.1 136.64 38.49 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.47 102.46 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.16 -0.776 . . . . 1.0 111.16 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -58.36 123.6 16.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.001 0.429 . . . . 1.0 110.276 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -90.27 137.88 31.99 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.364 0.602 . . . . 1.0 109.663 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.7 m -69.21 169.38 12.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.239 -0.891 . . . . 1.0 110.6 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -65.63 -20.35 66.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.402 -0.817 . . . . 1.0 110.166 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.93 -10.05 40.9 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 120.827 0.346 . . . . 1.0 110.544 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -107.88 -26.49 10.71 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.258 0.623 . . . . 1.0 111.416 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -68.45 -45.37 36.65 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.393 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 35.1 Cg_exo -62.57 -53.31 1.85 Allowed 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 122.317 2.012 . . . . 1.0 112.477 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -54.01 -36.84 63.41 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.649 -0.705 . . . . 1.0 110.994 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.5 tp -76.27 -36.87 58.23 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.93 0.395 . . . . 1.0 110.204 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.41 -20.42 65.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.852 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.7 m -97.02 -8.99 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 110.107 -0.331 . . . . 1.0 110.107 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.5 t -92.77 -26.5 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.415 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -63.36 -47.78 83.54 Favored Pre-proline 0 CA--C 1.551 0.988 0 O-C-N 122.243 -0.286 . . . . 1.0 110.809 -178.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 52' ' ' PHE . 69.7 Cg_exo -54.53 -39.31 88.81 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.336 2.024 . . . . 1.0 111.88 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -62.32 -42.89 99.75 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.096 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -64.25 -42.42 96.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.619 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.18 -29.93 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.84 -0.43 . . . . 1.0 109.84 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.8 m -60.88 -43.62 98.2 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.885 -0.326 . . . . 1.0 111.061 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -68.76 -33.4 73.82 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.27 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.2 mm -62.78 -45.13 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.16 -40.02 80.34 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.828 0.347 . . . . 1.0 110.429 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.9 m -76.6 -27.92 55.94 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.597 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 66' ' ' GLY . 59.4 ttm -60.16 -40.05 88.56 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 110.052 -0.351 . . . . 1.0 110.052 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 mt -62.11 -32.4 72.96 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.9 p -87.29 -59.75 2.17 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.982 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.5 p -78.39 -39.62 38.54 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.441 0.534 . . . . 1.0 112.441 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -80.86 -16.71 74.42 Favored Glycine 0 N--CA 1.474 1.195 0 N-CA-C 111.238 -0.745 . . . . 1.0 111.238 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 40.74 79.11 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.078 0.551 . . . . 1.0 111.621 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.13 157.94 27.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.108 0.48 . . . . 1.0 109.812 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -135.67 79.37 47.02 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.237 -0.892 . . . . 1.0 110.141 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -51.47 -13.32 1.29 Allowed 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 122.365 2.043 . . . . 1.0 111.939 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -73.26 -14.27 61.29 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.089 0.471 . . . . 1.0 110.04 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -138.73 144.95 39.72 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.431 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.06 141.01 47.43 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.277 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -160.64 140.04 10.73 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.3 m -131.97 144.46 50.82 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.639 0.375 . . . . 1.0 110.017 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.1 p -147.03 147.97 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.9 p -125.32 115.6 20.6 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 67.9 mt -98.33 158.22 15.71 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -139.6 123.01 17.15 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -154.94 133.49 11.97 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 53.73 24.2 4.19 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.814 0.34 . . . . 1.0 111.324 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.59 -25.79 7.03 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 111.23 -0.748 . . . . 1.0 111.23 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -65.13 146.39 55.04 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.1 m -139.23 107.07 5.65 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.589 -0.522 . . . . 1.0 109.589 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 54.1 t -98.23 137.55 36.81 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -95.56 134.05 38.88 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.23 133.28 38.85 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -148.4 140.94 24.39 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.576 -0.527 . . . . 1.0 109.576 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 74.9 p -92.38 -38.14 12.18 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 120.757 0.313 . . . . 1.0 111.332 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.0 mp 55.46 23.11 5.56 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.002 0.429 . . . . 1.0 110.119 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 93' ' ' CYS . . . 83.34 12.05 79.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.995 -1.242 . . . . 1.0 109.995 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.9 p -57.43 83.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.848 0.356 . . . . 1.0 110.995 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 91' ' ' GLY . 81.8 m -63.12 119.83 10.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.615 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.43 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . 64.21 31.43 80.81 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.43 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 41.9 m-85 -162.62 153.03 16.67 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.2 p -148.78 140.17 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.337 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -119.49 136.66 54.22 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.1 pt -137.12 160.89 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 120.944 0.402 . . . . 1.0 110.037 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.49 119.84 7.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.597 0.713 . . . . 1.0 110.1 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.7 t -93.36 130.83 41.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-N 114.643 -1.162 . . . . 1.0 108.719 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -137.95 115.84 9.55 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-O 118.689 -0.672 . . . . 1.0 109.69 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.49 145.95 38.6 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.371 1.381 . . . . 1.0 110.813 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.7 t -99.09 148.81 23.67 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 110.192 -0.299 . . . . 1.0 110.192 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 . . . . . 0 CA--C 1.513 -0.455 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 tp -121.59 128.57 52.09 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.232 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.81 153.99 33.51 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.142 -1.183 . . . . 1.0 110.142 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.23 62.67 0.05 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.141 0.496 . . . . 1.0 109.94 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -72.94 132.87 44.0 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.092 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.9 mt -112.92 153.15 28.42 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.469 -0.567 . . . . 1.0 109.469 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.8 m -96.5 136.06 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.442 -0.947 . . . . 1.0 108.442 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -78.11 135.65 37.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -168.1 113.68 0.67 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.181 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.48 -159.0 53.21 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 109.727 -1.349 . . . . 1.0 109.727 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -92.96 10.03 33.08 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 110.362 -0.236 . . . . 1.0 110.362 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -130.61 137.33 49.59 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.138 -0.483 . . . . 1.0 109.954 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.1 mp -89.83 135.98 33.31 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -89.86 115.94 27.56 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.076 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -98.24 104.56 16.61 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.883 -0.784 . . . . 1.0 108.883 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 mt -93.06 115.23 27.9 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.339 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.86 -30.4 70.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.749 -0.659 . . . . 1.0 110.128 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -70.77 -9.58 57.68 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.951 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -112.25 56.84 0.65 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.538 0.685 . . . . 1.0 110.555 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.85 175.28 6.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.58 -0.736 . . . . 1.0 109.432 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.7 m -145.67 163.63 34.3 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.8 mt -107.0 141.37 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.4 m -127.71 138.66 52.86 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.93 -135.06 14.81 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.567 -1.013 . . . . 1.0 110.567 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -168.57 132.96 1.58 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.651 -0.499 . . . . 1.0 109.651 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -115.75 126.89 54.64 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.176 -0.676 . . . . 1.0 109.176 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.8 m -67.88 161.11 27.05 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -56.29 -21.85 26.56 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.729 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.72 -12.58 33.57 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.66 0.267 . . . . 1.0 110.528 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.27 -27.78 8.93 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.025 0.53 . . . . 1.0 111.062 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.495 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -61.66 -46.57 93.55 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.561 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 45.7 Cg_exo -57.71 -47.77 19.77 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.043 1.829 . . . . 1.0 112.522 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -54.63 -51.96 63.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.981 -0.554 . . . . 1.0 111.793 -177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.458 HD11 ' CE1' ' A' ' 83' ' ' PHE . 4.3 mm? -61.69 -41.16 97.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.852 0.358 . . . . 1.0 110.995 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -66.09 -16.64 64.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.103 -0.498 . . . . 1.0 110.227 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.3 t -101.93 -14.72 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 110.168 -0.308 . . . . 1.0 110.168 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.51 -18.71 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.48 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -61.85 -47.23 92.15 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 110.141 -0.318 . . . . 1.0 110.141 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 52' ' ' PHE . 52.9 Cg_exo -56.56 -33.3 92.55 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.273 1.982 . . . . 1.0 111.037 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -59.29 -42.77 92.09 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.7 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -64.94 -42.1 94.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.143 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.1 mm -72.23 -26.71 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.376 -0.529 . . . . 1.0 109.63 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -70.1 -42.89 72.09 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.745 -0.382 . . . . 1.0 111.046 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.578 HE22 ' CD2' ' A' ' 80' ' ' HIS . 53.3 mt-30 -81.8 -50.4 9.28 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.377 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.8 mt -53.17 -46.24 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -55.58 -33.96 64.38 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.519 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m -76.11 -32.9 59.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.734 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.451 ' O ' ' N ' ' A' ' 66' ' ' GLY . 81.1 mmm -59.59 -29.16 67.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.937 0.399 . . . . 1.0 110.328 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.9 mt -60.01 -41.59 92.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.849 0.357 . . . . 1.0 110.125 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.9 m -85.4 -55.02 4.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.242 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.4 m -65.01 -42.05 94.81 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.696 -0.402 . . . . 1.0 111.339 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -86.11 -7.84 79.67 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 50.29 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.662 0.268 . . . . 1.0 110.393 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.4 tp -78.91 143.13 36.14 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -135.41 80.4 45.84 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.814 -0.63 . . . . 1.0 109.77 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.32 88.77 0.83 Allowed 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.11 1.873 . . . . 1.0 110.677 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -171.43 -9.47 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.927 0.394 . . . . 1.0 111.006 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -146.28 147.15 31.09 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.155 0.502 . . . . 1.0 110.867 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.22 131.2 47.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.63 -0.714 . . . . 1.0 109.944 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -162.4 139.22 7.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.431 -0.951 . . . . 1.0 108.431 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 58.3 m -129.88 140.88 50.89 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.6 t -132.94 134.49 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.488 -0.93 . . . . 1.0 108.488 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.2 m -109.7 119.92 40.89 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.54 142.49 40.53 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.122 -0.696 . . . . 1.0 109.122 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 42.3 p90 -133.75 126.47 30.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.578 ' CD2' HE22 ' A' ' 58' ' ' GLN . 79.2 m80 -156.25 139.42 15.56 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 54.45 34.31 20.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.928 0.394 . . . . 1.0 111.576 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.99 -28.63 1.62 Allowed Glycine 0 N--CA 1.467 0.725 0 N-CA-C 111.269 -0.732 . . . . 1.0 111.269 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.458 ' CE1' HD11 ' A' ' 48' ' ' LEU . 69.8 m-85 -70.81 150.46 45.82 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.7 m -138.65 112.77 8.61 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 62.1 m -100.73 143.27 31.09 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -106.38 143.09 35.0 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.12 151.05 40.28 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -162.21 137.67 7.31 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.117 -0.698 . . . . 1.0 109.117 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 67.1 p -87.3 -16.11 36.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.977 -0.101 . . . . 1.0 110.729 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.2 mt 59.19 8.05 1.0 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.162 0.506 . . . . 1.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.73 20.22 78.49 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 110.614 -0.995 . . . . 1.0 110.614 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.9 t -61.9 -145.91 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.782 0.325 . . . . 1.0 110.161 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.3 p -164.8 107.86 0.87 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.19 28.27 68.52 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.483 -1.047 . . . . 1.0 110.483 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -151.96 146.98 26.01 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.1 m -139.71 140.16 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.325 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 8.0 m-85 -125.51 131.92 52.72 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.811 -0.811 . . . . 1.0 108.811 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.4 pt -138.95 163.57 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.73 145.74 25.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.717 -0.845 . . . . 1.0 108.717 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.56 135.54 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.247 -0.888 . . . . 1.0 109.388 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -145.91 143.67 20.13 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.123 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.82 139.88 44.83 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.681 1.587 . . . . 1.0 111.57 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.3 p -81.16 141.85 33.82 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 . . . . . 0 N--CA 1.464 0.264 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 179.809 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 109.554 -0.536 . . . . 1.0 109.554 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 tt -121.82 131.45 54.06 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.733 -0.469 . . . . 1.0 109.733 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.54 164.36 25.46 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.174 -1.171 . . . . 1.0 110.174 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.08 135.82 0.61 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -136.98 130.59 31.73 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.1 mt -111.16 152.77 26.66 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.69 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.49 137.75 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -73.45 138.9 45.45 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.002 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -169.55 107.6 0.4 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.93 -169.94 44.71 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 109.824 -1.31 . . . . 1.0 109.824 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -84.81 23.76 1.14 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 122.717 -0.284 . . . . 1.0 110.32 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -143.65 143.01 31.27 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.748 -0.464 . . . . 1.0 109.748 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.7 mt -95.13 134.63 37.65 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -92.97 117.81 30.47 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.44 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -98.51 104.96 17.04 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.58 112.65 24.67 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.614 -0.721 . . . . 1.0 109.553 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.35 79.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.611 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -69.04 -11.99 61.28 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.567 -0.742 . . . . 1.0 110.583 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -107.97 55.36 0.65 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.879 0.371 . . . . 1.0 111.105 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.41 126.27 0.52 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.206 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -82.48 139.95 33.64 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.229 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.4 mt -85.71 141.33 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 76.9 p -130.9 147.7 52.57 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.001 0.52 . . . . 1.0 109.617 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.89 -150.32 50.34 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.823 -0.911 . . . . 1.0 110.823 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -158.49 130.36 6.72 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -111.53 125.68 54.17 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.609 0.764 . . . . 1.0 109.153 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -65.75 168.57 7.6 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.212 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.79 -22.16 66.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.68 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.42 -9.73 40.58 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 120.667 0.27 . . . . 1.0 110.602 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -108.26 -26.17 10.68 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.845 0.458 . . . . 1.0 111.421 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -67.59 -44.8 45.41 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 110.169 -0.308 . . . . 1.0 110.169 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 45.1 Cg_exo -59.43 -50.9 7.26 Favored 'Trans proline' 0 N--CA 1.503 2.062 0 C-N-CA 122.22 1.946 . . . . 1.0 112.23 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -55.99 -27.44 52.79 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.898 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -39.87 92.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -68.16 -24.93 65.04 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.927 -0.579 . . . . 1.0 111.053 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.64 -44.63 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.308 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.7 t -84.21 -15.1 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 121.205 0.526 . . . . 1.0 110.506 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -55.92 -53.15 66.28 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-O 118.658 -0.687 . . . . 1.0 111.804 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -68.04 -22.04 42.16 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 CA-C-N 121.443 1.551 . . . . 1.0 111.431 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.511 ' NE2' ' ND1' ' A' ' 80' ' ' HIS . 62.0 t-80 -59.24 -46.74 87.67 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.516 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.66 -42.61 91.14 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.87 -0.332 . . . . 1.0 110.531 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.4 mt -71.6 -42.52 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 120.729 -0.389 . . . . 1.0 110.076 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -57.75 -39.11 76.62 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.836 -0.345 . . . . 1.0 111.283 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.31 -46.55 13.48 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 110.565 -0.161 . . . . 1.0 110.565 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.9 mt -63.08 -43.98 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -58.41 -41.51 85.11 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.693 -0.403 . . . . 1.0 110.42 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.1 p -69.15 -31.82 70.75 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 121.018 -0.273 . . . . 1.0 110.359 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 66' ' ' GLY . 42.8 tpp -60.75 -40.9 94.14 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.59 -35.7 78.59 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.015 -0.365 . . . . 1.0 110.015 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.1 p -86.37 -58.84 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.76 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -63.54 -41.13 98.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.777 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -117.1 70.77 0.29 Allowed Glycine 0 N--CA 1.476 1.325 0 N-CA-C 111.448 -0.661 . . . . 1.0 111.448 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -47.2 86.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.006 0.403 . . . . 1.0 111.174 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 66' ' ' GLY . 4.5 tp -82.23 145.75 29.87 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.569 -0.9 . . . . 1.0 108.569 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -134.64 144.01 48.95 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 72' ' ' HIS . 82.1 Cg_exo -38.23 -87.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 122.485 2.123 . . . . 1.0 113.057 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.438 ' O ' ' CG ' ' A' ' 72' ' ' HIS . 81.6 mtp180 58.36 -56.62 0.04 OUTLIER 'General case' 0 C--N 1.346 0.447 0 C-N-CA 123.744 0.817 . . . . 1.0 112.689 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.548 ' N ' ' O ' ' A' ' 70' ' ' PRO . 74.2 m80 -158.66 149.14 19.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.751 -0.658 . . . . 1.0 110.023 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.51 144.13 54.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.504 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -160.51 102.77 1.37 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.038 0.447 . . . . 1.0 110.122 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.37 137.17 39.63 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.804 -0.635 . . . . 1.0 110.655 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.9 t -125.91 134.87 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.0 p -113.18 111.18 21.64 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.344 -0.613 . . . . 1.0 109.344 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.3 mt -95.67 151.47 19.32 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.42 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 50.0 p90 -146.86 127.3 14.05 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.649 0.261 . . . . 1.0 110.308 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.511 ' ND1' ' NE2' ' A' ' 54' ' ' HIS . 58.6 t-80 -159.63 4.11 0.09 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.597 0.237 . . . . 1.0 110.472 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -165.71 22.03 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.156 0.503 . . . . 1.0 110.252 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.89 -29.39 5.06 Favored Glycine 0 N--CA 1.468 0.815 0 N-CA-C 111.087 -0.805 . . . . 1.0 111.087 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -72.74 143.56 47.96 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.422 ' O ' ' CZ ' ' A' ' 101' ' ' TYR . 60.6 p -134.1 107.46 7.75 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.8 t -90.52 140.37 29.8 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -97.88 138.31 35.42 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.133 -0.692 . . . . 1.0 109.133 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.06 149.08 39.46 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 110.013 -0.366 . . . . 1.0 110.013 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -168.51 141.45 2.97 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.0 p -86.03 -29.38 23.5 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.804 0.335 . . . . 1.0 110.285 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.6 mt 59.2 17.7 5.9 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.613 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.74 10.42 76.49 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 109.979 -1.248 . . . . 1.0 109.979 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.4 t -49.59 -22.21 1.22 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 118.927 -0.559 . . . . 1.0 111.944 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 26.2 p 36.76 34.41 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.354 0.872 . . . . 1.0 113.354 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.36 -55.24 0.02 OUTLIER Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.849 -0.5 . . . . 1.0 111.849 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.23 139.13 54.22 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.72 0.408 . . . . 1.0 110.387 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.9 t -106.1 115.71 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -97.97 137.02 37.42 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.883 -0.784 . . . . 1.0 108.883 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.2 pt -138.31 161.19 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.29 147.76 27.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.942 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.05 131.21 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.082 -0.963 . . . . 1.0 109.357 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 11.3 p90 -131.71 94.25 25.94 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 108.734 -0.839 . . . . 1.0 108.734 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.79 137.64 34.49 Favored 'Trans proline' 0 N--CA 1.503 2.056 0 C-N-CA 121.524 1.483 . . . . 1.0 111.742 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 t -96.07 148.72 22.38 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 120.948 0.404 . . . . 1.0 110.219 -179.77 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -130.08 149.24 51.88 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.56 0.695 . . . . 1.0 110.481 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.82 138.24 20.54 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.639 -1.384 . . . . 1.0 109.639 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.29 53.81 0.22 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.455 0.645 . . . . 1.0 109.438 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -76.41 128.91 35.76 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.847 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.6 mt -92.63 150.0 20.98 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.891 -0.411 . . . . 1.0 109.891 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.5 p -104.24 136.49 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -76.12 130.74 38.77 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.358 -0.383 . . . . 1.0 109.998 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -170.29 109.7 0.38 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.45 -165.67 54.76 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 109.685 -1.366 . . . . 1.0 109.685 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -87.21 10.91 15.45 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.896 -0.409 . . . . 1.0 109.896 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -129.76 141.06 50.93 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.736 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 54.8 mt -90.55 124.99 35.46 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -82.85 116.01 21.98 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.637 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -101.05 107.33 18.75 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.04 118.36 31.72 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.649 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.47 80.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.034 0.445 . . . . 1.0 110.739 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -67.83 -11.2 58.07 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.905 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -111.3 58.62 0.62 Allowed 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.041 0.448 . . . . 1.0 110.508 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.09 176.35 4.67 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.978 -0.556 . . . . 1.0 109.626 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -133.19 127.91 34.83 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.587 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 pt -85.32 147.73 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 82.5 p -133.21 134.76 44.47 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.8 102.66 0.01 OUTLIER Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -58.75 129.79 43.79 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.995 0.426 . . . . 1.0 110.113 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -96.02 136.33 36.61 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.745 -0.662 . . . . 1.0 109.853 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -67.1 167.43 11.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.381 -0.827 . . . . 1.0 110.709 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -64.46 -20.58 66.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.605 -0.725 . . . . 1.0 110.616 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.57 -11.01 38.48 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.006 0.432 . . . . 1.0 110.517 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -107.72 -24.28 11.78 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.283 0.633 . . . . 1.0 111.812 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.47 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -70.68 -45.36 17.27 Favored Pre-proline 0 CA--C 1.551 0.995 0 O-C-N 122.093 -0.38 . . . . 1.0 110.27 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 52.5 Cg_exo -58.15 -50.58 9.61 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 122.328 2.019 . . . . 1.0 113.167 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -60.2 -43.93 95.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.303 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.2 tt -61.47 -39.64 91.62 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.34 -10.59 11.64 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.088 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 81.2 t -101.42 -15.34 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 109.557 -0.535 . . . . 1.0 109.557 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.93 -28.39 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 110.52 -0.178 . . . . 1.0 110.52 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.423 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -67.06 -46.65 52.92 Favored Pre-proline 0 N--CA 1.483 1.223 0 O-C-N 122.393 -0.192 . . . . 1.0 111.156 -178.682 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 52' ' ' PHE . 54.6 Cg_exo -56.59 -36.35 97.88 Favored 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 122.494 2.129 . . . . 1.0 111.885 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -65.31 -40.51 93.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 1.0 109.954 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 59' ' ' ILE . 59.3 t80 -64.21 -41.62 96.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.502 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.5 mm -69.43 -36.91 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.4 t -59.13 -45.57 90.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.625 -0.261 . . . . 1.0 111.392 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.436 ' O ' ' SD ' ' A' ' 62' ' ' MET . 29.1 mm100 -67.85 -37.81 82.35 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.852 -0.158 . . . . 1.0 110.846 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.66 HD11 ' CE2' ' A' ' 55' ' ' PHE . 82.0 mt -59.08 -43.67 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.915 -0.491 . . . . 1.0 109.815 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -58.13 -39.48 78.84 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.815 0.34 . . . . 1.0 110.275 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -65.34 -39.59 92.59 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.459 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -60.3 -40.71 91.45 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 110.348 -0.241 . . . . 1.0 110.348 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.69 -34.93 76.63 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.546 -0.539 . . . . 1.0 109.546 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.3 p -86.02 -62.41 1.53 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.309 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.8 p -74.72 -39.64 61.77 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.042 0.386 . . . . 1.0 112.042 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.29 -4.7 90.41 Favored Glycine 0 N--CA 1.47 0.961 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 31.79 78.6 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.699 0.8 . . . . 1.0 112.113 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.63 151.43 32.3 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.247 0.546 . . . . 1.0 109.657 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -141.29 74.84 23.97 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.154 -0.93 . . . . 1.0 110.013 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -48.2 105.97 0.1 OUTLIER 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 122.332 2.022 . . . . 1.0 111.648 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -171.02 -16.08 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.663 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -142.53 142.37 32.22 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.931 0.396 . . . . 1.0 110.999 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.3 125.73 24.51 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.768 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -162.01 103.99 1.16 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 27.7 p -90.29 148.13 23.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.433 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.58 152.27 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.8 p -128.01 110.27 12.35 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.801 -0.444 . . . . 1.0 109.801 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 78' ' ' LEU . 9.5 mp -91.94 158.87 16.03 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.828 -0.805 . . . . 1.0 108.828 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -140.94 122.63 15.24 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -157.81 134.6 9.89 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 53.92 27.5 7.38 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.104 0.478 . . . . 1.0 111.406 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.63 -24.91 4.12 Favored Glycine 0 N--CA 1.469 0.85 0 N-CA-C 111.532 -0.627 . . . . 1.0 111.532 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -67.61 140.85 56.9 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 67.8 m -129.27 109.19 10.91 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 39.8 t -95.53 140.74 29.93 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -106.0 130.2 53.97 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.85 140.2 45.64 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -145.05 133.56 21.96 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.771 -0.825 . . . . 1.0 108.771 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.8 p -92.69 -32.2 14.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.012 0.434 . . . . 1.0 110.712 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.46 12.69 1.56 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.526 -0.546 . . . . 1.0 109.526 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.81 18.28 77.4 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 109.179 -1.568 . . . . 1.0 109.179 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.8 m -67.49 75.6 0.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.111 0.482 . . . . 1.0 111.668 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 43.6 t -65.69 48.96 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.773 -1.103 . . . . 1.0 110.559 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.412 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . -166.38 -21.16 0.02 OUTLIER Glycine 0 CA--C 1.531 1.087 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.412 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 87.0 m-85 -158.41 170.78 21.45 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.938 0.369 . . . . 1.0 110.284 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.67 113.22 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -86.93 133.53 33.59 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.985 -0.376 . . . . 1.0 109.985 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.1 pt -143.33 161.85 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-N 118.221 0.464 . . . . 1.0 110.625 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.5 148.0 26.88 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.315 0.578 . . . . 1.0 110.4 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.451 ' H ' HD11 ' A' ' 16' ' ' LEU . 28.9 m -133.18 137.18 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.028 -0.987 . . . . 1.0 110.508 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -151.55 148.16 21.58 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.1 141.75 71.24 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 121.361 1.374 . . . . 1.0 111.257 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.0 m -74.48 136.96 42.25 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 . . . . . 0 N--CA 1.464 0.237 0 CA-C-O 120.775 0.322 . . . . 1.0 110.201 -179.826 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 108.364 -0.976 . . . . 1.0 108.364 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.2 tt -109.54 116.24 31.41 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.36 161.99 27.93 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 110.254 -1.139 . . . . 1.0 110.254 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.12 72.75 0.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 1.0 110.433 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -83.72 125.85 32.31 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.28 153.94 20.92 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.232 0.613 . . . . 1.0 109.445 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.14 140.87 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 108.817 -0.808 . . . . 1.0 108.817 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -81.38 108.34 14.91 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -65.0 -51.95 58.82 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.288 0.566 . . . . 1.0 109.676 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.95 -77.6 0.1 Allowed Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.058 -1.217 . . . . 1.0 110.058 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -100.28 8.06 43.99 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.892 0.477 . . . . 1.0 110.317 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -155.99 156.24 34.12 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.015 -0.365 . . . . 1.0 110.015 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.43 121.65 40.63 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.082 -0.71 . . . . 1.0 109.082 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.96 119.74 31.39 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.297 0.239 . . . . 1.0 110.6 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -99.84 101.99 13.29 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.82 109.12 19.06 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.848 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.81 -28.02 68.47 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.132 0.491 . . . . 1.0 110.708 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -68.33 -11.62 59.81 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.573 -0.739 . . . . 1.0 111.046 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -109.37 45.77 1.04 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 120.869 0.366 . . . . 1.0 110.118 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.71 127.4 0.91 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.759 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.5 m -95.24 167.74 11.16 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.3 tp -94.9 141.16 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.5 m -128.25 125.3 38.64 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.99 153.53 8.59 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.809 -0.916 . . . . 1.0 110.809 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -92.81 125.95 37.66 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.825 0.345 . . . . 1.0 110.271 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -112.1 129.47 56.21 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 m -71.3 164.32 25.94 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.969 0.414 . . . . 1.0 110.382 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -63.98 -20.25 65.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.459 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.95 -11.92 34.82 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.88 0.371 . . . . 1.0 110.284 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -107.19 -25.85 11.34 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.08 0.552 . . . . 1.0 111.452 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -67.8 -45.39 43.92 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 120.904 -0.319 . . . . 1.0 110.391 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 51.9 Cg_exo -56.65 -46.86 26.75 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 122.345 2.03 . . . . 1.0 112.527 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.67 -32.67 69.32 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.595 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tp -63.28 -37.75 88.46 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.13 0.491 . . . . 1.0 110.095 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -68.96 -11.06 60.34 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.462 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.9 t -82.76 -48.49 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 110.35 -0.241 . . . . 1.0 110.35 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.18 -26.79 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 120.622 0.249 . . . . 1.0 111.497 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -54.89 -61.83 5.17 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-O 119.51 -0.281 . . . . 1.0 111.373 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -60.85 -30.48 90.2 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.636 1.557 . . . . 1.0 111.288 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -61.89 -44.78 96.09 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.735 -0.468 . . . . 1.0 109.735 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -65.62 -41.94 92.13 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.529 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.5 mt -72.58 -36.83 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.143 0.497 . . . . 1.0 109.795 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 t -68.83 -40.23 79.56 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.316 0.858 . . . . 1.0 113.316 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -81.7 -46.19 14.65 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 122.113 -0.367 . . . . 1.0 111.57 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 tt -54.88 -36.03 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.777 0.322 . . . . 1.0 110.515 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -54.97 -46.22 75.05 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.605 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 m -70.87 -32.44 69.44 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.149 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.8 ttm -59.72 -31.64 69.8 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.316 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.05 -41.75 93.0 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.681 -0.489 . . . . 1.0 109.681 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.6 m -85.61 -55.57 3.93 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.381 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.6 p -66.47 -39.12 88.63 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 121.114 -0.235 . . . . 1.0 111.476 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.4 1.03 78.48 Favored Glycine 0 N--CA 1.472 1.064 0 N-CA-C 110.341 -1.104 . . . . 1.0 110.341 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 41.85 71.23 0.22 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.054 0.542 . . . . 1.0 111.069 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.0 144.99 29.58 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.201 0.524 . . . . 1.0 110.096 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -129.77 79.86 72.6 Favored Pre-proline 0 N--CA 1.471 0.589 0 CA-C-N 115.237 -0.892 . . . . 1.0 109.186 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -45.54 98.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.942 1.762 . . . . 1.0 112.406 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -170.19 -63.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.837 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -94.39 137.55 33.4 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 116.475 -0.329 . . . . 1.0 110.264 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.0 142.61 58.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.47 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -161.1 104.88 1.31 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 43.0 m -74.91 139.64 43.22 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.197 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.9 t -134.22 139.05 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.1 p -115.28 115.01 25.96 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.602 0.361 . . . . 1.0 110.261 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tt -102.58 143.07 32.74 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.857 0.463 . . . . 1.0 109.941 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.59 127.98 17.86 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 110.184 -0.302 . . . . 1.0 110.184 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -159.16 9.51 0.12 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.463 0.173 . . . . 1.0 111.032 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -166.11 34.3 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.255 0.55 . . . . 1.0 110.373 179.035 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.15 -28.07 1.43 Allowed Glycine 0 N--CA 1.465 0.595 0 N-CA-C 111.235 -0.746 . . . . 1.0 111.235 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.411 ' H ' ' C ' ' A' ' 81' ' ' ASN . 58.6 m-85 -83.36 146.26 28.58 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.8 p -132.49 108.17 8.95 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 96.1 m -87.13 132.9 33.7 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -91.58 135.99 33.46 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.67 0.668 . . . . 1.0 109.32 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.83 137.04 39.33 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -146.1 139.71 26.2 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.3 m -90.12 -11.64 40.67 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.82 0.343 . . . . 1.0 110.592 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.49 9.08 0.71 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.49 25.84 60.29 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.2 p -66.68 -140.32 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 53.0 t -167.67 -39.14 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.651 0.262 . . . . 1.0 110.307 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.418 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . -133.29 36.26 2.16 Favored Glycine 0 N--CA 1.477 1.385 0 N-CA-C 110.525 -1.03 . . . . 1.0 110.525 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.418 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 95.7 m-85 -157.22 145.62 19.48 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 45.0 t -134.44 134.82 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -122.51 133.04 54.59 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.5 pt -138.83 159.67 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-O 120.965 0.412 . . . . 1.0 110.303 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.68 124.5 10.56 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.532 0.682 . . . . 1.0 109.658 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.36 131.7 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.093 -0.958 . . . . 1.0 109.779 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -135.92 105.0 9.69 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 108.706 -0.849 . . . . 1.0 108.706 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -69.96 142.05 46.02 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 CA-C-N 121.223 1.473 . . . . 1.0 111.426 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 63.7 p -90.63 146.65 23.87 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.847 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 120.729 0.299 . . . . 1.0 110.238 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 121.088 0.47 . . . . 1.0 110.253 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 pp -41.88 148.62 0.16 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.92 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.38 179.66 16.06 Favored Glycine 0 N--CA 1.477 1.379 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.39 146.57 18.5 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -100.96 120.64 40.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.672 -0.695 . . . . 1.0 111.081 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.3 mt -131.34 131.81 44.02 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.83 140.97 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -71.47 132.22 44.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.994 -0.372 . . . . 1.0 109.994 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -157.69 105.05 2.0 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.04 -165.64 50.84 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 109.724 -1.35 . . . . 1.0 109.724 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -84.4 29.05 0.61 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.014 0.435 . . . . 1.0 109.868 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -148.27 143.86 27.24 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.339 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -96.45 130.15 43.66 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -85.91 115.79 23.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.057 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -96.41 109.11 21.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.482 -0.932 . . . . 1.0 108.482 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.01 115.86 28.24 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.936 -0.574 . . . . 1.0 109.67 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.03 -37.85 88.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.144 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -66.26 -9.44 32.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.737 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.48 67.59 0.67 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.327 0.584 . . . . 1.0 110.179 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.69 172.35 6.89 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.4 m -139.84 138.33 35.67 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 tp -93.83 145.01 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.4 p -129.72 148.1 51.57 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.59 -146.57 26.0 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 111.076 -0.809 . . . . 1.0 111.076 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -166.64 75.7 0.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.316 0.579 . . . . 1.0 110.519 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -61.49 138.19 58.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.248 0.546 . . . . 1.0 110.171 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 87.1 p -71.7 167.86 18.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.44 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -65.53 -20.9 66.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.379 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.59 -9.32 44.58 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.878 0.37 . . . . 1.0 110.551 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -109.32 -30.54 7.94 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.213 0.605 . . . . 1.0 111.288 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.473 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -61.58 -45.32 93.67 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 120.781 -0.367 . . . . 1.0 110.189 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 44.8 Cg_exo -59.15 -50.21 9.21 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 122.392 2.062 . . . . 1.0 112.664 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.38 -46.42 88.72 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.335 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.441 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.1 tt -60.66 -39.01 86.81 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.097 0.475 . . . . 1.0 109.98 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -60.62 -12.48 10.28 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.2 t -104.22 -18.48 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.8 t -90.28 -33.37 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.546 ' CE2' HD11 ' A' ' 56' ' ' ILE . 65.8 t80 -62.75 -49.67 81.36 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 118.534 -0.746 . . . . 1.0 111.248 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 52' ' ' PHE . 44.3 Cg_endo -58.83 -26.26 79.75 Favored 'Trans proline' 0 N--CA 1.511 2.507 0 CA-C-N 121.323 1.508 . . . . 1.0 112.132 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 80' ' ' HIS . 17.6 t60 -60.48 -43.39 97.02 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.839 0.352 . . . . 1.0 110.175 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -64.48 -40.57 95.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.094 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.546 HD11 ' CE2' ' A' ' 52' ' ' PHE . 57.7 mt -65.47 -43.86 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 120.064 -0.654 . . . . 1.0 109.286 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.6 t -58.7 -46.08 88.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.104 -0.238 . . . . 1.0 111.239 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -70.48 -38.67 74.42 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.846 -0.161 . . . . 1.0 111.028 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.2 mt -61.08 -45.63 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 109.999 -0.371 . . . . 1.0 109.999 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -52.98 -41.93 65.07 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.544 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.7 p -75.99 -29.82 58.34 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.649 -0.25 . . . . 1.0 110.463 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 66' ' ' GLY . 12.1 tmm? -61.66 -33.32 73.75 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 110.251 -0.277 . . . . 1.0 110.251 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.74 -40.61 97.77 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.8 p -75.17 -56.22 4.94 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.389 -0.368 . . . . 1.0 111.268 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.1 p -68.65 -39.07 80.84 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.68 0.276 . . . . 1.0 111.255 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -80.96 -14.91 78.64 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 52.06 84.77 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.6 tp -81.35 142.88 32.62 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.763 -0.829 . . . . 1.0 108.763 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -151.95 131.24 6.69 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 119.221 -0.419 . . . . 1.0 110.355 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.18 102.2 1.58 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.361 1.374 . . . . 1.0 110.408 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -146.23 -34.24 0.3 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.257 0.551 . . . . 1.0 111.391 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -166.26 155.53 11.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.048 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.35 146.64 50.66 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.428 -0.806 . . . . 1.0 110.308 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -159.66 102.95 1.53 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.322 0.582 . . . . 1.0 109.759 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.1 t -83.16 137.29 34.12 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.181 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.36 153.09 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -131.85 103.18 6.18 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 78' ' ' LEU . 9.8 mp -90.87 143.8 26.35 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.368 -0.975 . . . . 1.0 108.368 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -125.44 127.75 47.0 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 54' ' ' HIS . 79.6 t60 -163.04 139.67 7.36 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.4 m120 53.34 26.1 5.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.981 0.42 . . . . 1.0 111.311 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.79 -28.42 3.19 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -70.27 149.13 47.75 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.511 -0.552 . . . . 1.0 109.511 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.5 m -135.7 120.85 18.9 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.473 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 65.5 m -107.05 139.65 41.11 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.296 -1.001 . . . . 1.0 108.296 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -104.7 140.83 37.49 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 108.807 -0.812 . . . . 1.0 108.807 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.91 151.26 38.41 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 110.011 -0.366 . . . . 1.0 110.011 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -166.56 139.76 3.89 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.4 m -76.33 -20.04 57.63 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 110.468 -0.197 . . . . 1.0 110.468 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.0 mt 62.67 10.42 4.15 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.986 0.422 . . . . 1.0 110.202 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.61 13.46 83.46 Favored Glycine 0 N--CA 1.466 0.642 0 N-CA-C 110.546 -1.021 . . . . 1.0 110.546 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.6 p -62.13 -143.34 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.564 0.221 . . . . 1.0 110.473 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 23.7 p -170.64 107.39 0.3 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.78 0.324 . . . . 1.0 110.351 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.02 -9.64 37.74 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 111.216 -0.753 . . . . 1.0 111.216 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -113.94 141.95 46.74 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.039 0.536 . . . . 1.0 109.582 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.2 136.81 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 108.901 -0.777 . . . . 1.0 108.901 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -125.65 138.59 53.91 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.213 -1.032 . . . . 1.0 108.213 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.8 pt -137.38 165.2 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.982 0.42 . . . . 1.0 109.952 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.92 108.47 3.82 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.73 139.36 17.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 114.745 -1.116 . . . . 1.0 108.744 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -147.54 129.3 7.41 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.29 143.52 43.81 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 CA-C-N 120.539 1.228 . . . . 1.0 111.692 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 103' ' ' THR . 1.4 t -87.24 147.38 25.58 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.079 -0.51 . . . . 1.0 109.633 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 . . . . . 0 CA--C 1.532 0.265 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.236 -179.938 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 . . . . . 0 N--CA 1.469 0.483 0 N-CA-C 109.832 -0.432 . . . . 1.0 109.832 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 tt -119.93 114.86 22.69 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.45 156.77 43.47 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 109.822 -1.311 . . . . 1.0 109.822 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -165.34 71.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -73.91 128.99 36.99 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.0 mt -116.67 153.5 32.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.905 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.85 137.08 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.375 -0.972 . . . . 1.0 108.375 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -81.45 130.46 35.05 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -160.52 124.05 3.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.258 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.18 -147.53 50.82 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 109.953 -1.259 . . . . 1.0 109.953 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -105.18 15.42 27.5 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 110.171 -0.307 . . . . 1.0 110.171 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.411 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 17.8 mp0 -135.8 143.46 45.21 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.052 0.453 . . . . 1.0 110.122 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 50.8 mt -91.85 131.03 37.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -88.26 116.87 26.78 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -100.07 106.71 18.48 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 30' ' ' LEU . 11.0 mp -91.24 111.8 23.43 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.52 -35.1 73.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.237 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -71.62 -8.33 53.41 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.656 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -110.56 63.11 0.61 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.133 0.492 . . . . 1.0 110.378 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.9 175.09 4.56 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 t -141.43 138.06 32.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.957 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.0 mm -82.6 141.81 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.12 -0.326 . . . . 1.0 110.12 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.447 ' C ' ' H ' ' A' ' 39' ' ' LYS . 73.8 p -132.81 146.48 51.86 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.675 0.39 . . . . 1.0 110.035 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.99 -9.31 2.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 37' ' ' THR . 48.5 mtmt 50.77 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 O-C-N 122.462 -0.434 . . . . 1.0 111.25 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -69.36 139.91 54.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.299 0.571 . . . . 1.0 110.572 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.3 p -72.69 171.09 13.19 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.386 -0.825 . . . . 1.0 110.125 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.28 -19.28 65.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.434 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.98 -10.73 38.25 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 120.816 0.341 . . . . 1.0 110.544 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -109.27 -24.42 11.1 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.645 0.778 . . . . 1.0 111.227 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -67.27 -46.27 50.35 Favored Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.119 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 28.5 Cg_exo -63.75 -55.08 0.74 Allowed 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.22 1.947 . . . . 1.0 112.398 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -56.85 -45.22 82.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.254 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.16 -39.67 87.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.291 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -62.24 -20.23 64.01 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.384 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.4 t -92.55 -21.99 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.1 t -85.78 -13.45 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 110.094 -0.335 . . . . 1.0 110.094 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.444 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -65.49 -59.39 9.59 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 122.286 -0.259 . . . . 1.0 110.512 178.377 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 52' ' ' PHE . 30.8 Cg_endo -55.65 -24.66 46.63 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.642 1.561 . . . . 1.0 112.089 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -66.17 3.86 0.8 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.751 0.31 . . . . 1.0 110.988 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 53' ' ' PRO . 44.5 m-85 -131.95 -40.96 1.04 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.751 0.421 . . . . 1.0 110.424 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.13 -42.5 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.3 p -57.1 -41.98 79.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.977 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -67.05 -56.47 9.93 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.666 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.15 -45.71 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -52.37 -37.91 57.5 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.74 -0.384 . . . . 1.0 111.011 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.5 p -76.77 -32.33 57.65 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.125 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 78.0 mmm -56.43 -31.17 63.67 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.282 -0.266 . . . . 1.0 110.282 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.2 mt -61.51 -37.13 82.59 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.6 m -92.05 -58.8 2.28 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.161 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.5 m -66.58 -43.07 85.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.648 -0.421 . . . . 1.0 111.864 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.66 -10.54 81.33 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 110.544 -1.023 . . . . 1.0 110.544 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 47.46 77.29 0.09 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 110.183 -0.303 . . . . 1.0 110.183 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.517 HD13 ' N ' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -86.57 126.91 34.8 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 -178.25 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.517 ' N ' HD13 ' A' ' 68' ' ' LEU . 70.9 m-80 -145.64 151.07 45.6 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.572 -0.285 . . . . 1.0 110.523 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.36 87.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.503 2.046 0 C-N-CA 121.86 1.707 . . . . 1.0 111.688 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -133.09 -60.2 0.86 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 120.868 0.366 . . . . 1.0 110.571 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -153.56 140.01 18.7 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.952 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.74 126.14 28.78 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.689 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -138.39 103.77 4.99 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.4 t -78.59 136.01 37.41 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.819 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.5 t -125.62 136.26 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.9 p -116.97 110.96 18.94 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 68.1 mt -89.91 160.65 16.32 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 50.0 p90 -143.57 130.56 20.57 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.047 -0.353 . . . . 1.0 110.047 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.48 ' C ' ' H ' ' A' ' 82' ' ' GLY . 74.1 t60 -157.75 -96.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' A' ' 83' ' ' PHE . 59.0 t30 -70.02 35.43 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.87 0.366 . . . . 1.0 111.503 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . 77.53 -28.83 1.76 Allowed Glycine 0 N--CA 1.466 0.657 0 N-CA-C 110.735 -0.946 . . . . 1.0 110.735 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.489 ' CZ ' HG23 ' A' ' 100' ' ' VAL . 6.9 t80 -78.52 147.23 33.92 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.487 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 35.6 p -134.08 116.24 15.22 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.958 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 45.6 t -87.51 142.16 28.07 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -102.01 136.89 41.07 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.325 -0.621 . . . . 1.0 109.325 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.64 151.64 41.65 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -168.72 152.49 5.54 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.2 m -98.58 -18.18 18.27 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.667 0.27 . . . . 1.0 110.67 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.7 mp 59.41 8.97 1.29 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.07 15.37 76.48 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.101 -1.199 . . . . 1.0 110.101 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.1 m -65.62 -134.95 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.01 -0.367 . . . . 1.0 110.01 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 20.8 p -170.61 105.97 0.28 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.865 0.364 . . . . 1.0 110.054 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.37 33.9 78.61 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.652 -0.979 . . . . 1.0 110.652 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -151.25 137.16 18.14 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 m -142.3 138.33 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.307 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.429 ' N ' ' CD1' ' A' ' 97' ' ' TYR . 21.5 m-85 -116.69 120.39 38.45 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 156.8 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.296 -1.001 . . . . 1.0 108.296 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.43 150.8 30.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.18 -0.918 . . . . 1.0 109.328 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.489 HG23 ' CZ ' ' A' ' 83' ' ' PHE . 2.7 p -123.38 135.66 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 115.115 -0.948 . . . . 1.0 109.568 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 13.4 p90 -149.03 97.33 3.64 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.135 -0.938 . . . . 1.0 108.971 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -51.63 144.84 32.05 Favored 'Trans proline' 0 N--CA 1.507 2.279 0 C-N-CA 121.922 1.748 . . . . 1.0 112.058 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 80.7 p -63.29 134.04 55.17 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.348 -0.387 . . . . 1.0 109.98 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.747 0.308 . . . . 1.0 110.323 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 . . . . . 0 CA--C 1.52 -0.206 0 CA-C-O 120.784 0.326 . . . . 1.0 110.839 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.0 tp -116.39 118.32 32.4 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.388 -1.338 . . . . 1.0 107.388 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.34 161.9 33.02 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 108.73 -1.748 . . . . 1.0 108.73 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.39 67.6 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -73.31 122.17 21.58 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.295 -0.632 . . . . 1.0 109.295 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.6 mt -90.06 144.91 25.47 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.702 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -102.99 136.79 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -75.75 133.61 40.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.942 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -172.25 109.18 0.23 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.016 -0.735 . . . . 1.0 109.016 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.66 -161.48 53.76 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 109.759 -1.337 . . . . 1.0 109.759 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -87.14 5.87 35.7 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.732 0.301 . . . . 1.0 110.389 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -127.79 136.36 51.37 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.09 0.471 . . . . 1.0 110.054 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.2 mp -89.07 127.73 35.71 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.941 -0.762 . . . . 1.0 108.941 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -83.9 116.31 22.71 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.664 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -97.67 103.65 15.6 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.847 -1.168 . . . . 1.0 107.847 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 30' ' ' LEU . 10.5 mp -86.68 134.62 33.59 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.052 -0.722 . . . . 1.0 109.052 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.05 -24.58 30.38 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.883 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -73.93 -10.44 59.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.028 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -108.41 16.64 22.9 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.537 0.335 . . . . 1.0 110.473 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.22 127.67 10.0 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.2 m -86.92 170.27 11.77 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.853 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.4 pt -97.4 155.07 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 82.0 p -134.45 128.64 33.88 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.48 99.16 0.01 OUTLIER Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.102 -0.799 . . . . 1.0 111.102 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -56.07 99.64 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.789 0.328 . . . . 1.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -69.23 140.08 54.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.007 -0.542 . . . . 1.0 109.544 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -69.46 171.07 9.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.276 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -64.28 -21.18 66.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.58 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.32 -22.51 20.5 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 120.825 0.345 . . . . 1.0 110.103 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -96.87 -26.36 15.11 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.904 0.482 . . . . 1.0 110.717 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -60.36 -57.59 25.53 Favored Pre-proline 0 CA--C 1.555 1.135 0 O-C-N 122.089 -0.382 . . . . 1.0 110.127 177.534 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 45' ' ' CYS . 35.0 Cg_endo -56.22 -41.91 71.69 Favored 'Trans proline' 0 N--CA 1.51 2.478 0 C-N-CA 122.497 2.131 . . . . 1.0 112.688 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -56.74 -37.31 70.84 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.951 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.55 -31.11 47.25 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.047 0.451 . . . . 1.0 110.091 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.13 -40.82 86.84 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.629 -0.669 . . . . 1.0 110.685 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.2 m -75.12 -20.56 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -86.01 -20.54 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.184 0.516 . . . . 1.0 110.045 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.79 -57.06 26.53 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.063 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -56.6 -26.92 67.14 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.161 1.241 . . . . 1.0 111.72 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -77.35 16.08 0.66 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.749 0.309 . . . . 1.0 110.97 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -131.32 -37.33 1.24 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.12 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.7 mm -74.74 -30.78 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.8 m -60.82 -43.92 97.6 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.844 0.354 . . . . 1.0 111.132 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -65.42 -42.5 92.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.91 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.14 -46.94 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.37 -45.9 90.15 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.5 t -65.81 -40.67 92.09 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.495 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.428 ' O ' ' N ' ' A' ' 66' ' ' GLY . 45.6 ttm -50.67 -44.05 57.58 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.863 0.363 . . . . 1.0 110.925 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.37 -37.33 86.86 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.283 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -68.77 -61.72 1.69 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.756 0.312 . . . . 1.0 111.616 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.4 t -72.4 -39.47 67.92 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.067 0.46 . . . . 1.0 110.781 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -98.51 73.4 0.57 Allowed Glycine 0 N--CA 1.462 0.396 0 N-CA-C 109.073 -1.611 . . . . 1.0 109.073 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.25 88.82 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -82.72 123.67 29.51 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.774 -1.195 . . . . 1.0 107.774 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.418 ' N ' HD13 ' A' ' 68' ' ' LEU . 24.1 m120 -122.68 147.03 49.51 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-O 119.286 -0.388 . . . . 1.0 110.727 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.28 88.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.506 2.233 0 C-N-CA 121.419 1.412 . . . . 1.0 112.159 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -131.67 -50.83 0.98 Allowed 'General case' 0 N--CA 1.48 1.065 0 O-C-N 121.999 -0.438 . . . . 1.0 109.9 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -163.36 151.72 13.78 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.767 -178.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.85 150.31 20.5 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.717 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -155.4 139.64 16.61 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.2 t -130.55 143.63 50.88 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.628 -0.508 . . . . 1.0 109.628 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.86 144.88 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.597 -0.52 . . . . 1.0 109.597 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.6 p -115.36 116.36 28.14 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 67.4 mt -99.79 134.76 42.22 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.52 -0.919 . . . . 1.0 108.52 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.414 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 47.2 p90 -115.03 127.58 55.73 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -156.72 141.2 16.72 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.456 ' ND2' ' CD1' ' A' ' 83' ' ' PHE . 5.7 p-10 43.91 29.5 0.32 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.237 0.458 . . . . 1.0 112.237 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.21 -27.25 4.61 Favored Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.876 -0.89 . . . . 1.0 110.876 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.456 ' CD1' ' ND2' ' A' ' 81' ' ' ASN . 6.5 m-85 -68.78 150.02 48.34 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.0 m -142.29 108.11 5.14 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.139 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.5 m -93.63 143.04 26.68 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -99.36 140.75 33.08 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.61 150.27 37.15 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 110.288 -0.264 . . . . 1.0 110.288 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -164.54 134.18 3.82 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.8 m -77.21 -42.59 36.84 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.991 0.424 . . . . 1.0 110.729 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' A' ' 92' ' ' SER . 57.5 mt 58.01 37.09 26.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.118 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.41 5.93 1.99 Allowed Glycine 0 CA--C 1.533 1.209 0 N-CA-C 111.386 -0.686 . . . . 1.0 111.386 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 90' ' ' LEU . 28.7 t -104.36 57.47 0.71 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.7 p -58.41 -23.41 57.18 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 119.954 -0.698 . . . . 1.0 110.386 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.66 -12.82 48.77 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.907 -0.877 . . . . 1.0 110.907 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -155.18 119.57 4.7 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 t -101.59 113.68 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -90.49 131.01 36.48 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.163 -0.68 . . . . 1.0 109.163 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.9 pt -139.03 161.55 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.1 111.57 3.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.402 0.62 . . . . 1.0 109.397 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.1 t -91.49 136.07 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 114.845 -1.071 . . . . 1.0 108.658 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -145.38 128.19 8.21 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 119.029 -0.51 . . . . 1.0 109.761 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.27 145.74 39.22 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.374 1.383 . . . . 1.0 111.243 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.2 p -83.58 138.67 33.27 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 . . . . . 0 C--N 1.332 -0.172 0 CA-C-O 120.783 0.325 . . . . 1.0 110.343 -179.692 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -153.26 149.3 27.78 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.913 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -62.78 -45.96 90.23 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.711 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.3 m -124.55 130.83 53.19 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.093 0.557 . . . . 1.0 109.998 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.5 m -139.83 126.38 20.38 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -53.43 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.523 0.201 . . . . 1.0 110.766 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.01 -169.15 0.54 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.224 -0.75 . . . . 1.0 111.224 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 mt -56.71 146.36 25.99 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.155 0.502 . . . . 1.0 110.285 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -71.56 88.47 0.94 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.513 -0.767 . . . . 1.0 110.08 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -140.38 134.91 31.53 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -124.37 14.57 8.93 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.127 0.489 . . . . 1.0 109.985 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.404 ' H ' HG13 ' A' ' 12' ' ' ILE . 1.4 mt -71.88 -173.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 107.067 -1.457 . . . . 1.0 107.067 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -43.97 -60.81 2.4 Favored Pre-proline 0 N--CA 1.483 1.214 0 CA-C-N 118.936 0.789 . . . . 1.0 110.893 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -70.46 74.73 1.57 Allowed 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.756 1.638 . . . . 1.0 109.821 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -88.55 1.36 55.08 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.19 -0.319 . . . . 1.0 110.647 -177.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tt -113.35 133.52 55.1 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.059 -0.719 . . . . 1.0 109.059 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -136.01 -171.17 12.24 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 109.76 -1.336 . . . . 1.0 109.76 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.41 71.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.446 ' O ' ' NH1' ' A' ' 33' ' ' ARG . 16.8 ptm180 -75.33 123.85 26.07 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.083 0.468 . . . . 1.0 110.417 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.48 152.66 18.41 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.1 m -102.99 134.84 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.852 -0.796 . . . . 1.0 108.852 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -78.24 140.33 38.9 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.779 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -174.45 113.72 0.17 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.038 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.02 -147.82 45.21 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 109.228 -1.549 . . . . 1.0 109.228 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -99.25 10.99 40.33 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.067 0.434 . . . . 1.0 110.662 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -134.81 157.97 45.4 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.465 -0.568 . . . . 1.0 109.465 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mp -109.63 133.07 53.54 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -86.23 115.98 24.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.524 -0.307 . . . . 1.0 111.112 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -100.55 110.53 22.7 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.321 -0.992 . . . . 1.0 108.321 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 mt -96.04 114.48 26.19 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.21 0.604 . . . . 1.0 110.022 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.02 91.94 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.826 0.346 . . . . 1.0 111.408 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.39 -8.67 27.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.029 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 19' ' ' ARG . 52.6 ttp85 -110.4 67.82 0.65 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.16 0.505 . . . . 1.0 110.585 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -171.14 175.48 4.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.046 -0.724 . . . . 1.0 109.046 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.8 t -135.94 145.38 46.17 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.8 mt -107.46 141.24 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.955 -0.758 . . . . 1.0 108.955 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.8 t -126.89 148.12 50.03 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.29 -134.89 29.12 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -170.64 135.33 1.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.307 0.575 . . . . 1.0 110.277 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -112.66 124.26 52.14 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.719 0.808 . . . . 1.0 109.284 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.2 t -65.27 169.62 5.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.086 0.47 . . . . 1.0 110.625 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.47 -21.19 65.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.639 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.61 -10.58 36.92 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 117.721 0.237 . . . . 1.0 110.74 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -105.57 -31.78 8.79 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.789 0.435 . . . . 1.0 110.703 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -60.58 10.05 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.718 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -58.85 -43.98 39.46 Favored 'Trans proline' 0 N--CA 1.506 2.23 0 C-N-CA 122.148 1.899 . . . . 1.0 111.688 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -61.85 -36.89 82.52 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.735 -0.212 . . . . 1.0 110.909 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.8 tp -78.33 -36.71 45.96 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 122.095 -0.378 . . . . 1.0 110.429 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.01 -35.34 78.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.14 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -77.35 -20.49 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 110.261 -0.274 . . . . 1.0 110.261 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.48 -25.61 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.404 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.3 m-85 -55.3 -57.5 20.0 Favored Pre-proline 0 CA--C 1.555 1.149 0 CA-C-O 119.325 -0.369 . . . . 1.0 111.38 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 52' ' ' PHE . 35.4 Cg_endo -57.46 -28.13 79.24 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 121.823 1.682 . . . . 1.0 112.101 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -61.4 -49.58 76.29 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.358 -0.537 . . . . 1.0 109.921 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -67.35 -41.48 85.1 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.815 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.3 mt -67.25 -37.98 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 118.293 0.497 . . . . 1.0 109.74 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 m -53.17 -27.93 23.8 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.609 0.243 . . . . 1.0 110.663 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -83.14 -40.44 19.76 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.657 -0.247 . . . . 1.0 111.083 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mm -57.9 -48.55 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 120.781 -0.368 . . . . 1.0 110.383 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -53.42 -31.48 45.44 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.571 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.5 m -84.84 -33.9 22.79 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.019 0.378 . . . . 1.0 112.019 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.9 mmt -54.27 -42.86 70.44 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 122.352 -0.218 . . . . 1.0 111.009 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 pp -63.19 -31.2 72.28 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.819 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -90.18 -62.34 1.48 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.986 0.422 . . . . 1.0 110.758 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.4 m -66.12 -40.55 90.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.129 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.23 0.97 72.15 Favored Glycine 0 N--CA 1.467 0.767 0 N-CA-C 109.528 -1.429 . . . . 1.0 109.528 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 54.39 99.34 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.271 -0.464 . . . . 1.0 110.607 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.0 tp -79.21 132.89 36.66 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -160.92 90.76 1.59 Allowed Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.892 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -47.4 98.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.506 2.23 0 C-N-CA 121.763 1.642 . . . . 1.0 111.47 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -137.37 -47.05 0.56 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.287 0.565 . . . . 1.0 110.931 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -165.7 154.19 11.38 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.148 -0.933 . . . . 1.0 110.713 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.4 144.7 56.37 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.156 -0.929 . . . . 1.0 110.544 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -151.31 104.37 3.09 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.857 0.36 . . . . 1.0 110.044 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 76.2 m -77.72 131.79 37.84 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.525 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.45 134.88 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 109.078 -0.712 . . . . 1.0 109.078 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.4 p -113.15 111.55 22.29 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.8 mt -97.79 155.24 17.13 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.4 ' O ' ' CG ' ' A' ' 80' ' ' HIS . 39.9 p90 -141.69 124.85 16.36 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 110.083 -0.339 . . . . 1.0 110.083 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 79' ' ' TYR . 99.4 m-70 -156.6 139.33 15.13 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.832 -0.432 . . . . 1.0 109.832 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 54.33 34.55 20.89 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.926 0.393 . . . . 1.0 111.069 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.36 -29.55 1.68 Allowed Glycine 0 N--CA 1.468 0.768 0 N-CA-C 111.474 -0.65 . . . . 1.0 111.474 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -77.97 149.17 34.16 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.765 -0.457 . . . . 1.0 109.765 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.9 p -134.64 122.18 21.9 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.948 -0.389 . . . . 1.0 109.948 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 69.6 m -106.61 142.06 36.87 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -106.71 137.73 44.19 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.706 0.684 . . . . 1.0 109.173 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.38 151.81 47.84 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 120.53 0.205 . . . . 1.0 110.696 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -163.74 149.06 10.9 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 91' ' ' GLY . 68.2 p -91.31 -15.46 29.07 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 110.537 -0.171 . . . . 1.0 110.537 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.8 mp 58.43 5.63 0.46 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 110.136 -0.32 . . . . 1.0 110.136 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 89' ' ' THR . . . 77.27 12.93 84.13 Favored Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.19 -1.164 . . . . 1.0 110.19 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.0 t -77.18 148.78 35.72 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.009 0.433 . . . . 1.0 111.052 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 60.9 m -90.69 111.84 23.36 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.78 -0.645 . . . . 1.0 111.685 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . 69.72 39.8 76.82 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.113 -0.395 . . . . 1.0 112.113 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.431 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 79.4 m-85 -158.27 138.54 12.51 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.1 112.46 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -90.05 126.77 35.89 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.99 -0.744 . . . . 1.0 108.99 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.1 pt -130.15 157.11 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-O 120.947 0.403 . . . . 1.0 110.529 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.48 147.2 26.55 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.119 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.6 p -123.2 133.16 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.021 -0.991 . . . . 1.0 110.125 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -136.24 90.29 18.3 Favored Pre-proline 0 N--CA 1.47 0.562 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.82 140.98 67.15 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.439 1.426 . . . . 1.0 111.962 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.9 p -69.2 132.17 46.1 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.627 -0.508 . . . . 1.0 109.627 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -75.24 -60.5 2.27 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.841 0.353 . . . . 1.0 110.452 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 118.055 -0.974 . . . . 1.0 110.398 -179.588 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mtp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.052 -0.722 . . . . 1.0 109.052 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.0 p -61.84 -39.5 92.04 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.562 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -166.81 115.83 0.87 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.986 -0.552 . . . . 1.0 109.606 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.2 m -117.07 86.77 2.57 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.031 0.532 . . . . 1.0 110.19 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 58.1 p -127.93 123.92 36.11 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -90.16 44.78 1.22 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.966 0.413 . . . . 1.0 110.308 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -148.89 155.71 26.49 Favored Glycine 0 N--CA 1.47 0.916 0 N-CA-C 110.553 -1.019 . . . . 1.0 110.553 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -68.09 157.92 34.18 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -92.13 133.61 35.62 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.427 -0.582 . . . . 1.0 109.427 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.464 HH21 ' HD2' ' A' ' 15' ' ' ARG . 11.5 ptt-85 -152.17 -169.4 3.34 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 110.022 -0.362 . . . . 1.0 110.022 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -53.35 -52.93 57.63 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.67 -0.241 . . . . 1.0 110.923 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.535 HD12 ' NH2' ' A' ' 15' ' ' ARG . 92.1 mt -82.4 129.2 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.17 -57.64 0.49 Allowed Pre-proline 0 N--CA 1.47 0.558 0 CA-C-O 119.078 -0.487 . . . . 1.0 110.833 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.41 132.93 16.86 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 CA-C-N 120.187 1.102 . . . . 1.0 110.107 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.535 ' NH2' HD12 ' A' ' 12' ' ' ILE . 41.1 ttm180 -175.79 172.64 2.48 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.983 -1.117 . . . . 1.0 107.983 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.423 ' N ' ' CG ' ' A' ' 15' ' ' ARG . 6.0 tt -100.96 121.97 42.69 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.78 167.1 21.78 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.521 -1.032 . . . . 1.0 110.521 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.2 86.44 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.276 -0.639 . . . . 1.0 109.276 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.439 ' NH2' ' CD1' ' A' ' 95' ' ' TYR . 70.2 ttt-85 -85.34 114.7 22.61 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.8 mm? -88.91 146.75 24.73 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.144 -0.688 . . . . 1.0 109.144 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.45 136.78 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -78.95 131.74 36.45 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.657 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -170.23 113.27 0.46 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.75 -163.02 53.7 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -89.79 13.01 15.46 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 117.085 0.442 . . . . 1.0 110.096 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -131.64 148.72 52.62 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.827 -0.435 . . . . 1.0 109.827 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.3 mt -97.54 122.87 41.11 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -83.64 118.77 24.07 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.142 0.577 . . . . 1.0 111.044 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -103.78 110.69 22.89 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.06 114.95 27.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.259 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.46 -34.78 72.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.953 0.406 . . . . 1.0 111.079 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -66.7 -10.44 46.71 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.308 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -112.34 56.52 0.66 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.215 0.531 . . . . 1.0 110.465 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.97 176.97 4.51 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.803 -0.635 . . . . 1.0 109.364 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 92.0 p -149.42 159.81 43.97 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.1 pt -98.64 144.71 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.9 p -133.89 149.22 51.31 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.082 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.24 -129.3 20.24 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -168.44 127.28 1.15 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.608 0.718 . . . . 1.0 110.28 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -113.79 120.1 39.62 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.628 -0.878 . . . . 1.0 108.628 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.0 p -68.43 167.78 14.05 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.102 0.477 . . . . 1.0 110.592 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -63.44 -19.81 65.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.491 -0.777 . . . . 1.0 110.605 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.96 -12.18 36.74 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.698 0.285 . . . . 1.0 110.725 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -104.84 -38.34 6.69 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.121 0.568 . . . . 1.0 110.827 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.67 -61.98 3.25 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 119.894 -0.098 . . . . 1.0 110.958 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -57.91 -41.83 64.92 Favored 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 122.501 2.134 . . . . 1.0 112.583 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -62.88 -46.07 89.57 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.904 -0.318 . . . . 1.0 110.875 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.3 mt -63.06 -37.6 87.86 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.763 0.316 . . . . 1.0 110.209 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -59.51 -27.36 66.09 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.924 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.6 t -86.0 -30.6 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 81.9 t -78.89 -18.41 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 121.124 0.488 . . . . 1.0 109.788 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.5 -60.63 9.95 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.57 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -57.11 -22.09 45.92 Favored 'Trans proline' 0 N--CA 1.507 2.314 0 C-N-CA 122.098 1.865 . . . . 1.0 112.728 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -59.49 -45.2 92.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 120.448 -0.501 . . . . 1.0 110.151 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -65.76 -42.97 90.24 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.626 -0.429 . . . . 1.0 110.722 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.66 -41.88 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 120.993 -0.283 . . . . 1.0 110.355 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.8 p -58.18 -36.84 73.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.202 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -81.48 -28.65 33.99 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 119.712 -0.185 . . . . 1.0 111.462 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.8 mm -62.23 -44.2 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -58.69 -39.63 81.28 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.916 0.389 . . . . 1.0 110.608 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.1 m -61.09 -44.72 96.93 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.168 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 23.4 mmt -54.18 -40.79 67.87 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.574 0.226 . . . . 1.0 110.869 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.5 mt -62.01 -33.39 74.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.628 -0.508 . . . . 1.0 109.628 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -81.32 -57.2 3.6 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.199 0.444 . . . . 1.0 112.199 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.9 t -86.96 -38.69 16.41 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.08 0.4 . . . . 1.0 112.08 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.54 -8.22 62.57 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.161 -1.175 . . . . 1.0 110.161 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 43.83 81.3 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.491 0.317 . . . . 1.0 110.787 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.5 tp -80.63 137.12 36.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.662 -0.495 . . . . 1.0 109.662 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -127.48 78.34 74.81 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 123.122 0.569 . . . . 1.0 109.949 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -48.68 99.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 122.051 1.834 . . . . 1.0 112.458 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -169.6 -18.37 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.844 0.355 . . . . 1.0 110.797 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -150.12 147.56 27.91 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.109 0.48 . . . . 1.0 110.875 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.66 142.08 50.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.65 -0.704 . . . . 1.0 111.132 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -160.02 103.35 1.48 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 63.4 m -84.65 143.35 29.29 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.791 -0.641 . . . . 1.0 110.3 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.1 p -140.64 146.91 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.2 p -128.68 104.12 7.47 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.58 0.352 . . . . 1.0 110.098 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.0 mt -82.9 148.71 27.52 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.068 -0.715 . . . . 1.0 109.068 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -139.87 125.22 18.96 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.455 ' CD2' ' N ' ' A' ' 80' ' ' HIS . 0.1 OUTLIER -170.67 146.4 2.66 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.18 0.514 . . . . 1.0 110.168 -179.715 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 83' ' ' PHE . 59.6 t30 53.82 31.14 12.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.979 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.18 -27.86 1.18 Allowed Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.783 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.4 ' H ' ' C ' ' A' ' 81' ' ' ASN . 65.7 m-85 -83.19 154.01 24.46 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 117.081 0.44 . . . . 1.0 110.384 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 t -151.02 133.56 15.57 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.068 0.461 . . . . 1.0 110.85 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 68.4 m -106.89 142.5 36.41 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.008 -0.738 . . . . 1.0 109.008 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -106.39 141.97 36.84 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.441 0.564 . . . . 1.0 109.572 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.11 147.71 31.84 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 110.646 -0.131 . . . . 1.0 110.646 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -145.64 140.88 27.65 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.9 m -94.14 -22.43 18.47 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.43 15.85 0.24 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.752 0.821 . . . . 1.0 111.837 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.64 14.98 74.56 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 109.373 -1.491 . . . . 1.0 109.373 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.407 ' O ' ' SG ' ' A' ' 93' ' ' CYS . 13.4 t -50.19 -22.04 1.56 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.113 -0.544 . . . . 1.0 111.798 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 92' ' ' SER . 27.9 p 36.67 34.14 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 177.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.81 -48.47 0.08 OUTLIER Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.505 -0.855 . . . . 1.0 112.13 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.439 ' CD1' ' NH2' ' A' ' 19' ' ' ARG . 99.1 m-85 -107.09 145.43 32.43 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.752 -0.462 . . . . 1.0 109.752 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.79 140.5 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.634 0.773 . . . . 1.0 109.199 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -139.22 162.25 35.45 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.311 0.577 . . . . 1.0 109.683 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 42.4 pt -137.41 165.18 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 114.92 -1.036 . . . . 1.0 110.523 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.65 146.34 27.22 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.631 -0.713 . . . . 1.0 109.56 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 p -122.59 133.29 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 115.299 -0.864 . . . . 1.0 109.86 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -140.55 93.65 8.64 Favored Pre-proline 0 N--CA 1.471 0.601 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -51.19 139.35 43.77 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 121.33 1.353 . . . . 1.0 112.337 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 75.3 p -74.29 136.06 42.61 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -77.22 -38.34 51.53 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.789 0.328 . . . . 1.0 110.272 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.136 -0.935 . . . . 1.0 110.222 -179.793 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.4 t 52.81 89.84 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.264 -0.425 . . . . 1.0 111.054 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -59.97 -48.05 83.28 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.998 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.6 t -126.69 146.0 50.37 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.926 0.49 . . . . 1.0 110.11 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.54 127.18 15.19 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 120.929 0.395 . . . . 1.0 110.291 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -63.27 133.7 54.64 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.081 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.43 -162.35 36.31 Favored Glycine 0 N--CA 1.465 0.603 0 N-CA-C 110.2 -1.16 . . . . 1.0 110.2 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 8' ' ' LEU . 3.9 mm? -58.64 150.9 22.0 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.495 0.664 . . . . 1.0 110.462 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -88.05 108.45 19.24 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.986 -1.007 . . . . 1.0 109.799 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -137.63 135.11 36.25 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.47 -44.68 93.75 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.807 0.813 . . . . 1.0 111.357 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.0 pt -57.22 128.22 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 113.944 -1.48 . . . . 1.0 111.941 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.548 ' C ' ' H ' ' A' ' 15' ' ' ARG . 3.1 m -85.31 -34.34 0.51 Allowed Pre-proline 0 CA--C 1.549 0.908 0 CA-C-O 118.805 -0.617 . . . . 1.0 109.366 177.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 13' ' ' THR . 47.4 Cg_exo -52.28 21.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.525 3.326 0 C-N-CA 123.544 2.83 . . . . 1.0 114.172 175.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.548 ' H ' ' C ' ' A' ' 13' ' ' THR . 57.9 ttt85 -148.41 140.14 23.73 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.5 tt -122.53 140.07 53.18 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.177 0.591 . . . . 1.0 109.646 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.37 176.3 16.17 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.59 100.09 0.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -75.95 134.22 40.26 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.964 -0.754 . . . . 1.0 108.964 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.4 mt -127.21 146.03 50.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.363 -0.835 . . . . 1.0 109.941 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.2 137.2 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -71.61 136.13 47.25 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -166.91 100.64 0.55 Allowed 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.78 -165.65 54.56 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -84.84 26.98 0.78 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.77 0.319 . . . . 1.0 110.237 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -145.23 139.56 27.26 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.608 -0.516 . . . . 1.0 109.608 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.0 mt -91.55 131.64 36.84 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -82.29 114.95 21.12 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.217 -0.29 . . . . 1.0 110.217 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -100.07 105.69 17.36 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.62 141.0 28.96 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.54 -0.755 . . . . 1.0 109.598 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.46 -40.97 17.07 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.674 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 23.5 p-10 -72.28 -8.26 53.9 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.237 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -114.77 49.3 1.05 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 120.896 0.379 . . . . 1.0 110.211 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.82 127.23 1.57 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.905 0.383 . . . . 1.0 110.185 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.4 p -76.49 166.86 22.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 pt -125.37 153.79 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.0 p -137.1 136.64 38.49 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.47 102.46 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.16 -0.776 . . . . 1.0 111.16 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -58.36 123.6 16.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.001 0.429 . . . . 1.0 110.276 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -90.27 137.88 31.99 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.364 0.602 . . . . 1.0 109.663 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.7 m -69.21 169.38 12.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.239 -0.891 . . . . 1.0 110.6 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -65.63 -20.35 66.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.402 -0.817 . . . . 1.0 110.166 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.93 -10.05 40.9 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 120.827 0.346 . . . . 1.0 110.544 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -107.88 -26.49 10.71 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.258 0.623 . . . . 1.0 111.416 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -68.45 -45.37 36.65 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.393 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 35.1 Cg_exo -62.57 -53.31 1.85 Allowed 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 122.317 2.012 . . . . 1.0 112.477 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -54.01 -36.84 63.41 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.649 -0.705 . . . . 1.0 110.994 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.5 tp -76.27 -36.87 58.23 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.93 0.395 . . . . 1.0 110.204 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.41 -20.42 65.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.852 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.7 m -97.02 -8.99 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 110.107 -0.331 . . . . 1.0 110.107 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.5 t -92.77 -26.5 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.415 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -63.36 -47.78 83.54 Favored Pre-proline 0 CA--C 1.551 0.988 0 O-C-N 122.243 -0.286 . . . . 1.0 110.809 -178.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 52' ' ' PHE . 69.7 Cg_exo -54.53 -39.31 88.81 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.336 2.024 . . . . 1.0 111.88 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -62.32 -42.89 99.75 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.096 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -64.25 -42.42 96.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.619 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.18 -29.93 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.84 -0.43 . . . . 1.0 109.84 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.8 m -60.88 -43.62 98.2 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.885 -0.326 . . . . 1.0 111.061 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -68.76 -33.4 73.82 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.27 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.2 mm -62.78 -45.13 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.16 -40.02 80.34 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.828 0.347 . . . . 1.0 110.429 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.9 m -76.6 -27.92 55.94 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.597 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 66' ' ' GLY . 59.4 ttm -60.16 -40.05 88.56 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 110.052 -0.351 . . . . 1.0 110.052 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 mt -62.11 -32.4 72.96 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.9 p -87.29 -59.75 2.17 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.982 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.5 p -78.39 -39.62 38.54 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.441 0.534 . . . . 1.0 112.441 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -80.86 -16.71 74.42 Favored Glycine 0 N--CA 1.474 1.195 0 N-CA-C 111.238 -0.745 . . . . 1.0 111.238 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 40.74 79.11 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.078 0.551 . . . . 1.0 111.621 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.13 157.94 27.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.108 0.48 . . . . 1.0 109.812 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -135.67 79.37 47.02 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.237 -0.892 . . . . 1.0 110.141 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -51.47 -13.32 1.29 Allowed 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 122.365 2.043 . . . . 1.0 111.939 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -73.26 -14.27 61.29 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.089 0.471 . . . . 1.0 110.04 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -138.73 144.95 39.72 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.431 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.06 141.01 47.43 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.277 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -160.64 140.04 10.73 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.3 m -131.97 144.46 50.82 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.639 0.375 . . . . 1.0 110.017 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.1 p -147.03 147.97 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.9 p -125.32 115.6 20.6 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 67.9 mt -98.33 158.22 15.71 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -139.6 123.01 17.15 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -154.94 133.49 11.97 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 53.73 24.2 4.19 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.814 0.34 . . . . 1.0 111.324 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.59 -25.79 7.03 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 111.23 -0.748 . . . . 1.0 111.23 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -65.13 146.39 55.04 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.1 m -139.23 107.07 5.65 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.589 -0.522 . . . . 1.0 109.589 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 54.1 t -98.23 137.55 36.81 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -95.56 134.05 38.88 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.23 133.28 38.85 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -148.4 140.94 24.39 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.576 -0.527 . . . . 1.0 109.576 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 74.9 p -92.38 -38.14 12.18 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 120.757 0.313 . . . . 1.0 111.332 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.0 mp 55.46 23.11 5.56 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.002 0.429 . . . . 1.0 110.119 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 93' ' ' CYS . . . 83.34 12.05 79.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.995 -1.242 . . . . 1.0 109.995 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.9 p -57.43 83.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.848 0.356 . . . . 1.0 110.995 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 91' ' ' GLY . 81.8 m -63.12 119.83 10.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.615 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.43 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . 64.21 31.43 80.81 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.43 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 41.9 m-85 -162.62 153.03 16.67 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.2 p -148.78 140.17 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.337 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -119.49 136.66 54.22 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.1 pt -137.12 160.89 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 120.944 0.402 . . . . 1.0 110.037 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.49 119.84 7.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.597 0.713 . . . . 1.0 110.1 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.7 t -93.36 130.83 41.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-N 114.643 -1.162 . . . . 1.0 108.719 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -137.95 115.84 9.55 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-O 118.689 -0.672 . . . . 1.0 109.69 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.49 145.95 38.6 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.371 1.381 . . . . 1.0 110.813 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.7 t -99.09 148.81 23.67 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -77.84 115.86 17.91 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 110.192 -0.299 . . . . 1.0 110.192 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.981 -1.009 . . . . 1.0 109.474 179.732 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtp . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 t -169.21 89.97 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.262 -0.426 . . . . 1.0 109.986 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -66.72 118.61 10.51 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.1 m -118.47 116.48 26.77 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.9 m -145.47 129.34 17.32 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -52.73 -77.0 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.918 0.39 . . . . 1.0 110.698 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.21 -162.12 0.24 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 111.022 -0.831 . . . . 1.0 111.022 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.467 ' O ' ' NH1' ' A' ' 10' ' ' ARG . 4.2 mm? -59.26 154.65 15.95 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 121.382 0.611 . . . . 1.0 110.359 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -93.84 127.81 39.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.193 -0.912 . . . . 1.0 109.871 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.467 ' NH1' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -150.62 174.79 12.59 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -100.98 -49.13 4.21 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.435 0.636 . . . . 1.0 110.408 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.2 pt -64.48 132.07 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 114.498 -1.228 . . . . 1.0 109.855 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.56 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -74.82 -47.23 5.05 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 114.921 -1.036 . . . . 1.0 110.339 177.467 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 13' ' ' THR . 26.8 Cg_exo -29.97 -35.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.511 2.557 0 C-N-CA 123.201 2.601 . . . . 1.0 113.886 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 13' ' ' THR . 83.2 mtp180 -96.76 138.69 33.94 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.452 -0.794 . . . . 1.0 109.759 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 tp -121.59 128.57 52.09 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.232 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.81 153.99 33.51 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.142 -1.183 . . . . 1.0 110.142 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.23 62.67 0.05 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.141 0.496 . . . . 1.0 109.94 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -72.94 132.87 44.0 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.092 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.9 mt -112.92 153.15 28.42 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.469 -0.567 . . . . 1.0 109.469 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.8 m -96.5 136.06 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.442 -0.947 . . . . 1.0 108.442 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -78.11 135.65 37.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -168.1 113.68 0.67 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.181 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.48 -159.0 53.21 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 109.727 -1.349 . . . . 1.0 109.727 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -92.96 10.03 33.08 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 110.362 -0.236 . . . . 1.0 110.362 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -130.61 137.33 49.59 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.138 -0.483 . . . . 1.0 109.954 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.1 mp -89.83 135.98 33.31 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -89.86 115.94 27.56 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.076 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -98.24 104.56 16.61 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.883 -0.784 . . . . 1.0 108.883 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 mt -93.06 115.23 27.9 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.339 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.86 -30.4 70.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.749 -0.659 . . . . 1.0 110.128 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -70.77 -9.58 57.68 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.951 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -112.25 56.84 0.65 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.538 0.685 . . . . 1.0 110.555 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.85 175.28 6.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.58 -0.736 . . . . 1.0 109.432 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.7 m -145.67 163.63 34.3 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.8 mt -107.0 141.37 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.4 m -127.71 138.66 52.86 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.93 -135.06 14.81 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.567 -1.013 . . . . 1.0 110.567 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -168.57 132.96 1.58 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.651 -0.499 . . . . 1.0 109.651 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -115.75 126.89 54.64 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.176 -0.676 . . . . 1.0 109.176 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.8 m -67.88 161.11 27.05 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -56.29 -21.85 26.56 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.729 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.72 -12.58 33.57 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.66 0.267 . . . . 1.0 110.528 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.27 -27.78 8.93 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.025 0.53 . . . . 1.0 111.062 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.495 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -61.66 -46.57 93.55 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.561 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 45.7 Cg_exo -57.71 -47.77 19.77 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.043 1.829 . . . . 1.0 112.522 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -54.63 -51.96 63.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.981 -0.554 . . . . 1.0 111.793 -177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.458 HD11 ' CE1' ' A' ' 83' ' ' PHE . 4.3 mm? -61.69 -41.16 97.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.852 0.358 . . . . 1.0 110.995 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -66.09 -16.64 64.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.103 -0.498 . . . . 1.0 110.227 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.3 t -101.93 -14.72 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 110.168 -0.308 . . . . 1.0 110.168 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.51 -18.71 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.48 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -61.85 -47.23 92.15 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 110.141 -0.318 . . . . 1.0 110.141 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 52' ' ' PHE . 52.9 Cg_exo -56.56 -33.3 92.55 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.273 1.982 . . . . 1.0 111.037 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -59.29 -42.77 92.09 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.7 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -64.94 -42.1 94.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.143 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.1 mm -72.23 -26.71 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.376 -0.529 . . . . 1.0 109.63 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -70.1 -42.89 72.09 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.745 -0.382 . . . . 1.0 111.046 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.578 HE22 ' CD2' ' A' ' 80' ' ' HIS . 53.3 mt-30 -81.8 -50.4 9.28 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.377 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.8 mt -53.17 -46.24 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -55.58 -33.96 64.38 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.519 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m -76.11 -32.9 59.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.734 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.451 ' O ' ' N ' ' A' ' 66' ' ' GLY . 81.1 mmm -59.59 -29.16 67.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.937 0.399 . . . . 1.0 110.328 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.9 mt -60.01 -41.59 92.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.849 0.357 . . . . 1.0 110.125 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.9 m -85.4 -55.02 4.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.242 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.4 m -65.01 -42.05 94.81 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.696 -0.402 . . . . 1.0 111.339 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -86.11 -7.84 79.67 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 50.29 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.662 0.268 . . . . 1.0 110.393 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.4 tp -78.91 143.13 36.14 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -135.41 80.4 45.84 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.814 -0.63 . . . . 1.0 109.77 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.32 88.77 0.83 Allowed 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.11 1.873 . . . . 1.0 110.677 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -171.43 -9.47 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.927 0.394 . . . . 1.0 111.006 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -146.28 147.15 31.09 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.155 0.502 . . . . 1.0 110.867 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.22 131.2 47.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.63 -0.714 . . . . 1.0 109.944 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -162.4 139.22 7.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.431 -0.951 . . . . 1.0 108.431 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 58.3 m -129.88 140.88 50.89 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.6 t -132.94 134.49 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.488 -0.93 . . . . 1.0 108.488 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.2 m -109.7 119.92 40.89 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.54 142.49 40.53 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.122 -0.696 . . . . 1.0 109.122 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 42.3 p90 -133.75 126.47 30.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.578 ' CD2' HE22 ' A' ' 58' ' ' GLN . 79.2 m80 -156.25 139.42 15.56 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 54.45 34.31 20.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.928 0.394 . . . . 1.0 111.576 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.99 -28.63 1.62 Allowed Glycine 0 N--CA 1.467 0.725 0 N-CA-C 111.269 -0.732 . . . . 1.0 111.269 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.458 ' CE1' HD11 ' A' ' 48' ' ' LEU . 69.8 m-85 -70.81 150.46 45.82 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.7 m -138.65 112.77 8.61 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 62.1 m -100.73 143.27 31.09 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -106.38 143.09 35.0 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.12 151.05 40.28 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -162.21 137.67 7.31 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.117 -0.698 . . . . 1.0 109.117 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 67.1 p -87.3 -16.11 36.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.977 -0.101 . . . . 1.0 110.729 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.2 mt 59.19 8.05 1.0 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.162 0.506 . . . . 1.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.73 20.22 78.49 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 110.614 -0.995 . . . . 1.0 110.614 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.9 t -61.9 -145.91 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.782 0.325 . . . . 1.0 110.161 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.3 p -164.8 107.86 0.87 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.19 28.27 68.52 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.483 -1.047 . . . . 1.0 110.483 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -151.96 146.98 26.01 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.1 m -139.71 140.16 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.325 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 8.0 m-85 -125.51 131.92 52.72 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.811 -0.811 . . . . 1.0 108.811 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.4 pt -138.95 163.57 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.73 145.74 25.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.717 -0.845 . . . . 1.0 108.717 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.56 135.54 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.247 -0.888 . . . . 1.0 109.388 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -145.91 143.67 20.13 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.123 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.82 139.88 44.83 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.681 1.587 . . . . 1.0 111.57 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.3 p -81.16 141.85 33.82 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -88.82 96.57 10.74 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.736 -1.126 . . . . 1.0 110.495 179.454 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.1 mtp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 108.728 -0.841 . . . . 1.0 108.728 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.1 p -61.95 -40.63 96.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.677 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -88.36 51.04 2.09 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.423 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.9 m -58.52 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.879 -0.328 . . . . 1.0 110.369 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.9 p -136.65 129.26 30.43 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.889 0.376 . . . . 1.0 110.608 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -82.4 152.83 26.0 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.747 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.35 176.76 45.99 Favored Glycine 0 N--CA 1.465 0.572 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 8' ' ' LEU . 10.6 mp -60.68 143.05 55.03 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -87.79 121.74 30.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.049 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' NH1' ' NE ' ' A' ' 15' ' ' ARG . 98.2 mtt180 -145.59 133.91 21.79 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.79 -38.69 86.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.41 0.624 . . . . 1.0 111.163 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.665 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -75.55 129.8 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.006 -0.997 . . . . 1.0 111.163 -178.267 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.494 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -72.18 -44.06 10.47 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.517 177.319 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 13' ' ' THR . 0.2 OUTLIER -34.35 -37.51 0.12 Allowed 'Trans proline' 0 N--CA 1.509 2.385 0 C-N-CA 123.08 2.52 . . . . 1.0 113.863 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.481 ' NE ' ' NH1' ' A' ' 10' ' ' ARG . 78.9 mtp180 -96.09 137.52 35.04 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.554 -0.536 . . . . 1.0 109.554 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 tt -121.82 131.45 54.06 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.733 -0.469 . . . . 1.0 109.733 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.54 164.36 25.46 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.174 -1.171 . . . . 1.0 110.174 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.08 135.82 0.61 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -136.98 130.59 31.73 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.1 mt -111.16 152.77 26.66 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.69 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.49 137.75 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -73.45 138.9 45.45 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.002 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -169.55 107.6 0.4 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.93 -169.94 44.71 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 109.824 -1.31 . . . . 1.0 109.824 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -84.81 23.76 1.14 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 122.717 -0.284 . . . . 1.0 110.32 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -143.65 143.01 31.27 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.748 -0.464 . . . . 1.0 109.748 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.7 mt -95.13 134.63 37.65 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -92.97 117.81 30.47 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.44 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -98.51 104.96 17.04 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.58 112.65 24.67 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.614 -0.721 . . . . 1.0 109.553 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.35 79.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.611 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -69.04 -11.99 61.28 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.567 -0.742 . . . . 1.0 110.583 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -107.97 55.36 0.65 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.879 0.371 . . . . 1.0 111.105 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.41 126.27 0.52 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.206 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -82.48 139.95 33.64 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.229 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.4 mt -85.71 141.33 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 76.9 p -130.9 147.7 52.57 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.001 0.52 . . . . 1.0 109.617 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.89 -150.32 50.34 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.823 -0.911 . . . . 1.0 110.823 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -158.49 130.36 6.72 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -111.53 125.68 54.17 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.609 0.764 . . . . 1.0 109.153 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -65.75 168.57 7.6 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.212 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.79 -22.16 66.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.68 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.42 -9.73 40.58 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 120.667 0.27 . . . . 1.0 110.602 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -108.26 -26.17 10.68 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.845 0.458 . . . . 1.0 111.421 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -67.59 -44.8 45.41 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 110.169 -0.308 . . . . 1.0 110.169 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 45.1 Cg_exo -59.43 -50.9 7.26 Favored 'Trans proline' 0 N--CA 1.503 2.062 0 C-N-CA 122.22 1.946 . . . . 1.0 112.23 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -55.99 -27.44 52.79 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.898 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -39.87 92.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -68.16 -24.93 65.04 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.927 -0.579 . . . . 1.0 111.053 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.64 -44.63 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.308 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.7 t -84.21 -15.1 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 121.205 0.526 . . . . 1.0 110.506 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -55.92 -53.15 66.28 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-O 118.658 -0.687 . . . . 1.0 111.804 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -68.04 -22.04 42.16 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 CA-C-N 121.443 1.551 . . . . 1.0 111.431 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.511 ' NE2' ' ND1' ' A' ' 80' ' ' HIS . 62.0 t-80 -59.24 -46.74 87.67 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.516 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.66 -42.61 91.14 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.87 -0.332 . . . . 1.0 110.531 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.4 mt -71.6 -42.52 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 120.729 -0.389 . . . . 1.0 110.076 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -57.75 -39.11 76.62 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.836 -0.345 . . . . 1.0 111.283 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.31 -46.55 13.48 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 110.565 -0.161 . . . . 1.0 110.565 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.9 mt -63.08 -43.98 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -58.41 -41.51 85.11 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.693 -0.403 . . . . 1.0 110.42 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.1 p -69.15 -31.82 70.75 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 121.018 -0.273 . . . . 1.0 110.359 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 66' ' ' GLY . 42.8 tpp -60.75 -40.9 94.14 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.59 -35.7 78.59 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.015 -0.365 . . . . 1.0 110.015 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.1 p -86.37 -58.84 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.76 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -63.54 -41.13 98.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.777 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -117.1 70.77 0.29 Allowed Glycine 0 N--CA 1.476 1.325 0 N-CA-C 111.448 -0.661 . . . . 1.0 111.448 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -47.2 86.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.006 0.403 . . . . 1.0 111.174 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 66' ' ' GLY . 4.5 tp -82.23 145.75 29.87 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.569 -0.9 . . . . 1.0 108.569 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -134.64 144.01 48.95 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 72' ' ' HIS . 82.1 Cg_exo -38.23 -87.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 122.485 2.123 . . . . 1.0 113.057 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.438 ' O ' ' CG ' ' A' ' 72' ' ' HIS . 81.6 mtp180 58.36 -56.62 0.04 OUTLIER 'General case' 0 C--N 1.346 0.447 0 C-N-CA 123.744 0.817 . . . . 1.0 112.689 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.548 ' N ' ' O ' ' A' ' 70' ' ' PRO . 74.2 m80 -158.66 149.14 19.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.751 -0.658 . . . . 1.0 110.023 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.51 144.13 54.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.504 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -160.51 102.77 1.37 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.038 0.447 . . . . 1.0 110.122 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.37 137.17 39.63 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.804 -0.635 . . . . 1.0 110.655 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.9 t -125.91 134.87 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.0 p -113.18 111.18 21.64 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.344 -0.613 . . . . 1.0 109.344 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.3 mt -95.67 151.47 19.32 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.42 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 50.0 p90 -146.86 127.3 14.05 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.649 0.261 . . . . 1.0 110.308 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.511 ' ND1' ' NE2' ' A' ' 54' ' ' HIS . 58.6 t-80 -159.63 4.11 0.09 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.597 0.237 . . . . 1.0 110.472 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -165.71 22.03 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.156 0.503 . . . . 1.0 110.252 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.89 -29.39 5.06 Favored Glycine 0 N--CA 1.468 0.815 0 N-CA-C 111.087 -0.805 . . . . 1.0 111.087 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -72.74 143.56 47.96 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.422 ' O ' ' CZ ' ' A' ' 101' ' ' TYR . 60.6 p -134.1 107.46 7.75 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.8 t -90.52 140.37 29.8 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -97.88 138.31 35.42 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.133 -0.692 . . . . 1.0 109.133 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.06 149.08 39.46 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 110.013 -0.366 . . . . 1.0 110.013 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -168.51 141.45 2.97 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.0 p -86.03 -29.38 23.5 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.804 0.335 . . . . 1.0 110.285 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.6 mt 59.2 17.7 5.9 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.613 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.74 10.42 76.49 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 109.979 -1.248 . . . . 1.0 109.979 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.4 t -49.59 -22.21 1.22 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 118.927 -0.559 . . . . 1.0 111.944 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 26.2 p 36.76 34.41 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.354 0.872 . . . . 1.0 113.354 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.36 -55.24 0.02 OUTLIER Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.849 -0.5 . . . . 1.0 111.849 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.23 139.13 54.22 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.72 0.408 . . . . 1.0 110.387 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.9 t -106.1 115.71 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -97.97 137.02 37.42 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.883 -0.784 . . . . 1.0 108.883 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.2 pt -138.31 161.19 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.29 147.76 27.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.942 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.05 131.21 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.082 -0.963 . . . . 1.0 109.357 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 11.3 p90 -131.71 94.25 25.94 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 108.734 -0.839 . . . . 1.0 108.734 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.79 137.64 34.49 Favored 'Trans proline' 0 N--CA 1.503 2.056 0 C-N-CA 121.524 1.483 . . . . 1.0 111.742 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 105' ' ' ARG . 1.9 t -96.07 148.72 22.38 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -64.92 77.27 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.948 0.404 . . . . 1.0 110.219 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 103' ' ' THR . 47.1 ptt85 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.914 -1.041 . . . . 1.0 110.722 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ptt? . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -70.64 -5.89 32.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.619 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 68.62 -53.89 0.55 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.467 0.48 . . . . 1.0 110.986 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.7 p -119.4 95.16 4.68 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.997 0.519 . . . . 1.0 109.716 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.09 122.63 33.24 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.424 ' CD1' ' NH1' ' A' ' 33' ' ' ARG . 3.8 m-90 -79.34 144.81 33.86 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.982 0.42 . . . . 1.0 110.9 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.64 -172.74 55.04 Favored Glycine 0 N--CA 1.465 0.608 0 N-CA-C 110.361 -1.096 . . . . 1.0 110.361 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.8 mt -59.11 143.17 49.5 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.098 0.475 . . . . 1.0 110.062 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -90.34 104.11 16.72 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.133 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -133.17 135.74 45.31 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -64.17 -20.29 65.9 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.954 0.883 . . . . 1.0 110.087 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 77.0 mt -65.73 129.51 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 113.92 -1.491 . . . . 1.0 110.858 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.402 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -78.34 -55.18 1.12 Allowed Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 176.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 13' ' ' THR . 1.1 Cg_exo -31.39 -34.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.505 2.152 0 C-N-CA 123.258 2.639 . . . . 1.0 114.311 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -99.4 141.64 31.92 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -130.08 149.24 51.88 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.56 0.695 . . . . 1.0 110.481 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.82 138.24 20.54 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.639 -1.384 . . . . 1.0 109.639 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.29 53.81 0.22 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.455 0.645 . . . . 1.0 109.438 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -76.41 128.91 35.76 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.847 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.6 mt -92.63 150.0 20.98 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.891 -0.411 . . . . 1.0 109.891 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.5 p -104.24 136.49 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -76.12 130.74 38.77 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.358 -0.383 . . . . 1.0 109.998 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -170.29 109.7 0.38 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.45 -165.67 54.76 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 109.685 -1.366 . . . . 1.0 109.685 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -87.21 10.91 15.45 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.896 -0.409 . . . . 1.0 109.896 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -129.76 141.06 50.93 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.736 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 54.8 mt -90.55 124.99 35.46 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -82.85 116.01 21.98 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.637 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -101.05 107.33 18.75 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.04 118.36 31.72 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.649 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.47 80.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.034 0.445 . . . . 1.0 110.739 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -67.83 -11.2 58.07 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.905 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.424 ' NH1' ' CD1' ' A' ' 6' ' ' TRP . 23.8 mmm180 -111.3 58.62 0.62 Allowed 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.041 0.448 . . . . 1.0 110.508 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.09 176.35 4.67 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.978 -0.556 . . . . 1.0 109.626 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -133.19 127.91 34.83 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.587 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 pt -85.32 147.73 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 82.5 p -133.21 134.76 44.47 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.8 102.66 0.01 OUTLIER Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -58.75 129.79 43.79 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.995 0.426 . . . . 1.0 110.113 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -96.02 136.33 36.61 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.745 -0.662 . . . . 1.0 109.853 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -67.1 167.43 11.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.381 -0.827 . . . . 1.0 110.709 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -64.46 -20.58 66.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.605 -0.725 . . . . 1.0 110.616 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.57 -11.01 38.48 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.006 0.432 . . . . 1.0 110.517 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -107.72 -24.28 11.78 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.283 0.633 . . . . 1.0 111.812 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.47 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -70.68 -45.36 17.27 Favored Pre-proline 0 CA--C 1.551 0.995 0 O-C-N 122.093 -0.38 . . . . 1.0 110.27 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 52.5 Cg_exo -58.15 -50.58 9.61 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 122.328 2.019 . . . . 1.0 113.167 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -60.2 -43.93 95.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.303 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.2 tt -61.47 -39.64 91.62 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.34 -10.59 11.64 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.088 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 81.2 t -101.42 -15.34 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 109.557 -0.535 . . . . 1.0 109.557 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.93 -28.39 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 110.52 -0.178 . . . . 1.0 110.52 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.423 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -67.06 -46.65 52.92 Favored Pre-proline 0 N--CA 1.483 1.223 0 O-C-N 122.393 -0.192 . . . . 1.0 111.156 -178.682 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 52' ' ' PHE . 54.6 Cg_exo -56.59 -36.35 97.88 Favored 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 122.494 2.129 . . . . 1.0 111.885 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -65.31 -40.51 93.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 1.0 109.954 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 59' ' ' ILE . 59.3 t80 -64.21 -41.62 96.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.502 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.5 mm -69.43 -36.91 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.4 t -59.13 -45.57 90.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.625 -0.261 . . . . 1.0 111.392 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.436 ' O ' ' SD ' ' A' ' 62' ' ' MET . 29.1 mm100 -67.85 -37.81 82.35 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.852 -0.158 . . . . 1.0 110.846 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.66 HD11 ' CE2' ' A' ' 55' ' ' PHE . 82.0 mt -59.08 -43.67 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.915 -0.491 . . . . 1.0 109.815 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -58.13 -39.48 78.84 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.815 0.34 . . . . 1.0 110.275 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -65.34 -39.59 92.59 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.459 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -60.3 -40.71 91.45 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 110.348 -0.241 . . . . 1.0 110.348 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.69 -34.93 76.63 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.546 -0.539 . . . . 1.0 109.546 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.3 p -86.02 -62.41 1.53 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.309 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.8 p -74.72 -39.64 61.77 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.042 0.386 . . . . 1.0 112.042 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.29 -4.7 90.41 Favored Glycine 0 N--CA 1.47 0.961 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 31.79 78.6 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.699 0.8 . . . . 1.0 112.113 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.63 151.43 32.3 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.247 0.546 . . . . 1.0 109.657 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -141.29 74.84 23.97 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.154 -0.93 . . . . 1.0 110.013 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -48.2 105.97 0.1 OUTLIER 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 122.332 2.022 . . . . 1.0 111.648 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -171.02 -16.08 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.663 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -142.53 142.37 32.22 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.931 0.396 . . . . 1.0 110.999 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.3 125.73 24.51 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.768 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -162.01 103.99 1.16 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 27.7 p -90.29 148.13 23.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.433 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.58 152.27 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.8 p -128.01 110.27 12.35 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.801 -0.444 . . . . 1.0 109.801 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 78' ' ' LEU . 9.5 mp -91.94 158.87 16.03 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.828 -0.805 . . . . 1.0 108.828 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -140.94 122.63 15.24 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -157.81 134.6 9.89 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 53.92 27.5 7.38 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.104 0.478 . . . . 1.0 111.406 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.63 -24.91 4.12 Favored Glycine 0 N--CA 1.469 0.85 0 N-CA-C 111.532 -0.627 . . . . 1.0 111.532 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -67.61 140.85 56.9 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 67.8 m -129.27 109.19 10.91 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 39.8 t -95.53 140.74 29.93 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -106.0 130.2 53.97 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.85 140.2 45.64 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -145.05 133.56 21.96 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.771 -0.825 . . . . 1.0 108.771 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.8 p -92.69 -32.2 14.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.012 0.434 . . . . 1.0 110.712 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.46 12.69 1.56 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.526 -0.546 . . . . 1.0 109.526 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.81 18.28 77.4 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 109.179 -1.568 . . . . 1.0 109.179 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.8 m -67.49 75.6 0.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.111 0.482 . . . . 1.0 111.668 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 43.6 t -65.69 48.96 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.773 -1.103 . . . . 1.0 110.559 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.412 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . -166.38 -21.16 0.02 OUTLIER Glycine 0 CA--C 1.531 1.087 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.412 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 87.0 m-85 -158.41 170.78 21.45 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.938 0.369 . . . . 1.0 110.284 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.67 113.22 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -86.93 133.53 33.59 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.985 -0.376 . . . . 1.0 109.985 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.1 pt -143.33 161.85 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-N 118.221 0.464 . . . . 1.0 110.625 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.5 148.0 26.88 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.315 0.578 . . . . 1.0 110.4 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.451 ' H ' HD11 ' A' ' 16' ' ' LEU . 28.9 m -133.18 137.18 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.028 -0.987 . . . . 1.0 110.508 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -151.55 148.16 21.58 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.1 141.75 71.24 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 121.361 1.374 . . . . 1.0 111.257 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.0 m -74.48 136.96 42.25 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -65.31 -39.53 92.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.775 0.322 . . . . 1.0 110.201 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.997 -1.001 . . . . 1.0 110.733 -179.756 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.9 t -64.53 147.76 52.14 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.162 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -161.77 135.97 6.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.37 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 t -59.71 144.34 48.35 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.671 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.0 m -135.07 125.09 25.78 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -91.73 142.09 27.97 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.803 -0.443 . . . . 1.0 109.803 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 123.31 147.03 7.23 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.591 ' H ' ' NH2' ' A' ' 15' ' ' ARG . 2.9 mp -68.12 157.02 36.23 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.719 0.295 . . . . 1.0 110.385 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -91.6 128.99 37.64 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.676 ' H ' ' NE ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -152.25 -166.57 2.52 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.594 0.235 . . . . 1.0 110.71 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 18.6 p-10 -53.01 -56.07 18.8 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.203 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.6 pt -69.41 130.92 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 109.209 -0.664 . . . . 1.0 109.209 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.19 -48.21 3.4 Favored Pre-proline 0 N--CA 1.473 0.716 0 O-C-N 122.123 -0.361 . . . . 1.0 110.205 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -89.85 142.61 4.01 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.845 1.697 . . . . 1.0 110.494 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.591 ' NH2' ' H ' ' A' ' 8' ' ' LEU . 52.4 ttp180 -168.34 166.94 12.3 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.364 -0.976 . . . . 1.0 108.364 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.2 tt -109.54 116.24 31.41 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.36 161.99 27.93 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 110.254 -1.139 . . . . 1.0 110.254 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.12 72.75 0.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 1.0 110.433 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -83.72 125.85 32.31 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.28 153.94 20.92 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.232 0.613 . . . . 1.0 109.445 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.14 140.87 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 108.817 -0.808 . . . . 1.0 108.817 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -81.38 108.34 14.91 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -65.0 -51.95 58.82 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.288 0.566 . . . . 1.0 109.676 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.95 -77.6 0.1 Allowed Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.058 -1.217 . . . . 1.0 110.058 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -100.28 8.06 43.99 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.892 0.477 . . . . 1.0 110.317 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -155.99 156.24 34.12 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.015 -0.365 . . . . 1.0 110.015 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.43 121.65 40.63 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.082 -0.71 . . . . 1.0 109.082 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.96 119.74 31.39 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.297 0.239 . . . . 1.0 110.6 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -99.84 101.99 13.29 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.82 109.12 19.06 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.848 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.81 -28.02 68.47 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.132 0.491 . . . . 1.0 110.708 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -68.33 -11.62 59.81 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.573 -0.739 . . . . 1.0 111.046 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -109.37 45.77 1.04 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 120.869 0.366 . . . . 1.0 110.118 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.71 127.4 0.91 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.759 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.5 m -95.24 167.74 11.16 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.3 tp -94.9 141.16 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.5 m -128.25 125.3 38.64 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.99 153.53 8.59 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.809 -0.916 . . . . 1.0 110.809 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -92.81 125.95 37.66 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.825 0.345 . . . . 1.0 110.271 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -112.1 129.47 56.21 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 m -71.3 164.32 25.94 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.969 0.414 . . . . 1.0 110.382 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -63.98 -20.25 65.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.459 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.95 -11.92 34.82 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.88 0.371 . . . . 1.0 110.284 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -107.19 -25.85 11.34 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.08 0.552 . . . . 1.0 111.452 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -67.8 -45.39 43.92 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 120.904 -0.319 . . . . 1.0 110.391 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 51.9 Cg_exo -56.65 -46.86 26.75 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 122.345 2.03 . . . . 1.0 112.527 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.67 -32.67 69.32 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.595 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tp -63.28 -37.75 88.46 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.13 0.491 . . . . 1.0 110.095 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -68.96 -11.06 60.34 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.462 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.9 t -82.76 -48.49 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 110.35 -0.241 . . . . 1.0 110.35 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.18 -26.79 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 120.622 0.249 . . . . 1.0 111.497 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -54.89 -61.83 5.17 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-O 119.51 -0.281 . . . . 1.0 111.373 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -60.85 -30.48 90.2 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.636 1.557 . . . . 1.0 111.288 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -61.89 -44.78 96.09 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.735 -0.468 . . . . 1.0 109.735 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -65.62 -41.94 92.13 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.529 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.5 mt -72.58 -36.83 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.143 0.497 . . . . 1.0 109.795 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 t -68.83 -40.23 79.56 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.316 0.858 . . . . 1.0 113.316 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -81.7 -46.19 14.65 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 122.113 -0.367 . . . . 1.0 111.57 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 tt -54.88 -36.03 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.777 0.322 . . . . 1.0 110.515 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -54.97 -46.22 75.05 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.605 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 m -70.87 -32.44 69.44 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.149 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.8 ttm -59.72 -31.64 69.8 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.316 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.05 -41.75 93.0 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.681 -0.489 . . . . 1.0 109.681 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.6 m -85.61 -55.57 3.93 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.381 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.6 p -66.47 -39.12 88.63 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 121.114 -0.235 . . . . 1.0 111.476 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.4 1.03 78.48 Favored Glycine 0 N--CA 1.472 1.064 0 N-CA-C 110.341 -1.104 . . . . 1.0 110.341 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 41.85 71.23 0.22 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.054 0.542 . . . . 1.0 111.069 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.0 144.99 29.58 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.201 0.524 . . . . 1.0 110.096 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -129.77 79.86 72.6 Favored Pre-proline 0 N--CA 1.471 0.589 0 CA-C-N 115.237 -0.892 . . . . 1.0 109.186 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -45.54 98.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.942 1.762 . . . . 1.0 112.406 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -170.19 -63.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.837 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -94.39 137.55 33.4 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 116.475 -0.329 . . . . 1.0 110.264 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.0 142.61 58.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.47 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -161.1 104.88 1.31 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 43.0 m -74.91 139.64 43.22 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.197 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.9 t -134.22 139.05 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.1 p -115.28 115.01 25.96 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.602 0.361 . . . . 1.0 110.261 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tt -102.58 143.07 32.74 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.857 0.463 . . . . 1.0 109.941 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.59 127.98 17.86 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 110.184 -0.302 . . . . 1.0 110.184 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -159.16 9.51 0.12 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.463 0.173 . . . . 1.0 111.032 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -166.11 34.3 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.255 0.55 . . . . 1.0 110.373 179.035 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.15 -28.07 1.43 Allowed Glycine 0 N--CA 1.465 0.595 0 N-CA-C 111.235 -0.746 . . . . 1.0 111.235 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.411 ' H ' ' C ' ' A' ' 81' ' ' ASN . 58.6 m-85 -83.36 146.26 28.58 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.8 p -132.49 108.17 8.95 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 96.1 m -87.13 132.9 33.7 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -91.58 135.99 33.46 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.67 0.668 . . . . 1.0 109.32 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.83 137.04 39.33 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -146.1 139.71 26.2 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.3 m -90.12 -11.64 40.67 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.82 0.343 . . . . 1.0 110.592 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.49 9.08 0.71 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.49 25.84 60.29 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.2 p -66.68 -140.32 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 53.0 t -167.67 -39.14 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.651 0.262 . . . . 1.0 110.307 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.418 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . -133.29 36.26 2.16 Favored Glycine 0 N--CA 1.477 1.385 0 N-CA-C 110.525 -1.03 . . . . 1.0 110.525 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.418 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 95.7 m-85 -157.22 145.62 19.48 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 45.0 t -134.44 134.82 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -122.51 133.04 54.59 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.5 pt -138.83 159.67 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-O 120.965 0.412 . . . . 1.0 110.303 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.68 124.5 10.56 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.532 0.682 . . . . 1.0 109.658 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.36 131.7 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.093 -0.958 . . . . 1.0 109.779 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -135.92 105.0 9.69 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 108.706 -0.849 . . . . 1.0 108.706 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -69.96 142.05 46.02 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 CA-C-N 121.223 1.473 . . . . 1.0 111.426 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 63.7 p -90.63 146.65 23.87 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.847 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -68.86 79.4 0.3 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.729 0.299 . . . . 1.0 110.238 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.125 -0.941 . . . . 1.0 111.168 179.851 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 ptm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -64.29 157.78 25.11 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.312 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 54.29 51.14 14.86 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.819 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.2 m -58.44 129.21 40.99 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.212 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.4 m -133.84 126.77 31.2 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 109.677 -0.49 . . . . 1.0 109.677 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.402 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 8.8 m-90 -47.92 -65.24 0.6 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.813 0.34 . . . . 1.0 110.826 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.43 -176.55 0.12 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.502 -0.639 . . . . 1.0 111.502 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.442 ' O ' ' NH1' ' A' ' 10' ' ' ARG . 64.2 mt -56.79 144.92 31.07 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.579 0.704 . . . . 1.0 110.045 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.436 ' H ' ' CD ' ' A' ' 9' ' ' GLN . 26.2 mp0 -64.28 121.98 15.58 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.807 -178.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.664 ' NH2' ' H ' ' A' ' 17' ' ' GLY . 27.5 ptt-85 -149.25 137.29 20.61 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 25.2 p-10 -70.16 -43.09 71.58 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.89 0.852 . . . . 1.0 109.84 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 27.1 pt -78.77 130.75 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 114.216 -1.357 . . . . 1.0 112.128 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.561 ' C ' ' H ' ' A' ' 15' ' ' ARG . 0.1 OUTLIER -82.6 -39.14 0.83 Allowed Pre-proline 0 CA--C 1.553 1.071 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 177.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 13' ' ' THR . 74.1 Cg_exo -52.22 11.89 0.02 OUTLIER 'Trans proline' 0 N--CA 1.512 2.607 0 C-N-CA 123.11 2.54 . . . . 1.0 113.886 175.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.561 ' H ' ' C ' ' A' ' 13' ' ' THR . 51.5 ttt85 -139.65 44.24 1.96 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.088 0.47 . . . . 1.0 110.253 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 pp -41.88 148.62 0.16 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.92 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.664 ' H ' ' NH2' ' A' ' 10' ' ' ARG . . . -124.38 179.66 16.06 Favored Glycine 0 N--CA 1.477 1.379 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.39 146.57 18.5 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 6' ' ' TRP . 89.9 mtt-85 -100.96 120.64 40.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.672 -0.695 . . . . 1.0 111.081 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.3 mt -131.34 131.81 44.02 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.83 140.97 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -71.47 132.22 44.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.994 -0.372 . . . . 1.0 109.994 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -157.69 105.05 2.0 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.04 -165.64 50.84 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 109.724 -1.35 . . . . 1.0 109.724 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -84.4 29.05 0.61 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.014 0.435 . . . . 1.0 109.868 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -148.27 143.86 27.24 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.339 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -96.45 130.15 43.66 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -85.91 115.79 23.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.057 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -96.41 109.11 21.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.482 -0.932 . . . . 1.0 108.482 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.01 115.86 28.24 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.936 -0.574 . . . . 1.0 109.67 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.03 -37.85 88.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.144 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -66.26 -9.44 32.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.737 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.48 67.59 0.67 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.327 0.584 . . . . 1.0 110.179 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.69 172.35 6.89 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.4 m -139.84 138.33 35.67 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 tp -93.83 145.01 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.4 p -129.72 148.1 51.57 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.59 -146.57 26.0 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 111.076 -0.809 . . . . 1.0 111.076 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -166.64 75.7 0.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.316 0.579 . . . . 1.0 110.519 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -61.49 138.19 58.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.248 0.546 . . . . 1.0 110.171 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 87.1 p -71.7 167.86 18.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.44 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -65.53 -20.9 66.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.379 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.59 -9.32 44.58 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.878 0.37 . . . . 1.0 110.551 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -109.32 -30.54 7.94 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.213 0.605 . . . . 1.0 111.288 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.473 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -61.58 -45.32 93.67 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 120.781 -0.367 . . . . 1.0 110.189 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 44.8 Cg_exo -59.15 -50.21 9.21 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 122.392 2.062 . . . . 1.0 112.664 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.38 -46.42 88.72 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.335 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.441 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.1 tt -60.66 -39.01 86.81 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.097 0.475 . . . . 1.0 109.98 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -60.62 -12.48 10.28 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.2 t -104.22 -18.48 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.8 t -90.28 -33.37 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.546 ' CE2' HD11 ' A' ' 56' ' ' ILE . 65.8 t80 -62.75 -49.67 81.36 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 118.534 -0.746 . . . . 1.0 111.248 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 52' ' ' PHE . 44.3 Cg_endo -58.83 -26.26 79.75 Favored 'Trans proline' 0 N--CA 1.511 2.507 0 CA-C-N 121.323 1.508 . . . . 1.0 112.132 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 80' ' ' HIS . 17.6 t60 -60.48 -43.39 97.02 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.839 0.352 . . . . 1.0 110.175 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -64.48 -40.57 95.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.094 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.546 HD11 ' CE2' ' A' ' 52' ' ' PHE . 57.7 mt -65.47 -43.86 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 120.064 -0.654 . . . . 1.0 109.286 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.6 t -58.7 -46.08 88.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.104 -0.238 . . . . 1.0 111.239 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -70.48 -38.67 74.42 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.846 -0.161 . . . . 1.0 111.028 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.2 mt -61.08 -45.63 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 109.999 -0.371 . . . . 1.0 109.999 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -52.98 -41.93 65.07 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.544 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.7 p -75.99 -29.82 58.34 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.649 -0.25 . . . . 1.0 110.463 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 66' ' ' GLY . 12.1 tmm? -61.66 -33.32 73.75 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 110.251 -0.277 . . . . 1.0 110.251 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.74 -40.61 97.77 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.8 p -75.17 -56.22 4.94 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.389 -0.368 . . . . 1.0 111.268 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.1 p -68.65 -39.07 80.84 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.68 0.276 . . . . 1.0 111.255 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -80.96 -14.91 78.64 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 52.06 84.77 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.6 tp -81.35 142.88 32.62 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.763 -0.829 . . . . 1.0 108.763 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -151.95 131.24 6.69 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 119.221 -0.419 . . . . 1.0 110.355 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.18 102.2 1.58 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.361 1.374 . . . . 1.0 110.408 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -146.23 -34.24 0.3 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.257 0.551 . . . . 1.0 111.391 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -166.26 155.53 11.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.048 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.35 146.64 50.66 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.428 -0.806 . . . . 1.0 110.308 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -159.66 102.95 1.53 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.322 0.582 . . . . 1.0 109.759 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.1 t -83.16 137.29 34.12 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.181 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.36 153.09 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -131.85 103.18 6.18 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 78' ' ' LEU . 9.8 mp -90.87 143.8 26.35 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.368 -0.975 . . . . 1.0 108.368 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -125.44 127.75 47.0 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 54' ' ' HIS . 79.6 t60 -163.04 139.67 7.36 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.4 m120 53.34 26.1 5.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.981 0.42 . . . . 1.0 111.311 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.79 -28.42 3.19 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -70.27 149.13 47.75 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.511 -0.552 . . . . 1.0 109.511 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.5 m -135.7 120.85 18.9 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.473 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 65.5 m -107.05 139.65 41.11 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.296 -1.001 . . . . 1.0 108.296 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -104.7 140.83 37.49 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 108.807 -0.812 . . . . 1.0 108.807 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.91 151.26 38.41 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 110.011 -0.366 . . . . 1.0 110.011 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -166.56 139.76 3.89 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.4 m -76.33 -20.04 57.63 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 110.468 -0.197 . . . . 1.0 110.468 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.0 mt 62.67 10.42 4.15 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.986 0.422 . . . . 1.0 110.202 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.61 13.46 83.46 Favored Glycine 0 N--CA 1.466 0.642 0 N-CA-C 110.546 -1.021 . . . . 1.0 110.546 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.6 p -62.13 -143.34 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.564 0.221 . . . . 1.0 110.473 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 23.7 p -170.64 107.39 0.3 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.78 0.324 . . . . 1.0 110.351 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.02 -9.64 37.74 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 111.216 -0.753 . . . . 1.0 111.216 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -113.94 141.95 46.74 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.039 0.536 . . . . 1.0 109.582 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.2 136.81 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 108.901 -0.777 . . . . 1.0 108.901 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -125.65 138.59 53.91 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.213 -1.032 . . . . 1.0 108.213 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.8 pt -137.38 165.2 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.982 0.42 . . . . 1.0 109.952 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.92 108.47 3.82 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.73 139.36 17.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 114.745 -1.116 . . . . 1.0 108.744 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -147.54 129.3 7.41 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.29 143.52 43.81 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 CA-C-N 120.539 1.228 . . . . 1.0 111.692 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 103' ' ' THR . 1.4 t -87.24 147.38 25.58 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.079 -0.51 . . . . 1.0 109.633 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -72.29 110.38 6.69 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.236 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 . . . . . 0 C--O 1.218 -0.597 0 CA-C-O 118.114 -0.946 . . . . 1.0 109.777 179.651 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtm . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 4' ' ' THR . 20.9 m 53.93 38.85 29.67 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.064 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 58.5 t30 68.83 -45.85 0.55 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.148 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.401 ' H ' ' C ' ' A' ' 2' ' ' SER . 40.3 m -58.87 93.38 0.02 OUTLIER 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.165 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.4 m -102.84 125.33 49.54 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.543 -0.539 . . . . 1.0 109.543 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -50.37 -79.12 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.708 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.79 -157.84 0.28 Allowed Glycine 0 C--N 1.329 0.157 0 N-CA-C 110.663 -0.975 . . . . 1.0 110.663 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.5 mt -58.82 148.57 29.41 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.873 -0.418 . . . . 1.0 109.873 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -88.39 110.38 20.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.114 -0.493 . . . . 1.0 109.866 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.534 ' NH1' ' NH2' ' A' ' 15' ' ' ARG . 99.2 mtt180 -137.78 133.53 34.15 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -65.98 -35.55 80.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.502 0.668 . . . . 1.0 110.349 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 69.5 mt -59.71 125.65 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 114.397 -1.274 . . . . 1.0 110.012 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.487 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -81.09 -49.88 1.0 Allowed Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 107.938 -1.134 . . . . 1.0 107.938 177.413 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 13' ' ' THR . 33.0 Cg_exo -32.76 -33.95 0.05 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.631 2.221 . . . . 1.0 113.565 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.534 ' NH2' ' NH1' ' A' ' 10' ' ' ARG . 75.0 mtp180 -93.79 138.19 32.23 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.832 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 tt -119.93 114.86 22.69 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.45 156.77 43.47 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 109.822 -1.311 . . . . 1.0 109.822 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -165.34 71.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -73.91 128.99 36.99 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.0 mt -116.67 153.5 32.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.905 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.85 137.08 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.375 -0.972 . . . . 1.0 108.375 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -81.45 130.46 35.05 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -160.52 124.05 3.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.258 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.18 -147.53 50.82 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 109.953 -1.259 . . . . 1.0 109.953 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -105.18 15.42 27.5 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 110.171 -0.307 . . . . 1.0 110.171 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.411 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 17.8 mp0 -135.8 143.46 45.21 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.052 0.453 . . . . 1.0 110.122 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 50.8 mt -91.85 131.03 37.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -88.26 116.87 26.78 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -100.07 106.71 18.48 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 30' ' ' LEU . 11.0 mp -91.24 111.8 23.43 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.52 -35.1 73.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.237 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -71.62 -8.33 53.41 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.656 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -110.56 63.11 0.61 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.133 0.492 . . . . 1.0 110.378 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.9 175.09 4.56 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 t -141.43 138.06 32.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.957 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.0 mm -82.6 141.81 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.12 -0.326 . . . . 1.0 110.12 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.447 ' C ' ' H ' ' A' ' 39' ' ' LYS . 73.8 p -132.81 146.48 51.86 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.675 0.39 . . . . 1.0 110.035 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.99 -9.31 2.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 37' ' ' THR . 48.5 mtmt 50.77 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 O-C-N 122.462 -0.434 . . . . 1.0 111.25 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -69.36 139.91 54.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.299 0.571 . . . . 1.0 110.572 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.3 p -72.69 171.09 13.19 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.386 -0.825 . . . . 1.0 110.125 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.28 -19.28 65.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.434 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.98 -10.73 38.25 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 120.816 0.341 . . . . 1.0 110.544 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -109.27 -24.42 11.1 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.645 0.778 . . . . 1.0 111.227 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -67.27 -46.27 50.35 Favored Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.119 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 28.5 Cg_exo -63.75 -55.08 0.74 Allowed 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.22 1.947 . . . . 1.0 112.398 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -56.85 -45.22 82.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.254 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.16 -39.67 87.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.291 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -62.24 -20.23 64.01 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.384 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.4 t -92.55 -21.99 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.1 t -85.78 -13.45 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 110.094 -0.335 . . . . 1.0 110.094 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.444 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -65.49 -59.39 9.59 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 122.286 -0.259 . . . . 1.0 110.512 178.377 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 52' ' ' PHE . 30.8 Cg_endo -55.65 -24.66 46.63 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.642 1.561 . . . . 1.0 112.089 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -66.17 3.86 0.8 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.751 0.31 . . . . 1.0 110.988 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 53' ' ' PRO . 44.5 m-85 -131.95 -40.96 1.04 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.751 0.421 . . . . 1.0 110.424 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.13 -42.5 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.3 p -57.1 -41.98 79.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.977 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -67.05 -56.47 9.93 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.666 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.15 -45.71 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -52.37 -37.91 57.5 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.74 -0.384 . . . . 1.0 111.011 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.5 p -76.77 -32.33 57.65 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.125 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 78.0 mmm -56.43 -31.17 63.67 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.282 -0.266 . . . . 1.0 110.282 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.2 mt -61.51 -37.13 82.59 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.6 m -92.05 -58.8 2.28 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.161 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.5 m -66.58 -43.07 85.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.648 -0.421 . . . . 1.0 111.864 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.66 -10.54 81.33 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 110.544 -1.023 . . . . 1.0 110.544 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 47.46 77.29 0.09 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 110.183 -0.303 . . . . 1.0 110.183 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.517 HD13 ' N ' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -86.57 126.91 34.8 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 -178.25 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.517 ' N ' HD13 ' A' ' 68' ' ' LEU . 70.9 m-80 -145.64 151.07 45.6 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.572 -0.285 . . . . 1.0 110.523 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.36 87.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.503 2.046 0 C-N-CA 121.86 1.707 . . . . 1.0 111.688 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -133.09 -60.2 0.86 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 120.868 0.366 . . . . 1.0 110.571 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -153.56 140.01 18.7 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.952 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.74 126.14 28.78 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.689 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -138.39 103.77 4.99 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.4 t -78.59 136.01 37.41 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.819 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.5 t -125.62 136.26 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.9 p -116.97 110.96 18.94 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 68.1 mt -89.91 160.65 16.32 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 50.0 p90 -143.57 130.56 20.57 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.047 -0.353 . . . . 1.0 110.047 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.48 ' C ' ' H ' ' A' ' 82' ' ' GLY . 74.1 t60 -157.75 -96.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' A' ' 83' ' ' PHE . 59.0 t30 -70.02 35.43 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.87 0.366 . . . . 1.0 111.503 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . 77.53 -28.83 1.76 Allowed Glycine 0 N--CA 1.466 0.657 0 N-CA-C 110.735 -0.946 . . . . 1.0 110.735 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.489 ' CZ ' HG23 ' A' ' 100' ' ' VAL . 6.9 t80 -78.52 147.23 33.92 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.487 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 35.6 p -134.08 116.24 15.22 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.958 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 45.6 t -87.51 142.16 28.07 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -102.01 136.89 41.07 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.325 -0.621 . . . . 1.0 109.325 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.64 151.64 41.65 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -168.72 152.49 5.54 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.2 m -98.58 -18.18 18.27 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.667 0.27 . . . . 1.0 110.67 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.7 mp 59.41 8.97 1.29 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.07 15.37 76.48 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.101 -1.199 . . . . 1.0 110.101 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.1 m -65.62 -134.95 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.01 -0.367 . . . . 1.0 110.01 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 20.8 p -170.61 105.97 0.28 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.865 0.364 . . . . 1.0 110.054 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.37 33.9 78.61 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.652 -0.979 . . . . 1.0 110.652 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -151.25 137.16 18.14 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 m -142.3 138.33 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.307 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.429 ' N ' ' CD1' ' A' ' 97' ' ' TYR . 21.5 m-85 -116.69 120.39 38.45 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 156.8 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.296 -1.001 . . . . 1.0 108.296 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.43 150.8 30.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.18 -0.918 . . . . 1.0 109.328 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.489 HG23 ' CZ ' ' A' ' 83' ' ' PHE . 2.7 p -123.38 135.66 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 115.115 -0.948 . . . . 1.0 109.568 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 13.4 p90 -149.03 97.33 3.64 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.135 -0.938 . . . . 1.0 108.971 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -51.63 144.84 32.05 Favored 'Trans proline' 0 N--CA 1.507 2.279 0 C-N-CA 121.922 1.748 . . . . 1.0 112.058 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 80.7 p -63.29 134.04 55.17 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.348 -0.387 . . . . 1.0 109.98 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -68.78 -41.1 79.22 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.747 0.308 . . . . 1.0 110.323 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 . . . . . 0 C--O 1.222 -0.389 0 CA-C-O 118.143 -0.932 . . . . 1.0 110.115 -179.224 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 mmt . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.1 t -63.29 -19.81 64.92 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.391 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -63.71 -37.08 86.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.025 -0.534 . . . . 1.0 109.61 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 m -57.55 102.16 0.09 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.411 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.9 p -133.89 125.82 29.11 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -96.1 163.69 13.01 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.88 160.21 22.72 Favored Glycine 0 N--CA 1.471 0.991 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.2 mt -69.84 153.99 42.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.185 -0.507 . . . . 1.0 109.992 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -102.51 118.15 36.23 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.897 0.479 . . . . 1.0 109.785 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.408 ' C ' ' H ' ' A' ' 12' ' ' ILE . 79.8 mtp180 -143.15 -168.17 2.73 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.744 -0.836 . . . . 1.0 108.744 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -57.83 -5.26 0.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.651 -0.249 . . . . 1.0 111.216 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.408 ' H ' ' C ' ' A' ' 10' ' ' ARG . 79.7 mt -96.79 128.88 47.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.295 -1.002 . . . . 1.0 108.295 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -56.08 0.44 Allowed Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 108.295 -1.002 . . . . 1.0 108.295 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.01 126.38 5.69 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 121.228 1.285 . . . . 1.0 110.743 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -152.18 153.12 33.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.839 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.0 tp -116.39 118.32 32.4 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.388 -1.338 . . . . 1.0 107.388 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.34 161.9 33.02 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 108.73 -1.748 . . . . 1.0 108.73 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.39 67.6 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -73.31 122.17 21.58 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.295 -0.632 . . . . 1.0 109.295 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.6 mt -90.06 144.91 25.47 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.702 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -102.99 136.79 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -75.75 133.61 40.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.942 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -172.25 109.18 0.23 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.016 -0.735 . . . . 1.0 109.016 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.66 -161.48 53.76 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 109.759 -1.337 . . . . 1.0 109.759 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -87.14 5.87 35.7 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.732 0.301 . . . . 1.0 110.389 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -127.79 136.36 51.37 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.09 0.471 . . . . 1.0 110.054 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.2 mp -89.07 127.73 35.71 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.941 -0.762 . . . . 1.0 108.941 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -83.9 116.31 22.71 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.664 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -97.67 103.65 15.6 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.847 -1.168 . . . . 1.0 107.847 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 30' ' ' LEU . 10.5 mp -86.68 134.62 33.59 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.052 -0.722 . . . . 1.0 109.052 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.05 -24.58 30.38 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.883 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -73.93 -10.44 59.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.028 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -108.41 16.64 22.9 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.537 0.335 . . . . 1.0 110.473 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.22 127.67 10.0 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.2 m -86.92 170.27 11.77 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.853 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.4 pt -97.4 155.07 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 82.0 p -134.45 128.64 33.88 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.48 99.16 0.01 OUTLIER Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.102 -0.799 . . . . 1.0 111.102 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -56.07 99.64 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.789 0.328 . . . . 1.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -69.23 140.08 54.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.007 -0.542 . . . . 1.0 109.544 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -69.46 171.07 9.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.276 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -64.28 -21.18 66.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.58 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.32 -22.51 20.5 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 120.825 0.345 . . . . 1.0 110.103 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -96.87 -26.36 15.11 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.904 0.482 . . . . 1.0 110.717 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -60.36 -57.59 25.53 Favored Pre-proline 0 CA--C 1.555 1.135 0 O-C-N 122.089 -0.382 . . . . 1.0 110.127 177.534 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 45' ' ' CYS . 35.0 Cg_endo -56.22 -41.91 71.69 Favored 'Trans proline' 0 N--CA 1.51 2.478 0 C-N-CA 122.497 2.131 . . . . 1.0 112.688 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -56.74 -37.31 70.84 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.951 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.55 -31.11 47.25 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.047 0.451 . . . . 1.0 110.091 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.13 -40.82 86.84 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.629 -0.669 . . . . 1.0 110.685 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.2 m -75.12 -20.56 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -86.01 -20.54 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.184 0.516 . . . . 1.0 110.045 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.79 -57.06 26.53 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.063 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -56.6 -26.92 67.14 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.161 1.241 . . . . 1.0 111.72 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -77.35 16.08 0.66 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.749 0.309 . . . . 1.0 110.97 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -131.32 -37.33 1.24 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.12 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.7 mm -74.74 -30.78 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.8 m -60.82 -43.92 97.6 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.844 0.354 . . . . 1.0 111.132 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -65.42 -42.5 92.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.91 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.14 -46.94 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.37 -45.9 90.15 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.5 t -65.81 -40.67 92.09 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.495 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.428 ' O ' ' N ' ' A' ' 66' ' ' GLY . 45.6 ttm -50.67 -44.05 57.58 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.863 0.363 . . . . 1.0 110.925 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.37 -37.33 86.86 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.283 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -68.77 -61.72 1.69 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.756 0.312 . . . . 1.0 111.616 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.4 t -72.4 -39.47 67.92 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.067 0.46 . . . . 1.0 110.781 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -98.51 73.4 0.57 Allowed Glycine 0 N--CA 1.462 0.396 0 N-CA-C 109.073 -1.611 . . . . 1.0 109.073 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.25 88.82 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -82.72 123.67 29.51 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.774 -1.195 . . . . 1.0 107.774 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.418 ' N ' HD13 ' A' ' 68' ' ' LEU . 24.1 m120 -122.68 147.03 49.51 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-O 119.286 -0.388 . . . . 1.0 110.727 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.28 88.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.506 2.233 0 C-N-CA 121.419 1.412 . . . . 1.0 112.159 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -131.67 -50.83 0.98 Allowed 'General case' 0 N--CA 1.48 1.065 0 O-C-N 121.999 -0.438 . . . . 1.0 109.9 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -163.36 151.72 13.78 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.767 -178.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.85 150.31 20.5 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.717 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -155.4 139.64 16.61 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.2 t -130.55 143.63 50.88 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.628 -0.508 . . . . 1.0 109.628 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.86 144.88 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.597 -0.52 . . . . 1.0 109.597 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.6 p -115.36 116.36 28.14 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 67.4 mt -99.79 134.76 42.22 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.52 -0.919 . . . . 1.0 108.52 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.414 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 47.2 p90 -115.03 127.58 55.73 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -156.72 141.2 16.72 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.456 ' ND2' ' CD1' ' A' ' 83' ' ' PHE . 5.7 p-10 43.91 29.5 0.32 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.237 0.458 . . . . 1.0 112.237 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.21 -27.25 4.61 Favored Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.876 -0.89 . . . . 1.0 110.876 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.456 ' CD1' ' ND2' ' A' ' 81' ' ' ASN . 6.5 m-85 -68.78 150.02 48.34 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.0 m -142.29 108.11 5.14 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.139 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.5 m -93.63 143.04 26.68 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -99.36 140.75 33.08 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.61 150.27 37.15 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 110.288 -0.264 . . . . 1.0 110.288 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -164.54 134.18 3.82 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.8 m -77.21 -42.59 36.84 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.991 0.424 . . . . 1.0 110.729 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' A' ' 92' ' ' SER . 57.5 mt 58.01 37.09 26.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.118 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.41 5.93 1.99 Allowed Glycine 0 CA--C 1.533 1.209 0 N-CA-C 111.386 -0.686 . . . . 1.0 111.386 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 90' ' ' LEU . 28.7 t -104.36 57.47 0.71 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.7 p -58.41 -23.41 57.18 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 119.954 -0.698 . . . . 1.0 110.386 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.66 -12.82 48.77 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.907 -0.877 . . . . 1.0 110.907 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -155.18 119.57 4.7 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 t -101.59 113.68 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -90.49 131.01 36.48 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.163 -0.68 . . . . 1.0 109.163 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.9 pt -139.03 161.55 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.1 111.57 3.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.402 0.62 . . . . 1.0 109.397 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.1 t -91.49 136.07 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 114.845 -1.071 . . . . 1.0 108.658 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -145.38 128.19 8.21 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 119.029 -0.51 . . . . 1.0 109.761 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.27 145.74 39.22 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.374 1.383 . . . . 1.0 111.243 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.2 p -83.58 138.67 33.27 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -64.87 -47.08 79.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.783 0.325 . . . . 1.0 110.343 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.067 -0.968 . . . . 1.0 110.397 -179.303 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 110.647 -0.131 . . . . 1.0 110.647 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tt -113.35 133.52 55.1 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.059 -0.719 . . . . 1.0 109.059 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -136.01 -171.17 12.24 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 109.76 -1.336 . . . . 1.0 109.76 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.41 71.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.446 ' O ' ' NH1' ' A' ' 33' ' ' ARG . 16.8 ptm180 -75.33 123.85 26.07 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.083 0.468 . . . . 1.0 110.417 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.48 152.66 18.41 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.1 m -102.99 134.84 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.852 -0.796 . . . . 1.0 108.852 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -78.24 140.33 38.9 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.779 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -174.45 113.72 0.17 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.038 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.02 -147.82 45.21 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 109.228 -1.549 . . . . 1.0 109.228 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -99.25 10.99 40.33 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.067 0.434 . . . . 1.0 110.662 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -134.81 157.97 45.4 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.465 -0.568 . . . . 1.0 109.465 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mp -109.63 133.07 53.54 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -86.23 115.98 24.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.524 -0.307 . . . . 1.0 111.112 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -100.55 110.53 22.7 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.321 -0.992 . . . . 1.0 108.321 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 mt -96.04 114.48 26.19 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.21 0.604 . . . . 1.0 110.022 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.02 91.94 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.826 0.346 . . . . 1.0 111.408 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.39 -8.67 27.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.029 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 19' ' ' ARG . 52.6 ttp85 -110.4 67.82 0.65 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.16 0.505 . . . . 1.0 110.585 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -171.14 175.48 4.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.046 -0.724 . . . . 1.0 109.046 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.8 t -135.94 145.38 46.17 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.8 mt -107.46 141.24 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.955 -0.758 . . . . 1.0 108.955 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.8 t -126.89 148.12 50.03 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.29 -134.89 29.12 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -170.64 135.33 1.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.307 0.575 . . . . 1.0 110.277 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -112.66 124.26 52.14 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.719 0.808 . . . . 1.0 109.284 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.2 t -65.27 169.62 5.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.086 0.47 . . . . 1.0 110.625 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.47 -21.19 65.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.639 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.61 -10.58 36.92 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 117.721 0.237 . . . . 1.0 110.74 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -105.57 -31.78 8.79 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.789 0.435 . . . . 1.0 110.703 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -60.58 10.05 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.718 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -58.85 -43.98 39.46 Favored 'Trans proline' 0 N--CA 1.506 2.23 0 C-N-CA 122.148 1.899 . . . . 1.0 111.688 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -61.85 -36.89 82.52 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.735 -0.212 . . . . 1.0 110.909 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.8 tp -78.33 -36.71 45.96 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 122.095 -0.378 . . . . 1.0 110.429 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.01 -35.34 78.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.14 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -77.35 -20.49 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 110.261 -0.274 . . . . 1.0 110.261 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.48 -25.61 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.404 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.3 m-85 -55.3 -57.5 20.0 Favored Pre-proline 0 CA--C 1.555 1.149 0 CA-C-O 119.325 -0.369 . . . . 1.0 111.38 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 52' ' ' PHE . 35.4 Cg_endo -57.46 -28.13 79.24 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 121.823 1.682 . . . . 1.0 112.101 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -61.4 -49.58 76.29 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.358 -0.537 . . . . 1.0 109.921 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -67.35 -41.48 85.1 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.815 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.3 mt -67.25 -37.98 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 118.293 0.497 . . . . 1.0 109.74 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 m -53.17 -27.93 23.8 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.609 0.243 . . . . 1.0 110.663 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -83.14 -40.44 19.76 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.657 -0.247 . . . . 1.0 111.083 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mm -57.9 -48.55 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 120.781 -0.368 . . . . 1.0 110.383 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -53.42 -31.48 45.44 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.571 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.5 m -84.84 -33.9 22.79 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.019 0.378 . . . . 1.0 112.019 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.9 mmt -54.27 -42.86 70.44 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 122.352 -0.218 . . . . 1.0 111.009 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 pp -63.19 -31.2 72.28 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.819 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -90.18 -62.34 1.48 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.986 0.422 . . . . 1.0 110.758 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.4 m -66.12 -40.55 90.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.129 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.23 0.97 72.15 Favored Glycine 0 N--CA 1.467 0.767 0 N-CA-C 109.528 -1.429 . . . . 1.0 109.528 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 54.39 99.34 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.271 -0.464 . . . . 1.0 110.607 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.0 tp -79.21 132.89 36.66 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -160.92 90.76 1.59 Allowed Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.892 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -47.4 98.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.506 2.23 0 C-N-CA 121.763 1.642 . . . . 1.0 111.47 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -137.37 -47.05 0.56 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.287 0.565 . . . . 1.0 110.931 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -165.7 154.19 11.38 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.148 -0.933 . . . . 1.0 110.713 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.4 144.7 56.37 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.156 -0.929 . . . . 1.0 110.544 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -151.31 104.37 3.09 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.857 0.36 . . . . 1.0 110.044 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 76.2 m -77.72 131.79 37.84 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.525 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.45 134.88 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 109.078 -0.712 . . . . 1.0 109.078 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.4 p -113.15 111.55 22.29 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.8 mt -97.79 155.24 17.13 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.4 ' O ' ' CG ' ' A' ' 80' ' ' HIS . 39.9 p90 -141.69 124.85 16.36 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 110.083 -0.339 . . . . 1.0 110.083 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 79' ' ' TYR . 99.4 m-70 -156.6 139.33 15.13 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.832 -0.432 . . . . 1.0 109.832 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 54.33 34.55 20.89 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.926 0.393 . . . . 1.0 111.069 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.36 -29.55 1.68 Allowed Glycine 0 N--CA 1.468 0.768 0 N-CA-C 111.474 -0.65 . . . . 1.0 111.474 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -77.97 149.17 34.16 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.765 -0.457 . . . . 1.0 109.765 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.9 p -134.64 122.18 21.9 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.948 -0.389 . . . . 1.0 109.948 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 69.6 m -106.61 142.06 36.87 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -106.71 137.73 44.19 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.706 0.684 . . . . 1.0 109.173 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.38 151.81 47.84 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 120.53 0.205 . . . . 1.0 110.696 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -163.74 149.06 10.9 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 91' ' ' GLY . 68.2 p -91.31 -15.46 29.07 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 110.537 -0.171 . . . . 1.0 110.537 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.8 mp 58.43 5.63 0.46 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 110.136 -0.32 . . . . 1.0 110.136 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 89' ' ' THR . . . 77.27 12.93 84.13 Favored Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.19 -1.164 . . . . 1.0 110.19 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.0 t -77.18 148.78 35.72 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.009 0.433 . . . . 1.0 111.052 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 60.9 m -90.69 111.84 23.36 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.78 -0.645 . . . . 1.0 111.685 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . 69.72 39.8 76.82 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.113 -0.395 . . . . 1.0 112.113 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.431 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 79.4 m-85 -158.27 138.54 12.51 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.1 112.46 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -90.05 126.77 35.89 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.99 -0.744 . . . . 1.0 108.99 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.1 pt -130.15 157.11 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-O 120.947 0.403 . . . . 1.0 110.529 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.48 147.2 26.55 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.119 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.6 p -123.2 133.16 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.021 -0.991 . . . . 1.0 110.125 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -136.24 90.29 18.3 Favored Pre-proline 0 N--CA 1.47 0.562 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.82 140.98 67.15 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.439 1.426 . . . . 1.0 111.962 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.9 p -69.2 132.17 46.1 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.627 -0.508 . . . . 1.0 109.627 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 120.841 0.353 . . . . 1.0 110.452 -179.718 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.423 ' CG ' ' N ' ' A' ' 16' ' ' LEU . 41.1 ttm180 . . . . . 0 N--CA 1.463 0.192 0 N-CA-C 107.983 -1.117 . . . . 1.0 107.983 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.423 ' N ' ' CG ' ' A' ' 15' ' ' ARG . 6.0 tt -100.96 121.97 42.69 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.78 167.1 21.78 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.521 -1.032 . . . . 1.0 110.521 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.2 86.44 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.276 -0.639 . . . . 1.0 109.276 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.439 ' NH2' ' CD1' ' A' ' 95' ' ' TYR . 70.2 ttt-85 -85.34 114.7 22.61 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.8 mm? -88.91 146.75 24.73 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.144 -0.688 . . . . 1.0 109.144 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.45 136.78 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -78.95 131.74 36.45 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.657 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -170.23 113.27 0.46 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.75 -163.02 53.7 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -89.79 13.01 15.46 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 117.085 0.442 . . . . 1.0 110.096 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -131.64 148.72 52.62 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.827 -0.435 . . . . 1.0 109.827 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.3 mt -97.54 122.87 41.11 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -83.64 118.77 24.07 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.142 0.577 . . . . 1.0 111.044 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -103.78 110.69 22.89 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.06 114.95 27.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.259 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.46 -34.78 72.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.953 0.406 . . . . 1.0 111.079 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -66.7 -10.44 46.71 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.308 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -112.34 56.52 0.66 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.215 0.531 . . . . 1.0 110.465 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.97 176.97 4.51 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.803 -0.635 . . . . 1.0 109.364 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 92.0 p -149.42 159.81 43.97 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.1 pt -98.64 144.71 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.9 p -133.89 149.22 51.31 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.082 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.24 -129.3 20.24 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -168.44 127.28 1.15 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.608 0.718 . . . . 1.0 110.28 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -113.79 120.1 39.62 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.628 -0.878 . . . . 1.0 108.628 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.0 p -68.43 167.78 14.05 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.102 0.477 . . . . 1.0 110.592 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -63.44 -19.81 65.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.491 -0.777 . . . . 1.0 110.605 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.96 -12.18 36.74 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.698 0.285 . . . . 1.0 110.725 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -104.84 -38.34 6.69 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.121 0.568 . . . . 1.0 110.827 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.67 -61.98 3.25 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 119.894 -0.098 . . . . 1.0 110.958 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -57.91 -41.83 64.92 Favored 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 122.501 2.134 . . . . 1.0 112.583 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -62.88 -46.07 89.57 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.904 -0.318 . . . . 1.0 110.875 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.3 mt -63.06 -37.6 87.86 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.763 0.316 . . . . 1.0 110.209 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -59.51 -27.36 66.09 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.924 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.6 t -86.0 -30.6 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 81.9 t -78.89 -18.41 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 121.124 0.488 . . . . 1.0 109.788 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.5 -60.63 9.95 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.57 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -57.11 -22.09 45.92 Favored 'Trans proline' 0 N--CA 1.507 2.314 0 C-N-CA 122.098 1.865 . . . . 1.0 112.728 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -59.49 -45.2 92.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 120.448 -0.501 . . . . 1.0 110.151 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -65.76 -42.97 90.24 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.626 -0.429 . . . . 1.0 110.722 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.66 -41.88 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 120.993 -0.283 . . . . 1.0 110.355 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.8 p -58.18 -36.84 73.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.202 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -81.48 -28.65 33.99 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 119.712 -0.185 . . . . 1.0 111.462 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.8 mm -62.23 -44.2 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -58.69 -39.63 81.28 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.916 0.389 . . . . 1.0 110.608 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.1 m -61.09 -44.72 96.93 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.168 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 23.4 mmt -54.18 -40.79 67.87 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.574 0.226 . . . . 1.0 110.869 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.5 mt -62.01 -33.39 74.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.628 -0.508 . . . . 1.0 109.628 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -81.32 -57.2 3.6 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.199 0.444 . . . . 1.0 112.199 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.9 t -86.96 -38.69 16.41 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.08 0.4 . . . . 1.0 112.08 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.54 -8.22 62.57 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.161 -1.175 . . . . 1.0 110.161 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 43.83 81.3 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.491 0.317 . . . . 1.0 110.787 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.5 tp -80.63 137.12 36.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.662 -0.495 . . . . 1.0 109.662 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -127.48 78.34 74.81 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 123.122 0.569 . . . . 1.0 109.949 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -48.68 99.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 122.051 1.834 . . . . 1.0 112.458 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -169.6 -18.37 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.844 0.355 . . . . 1.0 110.797 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -150.12 147.56 27.91 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.109 0.48 . . . . 1.0 110.875 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.66 142.08 50.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.65 -0.704 . . . . 1.0 111.132 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -160.02 103.35 1.48 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 63.4 m -84.65 143.35 29.29 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.791 -0.641 . . . . 1.0 110.3 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.1 p -140.64 146.91 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.2 p -128.68 104.12 7.47 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.58 0.352 . . . . 1.0 110.098 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.0 mt -82.9 148.71 27.52 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.068 -0.715 . . . . 1.0 109.068 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -139.87 125.22 18.96 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.455 ' CD2' ' N ' ' A' ' 80' ' ' HIS . 0.1 OUTLIER -170.67 146.4 2.66 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.18 0.514 . . . . 1.0 110.168 -179.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 83' ' ' PHE . 59.6 t30 53.82 31.14 12.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.979 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.18 -27.86 1.18 Allowed Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.783 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.4 ' H ' ' C ' ' A' ' 81' ' ' ASN . 65.7 m-85 -83.19 154.01 24.46 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 117.081 0.44 . . . . 1.0 110.384 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 t -151.02 133.56 15.57 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.068 0.461 . . . . 1.0 110.85 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 68.4 m -106.89 142.5 36.41 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.008 -0.738 . . . . 1.0 109.008 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -106.39 141.97 36.84 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.441 0.564 . . . . 1.0 109.572 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.11 147.71 31.84 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 110.646 -0.131 . . . . 1.0 110.646 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -145.64 140.88 27.65 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.9 m -94.14 -22.43 18.47 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.43 15.85 0.24 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.752 0.821 . . . . 1.0 111.837 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.64 14.98 74.56 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 109.373 -1.491 . . . . 1.0 109.373 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.407 ' O ' ' SG ' ' A' ' 93' ' ' CYS . 13.4 t -50.19 -22.04 1.56 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.113 -0.544 . . . . 1.0 111.798 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 92' ' ' SER . 27.9 p 36.67 34.14 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 177.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.81 -48.47 0.08 OUTLIER Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.505 -0.855 . . . . 1.0 112.13 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.439 ' CD1' ' NH2' ' A' ' 19' ' ' ARG . 99.1 m-85 -107.09 145.43 32.43 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.752 -0.462 . . . . 1.0 109.752 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.79 140.5 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.634 0.773 . . . . 1.0 109.199 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -139.22 162.25 35.45 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.311 0.577 . . . . 1.0 109.683 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 42.4 pt -137.41 165.18 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 114.92 -1.036 . . . . 1.0 110.523 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.65 146.34 27.22 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.631 -0.713 . . . . 1.0 109.56 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 p -122.59 133.29 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 115.299 -0.864 . . . . 1.0 109.86 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -140.55 93.65 8.64 Favored Pre-proline 0 N--CA 1.471 0.601 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -51.19 139.35 43.77 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 121.33 1.353 . . . . 1.0 112.337 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 75.3 p -74.29 136.06 42.61 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 120.789 0.328 . . . . 1.0 110.272 179.703 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.9 ttt85 . . . . . 0 C--O 1.232 0.181 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.5 tt -122.53 140.07 53.18 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.177 0.591 . . . . 1.0 109.646 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.37 176.3 16.17 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.59 100.09 0.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -75.95 134.22 40.26 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.964 -0.754 . . . . 1.0 108.964 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.4 mt -127.21 146.03 50.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.363 -0.835 . . . . 1.0 109.941 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.2 137.2 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -71.61 136.13 47.25 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -166.91 100.64 0.55 Allowed 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.78 -165.65 54.56 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -84.84 26.98 0.78 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.77 0.319 . . . . 1.0 110.237 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -145.23 139.56 27.26 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.608 -0.516 . . . . 1.0 109.608 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.0 mt -91.55 131.64 36.84 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -82.29 114.95 21.12 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.217 -0.29 . . . . 1.0 110.217 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -100.07 105.69 17.36 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.62 141.0 28.96 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.54 -0.755 . . . . 1.0 109.598 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.46 -40.97 17.07 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.674 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 23.5 p-10 -72.28 -8.26 53.9 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.237 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -114.77 49.3 1.05 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 120.896 0.379 . . . . 1.0 110.211 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.82 127.23 1.57 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.905 0.383 . . . . 1.0 110.185 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.4 p -76.49 166.86 22.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 pt -125.37 153.79 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.0 p -137.1 136.64 38.49 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.47 102.46 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.16 -0.776 . . . . 1.0 111.16 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -58.36 123.6 16.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.001 0.429 . . . . 1.0 110.276 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -90.27 137.88 31.99 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.364 0.602 . . . . 1.0 109.663 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.7 m -69.21 169.38 12.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.239 -0.891 . . . . 1.0 110.6 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -65.63 -20.35 66.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.402 -0.817 . . . . 1.0 110.166 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.93 -10.05 40.9 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 120.827 0.346 . . . . 1.0 110.544 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -107.88 -26.49 10.71 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.258 0.623 . . . . 1.0 111.416 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -68.45 -45.37 36.65 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.393 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 35.1 Cg_exo -62.57 -53.31 1.85 Allowed 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 122.317 2.012 . . . . 1.0 112.477 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -54.01 -36.84 63.41 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.649 -0.705 . . . . 1.0 110.994 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.5 tp -76.27 -36.87 58.23 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.93 0.395 . . . . 1.0 110.204 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.41 -20.42 65.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.852 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.7 m -97.02 -8.99 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 110.107 -0.331 . . . . 1.0 110.107 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.5 t -92.77 -26.5 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.415 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -63.36 -47.78 83.54 Favored Pre-proline 0 CA--C 1.551 0.988 0 O-C-N 122.243 -0.286 . . . . 1.0 110.809 -178.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 52' ' ' PHE . 69.7 Cg_exo -54.53 -39.31 88.81 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.336 2.024 . . . . 1.0 111.88 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -62.32 -42.89 99.75 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.096 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -64.25 -42.42 96.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.619 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.18 -29.93 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.84 -0.43 . . . . 1.0 109.84 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.8 m -60.88 -43.62 98.2 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.885 -0.326 . . . . 1.0 111.061 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -68.76 -33.4 73.82 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.27 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.2 mm -62.78 -45.13 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.16 -40.02 80.34 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.828 0.347 . . . . 1.0 110.429 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.9 m -76.6 -27.92 55.94 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.597 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 66' ' ' GLY . 59.4 ttm -60.16 -40.05 88.56 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 110.052 -0.351 . . . . 1.0 110.052 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 mt -62.11 -32.4 72.96 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.9 p -87.29 -59.75 2.17 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.982 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.5 p -78.39 -39.62 38.54 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.441 0.534 . . . . 1.0 112.441 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -80.86 -16.71 74.42 Favored Glycine 0 N--CA 1.474 1.195 0 N-CA-C 111.238 -0.745 . . . . 1.0 111.238 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 40.74 79.11 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.078 0.551 . . . . 1.0 111.621 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.13 157.94 27.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.108 0.48 . . . . 1.0 109.812 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -135.67 79.37 47.02 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.237 -0.892 . . . . 1.0 110.141 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -51.47 -13.32 1.29 Allowed 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 122.365 2.043 . . . . 1.0 111.939 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -73.26 -14.27 61.29 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.089 0.471 . . . . 1.0 110.04 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -138.73 144.95 39.72 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.431 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.06 141.01 47.43 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.277 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -160.64 140.04 10.73 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.3 m -131.97 144.46 50.82 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.639 0.375 . . . . 1.0 110.017 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.1 p -147.03 147.97 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.9 p -125.32 115.6 20.6 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 67.9 mt -98.33 158.22 15.71 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -139.6 123.01 17.15 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -154.94 133.49 11.97 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 53.73 24.2 4.19 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.814 0.34 . . . . 1.0 111.324 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.59 -25.79 7.03 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 111.23 -0.748 . . . . 1.0 111.23 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -65.13 146.39 55.04 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.1 m -139.23 107.07 5.65 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.589 -0.522 . . . . 1.0 109.589 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 54.1 t -98.23 137.55 36.81 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -95.56 134.05 38.88 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.23 133.28 38.85 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -148.4 140.94 24.39 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.576 -0.527 . . . . 1.0 109.576 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 74.9 p -92.38 -38.14 12.18 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 120.757 0.313 . . . . 1.0 111.332 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.0 mp 55.46 23.11 5.56 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.002 0.429 . . . . 1.0 110.119 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 93' ' ' CYS . . . 83.34 12.05 79.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.995 -1.242 . . . . 1.0 109.995 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.9 p -57.43 83.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.848 0.356 . . . . 1.0 110.995 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 91' ' ' GLY . 81.8 m -63.12 119.83 10.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.615 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.43 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . 64.21 31.43 80.81 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.43 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 41.9 m-85 -162.62 153.03 16.67 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.2 p -148.78 140.17 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.337 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -119.49 136.66 54.22 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.1 pt -137.12 160.89 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 120.944 0.402 . . . . 1.0 110.037 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.49 119.84 7.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.597 0.713 . . . . 1.0 110.1 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.7 t -93.36 130.83 41.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-N 114.643 -1.162 . . . . 1.0 108.719 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -137.95 115.84 9.55 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-O 118.689 -0.672 . . . . 1.0 109.69 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.49 145.95 38.6 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.371 1.381 . . . . 1.0 110.813 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.7 t -99.09 148.81 23.67 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 110.192 -0.299 . . . . 1.0 110.192 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 . . . . . 0 CA--C 1.513 -0.455 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 tp -121.59 128.57 52.09 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.232 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.81 153.99 33.51 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.142 -1.183 . . . . 1.0 110.142 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.23 62.67 0.05 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.141 0.496 . . . . 1.0 109.94 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -72.94 132.87 44.0 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.092 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.9 mt -112.92 153.15 28.42 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.469 -0.567 . . . . 1.0 109.469 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.8 m -96.5 136.06 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.442 -0.947 . . . . 1.0 108.442 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -78.11 135.65 37.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -168.1 113.68 0.67 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.181 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.48 -159.0 53.21 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 109.727 -1.349 . . . . 1.0 109.727 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -92.96 10.03 33.08 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 110.362 -0.236 . . . . 1.0 110.362 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -130.61 137.33 49.59 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.138 -0.483 . . . . 1.0 109.954 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.1 mp -89.83 135.98 33.31 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -89.86 115.94 27.56 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.076 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -98.24 104.56 16.61 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.883 -0.784 . . . . 1.0 108.883 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 mt -93.06 115.23 27.9 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.339 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.86 -30.4 70.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.749 -0.659 . . . . 1.0 110.128 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -70.77 -9.58 57.68 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.951 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -112.25 56.84 0.65 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.538 0.685 . . . . 1.0 110.555 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.85 175.28 6.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.58 -0.736 . . . . 1.0 109.432 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.7 m -145.67 163.63 34.3 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.8 mt -107.0 141.37 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.4 m -127.71 138.66 52.86 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.93 -135.06 14.81 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.567 -1.013 . . . . 1.0 110.567 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -168.57 132.96 1.58 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.651 -0.499 . . . . 1.0 109.651 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -115.75 126.89 54.64 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.176 -0.676 . . . . 1.0 109.176 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.8 m -67.88 161.11 27.05 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -56.29 -21.85 26.56 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.729 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.72 -12.58 33.57 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.66 0.267 . . . . 1.0 110.528 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.27 -27.78 8.93 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.025 0.53 . . . . 1.0 111.062 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.495 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -61.66 -46.57 93.55 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 45.7 Cg_exo -57.71 -47.77 19.77 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.043 1.829 . . . . 1.0 112.522 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -54.63 -51.96 63.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.981 -0.554 . . . . 1.0 111.793 -177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.458 HD11 ' CE1' ' A' ' 83' ' ' PHE . 4.3 mm? -61.69 -41.16 97.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.852 0.358 . . . . 1.0 110.995 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -66.09 -16.64 64.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.103 -0.498 . . . . 1.0 110.227 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.3 t -101.93 -14.72 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 110.168 -0.308 . . . . 1.0 110.168 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.51 -18.71 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.48 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -61.85 -47.23 92.15 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 110.141 -0.318 . . . . 1.0 110.141 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 52' ' ' PHE . 52.9 Cg_exo -56.56 -33.3 92.55 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.273 1.982 . . . . 1.0 111.037 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.521 ' NE2' ' NE2' ' A' ' 58' ' ' GLN . 48.6 t60 -59.29 -42.77 92.09 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.7 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -64.94 -42.1 94.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.143 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.1 mm -72.23 -26.71 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.376 -0.529 . . . . 1.0 109.63 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -70.1 -42.89 72.09 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.745 -0.382 . . . . 1.0 111.046 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.521 ' NE2' ' NE2' ' A' ' 54' ' ' HIS . 48.5 mt-30 -81.8 -50.4 9.28 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.377 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.8 mt -53.17 -46.24 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -55.58 -33.96 64.38 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.519 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m -76.11 -32.9 59.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.734 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.451 ' O ' ' N ' ' A' ' 66' ' ' GLY . 81.1 mmm -59.59 -29.16 67.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.937 0.399 . . . . 1.0 110.328 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.9 mt -60.01 -41.59 92.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.849 0.357 . . . . 1.0 110.125 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.9 m -85.4 -55.02 4.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.242 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.4 m -65.01 -42.05 94.81 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.696 -0.402 . . . . 1.0 111.339 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -86.11 -7.84 79.67 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 50.29 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.662 0.268 . . . . 1.0 110.393 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.4 tp -78.91 143.13 36.14 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -135.41 80.4 45.84 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.814 -0.63 . . . . 1.0 109.77 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.32 88.77 0.83 Allowed 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.11 1.873 . . . . 1.0 110.677 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -171.43 -9.47 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.927 0.394 . . . . 1.0 111.006 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -146.28 147.15 31.09 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.155 0.502 . . . . 1.0 110.867 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.22 131.2 47.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.63 -0.714 . . . . 1.0 109.944 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -162.4 139.22 7.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.431 -0.951 . . . . 1.0 108.431 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 58.3 m -129.88 140.88 50.89 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.6 t -132.94 134.49 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.488 -0.93 . . . . 1.0 108.488 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.2 m -109.7 119.92 40.89 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.54 142.49 40.53 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.122 -0.696 . . . . 1.0 109.122 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 42.3 p90 -133.75 126.47 30.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -156.25 139.42 15.56 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 54.45 34.31 20.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.928 0.394 . . . . 1.0 111.576 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.99 -28.63 1.62 Allowed Glycine 0 N--CA 1.467 0.725 0 N-CA-C 111.269 -0.732 . . . . 1.0 111.269 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.458 ' CE1' HD11 ' A' ' 48' ' ' LEU . 69.8 m-85 -70.81 150.46 45.82 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.7 m -138.65 112.77 8.61 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 62.1 m -100.73 143.27 31.09 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -106.38 143.09 35.0 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.12 151.05 40.28 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -162.21 137.67 7.31 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.117 -0.698 . . . . 1.0 109.117 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 67.1 p -87.3 -16.11 36.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.977 -0.101 . . . . 1.0 110.729 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.2 mt 59.19 8.05 1.0 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.162 0.506 . . . . 1.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.73 20.22 78.49 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 110.614 -0.995 . . . . 1.0 110.614 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.9 t -61.9 -145.91 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.782 0.325 . . . . 1.0 110.161 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.3 p -164.8 107.86 0.87 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.19 28.27 68.52 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.483 -1.047 . . . . 1.0 110.483 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -151.96 146.98 26.01 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.1 m -139.71 140.16 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.325 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 8.0 m-85 -125.51 131.92 52.72 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.811 -0.811 . . . . 1.0 108.811 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.4 pt -138.95 163.57 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.73 145.74 25.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.717 -0.845 . . . . 1.0 108.717 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.56 135.54 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.247 -0.888 . . . . 1.0 109.388 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -145.91 143.67 20.13 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.123 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.82 139.88 44.83 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.681 1.587 . . . . 1.0 111.57 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.3 p -81.16 141.85 33.82 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 . . . . . 0 N--CA 1.464 0.264 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 179.809 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 109.554 -0.536 . . . . 1.0 109.554 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 tt -121.82 131.45 54.06 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.733 -0.469 . . . . 1.0 109.733 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.54 164.36 25.46 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.174 -1.171 . . . . 1.0 110.174 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.08 135.82 0.61 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -136.98 130.59 31.73 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.1 mt -111.16 152.77 26.66 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.69 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.49 137.75 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -73.45 138.9 45.45 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.002 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -169.55 107.6 0.4 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.93 -169.94 44.71 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 109.824 -1.31 . . . . 1.0 109.824 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -84.81 23.76 1.14 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 122.717 -0.284 . . . . 1.0 110.32 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -143.65 143.01 31.27 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.748 -0.464 . . . . 1.0 109.748 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.7 mt -95.13 134.63 37.65 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -92.97 117.81 30.47 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.44 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -98.51 104.96 17.04 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.58 112.65 24.67 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.614 -0.721 . . . . 1.0 109.553 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.35 79.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.611 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -69.04 -11.99 61.28 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.567 -0.742 . . . . 1.0 110.583 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -107.97 55.36 0.65 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.879 0.371 . . . . 1.0 111.105 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.41 126.27 0.52 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.206 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -82.48 139.95 33.64 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.229 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.4 mt -85.71 141.33 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 76.9 p -130.9 147.7 52.57 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.001 0.52 . . . . 1.0 109.617 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.89 -150.32 50.34 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.823 -0.911 . . . . 1.0 110.823 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -158.49 130.36 6.72 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -111.53 125.68 54.17 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.609 0.764 . . . . 1.0 109.153 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -65.75 168.57 7.6 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.212 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.79 -22.16 66.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.68 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.42 -9.73 40.58 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 120.667 0.27 . . . . 1.0 110.602 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -108.26 -26.17 10.68 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.845 0.458 . . . . 1.0 111.421 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -67.59 -44.8 45.41 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 110.169 -0.308 . . . . 1.0 110.169 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 45.1 Cg_exo -59.43 -50.9 7.26 Favored 'Trans proline' 0 N--CA 1.503 2.062 0 C-N-CA 122.22 1.946 . . . . 1.0 112.23 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -55.99 -27.44 52.79 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.898 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -39.87 92.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -68.16 -24.93 65.04 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.927 -0.579 . . . . 1.0 111.053 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.64 -44.63 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.308 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.7 t -84.21 -15.1 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 121.205 0.526 . . . . 1.0 110.506 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -55.92 -53.15 66.28 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-O 118.658 -0.687 . . . . 1.0 111.804 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -68.04 -22.04 42.16 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 CA-C-N 121.443 1.551 . . . . 1.0 111.431 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.511 ' NE2' ' ND1' ' A' ' 80' ' ' HIS . 62.0 t-80 -59.24 -46.74 87.67 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.516 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.66 -42.61 91.14 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.87 -0.332 . . . . 1.0 110.531 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.4 mt -71.6 -42.52 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 120.729 -0.389 . . . . 1.0 110.076 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -57.75 -39.11 76.62 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.836 -0.345 . . . . 1.0 111.283 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.31 -46.55 13.48 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 110.565 -0.161 . . . . 1.0 110.565 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.9 mt -63.08 -43.98 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -58.41 -41.51 85.11 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.693 -0.403 . . . . 1.0 110.42 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.1 p -69.15 -31.82 70.75 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 121.018 -0.273 . . . . 1.0 110.359 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 66' ' ' GLY . 42.8 tpp -60.75 -40.9 94.14 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.59 -35.7 78.59 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.015 -0.365 . . . . 1.0 110.015 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.1 p -86.37 -58.84 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.76 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -63.54 -41.13 98.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.777 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -117.1 70.77 0.29 Allowed Glycine 0 N--CA 1.476 1.325 0 N-CA-C 111.448 -0.661 . . . . 1.0 111.448 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -47.2 86.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.006 0.403 . . . . 1.0 111.174 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 66' ' ' GLY . 4.5 tp -82.23 145.75 29.87 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.569 -0.9 . . . . 1.0 108.569 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -134.64 144.01 48.95 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 72' ' ' HIS . 82.1 Cg_exo -38.23 -87.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 122.485 2.123 . . . . 1.0 113.057 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.438 ' O ' ' CG ' ' A' ' 72' ' ' HIS . 81.6 mtp180 58.36 -56.62 0.04 OUTLIER 'General case' 0 C--N 1.346 0.447 0 C-N-CA 123.744 0.817 . . . . 1.0 112.689 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.548 ' N ' ' O ' ' A' ' 70' ' ' PRO . 74.2 m80 -158.66 149.14 19.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.751 -0.658 . . . . 1.0 110.023 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.51 144.13 54.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.504 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.51 102.77 1.37 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.038 0.447 . . . . 1.0 110.122 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.37 137.17 39.63 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.804 -0.635 . . . . 1.0 110.655 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.9 t -125.91 134.87 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.0 p -113.18 111.18 21.64 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.344 -0.613 . . . . 1.0 109.344 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.3 mt -95.67 151.47 19.32 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.42 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 50.0 p90 -146.86 127.3 14.05 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.649 0.261 . . . . 1.0 110.308 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.511 ' ND1' ' NE2' ' A' ' 54' ' ' HIS . 58.6 t-80 -159.63 4.11 0.09 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.597 0.237 . . . . 1.0 110.472 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -165.71 22.03 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.156 0.503 . . . . 1.0 110.252 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.89 -29.39 5.06 Favored Glycine 0 N--CA 1.468 0.815 0 N-CA-C 111.087 -0.805 . . . . 1.0 111.087 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -72.74 143.56 47.96 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.422 ' O ' ' CZ ' ' A' ' 101' ' ' TYR . 60.6 p -134.1 107.46 7.75 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.8 t -90.52 140.37 29.8 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -97.88 138.31 35.42 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.133 -0.692 . . . . 1.0 109.133 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.06 149.08 39.46 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 110.013 -0.366 . . . . 1.0 110.013 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -168.51 141.45 2.97 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.0 p -86.03 -29.38 23.5 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.804 0.335 . . . . 1.0 110.285 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.6 mt 59.2 17.7 5.9 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.613 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.74 10.42 76.49 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 109.979 -1.248 . . . . 1.0 109.979 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.4 t -49.59 -22.21 1.22 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 118.927 -0.559 . . . . 1.0 111.944 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 26.2 p 36.76 34.41 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.354 0.872 . . . . 1.0 113.354 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.36 -55.24 0.02 OUTLIER Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.849 -0.5 . . . . 1.0 111.849 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.23 139.13 54.22 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.72 0.408 . . . . 1.0 110.387 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.9 t -106.1 115.71 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -97.97 137.02 37.42 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.883 -0.784 . . . . 1.0 108.883 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.2 pt -138.31 161.19 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.29 147.76 27.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.942 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.05 131.21 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.082 -0.963 . . . . 1.0 109.357 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 11.3 p90 -131.71 94.25 25.94 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 108.734 -0.839 . . . . 1.0 108.734 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.79 137.64 34.49 Favored 'Trans proline' 0 N--CA 1.503 2.056 0 C-N-CA 121.524 1.483 . . . . 1.0 111.742 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 t -96.07 148.72 22.38 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 120.948 0.404 . . . . 1.0 110.219 -179.77 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -130.08 149.24 51.88 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.56 0.695 . . . . 1.0 110.481 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.82 138.24 20.54 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.639 -1.384 . . . . 1.0 109.639 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.29 53.81 0.22 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.455 0.645 . . . . 1.0 109.438 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -76.41 128.91 35.76 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.847 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.6 mt -92.63 150.0 20.98 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.891 -0.411 . . . . 1.0 109.891 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.5 p -104.24 136.49 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -76.12 130.74 38.77 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.358 -0.383 . . . . 1.0 109.998 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -170.29 109.7 0.38 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.45 -165.67 54.76 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 109.685 -1.366 . . . . 1.0 109.685 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -87.21 10.91 15.45 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.896 -0.409 . . . . 1.0 109.896 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -129.76 141.06 50.93 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.736 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 54.8 mt -90.55 124.99 35.46 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -82.85 116.01 21.98 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.637 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -101.05 107.33 18.75 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.04 118.36 31.72 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.649 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.47 80.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.034 0.445 . . . . 1.0 110.739 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -67.83 -11.2 58.07 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.905 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -111.3 58.62 0.62 Allowed 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.041 0.448 . . . . 1.0 110.508 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.09 176.35 4.67 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.978 -0.556 . . . . 1.0 109.626 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -133.19 127.91 34.83 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.587 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 pt -85.32 147.73 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 82.5 p -133.21 134.76 44.47 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.8 102.66 0.01 OUTLIER Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -58.75 129.79 43.79 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.995 0.426 . . . . 1.0 110.113 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -96.02 136.33 36.61 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.745 -0.662 . . . . 1.0 109.853 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -67.1 167.43 11.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.381 -0.827 . . . . 1.0 110.709 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -64.46 -20.58 66.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.605 -0.725 . . . . 1.0 110.616 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.57 -11.01 38.48 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.006 0.432 . . . . 1.0 110.517 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -107.72 -24.28 11.78 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.283 0.633 . . . . 1.0 111.812 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.47 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -70.68 -45.36 17.27 Favored Pre-proline 0 CA--C 1.551 0.995 0 O-C-N 122.093 -0.38 . . . . 1.0 110.27 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 52.5 Cg_exo -58.15 -50.58 9.61 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 122.328 2.019 . . . . 1.0 113.167 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -60.2 -43.93 95.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.303 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.2 tt -61.47 -39.64 91.62 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.34 -10.59 11.64 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.088 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 81.2 t -101.42 -15.34 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 109.557 -0.535 . . . . 1.0 109.557 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.93 -28.39 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 110.52 -0.178 . . . . 1.0 110.52 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.423 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -67.06 -46.65 52.92 Favored Pre-proline 0 N--CA 1.483 1.223 0 O-C-N 122.393 -0.192 . . . . 1.0 111.156 -178.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 52' ' ' PHE . 54.6 Cg_exo -56.59 -36.35 97.88 Favored 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 122.494 2.129 . . . . 1.0 111.885 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -65.31 -40.51 93.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 1.0 109.954 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 59' ' ' ILE . 59.3 t80 -64.21 -41.62 96.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.502 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.5 mm -69.43 -36.91 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.4 t -59.13 -45.57 90.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.625 -0.261 . . . . 1.0 111.392 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.436 ' O ' ' SD ' ' A' ' 62' ' ' MET . 29.1 mm100 -67.85 -37.81 82.35 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.852 -0.158 . . . . 1.0 110.846 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.66 HD11 ' CE2' ' A' ' 55' ' ' PHE . 82.0 mt -59.08 -43.67 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.915 -0.491 . . . . 1.0 109.815 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -58.13 -39.48 78.84 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.815 0.34 . . . . 1.0 110.275 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -65.34 -39.59 92.59 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.459 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -60.3 -40.71 91.45 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 110.348 -0.241 . . . . 1.0 110.348 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.69 -34.93 76.63 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.546 -0.539 . . . . 1.0 109.546 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.3 p -86.02 -62.41 1.53 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.309 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.8 p -74.72 -39.64 61.77 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.042 0.386 . . . . 1.0 112.042 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.29 -4.7 90.41 Favored Glycine 0 N--CA 1.47 0.961 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 31.79 78.6 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.699 0.8 . . . . 1.0 112.113 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.63 151.43 32.3 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.247 0.546 . . . . 1.0 109.657 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -141.29 74.84 23.97 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.154 -0.93 . . . . 1.0 110.013 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -48.2 105.97 0.1 OUTLIER 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 122.332 2.022 . . . . 1.0 111.648 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -171.02 -16.08 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.663 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -142.53 142.37 32.22 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.931 0.396 . . . . 1.0 110.999 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.3 125.73 24.51 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.768 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -162.01 103.99 1.16 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 27.7 p -90.29 148.13 23.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.433 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.58 152.27 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.8 p -128.01 110.27 12.35 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.801 -0.444 . . . . 1.0 109.801 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 78' ' ' LEU . 9.5 mp -91.94 158.87 16.03 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.828 -0.805 . . . . 1.0 108.828 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -140.94 122.63 15.24 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -157.81 134.6 9.89 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 53.92 27.5 7.38 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.104 0.478 . . . . 1.0 111.406 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.63 -24.91 4.12 Favored Glycine 0 N--CA 1.469 0.85 0 N-CA-C 111.532 -0.627 . . . . 1.0 111.532 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -67.61 140.85 56.9 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 67.8 m -129.27 109.19 10.91 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 39.8 t -95.53 140.74 29.93 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -106.0 130.2 53.97 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.85 140.2 45.64 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -145.05 133.56 21.96 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.771 -0.825 . . . . 1.0 108.771 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.8 p -92.69 -32.2 14.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.012 0.434 . . . . 1.0 110.712 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.46 12.69 1.56 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.526 -0.546 . . . . 1.0 109.526 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.81 18.28 77.4 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 109.179 -1.568 . . . . 1.0 109.179 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.8 m -67.49 75.6 0.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.111 0.482 . . . . 1.0 111.668 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 43.6 t -65.69 48.96 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.773 -1.103 . . . . 1.0 110.559 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.412 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . -166.38 -21.16 0.02 OUTLIER Glycine 0 CA--C 1.531 1.087 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.412 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 87.0 m-85 -158.41 170.78 21.45 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.938 0.369 . . . . 1.0 110.284 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.67 113.22 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -86.93 133.53 33.59 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.985 -0.376 . . . . 1.0 109.985 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.1 pt -143.33 161.85 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-N 118.221 0.464 . . . . 1.0 110.625 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.5 148.0 26.88 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.315 0.578 . . . . 1.0 110.4 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.451 ' H ' HD11 ' A' ' 16' ' ' LEU . 28.9 m -133.18 137.18 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.028 -0.987 . . . . 1.0 110.508 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -151.55 148.16 21.58 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.1 141.75 71.24 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 121.361 1.374 . . . . 1.0 111.257 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.0 m -74.48 136.96 42.25 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 . . . . . 0 N--CA 1.464 0.237 0 CA-C-O 120.775 0.322 . . . . 1.0 110.201 -179.826 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 108.364 -0.976 . . . . 1.0 108.364 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.2 tt -109.54 116.24 31.41 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.36 161.99 27.93 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 110.254 -1.139 . . . . 1.0 110.254 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.12 72.75 0.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 1.0 110.433 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -83.72 125.85 32.31 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.28 153.94 20.92 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.232 0.613 . . . . 1.0 109.445 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.14 140.87 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 108.817 -0.808 . . . . 1.0 108.817 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -81.38 108.34 14.91 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -65.0 -51.95 58.82 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.288 0.566 . . . . 1.0 109.676 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.95 -77.6 0.1 Allowed Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.058 -1.217 . . . . 1.0 110.058 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -100.28 8.06 43.99 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.892 0.477 . . . . 1.0 110.317 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -155.99 156.24 34.12 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.015 -0.365 . . . . 1.0 110.015 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.43 121.65 40.63 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.082 -0.71 . . . . 1.0 109.082 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.96 119.74 31.39 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.297 0.239 . . . . 1.0 110.6 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -99.84 101.99 13.29 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.82 109.12 19.06 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.848 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.81 -28.02 68.47 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.132 0.491 . . . . 1.0 110.708 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -68.33 -11.62 59.81 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.573 -0.739 . . . . 1.0 111.046 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -109.37 45.77 1.04 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 120.869 0.366 . . . . 1.0 110.118 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.71 127.4 0.91 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.759 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.5 m -95.24 167.74 11.16 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.3 tp -94.9 141.16 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.5 m -128.25 125.3 38.64 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.99 153.53 8.59 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.809 -0.916 . . . . 1.0 110.809 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -92.81 125.95 37.66 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.825 0.345 . . . . 1.0 110.271 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -112.1 129.47 56.21 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 m -71.3 164.32 25.94 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.969 0.414 . . . . 1.0 110.382 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -63.98 -20.25 65.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.459 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.95 -11.92 34.82 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.88 0.371 . . . . 1.0 110.284 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -107.19 -25.85 11.34 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.08 0.552 . . . . 1.0 111.452 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -67.8 -45.39 43.92 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 120.904 -0.319 . . . . 1.0 110.391 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 51.9 Cg_exo -56.65 -46.86 26.75 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 122.345 2.03 . . . . 1.0 112.527 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.67 -32.67 69.32 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.595 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tp -63.28 -37.75 88.46 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.13 0.491 . . . . 1.0 110.095 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -68.96 -11.06 60.34 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.462 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.9 t -82.76 -48.49 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 110.35 -0.241 . . . . 1.0 110.35 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.18 -26.79 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 120.622 0.249 . . . . 1.0 111.497 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -54.89 -61.83 5.17 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-O 119.51 -0.281 . . . . 1.0 111.373 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -60.85 -30.48 90.2 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.636 1.557 . . . . 1.0 111.288 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -61.89 -44.78 96.09 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.735 -0.468 . . . . 1.0 109.735 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -65.62 -41.94 92.13 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.529 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.5 mt -72.58 -36.83 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.143 0.497 . . . . 1.0 109.795 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 t -68.83 -40.23 79.56 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.316 0.858 . . . . 1.0 113.316 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -81.7 -46.19 14.65 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 122.113 -0.367 . . . . 1.0 111.57 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 tt -54.88 -36.03 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.777 0.322 . . . . 1.0 110.515 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -54.97 -46.22 75.05 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.605 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 m -70.87 -32.44 69.44 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.149 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.8 ttm -59.72 -31.64 69.8 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.316 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.05 -41.75 93.0 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.681 -0.489 . . . . 1.0 109.681 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.6 m -85.61 -55.57 3.93 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.381 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.6 p -66.47 -39.12 88.63 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 121.114 -0.235 . . . . 1.0 111.476 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.4 1.03 78.48 Favored Glycine 0 N--CA 1.472 1.064 0 N-CA-C 110.341 -1.104 . . . . 1.0 110.341 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 41.85 71.23 0.22 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.054 0.542 . . . . 1.0 111.069 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.0 144.99 29.58 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.201 0.524 . . . . 1.0 110.096 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -129.77 79.86 72.6 Favored Pre-proline 0 N--CA 1.471 0.589 0 CA-C-N 115.237 -0.892 . . . . 1.0 109.186 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -45.54 98.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.942 1.762 . . . . 1.0 112.406 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -170.19 -63.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.837 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -94.39 137.55 33.4 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 116.475 -0.329 . . . . 1.0 110.264 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.0 142.61 58.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.47 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -161.1 104.88 1.31 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 43.0 m -74.91 139.64 43.22 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.197 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.9 t -134.22 139.05 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.1 p -115.28 115.01 25.96 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.602 0.361 . . . . 1.0 110.261 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tt -102.58 143.07 32.74 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.857 0.463 . . . . 1.0 109.941 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.59 127.98 17.86 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 110.184 -0.302 . . . . 1.0 110.184 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -159.16 9.51 0.12 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.463 0.173 . . . . 1.0 111.032 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -166.11 34.3 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.255 0.55 . . . . 1.0 110.373 179.035 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.15 -28.07 1.43 Allowed Glycine 0 N--CA 1.465 0.595 0 N-CA-C 111.235 -0.746 . . . . 1.0 111.235 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.411 ' H ' ' C ' ' A' ' 81' ' ' ASN . 58.6 m-85 -83.36 146.26 28.58 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.8 p -132.49 108.17 8.95 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 96.1 m -87.13 132.9 33.7 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -91.58 135.99 33.46 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.67 0.668 . . . . 1.0 109.32 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.83 137.04 39.33 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -146.1 139.71 26.2 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.3 m -90.12 -11.64 40.67 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.82 0.343 . . . . 1.0 110.592 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.49 9.08 0.71 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.49 25.84 60.29 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.2 p -66.68 -140.32 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 53.0 t -167.67 -39.14 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.651 0.262 . . . . 1.0 110.307 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.418 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . -133.29 36.26 2.16 Favored Glycine 0 N--CA 1.477 1.385 0 N-CA-C 110.525 -1.03 . . . . 1.0 110.525 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.418 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 95.7 m-85 -157.22 145.62 19.48 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 45.0 t -134.44 134.82 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -122.51 133.04 54.59 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.5 pt -138.83 159.67 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-O 120.965 0.412 . . . . 1.0 110.303 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.68 124.5 10.56 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.532 0.682 . . . . 1.0 109.658 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.36 131.7 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.093 -0.958 . . . . 1.0 109.779 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -135.92 105.0 9.69 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 108.706 -0.849 . . . . 1.0 108.706 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -69.96 142.05 46.02 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 CA-C-N 121.223 1.473 . . . . 1.0 111.426 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 63.7 p -90.63 146.65 23.87 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.847 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 120.729 0.299 . . . . 1.0 110.238 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 121.088 0.47 . . . . 1.0 110.253 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 pp -41.88 148.62 0.16 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.92 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.38 179.66 16.06 Favored Glycine 0 N--CA 1.477 1.379 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.39 146.57 18.5 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -100.96 120.64 40.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.672 -0.695 . . . . 1.0 111.081 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.3 mt -131.34 131.81 44.02 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.83 140.97 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -71.47 132.22 44.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.994 -0.372 . . . . 1.0 109.994 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -157.69 105.05 2.0 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.04 -165.64 50.84 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 109.724 -1.35 . . . . 1.0 109.724 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -84.4 29.05 0.61 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.014 0.435 . . . . 1.0 109.868 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -148.27 143.86 27.24 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.339 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -96.45 130.15 43.66 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -85.91 115.79 23.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.057 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -96.41 109.11 21.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.482 -0.932 . . . . 1.0 108.482 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.01 115.86 28.24 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.936 -0.574 . . . . 1.0 109.67 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.03 -37.85 88.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.144 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -66.26 -9.44 32.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.737 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.48 67.59 0.67 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.327 0.584 . . . . 1.0 110.179 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.69 172.35 6.89 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.4 m -139.84 138.33 35.67 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 tp -93.83 145.01 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.4 p -129.72 148.1 51.57 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.59 -146.57 26.0 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 111.076 -0.809 . . . . 1.0 111.076 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -166.64 75.7 0.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.316 0.579 . . . . 1.0 110.519 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -61.49 138.19 58.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.248 0.546 . . . . 1.0 110.171 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 87.1 p -71.7 167.86 18.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.44 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -65.53 -20.9 66.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.379 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.59 -9.32 44.58 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.878 0.37 . . . . 1.0 110.551 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -109.32 -30.54 7.94 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.213 0.605 . . . . 1.0 111.288 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.473 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -61.58 -45.32 93.67 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 120.781 -0.367 . . . . 1.0 110.189 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 44.8 Cg_exo -59.15 -50.21 9.21 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 122.392 2.062 . . . . 1.0 112.664 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.38 -46.42 88.72 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.335 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.441 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.1 tt -60.66 -39.01 86.81 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.097 0.475 . . . . 1.0 109.98 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -60.62 -12.48 10.28 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.2 t -104.22 -18.48 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.8 t -90.28 -33.37 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.546 ' CE2' HD11 ' A' ' 56' ' ' ILE . 65.8 t80 -62.75 -49.67 81.36 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 118.534 -0.746 . . . . 1.0 111.248 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 52' ' ' PHE . 44.3 Cg_endo -58.83 -26.26 79.75 Favored 'Trans proline' 0 N--CA 1.511 2.507 0 CA-C-N 121.323 1.508 . . . . 1.0 112.132 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 80' ' ' HIS . 17.6 t60 -60.48 -43.39 97.02 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.839 0.352 . . . . 1.0 110.175 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -64.48 -40.57 95.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.094 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.546 HD11 ' CE2' ' A' ' 52' ' ' PHE . 57.7 mt -65.47 -43.86 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 120.064 -0.654 . . . . 1.0 109.286 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.6 t -58.7 -46.08 88.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.104 -0.238 . . . . 1.0 111.239 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -70.48 -38.67 74.42 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.846 -0.161 . . . . 1.0 111.028 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.2 mt -61.08 -45.63 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 109.999 -0.371 . . . . 1.0 109.999 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -52.98 -41.93 65.07 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.544 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.7 p -75.99 -29.82 58.34 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.649 -0.25 . . . . 1.0 110.463 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 66' ' ' GLY . 12.1 tmm? -61.66 -33.32 73.75 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 110.251 -0.277 . . . . 1.0 110.251 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.74 -40.61 97.77 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.8 p -75.17 -56.22 4.94 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.389 -0.368 . . . . 1.0 111.268 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.1 p -68.65 -39.07 80.84 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.68 0.276 . . . . 1.0 111.255 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -80.96 -14.91 78.64 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 52.06 84.77 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.6 tp -81.35 142.88 32.62 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.763 -0.829 . . . . 1.0 108.763 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -151.95 131.24 6.69 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 119.221 -0.419 . . . . 1.0 110.355 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.18 102.2 1.58 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.361 1.374 . . . . 1.0 110.408 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -146.23 -34.24 0.3 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.257 0.551 . . . . 1.0 111.391 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -166.26 155.53 11.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.048 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.35 146.64 50.66 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.428 -0.806 . . . . 1.0 110.308 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -159.66 102.95 1.53 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.322 0.582 . . . . 1.0 109.759 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.1 t -83.16 137.29 34.12 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.181 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.36 153.09 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -131.85 103.18 6.18 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 78' ' ' LEU . 9.8 mp -90.87 143.8 26.35 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.368 -0.975 . . . . 1.0 108.368 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -125.44 127.75 47.0 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 54' ' ' HIS . 79.6 t60 -163.04 139.67 7.36 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.4 m120 53.34 26.1 5.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.981 0.42 . . . . 1.0 111.311 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.79 -28.42 3.19 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -70.27 149.13 47.75 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.511 -0.552 . . . . 1.0 109.511 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.5 m -135.7 120.85 18.9 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.473 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 65.5 m -107.05 139.65 41.11 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.296 -1.001 . . . . 1.0 108.296 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -104.7 140.83 37.49 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 108.807 -0.812 . . . . 1.0 108.807 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.91 151.26 38.41 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 110.011 -0.366 . . . . 1.0 110.011 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -166.56 139.76 3.89 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.4 m -76.33 -20.04 57.63 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 110.468 -0.197 . . . . 1.0 110.468 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.0 mt 62.67 10.42 4.15 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.986 0.422 . . . . 1.0 110.202 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.61 13.46 83.46 Favored Glycine 0 N--CA 1.466 0.642 0 N-CA-C 110.546 -1.021 . . . . 1.0 110.546 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.6 p -62.13 -143.34 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.564 0.221 . . . . 1.0 110.473 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 23.7 p -170.64 107.39 0.3 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.78 0.324 . . . . 1.0 110.351 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.02 -9.64 37.74 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 111.216 -0.753 . . . . 1.0 111.216 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -113.94 141.95 46.74 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.039 0.536 . . . . 1.0 109.582 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.2 136.81 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 108.901 -0.777 . . . . 1.0 108.901 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -125.65 138.59 53.91 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.213 -1.032 . . . . 1.0 108.213 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.8 pt -137.38 165.2 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.982 0.42 . . . . 1.0 109.952 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.92 108.47 3.82 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.73 139.36 17.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 114.745 -1.116 . . . . 1.0 108.744 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -147.54 129.3 7.41 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.29 143.52 43.81 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 CA-C-N 120.539 1.228 . . . . 1.0 111.692 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 103' ' ' THR . 1.4 t -87.24 147.38 25.58 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.079 -0.51 . . . . 1.0 109.633 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 . . . . . 0 CA--C 1.532 0.265 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.236 -179.938 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 . . . . . 0 N--CA 1.469 0.483 0 N-CA-C 109.832 -0.432 . . . . 1.0 109.832 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 tt -119.93 114.86 22.69 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.45 156.77 43.47 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 109.822 -1.311 . . . . 1.0 109.822 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -165.34 71.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -73.91 128.99 36.99 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.0 mt -116.67 153.5 32.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.905 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.85 137.08 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.375 -0.972 . . . . 1.0 108.375 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -81.45 130.46 35.05 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -160.52 124.05 3.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.258 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.18 -147.53 50.82 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 109.953 -1.259 . . . . 1.0 109.953 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -105.18 15.42 27.5 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 110.171 -0.307 . . . . 1.0 110.171 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.411 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 17.8 mp0 -135.8 143.46 45.21 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.052 0.453 . . . . 1.0 110.122 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 50.8 mt -91.85 131.03 37.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -88.26 116.87 26.78 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -100.07 106.71 18.48 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 30' ' ' LEU . 11.0 mp -91.24 111.8 23.43 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.52 -35.1 73.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.237 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -71.62 -8.33 53.41 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.656 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -110.56 63.11 0.61 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.133 0.492 . . . . 1.0 110.378 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.9 175.09 4.56 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 t -141.43 138.06 32.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.957 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.0 mm -82.6 141.81 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.12 -0.326 . . . . 1.0 110.12 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.447 ' C ' ' H ' ' A' ' 39' ' ' LYS . 73.8 p -132.81 146.48 51.86 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.675 0.39 . . . . 1.0 110.035 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.99 -9.31 2.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 37' ' ' THR . 48.5 mtmt 50.77 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 O-C-N 122.462 -0.434 . . . . 1.0 111.25 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -69.36 139.91 54.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.299 0.571 . . . . 1.0 110.572 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.3 p -72.69 171.09 13.19 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.386 -0.825 . . . . 1.0 110.125 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.28 -19.28 65.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.434 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.98 -10.73 38.25 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 120.816 0.341 . . . . 1.0 110.544 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -109.27 -24.42 11.1 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.645 0.778 . . . . 1.0 111.227 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -67.27 -46.27 50.35 Favored Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 28.5 Cg_exo -63.75 -55.08 0.74 Allowed 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.22 1.947 . . . . 1.0 112.398 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -56.85 -45.22 82.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.254 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.16 -39.67 87.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.291 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -62.24 -20.23 64.01 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.384 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.4 t -92.55 -21.99 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.1 t -85.78 -13.45 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 110.094 -0.335 . . . . 1.0 110.094 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.444 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -65.49 -59.39 9.59 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 122.286 -0.259 . . . . 1.0 110.512 178.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 52' ' ' PHE . 30.8 Cg_endo -55.65 -24.66 46.63 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.642 1.561 . . . . 1.0 112.089 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -66.17 3.86 0.8 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.751 0.31 . . . . 1.0 110.988 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 53' ' ' PRO . 44.5 m-85 -131.95 -40.96 1.04 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.751 0.421 . . . . 1.0 110.424 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.13 -42.5 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.3 p -57.1 -41.98 79.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.977 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -67.05 -56.47 9.93 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.666 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.15 -45.71 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -52.37 -37.91 57.5 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.74 -0.384 . . . . 1.0 111.011 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.5 p -76.77 -32.33 57.65 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.125 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 78.0 mmm -56.43 -31.17 63.67 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.282 -0.266 . . . . 1.0 110.282 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.2 mt -61.51 -37.13 82.59 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.6 m -92.05 -58.8 2.28 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.161 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.5 m -66.58 -43.07 85.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.648 -0.421 . . . . 1.0 111.864 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.66 -10.54 81.33 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 110.544 -1.023 . . . . 1.0 110.544 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 47.46 77.29 0.09 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 110.183 -0.303 . . . . 1.0 110.183 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.517 HD13 ' N ' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -86.57 126.91 34.8 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 -178.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.517 ' N ' HD13 ' A' ' 68' ' ' LEU . 70.9 m-80 -145.64 151.07 45.6 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.572 -0.285 . . . . 1.0 110.523 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.36 87.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.503 2.046 0 C-N-CA 121.86 1.707 . . . . 1.0 111.688 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -133.09 -60.2 0.86 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 120.868 0.366 . . . . 1.0 110.571 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -153.56 140.01 18.7 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.952 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.74 126.14 28.78 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.689 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -138.39 103.77 4.99 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.4 t -78.59 136.01 37.41 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.819 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.5 t -125.62 136.26 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.9 p -116.97 110.96 18.94 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 68.1 mt -89.91 160.65 16.32 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 50.0 p90 -143.57 130.56 20.57 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.047 -0.353 . . . . 1.0 110.047 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.48 ' C ' ' H ' ' A' ' 82' ' ' GLY . 74.1 t60 -157.75 -96.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' A' ' 83' ' ' PHE . 59.0 t30 -70.02 35.43 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.87 0.366 . . . . 1.0 111.503 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . 77.53 -28.83 1.76 Allowed Glycine 0 N--CA 1.466 0.657 0 N-CA-C 110.735 -0.946 . . . . 1.0 110.735 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.489 ' CZ ' HG23 ' A' ' 100' ' ' VAL . 6.9 t80 -78.52 147.23 33.92 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.487 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 35.6 p -134.08 116.24 15.22 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.958 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 45.6 t -87.51 142.16 28.07 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -102.01 136.89 41.07 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.325 -0.621 . . . . 1.0 109.325 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.64 151.64 41.65 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -168.72 152.49 5.54 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.2 m -98.58 -18.18 18.27 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.667 0.27 . . . . 1.0 110.67 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.7 mp 59.41 8.97 1.29 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.07 15.37 76.48 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.101 -1.199 . . . . 1.0 110.101 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.1 m -65.62 -134.95 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.01 -0.367 . . . . 1.0 110.01 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 20.8 p -170.61 105.97 0.28 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.865 0.364 . . . . 1.0 110.054 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.37 33.9 78.61 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.652 -0.979 . . . . 1.0 110.652 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -151.25 137.16 18.14 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 m -142.3 138.33 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.307 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.429 ' N ' ' CD1' ' A' ' 97' ' ' TYR . 21.5 m-85 -116.69 120.39 38.45 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 156.8 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.296 -1.001 . . . . 1.0 108.296 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.43 150.8 30.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.18 -0.918 . . . . 1.0 109.328 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.489 HG23 ' CZ ' ' A' ' 83' ' ' PHE . 2.7 p -123.38 135.66 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 115.115 -0.948 . . . . 1.0 109.568 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 13.4 p90 -149.03 97.33 3.64 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.135 -0.938 . . . . 1.0 108.971 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -51.63 144.84 32.05 Favored 'Trans proline' 0 N--CA 1.507 2.279 0 C-N-CA 121.922 1.748 . . . . 1.0 112.058 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 80.7 p -63.29 134.04 55.17 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.348 -0.387 . . . . 1.0 109.98 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.747 0.308 . . . . 1.0 110.323 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 . . . . . 0 CA--C 1.52 -0.206 0 CA-C-O 120.784 0.326 . . . . 1.0 110.839 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.0 tp -116.39 118.32 32.4 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.388 -1.338 . . . . 1.0 107.388 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.34 161.9 33.02 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 108.73 -1.748 . . . . 1.0 108.73 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.39 67.6 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -73.31 122.17 21.58 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.295 -0.632 . . . . 1.0 109.295 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.6 mt -90.06 144.91 25.47 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.702 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -102.99 136.79 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -75.75 133.61 40.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.942 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -172.25 109.18 0.23 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.016 -0.735 . . . . 1.0 109.016 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.66 -161.48 53.76 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 109.759 -1.337 . . . . 1.0 109.759 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -87.14 5.87 35.7 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.732 0.301 . . . . 1.0 110.389 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -127.79 136.36 51.37 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.09 0.471 . . . . 1.0 110.054 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.2 mp -89.07 127.73 35.71 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.941 -0.762 . . . . 1.0 108.941 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -83.9 116.31 22.71 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.664 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -97.67 103.65 15.6 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.847 -1.168 . . . . 1.0 107.847 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 30' ' ' LEU . 10.5 mp -86.68 134.62 33.59 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.052 -0.722 . . . . 1.0 109.052 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.05 -24.58 30.38 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.883 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -73.93 -10.44 59.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.028 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -108.41 16.64 22.9 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.537 0.335 . . . . 1.0 110.473 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.22 127.67 10.0 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.2 m -86.92 170.27 11.77 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.853 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.4 pt -97.4 155.07 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 82.0 p -134.45 128.64 33.88 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.48 99.16 0.01 OUTLIER Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.102 -0.799 . . . . 1.0 111.102 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -56.07 99.64 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.789 0.328 . . . . 1.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -69.23 140.08 54.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.007 -0.542 . . . . 1.0 109.544 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -69.46 171.07 9.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.276 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -64.28 -21.18 66.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.58 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.32 -22.51 20.5 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 120.825 0.345 . . . . 1.0 110.103 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -96.87 -26.36 15.11 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.904 0.482 . . . . 1.0 110.717 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -60.36 -57.59 25.53 Favored Pre-proline 0 CA--C 1.555 1.135 0 O-C-N 122.089 -0.382 . . . . 1.0 110.127 177.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 45' ' ' CYS . 35.0 Cg_endo -56.22 -41.91 71.69 Favored 'Trans proline' 0 N--CA 1.51 2.478 0 C-N-CA 122.497 2.131 . . . . 1.0 112.688 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -56.74 -37.31 70.84 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.951 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.55 -31.11 47.25 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.047 0.451 . . . . 1.0 110.091 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.13 -40.82 86.84 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.629 -0.669 . . . . 1.0 110.685 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.2 m -75.12 -20.56 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -86.01 -20.54 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.184 0.516 . . . . 1.0 110.045 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.79 -57.06 26.53 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.063 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -56.6 -26.92 67.14 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.161 1.241 . . . . 1.0 111.72 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -77.35 16.08 0.66 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.749 0.309 . . . . 1.0 110.97 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -131.32 -37.33 1.24 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.12 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.7 mm -74.74 -30.78 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.8 m -60.82 -43.92 97.6 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.844 0.354 . . . . 1.0 111.132 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -65.42 -42.5 92.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.91 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.14 -46.94 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.37 -45.9 90.15 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.5 t -65.81 -40.67 92.09 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.495 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.428 ' O ' ' N ' ' A' ' 66' ' ' GLY . 45.6 ttm -50.67 -44.05 57.58 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.863 0.363 . . . . 1.0 110.925 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.37 -37.33 86.86 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.283 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -68.77 -61.72 1.69 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.756 0.312 . . . . 1.0 111.616 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.4 t -72.4 -39.47 67.92 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.067 0.46 . . . . 1.0 110.781 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -98.51 73.4 0.57 Allowed Glycine 0 N--CA 1.462 0.396 0 N-CA-C 109.073 -1.611 . . . . 1.0 109.073 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.25 88.82 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -82.72 123.67 29.51 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.774 -1.195 . . . . 1.0 107.774 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.418 ' N ' HD13 ' A' ' 68' ' ' LEU . 24.1 m120 -122.68 147.03 49.51 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-O 119.286 -0.388 . . . . 1.0 110.727 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.28 88.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.506 2.233 0 C-N-CA 121.419 1.412 . . . . 1.0 112.159 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -131.67 -50.83 0.98 Allowed 'General case' 0 N--CA 1.48 1.065 0 O-C-N 121.999 -0.438 . . . . 1.0 109.9 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -163.36 151.72 13.78 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.767 -178.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.85 150.31 20.5 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.717 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -155.4 139.64 16.61 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.2 t -130.55 143.63 50.88 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.628 -0.508 . . . . 1.0 109.628 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.86 144.88 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.597 -0.52 . . . . 1.0 109.597 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.6 p -115.36 116.36 28.14 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 67.4 mt -99.79 134.76 42.22 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.52 -0.919 . . . . 1.0 108.52 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.414 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 47.2 p90 -115.03 127.58 55.73 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -156.72 141.2 16.72 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.456 ' ND2' ' CD1' ' A' ' 83' ' ' PHE . 5.7 p-10 43.91 29.5 0.32 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.237 0.458 . . . . 1.0 112.237 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.21 -27.25 4.61 Favored Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.876 -0.89 . . . . 1.0 110.876 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.456 ' CD1' ' ND2' ' A' ' 81' ' ' ASN . 6.5 m-85 -68.78 150.02 48.34 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.0 m -142.29 108.11 5.14 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.139 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.5 m -93.63 143.04 26.68 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -99.36 140.75 33.08 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.61 150.27 37.15 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 110.288 -0.264 . . . . 1.0 110.288 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -164.54 134.18 3.82 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.8 m -77.21 -42.59 36.84 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.991 0.424 . . . . 1.0 110.729 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' A' ' 92' ' ' SER . 57.5 mt 58.01 37.09 26.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.118 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.41 5.93 1.99 Allowed Glycine 0 CA--C 1.533 1.209 0 N-CA-C 111.386 -0.686 . . . . 1.0 111.386 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 90' ' ' LEU . 28.7 t -104.36 57.47 0.71 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.7 p -58.41 -23.41 57.18 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 119.954 -0.698 . . . . 1.0 110.386 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.66 -12.82 48.77 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.907 -0.877 . . . . 1.0 110.907 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -155.18 119.57 4.7 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 t -101.59 113.68 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -90.49 131.01 36.48 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.163 -0.68 . . . . 1.0 109.163 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.9 pt -139.03 161.55 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.1 111.57 3.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.402 0.62 . . . . 1.0 109.397 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.1 t -91.49 136.07 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 114.845 -1.071 . . . . 1.0 108.658 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -145.38 128.19 8.21 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 119.029 -0.51 . . . . 1.0 109.761 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.27 145.74 39.22 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.374 1.383 . . . . 1.0 111.243 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.2 p -83.58 138.67 33.27 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 . . . . . 0 C--N 1.332 -0.172 0 CA-C-O 120.783 0.325 . . . . 1.0 110.343 -179.692 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -153.26 149.3 27.78 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.913 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -62.78 -45.96 90.23 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.711 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.3 m -124.55 130.83 53.19 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.093 0.557 . . . . 1.0 109.998 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.5 m -139.83 126.38 20.38 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -53.43 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.523 0.201 . . . . 1.0 110.766 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.01 -169.15 0.54 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.224 -0.75 . . . . 1.0 111.224 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 mt -56.71 146.36 25.99 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.155 0.502 . . . . 1.0 110.285 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -71.56 88.47 0.94 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.513 -0.767 . . . . 1.0 110.08 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -140.38 134.91 31.53 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -124.37 14.57 8.93 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.127 0.489 . . . . 1.0 109.985 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.404 ' H ' HG13 ' A' ' 12' ' ' ILE . 1.4 mt -71.88 -173.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 107.067 -1.457 . . . . 1.0 107.067 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -43.97 -60.81 2.4 Favored Pre-proline 0 N--CA 1.483 1.214 0 CA-C-N 118.936 0.789 . . . . 1.0 110.893 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -70.46 74.73 1.57 Allowed 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.756 1.638 . . . . 1.0 109.821 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -88.55 1.36 55.08 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.19 -0.319 . . . . 1.0 110.647 -177.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tt -113.35 133.52 55.1 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.059 -0.719 . . . . 1.0 109.059 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -136.01 -171.17 12.24 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 109.76 -1.336 . . . . 1.0 109.76 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.41 71.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.446 ' O ' ' NH1' ' A' ' 33' ' ' ARG . 16.8 ptm180 -75.33 123.85 26.07 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.083 0.468 . . . . 1.0 110.417 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.48 152.66 18.41 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.1 m -102.99 134.84 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.852 -0.796 . . . . 1.0 108.852 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -78.24 140.33 38.9 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.779 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -174.45 113.72 0.17 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.038 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.02 -147.82 45.21 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 109.228 -1.549 . . . . 1.0 109.228 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -99.25 10.99 40.33 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.067 0.434 . . . . 1.0 110.662 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -134.81 157.97 45.4 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.465 -0.568 . . . . 1.0 109.465 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mp -109.63 133.07 53.54 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -86.23 115.98 24.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.524 -0.307 . . . . 1.0 111.112 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -100.55 110.53 22.7 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.321 -0.992 . . . . 1.0 108.321 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 mt -96.04 114.48 26.19 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.21 0.604 . . . . 1.0 110.022 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.02 91.94 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.826 0.346 . . . . 1.0 111.408 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.39 -8.67 27.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.029 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 19' ' ' ARG . 52.6 ttp85 -110.4 67.82 0.65 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.16 0.505 . . . . 1.0 110.585 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -171.14 175.48 4.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.046 -0.724 . . . . 1.0 109.046 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.8 t -135.94 145.38 46.17 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.8 mt -107.46 141.24 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.955 -0.758 . . . . 1.0 108.955 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.8 t -126.89 148.12 50.03 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.29 -134.89 29.12 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -170.64 135.33 1.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.307 0.575 . . . . 1.0 110.277 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -112.66 124.26 52.14 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.719 0.808 . . . . 1.0 109.284 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.2 t -65.27 169.62 5.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.086 0.47 . . . . 1.0 110.625 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.47 -21.19 65.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.639 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.61 -10.58 36.92 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 117.721 0.237 . . . . 1.0 110.74 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -105.57 -31.78 8.79 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.789 0.435 . . . . 1.0 110.703 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -60.58 10.05 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.718 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -58.85 -43.98 39.46 Favored 'Trans proline' 0 N--CA 1.506 2.23 0 C-N-CA 122.148 1.899 . . . . 1.0 111.688 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -61.85 -36.89 82.52 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.735 -0.212 . . . . 1.0 110.909 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.8 tp -78.33 -36.71 45.96 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 122.095 -0.378 . . . . 1.0 110.429 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.01 -35.34 78.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.14 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -77.35 -20.49 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 110.261 -0.274 . . . . 1.0 110.261 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.48 -25.61 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.404 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.3 m-85 -55.3 -57.5 20.0 Favored Pre-proline 0 CA--C 1.555 1.149 0 CA-C-O 119.325 -0.369 . . . . 1.0 111.38 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 52' ' ' PHE . 35.4 Cg_endo -57.46 -28.13 79.24 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 121.823 1.682 . . . . 1.0 112.101 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -61.4 -49.58 76.29 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.358 -0.537 . . . . 1.0 109.921 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -67.35 -41.48 85.1 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.815 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.3 mt -67.25 -37.98 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 118.293 0.497 . . . . 1.0 109.74 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 m -53.17 -27.93 23.8 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.609 0.243 . . . . 1.0 110.663 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -83.14 -40.44 19.76 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.657 -0.247 . . . . 1.0 111.083 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mm -57.9 -48.55 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 120.781 -0.368 . . . . 1.0 110.383 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -53.42 -31.48 45.44 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.571 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.5 m -84.84 -33.9 22.79 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.019 0.378 . . . . 1.0 112.019 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.9 mmt -54.27 -42.86 70.44 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 122.352 -0.218 . . . . 1.0 111.009 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 pp -63.19 -31.2 72.28 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.819 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -90.18 -62.34 1.48 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.986 0.422 . . . . 1.0 110.758 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.4 m -66.12 -40.55 90.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.129 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.23 0.97 72.15 Favored Glycine 0 N--CA 1.467 0.767 0 N-CA-C 109.528 -1.429 . . . . 1.0 109.528 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 54.39 99.34 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.271 -0.464 . . . . 1.0 110.607 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.0 tp -79.21 132.89 36.66 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -160.92 90.76 1.59 Allowed Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.892 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -47.4 98.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.506 2.23 0 C-N-CA 121.763 1.642 . . . . 1.0 111.47 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -137.37 -47.05 0.56 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.287 0.565 . . . . 1.0 110.931 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -165.7 154.19 11.38 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.148 -0.933 . . . . 1.0 110.713 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.4 144.7 56.37 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.156 -0.929 . . . . 1.0 110.544 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -151.31 104.37 3.09 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.857 0.36 . . . . 1.0 110.044 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 76.2 m -77.72 131.79 37.84 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.525 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.45 134.88 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 109.078 -0.712 . . . . 1.0 109.078 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.4 p -113.15 111.55 22.29 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.8 mt -97.79 155.24 17.13 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.4 ' O ' ' CG ' ' A' ' 80' ' ' HIS . 39.9 p90 -141.69 124.85 16.36 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 110.083 -0.339 . . . . 1.0 110.083 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 79' ' ' TYR . 99.4 m-70 -156.6 139.33 15.13 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.832 -0.432 . . . . 1.0 109.832 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 54.33 34.55 20.89 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.926 0.393 . . . . 1.0 111.069 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.36 -29.55 1.68 Allowed Glycine 0 N--CA 1.468 0.768 0 N-CA-C 111.474 -0.65 . . . . 1.0 111.474 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -77.97 149.17 34.16 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.765 -0.457 . . . . 1.0 109.765 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.9 p -134.64 122.18 21.9 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.948 -0.389 . . . . 1.0 109.948 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 69.6 m -106.61 142.06 36.87 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -106.71 137.73 44.19 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.706 0.684 . . . . 1.0 109.173 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.38 151.81 47.84 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 120.53 0.205 . . . . 1.0 110.696 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -163.74 149.06 10.9 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 91' ' ' GLY . 68.2 p -91.31 -15.46 29.07 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 110.537 -0.171 . . . . 1.0 110.537 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.8 mp 58.43 5.63 0.46 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 110.136 -0.32 . . . . 1.0 110.136 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 89' ' ' THR . . . 77.27 12.93 84.13 Favored Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.19 -1.164 . . . . 1.0 110.19 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.0 t -77.18 148.78 35.72 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.009 0.433 . . . . 1.0 111.052 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 60.9 m -90.69 111.84 23.36 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.78 -0.645 . . . . 1.0 111.685 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . 69.72 39.8 76.82 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.113 -0.395 . . . . 1.0 112.113 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.431 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 79.4 m-85 -158.27 138.54 12.51 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.1 112.46 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -90.05 126.77 35.89 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.99 -0.744 . . . . 1.0 108.99 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.1 pt -130.15 157.11 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-O 120.947 0.403 . . . . 1.0 110.529 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.48 147.2 26.55 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.119 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.6 p -123.2 133.16 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.021 -0.991 . . . . 1.0 110.125 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -136.24 90.29 18.3 Favored Pre-proline 0 N--CA 1.47 0.562 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.82 140.98 67.15 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.439 1.426 . . . . 1.0 111.962 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.9 p -69.2 132.17 46.1 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.627 -0.508 . . . . 1.0 109.627 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -75.24 -60.5 2.27 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.841 0.353 . . . . 1.0 110.452 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 118.055 -0.974 . . . . 1.0 110.398 -179.588 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mtp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.052 -0.722 . . . . 1.0 109.052 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.0 p -61.84 -39.5 92.04 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.562 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -166.81 115.83 0.87 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.986 -0.552 . . . . 1.0 109.606 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.2 m -117.07 86.77 2.57 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.031 0.532 . . . . 1.0 110.19 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 58.1 p -127.93 123.92 36.11 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -90.16 44.78 1.22 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.966 0.413 . . . . 1.0 110.308 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -148.89 155.71 26.49 Favored Glycine 0 N--CA 1.47 0.916 0 N-CA-C 110.553 -1.019 . . . . 1.0 110.553 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -68.09 157.92 34.18 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -92.13 133.61 35.62 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.427 -0.582 . . . . 1.0 109.427 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.464 HH21 ' HD2' ' A' ' 15' ' ' ARG . 11.5 ptt-85 -152.17 -169.4 3.34 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 110.022 -0.362 . . . . 1.0 110.022 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -53.35 -52.93 57.63 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.67 -0.241 . . . . 1.0 110.923 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.535 HD12 ' NH2' ' A' ' 15' ' ' ARG . 92.1 mt -82.4 129.2 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.17 -57.64 0.49 Allowed Pre-proline 0 N--CA 1.47 0.558 0 CA-C-O 119.078 -0.487 . . . . 1.0 110.833 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.41 132.93 16.86 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 CA-C-N 120.187 1.102 . . . . 1.0 110.107 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.535 ' NH2' HD12 ' A' ' 12' ' ' ILE . 41.1 ttm180 -175.79 172.64 2.48 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.983 -1.117 . . . . 1.0 107.983 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.423 ' N ' ' CG ' ' A' ' 15' ' ' ARG . 6.0 tt -100.96 121.97 42.69 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.78 167.1 21.78 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.521 -1.032 . . . . 1.0 110.521 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.2 86.44 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.276 -0.639 . . . . 1.0 109.276 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.439 ' NH2' ' CD1' ' A' ' 95' ' ' TYR . 70.2 ttt-85 -85.34 114.7 22.61 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.8 mm? -88.91 146.75 24.73 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.144 -0.688 . . . . 1.0 109.144 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.45 136.78 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -78.95 131.74 36.45 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.657 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -170.23 113.27 0.46 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.75 -163.02 53.7 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -89.79 13.01 15.46 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 117.085 0.442 . . . . 1.0 110.096 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -131.64 148.72 52.62 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.827 -0.435 . . . . 1.0 109.827 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.3 mt -97.54 122.87 41.11 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -83.64 118.77 24.07 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.142 0.577 . . . . 1.0 111.044 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -103.78 110.69 22.89 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.06 114.95 27.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.259 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.46 -34.78 72.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.953 0.406 . . . . 1.0 111.079 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -66.7 -10.44 46.71 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.308 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -112.34 56.52 0.66 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.215 0.531 . . . . 1.0 110.465 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.97 176.97 4.51 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.803 -0.635 . . . . 1.0 109.364 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 92.0 p -149.42 159.81 43.97 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.1 pt -98.64 144.71 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.9 p -133.89 149.22 51.31 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.082 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.24 -129.3 20.24 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -168.44 127.28 1.15 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.608 0.718 . . . . 1.0 110.28 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -113.79 120.1 39.62 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.628 -0.878 . . . . 1.0 108.628 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.0 p -68.43 167.78 14.05 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.102 0.477 . . . . 1.0 110.592 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -63.44 -19.81 65.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.491 -0.777 . . . . 1.0 110.605 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.96 -12.18 36.74 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.698 0.285 . . . . 1.0 110.725 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -104.84 -38.34 6.69 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.121 0.568 . . . . 1.0 110.827 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.67 -61.98 3.25 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 119.894 -0.098 . . . . 1.0 110.958 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -57.91 -41.83 64.92 Favored 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 122.501 2.134 . . . . 1.0 112.583 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -62.88 -46.07 89.57 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.904 -0.318 . . . . 1.0 110.875 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.3 mt -63.06 -37.6 87.86 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.763 0.316 . . . . 1.0 110.209 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -59.51 -27.36 66.09 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.924 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.6 t -86.0 -30.6 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 81.9 t -78.89 -18.41 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 121.124 0.488 . . . . 1.0 109.788 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.5 -60.63 9.95 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.57 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -57.11 -22.09 45.92 Favored 'Trans proline' 0 N--CA 1.507 2.314 0 C-N-CA 122.098 1.865 . . . . 1.0 112.728 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -59.49 -45.2 92.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 120.448 -0.501 . . . . 1.0 110.151 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -65.76 -42.97 90.24 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.626 -0.429 . . . . 1.0 110.722 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.66 -41.88 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 120.993 -0.283 . . . . 1.0 110.355 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.8 p -58.18 -36.84 73.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.202 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -81.48 -28.65 33.99 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 119.712 -0.185 . . . . 1.0 111.462 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.8 mm -62.23 -44.2 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -58.69 -39.63 81.28 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.916 0.389 . . . . 1.0 110.608 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.1 m -61.09 -44.72 96.93 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.168 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 23.4 mmt -54.18 -40.79 67.87 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.574 0.226 . . . . 1.0 110.869 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.5 mt -62.01 -33.39 74.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.628 -0.508 . . . . 1.0 109.628 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -81.32 -57.2 3.6 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.199 0.444 . . . . 1.0 112.199 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.9 t -86.96 -38.69 16.41 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.08 0.4 . . . . 1.0 112.08 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.54 -8.22 62.57 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.161 -1.175 . . . . 1.0 110.161 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 43.83 81.3 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.491 0.317 . . . . 1.0 110.787 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.5 tp -80.63 137.12 36.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.662 -0.495 . . . . 1.0 109.662 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -127.48 78.34 74.81 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 123.122 0.569 . . . . 1.0 109.949 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -48.68 99.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 122.051 1.834 . . . . 1.0 112.458 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -169.6 -18.37 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.844 0.355 . . . . 1.0 110.797 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -150.12 147.56 27.91 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.109 0.48 . . . . 1.0 110.875 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.66 142.08 50.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.65 -0.704 . . . . 1.0 111.132 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -160.02 103.35 1.48 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 63.4 m -84.65 143.35 29.29 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.791 -0.641 . . . . 1.0 110.3 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.1 p -140.64 146.91 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.2 p -128.68 104.12 7.47 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.58 0.352 . . . . 1.0 110.098 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.0 mt -82.9 148.71 27.52 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.068 -0.715 . . . . 1.0 109.068 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -139.87 125.22 18.96 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.455 ' CD2' ' N ' ' A' ' 80' ' ' HIS . 0.1 OUTLIER -170.67 146.4 2.66 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.18 0.514 . . . . 1.0 110.168 -179.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 83' ' ' PHE . 59.6 t30 53.82 31.14 12.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.979 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.18 -27.86 1.18 Allowed Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.783 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.4 ' H ' ' C ' ' A' ' 81' ' ' ASN . 65.7 m-85 -83.19 154.01 24.46 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 117.081 0.44 . . . . 1.0 110.384 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 t -151.02 133.56 15.57 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.068 0.461 . . . . 1.0 110.85 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 68.4 m -106.89 142.5 36.41 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.008 -0.738 . . . . 1.0 109.008 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -106.39 141.97 36.84 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.441 0.564 . . . . 1.0 109.572 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.11 147.71 31.84 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 110.646 -0.131 . . . . 1.0 110.646 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -145.64 140.88 27.65 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.9 m -94.14 -22.43 18.47 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.43 15.85 0.24 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.752 0.821 . . . . 1.0 111.837 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.64 14.98 74.56 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 109.373 -1.491 . . . . 1.0 109.373 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.407 ' O ' ' SG ' ' A' ' 93' ' ' CYS . 13.4 t -50.19 -22.04 1.56 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.113 -0.544 . . . . 1.0 111.798 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 92' ' ' SER . 27.9 p 36.67 34.14 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 177.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.81 -48.47 0.08 OUTLIER Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.505 -0.855 . . . . 1.0 112.13 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.439 ' CD1' ' NH2' ' A' ' 19' ' ' ARG . 99.1 m-85 -107.09 145.43 32.43 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.752 -0.462 . . . . 1.0 109.752 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.79 140.5 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.634 0.773 . . . . 1.0 109.199 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -139.22 162.25 35.45 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.311 0.577 . . . . 1.0 109.683 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 42.4 pt -137.41 165.18 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 114.92 -1.036 . . . . 1.0 110.523 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.65 146.34 27.22 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.631 -0.713 . . . . 1.0 109.56 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 p -122.59 133.29 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 115.299 -0.864 . . . . 1.0 109.86 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -140.55 93.65 8.64 Favored Pre-proline 0 N--CA 1.471 0.601 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -51.19 139.35 43.77 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 121.33 1.353 . . . . 1.0 112.337 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 75.3 p -74.29 136.06 42.61 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -77.22 -38.34 51.53 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.789 0.328 . . . . 1.0 110.272 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.136 -0.935 . . . . 1.0 110.222 -179.793 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.4 t 52.81 89.84 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.264 -0.425 . . . . 1.0 111.054 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -59.97 -48.05 83.28 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.998 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.6 t -126.69 146.0 50.37 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.926 0.49 . . . . 1.0 110.11 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.54 127.18 15.19 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 120.929 0.395 . . . . 1.0 110.291 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -63.27 133.7 54.64 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.081 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.43 -162.35 36.31 Favored Glycine 0 N--CA 1.465 0.603 0 N-CA-C 110.2 -1.16 . . . . 1.0 110.2 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 8' ' ' LEU . 3.9 mm? -58.64 150.9 22.0 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.495 0.664 . . . . 1.0 110.462 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -88.05 108.45 19.24 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.986 -1.007 . . . . 1.0 109.799 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -137.63 135.11 36.25 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.47 -44.68 93.75 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.807 0.813 . . . . 1.0 111.357 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.0 pt -57.22 128.22 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 113.944 -1.48 . . . . 1.0 111.941 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.548 ' C ' ' H ' ' A' ' 15' ' ' ARG . 3.1 m -85.31 -34.34 0.51 Allowed Pre-proline 0 CA--C 1.549 0.908 0 CA-C-O 118.805 -0.617 . . . . 1.0 109.366 177.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 13' ' ' THR . 47.4 Cg_exo -52.28 21.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.525 3.326 0 C-N-CA 123.544 2.83 . . . . 1.0 114.172 175.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.548 ' H ' ' C ' ' A' ' 13' ' ' THR . 57.9 ttt85 -148.41 140.14 23.73 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.5 tt -122.53 140.07 53.18 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.177 0.591 . . . . 1.0 109.646 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.37 176.3 16.17 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.59 100.09 0.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -75.95 134.22 40.26 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.964 -0.754 . . . . 1.0 108.964 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.4 mt -127.21 146.03 50.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.363 -0.835 . . . . 1.0 109.941 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.2 137.2 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -71.61 136.13 47.25 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -166.91 100.64 0.55 Allowed 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.78 -165.65 54.56 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -84.84 26.98 0.78 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.77 0.319 . . . . 1.0 110.237 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -145.23 139.56 27.26 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.608 -0.516 . . . . 1.0 109.608 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.0 mt -91.55 131.64 36.84 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -82.29 114.95 21.12 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.217 -0.29 . . . . 1.0 110.217 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -100.07 105.69 17.36 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.62 141.0 28.96 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.54 -0.755 . . . . 1.0 109.598 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.46 -40.97 17.07 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.674 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 23.5 p-10 -72.28 -8.26 53.9 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.237 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -114.77 49.3 1.05 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 120.896 0.379 . . . . 1.0 110.211 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.82 127.23 1.57 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.905 0.383 . . . . 1.0 110.185 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.4 p -76.49 166.86 22.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 pt -125.37 153.79 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.0 p -137.1 136.64 38.49 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.47 102.46 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.16 -0.776 . . . . 1.0 111.16 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -58.36 123.6 16.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.001 0.429 . . . . 1.0 110.276 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -90.27 137.88 31.99 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.364 0.602 . . . . 1.0 109.663 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.7 m -69.21 169.38 12.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.239 -0.891 . . . . 1.0 110.6 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -65.63 -20.35 66.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.402 -0.817 . . . . 1.0 110.166 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.93 -10.05 40.9 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 120.827 0.346 . . . . 1.0 110.544 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -107.88 -26.49 10.71 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.258 0.623 . . . . 1.0 111.416 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -68.45 -45.37 36.65 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.393 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 35.1 Cg_exo -62.57 -53.31 1.85 Allowed 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 122.317 2.012 . . . . 1.0 112.477 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -54.01 -36.84 63.41 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.649 -0.705 . . . . 1.0 110.994 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.5 tp -76.27 -36.87 58.23 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.93 0.395 . . . . 1.0 110.204 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.41 -20.42 65.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.852 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.7 m -97.02 -8.99 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 110.107 -0.331 . . . . 1.0 110.107 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.5 t -92.77 -26.5 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.415 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -63.36 -47.78 83.54 Favored Pre-proline 0 CA--C 1.551 0.988 0 O-C-N 122.243 -0.286 . . . . 1.0 110.809 -178.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 52' ' ' PHE . 69.7 Cg_exo -54.53 -39.31 88.81 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.336 2.024 . . . . 1.0 111.88 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -62.32 -42.89 99.75 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.096 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -64.25 -42.42 96.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.619 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.18 -29.93 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.84 -0.43 . . . . 1.0 109.84 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.8 m -60.88 -43.62 98.2 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.885 -0.326 . . . . 1.0 111.061 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -68.76 -33.4 73.82 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.27 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.2 mm -62.78 -45.13 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.16 -40.02 80.34 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.828 0.347 . . . . 1.0 110.429 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.9 m -76.6 -27.92 55.94 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.597 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 66' ' ' GLY . 59.4 ttm -60.16 -40.05 88.56 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 110.052 -0.351 . . . . 1.0 110.052 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 mt -62.11 -32.4 72.96 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.9 p -87.29 -59.75 2.17 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.982 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.5 p -78.39 -39.62 38.54 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.441 0.534 . . . . 1.0 112.441 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -80.86 -16.71 74.42 Favored Glycine 0 N--CA 1.474 1.195 0 N-CA-C 111.238 -0.745 . . . . 1.0 111.238 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 40.74 79.11 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.078 0.551 . . . . 1.0 111.621 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.13 157.94 27.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.108 0.48 . . . . 1.0 109.812 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -135.67 79.37 47.02 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.237 -0.892 . . . . 1.0 110.141 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -51.47 -13.32 1.29 Allowed 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 122.365 2.043 . . . . 1.0 111.939 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -73.26 -14.27 61.29 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.089 0.471 . . . . 1.0 110.04 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -138.73 144.95 39.72 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.431 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.06 141.01 47.43 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.277 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -160.64 140.04 10.73 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.3 m -131.97 144.46 50.82 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.639 0.375 . . . . 1.0 110.017 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.1 p -147.03 147.97 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.9 p -125.32 115.6 20.6 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 67.9 mt -98.33 158.22 15.71 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -139.6 123.01 17.15 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -154.94 133.49 11.97 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 53.73 24.2 4.19 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.814 0.34 . . . . 1.0 111.324 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.59 -25.79 7.03 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 111.23 -0.748 . . . . 1.0 111.23 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -65.13 146.39 55.04 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.1 m -139.23 107.07 5.65 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.589 -0.522 . . . . 1.0 109.589 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 54.1 t -98.23 137.55 36.81 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -95.56 134.05 38.88 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.23 133.28 38.85 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -148.4 140.94 24.39 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.576 -0.527 . . . . 1.0 109.576 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 74.9 p -92.38 -38.14 12.18 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 120.757 0.313 . . . . 1.0 111.332 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.0 mp 55.46 23.11 5.56 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.002 0.429 . . . . 1.0 110.119 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 93' ' ' CYS . . . 83.34 12.05 79.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.995 -1.242 . . . . 1.0 109.995 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.9 p -57.43 83.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.848 0.356 . . . . 1.0 110.995 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 91' ' ' GLY . 81.8 m -63.12 119.83 10.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.615 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.43 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . 64.21 31.43 80.81 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.43 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 41.9 m-85 -162.62 153.03 16.67 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.2 p -148.78 140.17 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.337 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -119.49 136.66 54.22 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.1 pt -137.12 160.89 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 120.944 0.402 . . . . 1.0 110.037 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.49 119.84 7.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.597 0.713 . . . . 1.0 110.1 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.7 t -93.36 130.83 41.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-N 114.643 -1.162 . . . . 1.0 108.719 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -137.95 115.84 9.55 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-O 118.689 -0.672 . . . . 1.0 109.69 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.49 145.95 38.6 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.371 1.381 . . . . 1.0 110.813 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.7 t -99.09 148.81 23.67 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -77.84 115.86 17.91 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 110.192 -0.299 . . . . 1.0 110.192 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.981 -1.009 . . . . 1.0 109.474 179.732 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtp . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 t -169.21 89.97 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.262 -0.426 . . . . 1.0 109.986 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -66.72 118.61 10.51 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.1 m -118.47 116.48 26.77 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.9 m -145.47 129.34 17.32 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -52.73 -77.0 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.918 0.39 . . . . 1.0 110.698 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.21 -162.12 0.24 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 111.022 -0.831 . . . . 1.0 111.022 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.467 ' O ' ' NH1' ' A' ' 10' ' ' ARG . 4.2 mm? -59.26 154.65 15.95 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 121.382 0.611 . . . . 1.0 110.359 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -93.84 127.81 39.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.193 -0.912 . . . . 1.0 109.871 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.467 ' NH1' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -150.62 174.79 12.59 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -100.98 -49.13 4.21 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.435 0.636 . . . . 1.0 110.408 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.2 pt -64.48 132.07 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 114.498 -1.228 . . . . 1.0 109.855 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.56 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -74.82 -47.23 5.05 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 114.921 -1.036 . . . . 1.0 110.339 177.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 13' ' ' THR . 26.8 Cg_exo -29.97 -35.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.511 2.557 0 C-N-CA 123.201 2.601 . . . . 1.0 113.886 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 13' ' ' THR . 83.2 mtp180 -96.76 138.69 33.94 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.452 -0.794 . . . . 1.0 109.759 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 tp -121.59 128.57 52.09 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.232 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.81 153.99 33.51 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.142 -1.183 . . . . 1.0 110.142 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.23 62.67 0.05 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.141 0.496 . . . . 1.0 109.94 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -72.94 132.87 44.0 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.092 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.9 mt -112.92 153.15 28.42 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.469 -0.567 . . . . 1.0 109.469 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.8 m -96.5 136.06 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.442 -0.947 . . . . 1.0 108.442 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -78.11 135.65 37.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -168.1 113.68 0.67 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.181 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.48 -159.0 53.21 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 109.727 -1.349 . . . . 1.0 109.727 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -92.96 10.03 33.08 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 110.362 -0.236 . . . . 1.0 110.362 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -130.61 137.33 49.59 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.138 -0.483 . . . . 1.0 109.954 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.1 mp -89.83 135.98 33.31 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -89.86 115.94 27.56 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.076 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -98.24 104.56 16.61 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.883 -0.784 . . . . 1.0 108.883 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 mt -93.06 115.23 27.9 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.339 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.86 -30.4 70.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.749 -0.659 . . . . 1.0 110.128 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -70.77 -9.58 57.68 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.951 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -112.25 56.84 0.65 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.538 0.685 . . . . 1.0 110.555 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.85 175.28 6.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.58 -0.736 . . . . 1.0 109.432 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.7 m -145.67 163.63 34.3 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.8 mt -107.0 141.37 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.4 m -127.71 138.66 52.86 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.93 -135.06 14.81 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.567 -1.013 . . . . 1.0 110.567 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -168.57 132.96 1.58 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.651 -0.499 . . . . 1.0 109.651 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -115.75 126.89 54.64 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.176 -0.676 . . . . 1.0 109.176 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.8 m -67.88 161.11 27.05 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -56.29 -21.85 26.56 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.729 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.72 -12.58 33.57 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.66 0.267 . . . . 1.0 110.528 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.27 -27.78 8.93 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.025 0.53 . . . . 1.0 111.062 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.495 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -61.66 -46.57 93.55 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 45.7 Cg_exo -57.71 -47.77 19.77 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.043 1.829 . . . . 1.0 112.522 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -54.63 -51.96 63.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.981 -0.554 . . . . 1.0 111.793 -177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.458 HD11 ' CE1' ' A' ' 83' ' ' PHE . 4.3 mm? -61.69 -41.16 97.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.852 0.358 . . . . 1.0 110.995 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -66.09 -16.64 64.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.103 -0.498 . . . . 1.0 110.227 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.3 t -101.93 -14.72 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 110.168 -0.308 . . . . 1.0 110.168 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.51 -18.71 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.48 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -61.85 -47.23 92.15 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 110.141 -0.318 . . . . 1.0 110.141 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 52' ' ' PHE . 52.9 Cg_exo -56.56 -33.3 92.55 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.273 1.982 . . . . 1.0 111.037 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.521 ' NE2' ' NE2' ' A' ' 58' ' ' GLN . 48.6 t60 -59.29 -42.77 92.09 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.7 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -64.94 -42.1 94.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.143 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.1 mm -72.23 -26.71 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.376 -0.529 . . . . 1.0 109.63 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -70.1 -42.89 72.09 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.745 -0.382 . . . . 1.0 111.046 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.521 ' NE2' ' NE2' ' A' ' 54' ' ' HIS . 48.5 mt-30 -81.8 -50.4 9.28 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.377 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.8 mt -53.17 -46.24 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -55.58 -33.96 64.38 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.519 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m -76.11 -32.9 59.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.734 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.451 ' O ' ' N ' ' A' ' 66' ' ' GLY . 81.1 mmm -59.59 -29.16 67.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.937 0.399 . . . . 1.0 110.328 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.9 mt -60.01 -41.59 92.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.849 0.357 . . . . 1.0 110.125 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.9 m -85.4 -55.02 4.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.242 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.4 m -65.01 -42.05 94.81 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.696 -0.402 . . . . 1.0 111.339 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -86.11 -7.84 79.67 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 50.29 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.662 0.268 . . . . 1.0 110.393 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.4 tp -78.91 143.13 36.14 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -135.41 80.4 45.84 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.814 -0.63 . . . . 1.0 109.77 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.32 88.77 0.83 Allowed 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.11 1.873 . . . . 1.0 110.677 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -171.43 -9.47 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.927 0.394 . . . . 1.0 111.006 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -146.28 147.15 31.09 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.155 0.502 . . . . 1.0 110.867 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.22 131.2 47.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.63 -0.714 . . . . 1.0 109.944 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -162.4 139.22 7.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.431 -0.951 . . . . 1.0 108.431 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 58.3 m -129.88 140.88 50.89 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.6 t -132.94 134.49 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.488 -0.93 . . . . 1.0 108.488 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.2 m -109.7 119.92 40.89 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.54 142.49 40.53 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.122 -0.696 . . . . 1.0 109.122 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 42.3 p90 -133.75 126.47 30.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -156.25 139.42 15.56 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 54.45 34.31 20.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.928 0.394 . . . . 1.0 111.576 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.99 -28.63 1.62 Allowed Glycine 0 N--CA 1.467 0.725 0 N-CA-C 111.269 -0.732 . . . . 1.0 111.269 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.458 ' CE1' HD11 ' A' ' 48' ' ' LEU . 69.8 m-85 -70.81 150.46 45.82 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.7 m -138.65 112.77 8.61 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 62.1 m -100.73 143.27 31.09 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -106.38 143.09 35.0 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.12 151.05 40.28 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -162.21 137.67 7.31 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.117 -0.698 . . . . 1.0 109.117 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 67.1 p -87.3 -16.11 36.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.977 -0.101 . . . . 1.0 110.729 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.2 mt 59.19 8.05 1.0 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.162 0.506 . . . . 1.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.73 20.22 78.49 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 110.614 -0.995 . . . . 1.0 110.614 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.9 t -61.9 -145.91 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.782 0.325 . . . . 1.0 110.161 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.3 p -164.8 107.86 0.87 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.19 28.27 68.52 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.483 -1.047 . . . . 1.0 110.483 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -151.96 146.98 26.01 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.1 m -139.71 140.16 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.325 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 8.0 m-85 -125.51 131.92 52.72 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.811 -0.811 . . . . 1.0 108.811 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.4 pt -138.95 163.57 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.73 145.74 25.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.717 -0.845 . . . . 1.0 108.717 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.56 135.54 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.247 -0.888 . . . . 1.0 109.388 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -145.91 143.67 20.13 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.123 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.82 139.88 44.83 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.681 1.587 . . . . 1.0 111.57 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.3 p -81.16 141.85 33.82 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -88.82 96.57 10.74 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.736 -1.126 . . . . 1.0 110.495 179.454 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.1 mtp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 108.728 -0.841 . . . . 1.0 108.728 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.1 p -61.95 -40.63 96.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.677 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -88.36 51.04 2.09 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.423 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.9 m -58.52 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.879 -0.328 . . . . 1.0 110.369 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.9 p -136.65 129.26 30.43 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.889 0.376 . . . . 1.0 110.608 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -82.4 152.83 26.0 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.747 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.35 176.76 45.99 Favored Glycine 0 N--CA 1.465 0.572 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 8' ' ' LEU . 10.6 mp -60.68 143.05 55.03 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -87.79 121.74 30.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.049 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' NH1' ' NE ' ' A' ' 15' ' ' ARG . 98.2 mtt180 -145.59 133.91 21.79 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.79 -38.69 86.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.41 0.624 . . . . 1.0 111.163 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.665 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -75.55 129.8 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.006 -0.997 . . . . 1.0 111.163 -178.267 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.494 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -72.18 -44.06 10.47 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.517 177.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 13' ' ' THR . 0.2 OUTLIER -34.35 -37.51 0.12 Allowed 'Trans proline' 0 N--CA 1.509 2.385 0 C-N-CA 123.08 2.52 . . . . 1.0 113.863 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.481 ' NE ' ' NH1' ' A' ' 10' ' ' ARG . 78.9 mtp180 -96.09 137.52 35.04 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.554 -0.536 . . . . 1.0 109.554 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 tt -121.82 131.45 54.06 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.733 -0.469 . . . . 1.0 109.733 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.54 164.36 25.46 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.174 -1.171 . . . . 1.0 110.174 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.08 135.82 0.61 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -136.98 130.59 31.73 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.1 mt -111.16 152.77 26.66 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.69 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.49 137.75 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -73.45 138.9 45.45 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.002 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -169.55 107.6 0.4 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.93 -169.94 44.71 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 109.824 -1.31 . . . . 1.0 109.824 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -84.81 23.76 1.14 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 122.717 -0.284 . . . . 1.0 110.32 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -143.65 143.01 31.27 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.748 -0.464 . . . . 1.0 109.748 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.7 mt -95.13 134.63 37.65 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -92.97 117.81 30.47 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.44 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -98.51 104.96 17.04 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.58 112.65 24.67 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.614 -0.721 . . . . 1.0 109.553 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.35 79.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.611 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -69.04 -11.99 61.28 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.567 -0.742 . . . . 1.0 110.583 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -107.97 55.36 0.65 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.879 0.371 . . . . 1.0 111.105 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.41 126.27 0.52 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.206 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -82.48 139.95 33.64 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.229 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.4 mt -85.71 141.33 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 76.9 p -130.9 147.7 52.57 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.001 0.52 . . . . 1.0 109.617 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.89 -150.32 50.34 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.823 -0.911 . . . . 1.0 110.823 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -158.49 130.36 6.72 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -111.53 125.68 54.17 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.609 0.764 . . . . 1.0 109.153 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -65.75 168.57 7.6 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.212 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.79 -22.16 66.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.68 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.42 -9.73 40.58 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 120.667 0.27 . . . . 1.0 110.602 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -108.26 -26.17 10.68 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.845 0.458 . . . . 1.0 111.421 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -67.59 -44.8 45.41 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 110.169 -0.308 . . . . 1.0 110.169 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 45.1 Cg_exo -59.43 -50.9 7.26 Favored 'Trans proline' 0 N--CA 1.503 2.062 0 C-N-CA 122.22 1.946 . . . . 1.0 112.23 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -55.99 -27.44 52.79 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.898 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -39.87 92.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -68.16 -24.93 65.04 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.927 -0.579 . . . . 1.0 111.053 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.64 -44.63 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.308 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.7 t -84.21 -15.1 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 121.205 0.526 . . . . 1.0 110.506 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -55.92 -53.15 66.28 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-O 118.658 -0.687 . . . . 1.0 111.804 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -68.04 -22.04 42.16 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 CA-C-N 121.443 1.551 . . . . 1.0 111.431 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.511 ' NE2' ' ND1' ' A' ' 80' ' ' HIS . 62.0 t-80 -59.24 -46.74 87.67 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.516 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.66 -42.61 91.14 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.87 -0.332 . . . . 1.0 110.531 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.4 mt -71.6 -42.52 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 120.729 -0.389 . . . . 1.0 110.076 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -57.75 -39.11 76.62 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.836 -0.345 . . . . 1.0 111.283 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.31 -46.55 13.48 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 110.565 -0.161 . . . . 1.0 110.565 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.9 mt -63.08 -43.98 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -58.41 -41.51 85.11 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.693 -0.403 . . . . 1.0 110.42 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.1 p -69.15 -31.82 70.75 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 121.018 -0.273 . . . . 1.0 110.359 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 66' ' ' GLY . 42.8 tpp -60.75 -40.9 94.14 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.59 -35.7 78.59 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.015 -0.365 . . . . 1.0 110.015 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.1 p -86.37 -58.84 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.76 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -63.54 -41.13 98.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.777 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -117.1 70.77 0.29 Allowed Glycine 0 N--CA 1.476 1.325 0 N-CA-C 111.448 -0.661 . . . . 1.0 111.448 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -47.2 86.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.006 0.403 . . . . 1.0 111.174 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 66' ' ' GLY . 4.5 tp -82.23 145.75 29.87 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.569 -0.9 . . . . 1.0 108.569 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -134.64 144.01 48.95 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 72' ' ' HIS . 82.1 Cg_exo -38.23 -87.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 122.485 2.123 . . . . 1.0 113.057 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.438 ' O ' ' CG ' ' A' ' 72' ' ' HIS . 81.6 mtp180 58.36 -56.62 0.04 OUTLIER 'General case' 0 C--N 1.346 0.447 0 C-N-CA 123.744 0.817 . . . . 1.0 112.689 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.548 ' N ' ' O ' ' A' ' 70' ' ' PRO . 74.2 m80 -158.66 149.14 19.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.751 -0.658 . . . . 1.0 110.023 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.51 144.13 54.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.504 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.51 102.77 1.37 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.038 0.447 . . . . 1.0 110.122 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.37 137.17 39.63 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.804 -0.635 . . . . 1.0 110.655 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.9 t -125.91 134.87 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.0 p -113.18 111.18 21.64 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.344 -0.613 . . . . 1.0 109.344 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.3 mt -95.67 151.47 19.32 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.42 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 50.0 p90 -146.86 127.3 14.05 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.649 0.261 . . . . 1.0 110.308 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.511 ' ND1' ' NE2' ' A' ' 54' ' ' HIS . 58.6 t-80 -159.63 4.11 0.09 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.597 0.237 . . . . 1.0 110.472 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -165.71 22.03 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.156 0.503 . . . . 1.0 110.252 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.89 -29.39 5.06 Favored Glycine 0 N--CA 1.468 0.815 0 N-CA-C 111.087 -0.805 . . . . 1.0 111.087 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -72.74 143.56 47.96 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.422 ' O ' ' CZ ' ' A' ' 101' ' ' TYR . 60.6 p -134.1 107.46 7.75 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.8 t -90.52 140.37 29.8 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -97.88 138.31 35.42 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.133 -0.692 . . . . 1.0 109.133 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.06 149.08 39.46 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 110.013 -0.366 . . . . 1.0 110.013 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -168.51 141.45 2.97 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.0 p -86.03 -29.38 23.5 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.804 0.335 . . . . 1.0 110.285 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.6 mt 59.2 17.7 5.9 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.613 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.74 10.42 76.49 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 109.979 -1.248 . . . . 1.0 109.979 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.4 t -49.59 -22.21 1.22 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 118.927 -0.559 . . . . 1.0 111.944 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 26.2 p 36.76 34.41 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.354 0.872 . . . . 1.0 113.354 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.36 -55.24 0.02 OUTLIER Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.849 -0.5 . . . . 1.0 111.849 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.23 139.13 54.22 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.72 0.408 . . . . 1.0 110.387 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.9 t -106.1 115.71 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -97.97 137.02 37.42 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.883 -0.784 . . . . 1.0 108.883 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.2 pt -138.31 161.19 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.29 147.76 27.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.942 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.05 131.21 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.082 -0.963 . . . . 1.0 109.357 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 11.3 p90 -131.71 94.25 25.94 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 108.734 -0.839 . . . . 1.0 108.734 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.79 137.64 34.49 Favored 'Trans proline' 0 N--CA 1.503 2.056 0 C-N-CA 121.524 1.483 . . . . 1.0 111.742 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 105' ' ' ARG . 1.9 t -96.07 148.72 22.38 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -64.92 77.27 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.948 0.404 . . . . 1.0 110.219 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 103' ' ' THR . 47.1 ptt85 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.914 -1.041 . . . . 1.0 110.722 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ptt? . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -70.64 -5.89 32.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.619 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.62 -53.89 0.55 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.467 0.48 . . . . 1.0 110.986 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.7 p -119.4 95.16 4.68 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.997 0.519 . . . . 1.0 109.716 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.09 122.63 33.24 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.424 ' CD1' ' NH1' ' A' ' 33' ' ' ARG . 3.8 m-90 -79.34 144.81 33.86 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.982 0.42 . . . . 1.0 110.9 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.64 -172.74 55.04 Favored Glycine 0 N--CA 1.465 0.608 0 N-CA-C 110.361 -1.096 . . . . 1.0 110.361 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.8 mt -59.11 143.17 49.5 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.098 0.475 . . . . 1.0 110.062 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -90.34 104.11 16.72 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.133 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -133.17 135.74 45.31 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -64.17 -20.29 65.9 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.954 0.883 . . . . 1.0 110.087 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 77.0 mt -65.73 129.51 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 113.92 -1.491 . . . . 1.0 110.858 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.402 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -78.34 -55.18 1.12 Allowed Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 176.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 13' ' ' THR . 1.1 Cg_exo -31.39 -34.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.505 2.152 0 C-N-CA 123.258 2.639 . . . . 1.0 114.311 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -99.4 141.64 31.92 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -130.08 149.24 51.88 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.56 0.695 . . . . 1.0 110.481 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.82 138.24 20.54 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.639 -1.384 . . . . 1.0 109.639 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.29 53.81 0.22 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.455 0.645 . . . . 1.0 109.438 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -76.41 128.91 35.76 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.847 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.6 mt -92.63 150.0 20.98 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.891 -0.411 . . . . 1.0 109.891 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.5 p -104.24 136.49 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -76.12 130.74 38.77 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.358 -0.383 . . . . 1.0 109.998 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -170.29 109.7 0.38 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.45 -165.67 54.76 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 109.685 -1.366 . . . . 1.0 109.685 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -87.21 10.91 15.45 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.896 -0.409 . . . . 1.0 109.896 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -129.76 141.06 50.93 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.736 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 54.8 mt -90.55 124.99 35.46 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -82.85 116.01 21.98 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.637 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -101.05 107.33 18.75 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.04 118.36 31.72 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.649 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.47 80.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.034 0.445 . . . . 1.0 110.739 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -67.83 -11.2 58.07 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.905 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.424 ' NH1' ' CD1' ' A' ' 6' ' ' TRP . 23.8 mmm180 -111.3 58.62 0.62 Allowed 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.041 0.448 . . . . 1.0 110.508 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.09 176.35 4.67 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.978 -0.556 . . . . 1.0 109.626 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -133.19 127.91 34.83 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.587 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 pt -85.32 147.73 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 82.5 p -133.21 134.76 44.47 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.8 102.66 0.01 OUTLIER Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -58.75 129.79 43.79 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.995 0.426 . . . . 1.0 110.113 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -96.02 136.33 36.61 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.745 -0.662 . . . . 1.0 109.853 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -67.1 167.43 11.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.381 -0.827 . . . . 1.0 110.709 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -64.46 -20.58 66.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.605 -0.725 . . . . 1.0 110.616 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.57 -11.01 38.48 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.006 0.432 . . . . 1.0 110.517 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -107.72 -24.28 11.78 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.283 0.633 . . . . 1.0 111.812 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.47 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -70.68 -45.36 17.27 Favored Pre-proline 0 CA--C 1.551 0.995 0 O-C-N 122.093 -0.38 . . . . 1.0 110.27 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 52.5 Cg_exo -58.15 -50.58 9.61 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 122.328 2.019 . . . . 1.0 113.167 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -60.2 -43.93 95.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.303 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.2 tt -61.47 -39.64 91.62 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.34 -10.59 11.64 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.088 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 81.2 t -101.42 -15.34 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 109.557 -0.535 . . . . 1.0 109.557 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.93 -28.39 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 110.52 -0.178 . . . . 1.0 110.52 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.423 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -67.06 -46.65 52.92 Favored Pre-proline 0 N--CA 1.483 1.223 0 O-C-N 122.393 -0.192 . . . . 1.0 111.156 -178.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 52' ' ' PHE . 54.6 Cg_exo -56.59 -36.35 97.88 Favored 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 122.494 2.129 . . . . 1.0 111.885 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -65.31 -40.51 93.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 1.0 109.954 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 59' ' ' ILE . 59.3 t80 -64.21 -41.62 96.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.502 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.5 mm -69.43 -36.91 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.4 t -59.13 -45.57 90.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.625 -0.261 . . . . 1.0 111.392 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.436 ' O ' ' SD ' ' A' ' 62' ' ' MET . 29.1 mm100 -67.85 -37.81 82.35 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.852 -0.158 . . . . 1.0 110.846 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.66 HD11 ' CE2' ' A' ' 55' ' ' PHE . 82.0 mt -59.08 -43.67 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.915 -0.491 . . . . 1.0 109.815 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -58.13 -39.48 78.84 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.815 0.34 . . . . 1.0 110.275 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -65.34 -39.59 92.59 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.459 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -60.3 -40.71 91.45 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 110.348 -0.241 . . . . 1.0 110.348 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.69 -34.93 76.63 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.546 -0.539 . . . . 1.0 109.546 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.3 p -86.02 -62.41 1.53 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.309 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.8 p -74.72 -39.64 61.77 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.042 0.386 . . . . 1.0 112.042 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.29 -4.7 90.41 Favored Glycine 0 N--CA 1.47 0.961 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 31.79 78.6 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.699 0.8 . . . . 1.0 112.113 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.63 151.43 32.3 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.247 0.546 . . . . 1.0 109.657 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -141.29 74.84 23.97 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.154 -0.93 . . . . 1.0 110.013 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -48.2 105.97 0.1 OUTLIER 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 122.332 2.022 . . . . 1.0 111.648 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -171.02 -16.08 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.663 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -142.53 142.37 32.22 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.931 0.396 . . . . 1.0 110.999 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.3 125.73 24.51 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.768 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -162.01 103.99 1.16 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 27.7 p -90.29 148.13 23.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.433 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.58 152.27 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.8 p -128.01 110.27 12.35 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.801 -0.444 . . . . 1.0 109.801 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 78' ' ' LEU . 9.5 mp -91.94 158.87 16.03 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.828 -0.805 . . . . 1.0 108.828 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -140.94 122.63 15.24 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -157.81 134.6 9.89 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 53.92 27.5 7.38 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.104 0.478 . . . . 1.0 111.406 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.63 -24.91 4.12 Favored Glycine 0 N--CA 1.469 0.85 0 N-CA-C 111.532 -0.627 . . . . 1.0 111.532 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -67.61 140.85 56.9 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 67.8 m -129.27 109.19 10.91 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 39.8 t -95.53 140.74 29.93 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -106.0 130.2 53.97 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.85 140.2 45.64 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -145.05 133.56 21.96 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.771 -0.825 . . . . 1.0 108.771 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.8 p -92.69 -32.2 14.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.012 0.434 . . . . 1.0 110.712 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.46 12.69 1.56 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.526 -0.546 . . . . 1.0 109.526 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.81 18.28 77.4 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 109.179 -1.568 . . . . 1.0 109.179 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.8 m -67.49 75.6 0.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.111 0.482 . . . . 1.0 111.668 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 43.6 t -65.69 48.96 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.773 -1.103 . . . . 1.0 110.559 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.412 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . -166.38 -21.16 0.02 OUTLIER Glycine 0 CA--C 1.531 1.087 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.412 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 87.0 m-85 -158.41 170.78 21.45 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.938 0.369 . . . . 1.0 110.284 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.67 113.22 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -86.93 133.53 33.59 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.985 -0.376 . . . . 1.0 109.985 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.1 pt -143.33 161.85 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-N 118.221 0.464 . . . . 1.0 110.625 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.5 148.0 26.88 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.315 0.578 . . . . 1.0 110.4 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.451 ' H ' HD11 ' A' ' 16' ' ' LEU . 28.9 m -133.18 137.18 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.028 -0.987 . . . . 1.0 110.508 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -151.55 148.16 21.58 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.1 141.75 71.24 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 121.361 1.374 . . . . 1.0 111.257 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.0 m -74.48 136.96 42.25 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -65.31 -39.53 92.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.775 0.322 . . . . 1.0 110.201 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.997 -1.001 . . . . 1.0 110.733 -179.756 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.9 t -64.53 147.76 52.14 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.162 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -161.77 135.97 6.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.37 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 t -59.71 144.34 48.35 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.671 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.0 m -135.07 125.09 25.78 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -91.73 142.09 27.97 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.803 -0.443 . . . . 1.0 109.803 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 123.31 147.03 7.23 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.591 ' H ' ' NH2' ' A' ' 15' ' ' ARG . 2.9 mp -68.12 157.02 36.23 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.719 0.295 . . . . 1.0 110.385 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -91.6 128.99 37.64 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.676 ' H ' ' NE ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -152.25 -166.57 2.52 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.594 0.235 . . . . 1.0 110.71 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 18.6 p-10 -53.01 -56.07 18.8 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.203 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.6 pt -69.41 130.92 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 109.209 -0.664 . . . . 1.0 109.209 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.19 -48.21 3.4 Favored Pre-proline 0 N--CA 1.473 0.716 0 O-C-N 122.123 -0.361 . . . . 1.0 110.205 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -89.85 142.61 4.01 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.845 1.697 . . . . 1.0 110.494 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.591 ' NH2' ' H ' ' A' ' 8' ' ' LEU . 52.4 ttp180 -168.34 166.94 12.3 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.364 -0.976 . . . . 1.0 108.364 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.2 tt -109.54 116.24 31.41 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.36 161.99 27.93 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 110.254 -1.139 . . . . 1.0 110.254 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.12 72.75 0.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 1.0 110.433 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -83.72 125.85 32.31 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.28 153.94 20.92 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.232 0.613 . . . . 1.0 109.445 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.14 140.87 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 108.817 -0.808 . . . . 1.0 108.817 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -81.38 108.34 14.91 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -65.0 -51.95 58.82 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.288 0.566 . . . . 1.0 109.676 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.95 -77.6 0.1 Allowed Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.058 -1.217 . . . . 1.0 110.058 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -100.28 8.06 43.99 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.892 0.477 . . . . 1.0 110.317 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -155.99 156.24 34.12 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.015 -0.365 . . . . 1.0 110.015 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.43 121.65 40.63 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.082 -0.71 . . . . 1.0 109.082 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.96 119.74 31.39 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.297 0.239 . . . . 1.0 110.6 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -99.84 101.99 13.29 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.82 109.12 19.06 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.848 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.81 -28.02 68.47 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.132 0.491 . . . . 1.0 110.708 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -68.33 -11.62 59.81 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.573 -0.739 . . . . 1.0 111.046 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -109.37 45.77 1.04 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 120.869 0.366 . . . . 1.0 110.118 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.71 127.4 0.91 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.759 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.5 m -95.24 167.74 11.16 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.3 tp -94.9 141.16 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.5 m -128.25 125.3 38.64 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.99 153.53 8.59 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.809 -0.916 . . . . 1.0 110.809 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -92.81 125.95 37.66 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.825 0.345 . . . . 1.0 110.271 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -112.1 129.47 56.21 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 m -71.3 164.32 25.94 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.969 0.414 . . . . 1.0 110.382 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -63.98 -20.25 65.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.459 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.95 -11.92 34.82 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.88 0.371 . . . . 1.0 110.284 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -107.19 -25.85 11.34 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.08 0.552 . . . . 1.0 111.452 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -67.8 -45.39 43.92 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 120.904 -0.319 . . . . 1.0 110.391 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 51.9 Cg_exo -56.65 -46.86 26.75 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 122.345 2.03 . . . . 1.0 112.527 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.67 -32.67 69.32 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.595 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tp -63.28 -37.75 88.46 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.13 0.491 . . . . 1.0 110.095 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -68.96 -11.06 60.34 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.462 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.9 t -82.76 -48.49 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 110.35 -0.241 . . . . 1.0 110.35 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.18 -26.79 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 120.622 0.249 . . . . 1.0 111.497 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -54.89 -61.83 5.17 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-O 119.51 -0.281 . . . . 1.0 111.373 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -60.85 -30.48 90.2 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.636 1.557 . . . . 1.0 111.288 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -61.89 -44.78 96.09 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.735 -0.468 . . . . 1.0 109.735 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -65.62 -41.94 92.13 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.529 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.5 mt -72.58 -36.83 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.143 0.497 . . . . 1.0 109.795 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 t -68.83 -40.23 79.56 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.316 0.858 . . . . 1.0 113.316 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -81.7 -46.19 14.65 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 122.113 -0.367 . . . . 1.0 111.57 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 tt -54.88 -36.03 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.777 0.322 . . . . 1.0 110.515 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -54.97 -46.22 75.05 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.605 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 m -70.87 -32.44 69.44 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.149 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.8 ttm -59.72 -31.64 69.8 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.316 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.05 -41.75 93.0 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.681 -0.489 . . . . 1.0 109.681 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.6 m -85.61 -55.57 3.93 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.381 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.6 p -66.47 -39.12 88.63 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 121.114 -0.235 . . . . 1.0 111.476 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.4 1.03 78.48 Favored Glycine 0 N--CA 1.472 1.064 0 N-CA-C 110.341 -1.104 . . . . 1.0 110.341 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 41.85 71.23 0.22 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.054 0.542 . . . . 1.0 111.069 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.0 144.99 29.58 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.201 0.524 . . . . 1.0 110.096 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -129.77 79.86 72.6 Favored Pre-proline 0 N--CA 1.471 0.589 0 CA-C-N 115.237 -0.892 . . . . 1.0 109.186 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -45.54 98.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.942 1.762 . . . . 1.0 112.406 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -170.19 -63.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.837 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -94.39 137.55 33.4 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 116.475 -0.329 . . . . 1.0 110.264 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.0 142.61 58.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.47 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -161.1 104.88 1.31 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 43.0 m -74.91 139.64 43.22 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.197 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.9 t -134.22 139.05 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.1 p -115.28 115.01 25.96 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.602 0.361 . . . . 1.0 110.261 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tt -102.58 143.07 32.74 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.857 0.463 . . . . 1.0 109.941 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.59 127.98 17.86 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 110.184 -0.302 . . . . 1.0 110.184 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -159.16 9.51 0.12 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.463 0.173 . . . . 1.0 111.032 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -166.11 34.3 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.255 0.55 . . . . 1.0 110.373 179.035 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.15 -28.07 1.43 Allowed Glycine 0 N--CA 1.465 0.595 0 N-CA-C 111.235 -0.746 . . . . 1.0 111.235 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.411 ' H ' ' C ' ' A' ' 81' ' ' ASN . 58.6 m-85 -83.36 146.26 28.58 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.8 p -132.49 108.17 8.95 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 96.1 m -87.13 132.9 33.7 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -91.58 135.99 33.46 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.67 0.668 . . . . 1.0 109.32 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.83 137.04 39.33 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -146.1 139.71 26.2 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.3 m -90.12 -11.64 40.67 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.82 0.343 . . . . 1.0 110.592 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.49 9.08 0.71 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.49 25.84 60.29 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.2 p -66.68 -140.32 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 53.0 t -167.67 -39.14 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.651 0.262 . . . . 1.0 110.307 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.418 ' O ' ' CG ' ' A' ' 95' ' ' TYR . . . -133.29 36.26 2.16 Favored Glycine 0 N--CA 1.477 1.385 0 N-CA-C 110.525 -1.03 . . . . 1.0 110.525 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.418 ' CG ' ' O ' ' A' ' 94' ' ' GLY . 95.7 m-85 -157.22 145.62 19.48 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 45.0 t -134.44 134.82 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -122.51 133.04 54.59 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.5 pt -138.83 159.67 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-O 120.965 0.412 . . . . 1.0 110.303 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.68 124.5 10.56 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.532 0.682 . . . . 1.0 109.658 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.36 131.7 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.093 -0.958 . . . . 1.0 109.779 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -135.92 105.0 9.69 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 108.706 -0.849 . . . . 1.0 108.706 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -69.96 142.05 46.02 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 CA-C-N 121.223 1.473 . . . . 1.0 111.426 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 63.7 p -90.63 146.65 23.87 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.847 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -68.86 79.4 0.3 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.729 0.299 . . . . 1.0 110.238 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.125 -0.941 . . . . 1.0 111.168 179.851 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 ptm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -64.29 157.78 25.11 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.312 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 54.29 51.14 14.86 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.819 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.2 m -58.44 129.21 40.99 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.212 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.4 m -133.84 126.77 31.2 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 109.677 -0.49 . . . . 1.0 109.677 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.402 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 8.8 m-90 -47.92 -65.24 0.6 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.813 0.34 . . . . 1.0 110.826 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.43 -176.55 0.12 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.502 -0.639 . . . . 1.0 111.502 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.442 ' O ' ' NH1' ' A' ' 10' ' ' ARG . 64.2 mt -56.79 144.92 31.07 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.579 0.704 . . . . 1.0 110.045 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.436 ' H ' ' CD ' ' A' ' 9' ' ' GLN . 26.2 mp0 -64.28 121.98 15.58 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.807 -178.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.664 ' NH2' ' H ' ' A' ' 17' ' ' GLY . 27.5 ptt-85 -149.25 137.29 20.61 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 25.2 p-10 -70.16 -43.09 71.58 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.89 0.852 . . . . 1.0 109.84 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 27.1 pt -78.77 130.75 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 114.216 -1.357 . . . . 1.0 112.128 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.561 ' C ' ' H ' ' A' ' 15' ' ' ARG . 0.1 OUTLIER -82.6 -39.14 0.83 Allowed Pre-proline 0 CA--C 1.553 1.071 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 177.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 13' ' ' THR . 74.1 Cg_exo -52.22 11.89 0.02 OUTLIER 'Trans proline' 0 N--CA 1.512 2.607 0 C-N-CA 123.11 2.54 . . . . 1.0 113.886 175.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.561 ' H ' ' C ' ' A' ' 13' ' ' THR . 51.5 ttt85 -139.65 44.24 1.96 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.088 0.47 . . . . 1.0 110.253 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 pp -41.88 148.62 0.16 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.92 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.664 ' H ' ' NH2' ' A' ' 10' ' ' ARG . . . -124.38 179.66 16.06 Favored Glycine 0 N--CA 1.477 1.379 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.39 146.57 18.5 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 6' ' ' TRP . 89.9 mtt-85 -100.96 120.64 40.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.672 -0.695 . . . . 1.0 111.081 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.3 mt -131.34 131.81 44.02 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.83 140.97 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -71.47 132.22 44.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.994 -0.372 . . . . 1.0 109.994 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -157.69 105.05 2.0 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.04 -165.64 50.84 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 109.724 -1.35 . . . . 1.0 109.724 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -84.4 29.05 0.61 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.014 0.435 . . . . 1.0 109.868 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -148.27 143.86 27.24 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.339 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -96.45 130.15 43.66 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -85.91 115.79 23.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.057 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -96.41 109.11 21.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.482 -0.932 . . . . 1.0 108.482 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.01 115.86 28.24 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.936 -0.574 . . . . 1.0 109.67 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.03 -37.85 88.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.144 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -66.26 -9.44 32.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.737 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.48 67.59 0.67 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.327 0.584 . . . . 1.0 110.179 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.69 172.35 6.89 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.4 m -139.84 138.33 35.67 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 tp -93.83 145.01 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.4 p -129.72 148.1 51.57 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.59 -146.57 26.0 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 111.076 -0.809 . . . . 1.0 111.076 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -166.64 75.7 0.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.316 0.579 . . . . 1.0 110.519 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -61.49 138.19 58.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.248 0.546 . . . . 1.0 110.171 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 87.1 p -71.7 167.86 18.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.44 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -65.53 -20.9 66.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.379 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.59 -9.32 44.58 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.878 0.37 . . . . 1.0 110.551 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -109.32 -30.54 7.94 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.213 0.605 . . . . 1.0 111.288 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.473 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -61.58 -45.32 93.67 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 120.781 -0.367 . . . . 1.0 110.189 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 44.8 Cg_exo -59.15 -50.21 9.21 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 122.392 2.062 . . . . 1.0 112.664 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.38 -46.42 88.72 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.335 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.441 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.1 tt -60.66 -39.01 86.81 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.097 0.475 . . . . 1.0 109.98 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -60.62 -12.48 10.28 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.2 t -104.22 -18.48 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.8 t -90.28 -33.37 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.546 ' CE2' HD11 ' A' ' 56' ' ' ILE . 65.8 t80 -62.75 -49.67 81.36 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 118.534 -0.746 . . . . 1.0 111.248 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 52' ' ' PHE . 44.3 Cg_endo -58.83 -26.26 79.75 Favored 'Trans proline' 0 N--CA 1.511 2.507 0 CA-C-N 121.323 1.508 . . . . 1.0 112.132 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 80' ' ' HIS . 17.6 t60 -60.48 -43.39 97.02 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.839 0.352 . . . . 1.0 110.175 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -64.48 -40.57 95.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.094 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.546 HD11 ' CE2' ' A' ' 52' ' ' PHE . 57.7 mt -65.47 -43.86 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 120.064 -0.654 . . . . 1.0 109.286 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.6 t -58.7 -46.08 88.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.104 -0.238 . . . . 1.0 111.239 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -70.48 -38.67 74.42 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.846 -0.161 . . . . 1.0 111.028 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.2 mt -61.08 -45.63 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 109.999 -0.371 . . . . 1.0 109.999 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -52.98 -41.93 65.07 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.544 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.7 p -75.99 -29.82 58.34 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.649 -0.25 . . . . 1.0 110.463 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 66' ' ' GLY . 12.1 tmm? -61.66 -33.32 73.75 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 110.251 -0.277 . . . . 1.0 110.251 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.74 -40.61 97.77 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.8 p -75.17 -56.22 4.94 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.389 -0.368 . . . . 1.0 111.268 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.1 p -68.65 -39.07 80.84 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.68 0.276 . . . . 1.0 111.255 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -80.96 -14.91 78.64 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 52.06 84.77 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.6 tp -81.35 142.88 32.62 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.763 -0.829 . . . . 1.0 108.763 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -151.95 131.24 6.69 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 119.221 -0.419 . . . . 1.0 110.355 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.18 102.2 1.58 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.361 1.374 . . . . 1.0 110.408 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -146.23 -34.24 0.3 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.257 0.551 . . . . 1.0 111.391 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -166.26 155.53 11.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.048 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.35 146.64 50.66 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.428 -0.806 . . . . 1.0 110.308 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -159.66 102.95 1.53 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.322 0.582 . . . . 1.0 109.759 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.1 t -83.16 137.29 34.12 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.181 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.36 153.09 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -131.85 103.18 6.18 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 78' ' ' LEU . 9.8 mp -90.87 143.8 26.35 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.368 -0.975 . . . . 1.0 108.368 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -125.44 127.75 47.0 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 54' ' ' HIS . 79.6 t60 -163.04 139.67 7.36 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.4 m120 53.34 26.1 5.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.981 0.42 . . . . 1.0 111.311 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.79 -28.42 3.19 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -70.27 149.13 47.75 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.511 -0.552 . . . . 1.0 109.511 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.5 m -135.7 120.85 18.9 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.473 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 65.5 m -107.05 139.65 41.11 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.296 -1.001 . . . . 1.0 108.296 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -104.7 140.83 37.49 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 108.807 -0.812 . . . . 1.0 108.807 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.91 151.26 38.41 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 110.011 -0.366 . . . . 1.0 110.011 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -166.56 139.76 3.89 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.4 m -76.33 -20.04 57.63 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 110.468 -0.197 . . . . 1.0 110.468 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.0 mt 62.67 10.42 4.15 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.986 0.422 . . . . 1.0 110.202 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.61 13.46 83.46 Favored Glycine 0 N--CA 1.466 0.642 0 N-CA-C 110.546 -1.021 . . . . 1.0 110.546 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.6 p -62.13 -143.34 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.564 0.221 . . . . 1.0 110.473 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 23.7 p -170.64 107.39 0.3 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.78 0.324 . . . . 1.0 110.351 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.02 -9.64 37.74 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 111.216 -0.753 . . . . 1.0 111.216 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -113.94 141.95 46.74 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.039 0.536 . . . . 1.0 109.582 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.2 136.81 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 108.901 -0.777 . . . . 1.0 108.901 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -125.65 138.59 53.91 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.213 -1.032 . . . . 1.0 108.213 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.8 pt -137.38 165.2 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.982 0.42 . . . . 1.0 109.952 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.92 108.47 3.82 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.73 139.36 17.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 114.745 -1.116 . . . . 1.0 108.744 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -147.54 129.3 7.41 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.29 143.52 43.81 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 CA-C-N 120.539 1.228 . . . . 1.0 111.692 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 103' ' ' THR . 1.4 t -87.24 147.38 25.58 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.079 -0.51 . . . . 1.0 109.633 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -72.29 110.38 6.69 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.236 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 . . . . . 0 C--O 1.218 -0.597 0 CA-C-O 118.114 -0.946 . . . . 1.0 109.777 179.651 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtm . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 4' ' ' THR . 20.9 m 53.93 38.85 29.67 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.064 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 58.5 t30 68.83 -45.85 0.55 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.148 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.401 ' H ' ' C ' ' A' ' 2' ' ' SER . 40.3 m -58.87 93.38 0.02 OUTLIER 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.165 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.4 m -102.84 125.33 49.54 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.543 -0.539 . . . . 1.0 109.543 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -50.37 -79.12 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.708 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.79 -157.84 0.28 Allowed Glycine 0 C--N 1.329 0.157 0 N-CA-C 110.663 -0.975 . . . . 1.0 110.663 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.5 mt -58.82 148.57 29.41 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.873 -0.418 . . . . 1.0 109.873 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -88.39 110.38 20.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.114 -0.493 . . . . 1.0 109.866 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.534 ' NH1' ' NH2' ' A' ' 15' ' ' ARG . 99.2 mtt180 -137.78 133.53 34.15 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -65.98 -35.55 80.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.502 0.668 . . . . 1.0 110.349 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 69.5 mt -59.71 125.65 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 114.397 -1.274 . . . . 1.0 110.012 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.487 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -81.09 -49.88 1.0 Allowed Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 107.938 -1.134 . . . . 1.0 107.938 177.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 13' ' ' THR . 33.0 Cg_exo -32.76 -33.95 0.05 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.631 2.221 . . . . 1.0 113.565 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.534 ' NH2' ' NH1' ' A' ' 10' ' ' ARG . 75.0 mtp180 -93.79 138.19 32.23 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.832 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 tt -119.93 114.86 22.69 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.45 156.77 43.47 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 109.822 -1.311 . . . . 1.0 109.822 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -165.34 71.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -73.91 128.99 36.99 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.0 mt -116.67 153.5 32.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.905 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.85 137.08 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.375 -0.972 . . . . 1.0 108.375 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -81.45 130.46 35.05 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -160.52 124.05 3.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.258 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.18 -147.53 50.82 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 109.953 -1.259 . . . . 1.0 109.953 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -105.18 15.42 27.5 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 110.171 -0.307 . . . . 1.0 110.171 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.411 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 17.8 mp0 -135.8 143.46 45.21 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.052 0.453 . . . . 1.0 110.122 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 50.8 mt -91.85 131.03 37.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -88.26 116.87 26.78 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -100.07 106.71 18.48 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 30' ' ' LEU . 11.0 mp -91.24 111.8 23.43 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.52 -35.1 73.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.237 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -71.62 -8.33 53.41 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.656 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -110.56 63.11 0.61 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.133 0.492 . . . . 1.0 110.378 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.9 175.09 4.56 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 t -141.43 138.06 32.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.957 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.0 mm -82.6 141.81 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.12 -0.326 . . . . 1.0 110.12 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.447 ' C ' ' H ' ' A' ' 39' ' ' LYS . 73.8 p -132.81 146.48 51.86 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.675 0.39 . . . . 1.0 110.035 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.99 -9.31 2.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 37' ' ' THR . 48.5 mtmt 50.77 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 O-C-N 122.462 -0.434 . . . . 1.0 111.25 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -69.36 139.91 54.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.299 0.571 . . . . 1.0 110.572 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.3 p -72.69 171.09 13.19 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.386 -0.825 . . . . 1.0 110.125 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.28 -19.28 65.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.434 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.98 -10.73 38.25 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 120.816 0.341 . . . . 1.0 110.544 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -109.27 -24.42 11.1 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.645 0.778 . . . . 1.0 111.227 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -67.27 -46.27 50.35 Favored Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 45' ' ' CYS . 28.5 Cg_exo -63.75 -55.08 0.74 Allowed 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.22 1.947 . . . . 1.0 112.398 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -56.85 -45.22 82.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.254 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.16 -39.67 87.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.291 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -62.24 -20.23 64.01 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.384 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.4 t -92.55 -21.99 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.1 t -85.78 -13.45 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 110.094 -0.335 . . . . 1.0 110.094 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.444 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -65.49 -59.39 9.59 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 122.286 -0.259 . . . . 1.0 110.512 178.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 52' ' ' PHE . 30.8 Cg_endo -55.65 -24.66 46.63 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.642 1.561 . . . . 1.0 112.089 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -66.17 3.86 0.8 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.751 0.31 . . . . 1.0 110.988 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 53' ' ' PRO . 44.5 m-85 -131.95 -40.96 1.04 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.751 0.421 . . . . 1.0 110.424 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.13 -42.5 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.3 p -57.1 -41.98 79.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.977 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -67.05 -56.47 9.93 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.666 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.15 -45.71 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -52.37 -37.91 57.5 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.74 -0.384 . . . . 1.0 111.011 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.5 p -76.77 -32.33 57.65 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.125 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 78.0 mmm -56.43 -31.17 63.67 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.282 -0.266 . . . . 1.0 110.282 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.2 mt -61.51 -37.13 82.59 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.6 m -92.05 -58.8 2.28 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.161 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.5 m -66.58 -43.07 85.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.648 -0.421 . . . . 1.0 111.864 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.66 -10.54 81.33 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 110.544 -1.023 . . . . 1.0 110.544 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 47.46 77.29 0.09 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 110.183 -0.303 . . . . 1.0 110.183 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.517 HD13 ' N ' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -86.57 126.91 34.8 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 -178.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.517 ' N ' HD13 ' A' ' 68' ' ' LEU . 70.9 m-80 -145.64 151.07 45.6 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.572 -0.285 . . . . 1.0 110.523 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.36 87.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.503 2.046 0 C-N-CA 121.86 1.707 . . . . 1.0 111.688 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -133.09 -60.2 0.86 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 120.868 0.366 . . . . 1.0 110.571 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -153.56 140.01 18.7 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.952 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.74 126.14 28.78 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.689 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -138.39 103.77 4.99 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.4 t -78.59 136.01 37.41 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.819 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.5 t -125.62 136.26 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.9 p -116.97 110.96 18.94 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 68.1 mt -89.91 160.65 16.32 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 50.0 p90 -143.57 130.56 20.57 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.047 -0.353 . . . . 1.0 110.047 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.48 ' C ' ' H ' ' A' ' 82' ' ' GLY . 74.1 t60 -157.75 -96.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' A' ' 83' ' ' PHE . 59.0 t30 -70.02 35.43 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.87 0.366 . . . . 1.0 111.503 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 80' ' ' HIS . . . 77.53 -28.83 1.76 Allowed Glycine 0 N--CA 1.466 0.657 0 N-CA-C 110.735 -0.946 . . . . 1.0 110.735 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.489 ' CZ ' HG23 ' A' ' 100' ' ' VAL . 6.9 t80 -78.52 147.23 33.92 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.487 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 35.6 p -134.08 116.24 15.22 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.958 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 45.6 t -87.51 142.16 28.07 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -102.01 136.89 41.07 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.325 -0.621 . . . . 1.0 109.325 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.64 151.64 41.65 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -168.72 152.49 5.54 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.2 m -98.58 -18.18 18.27 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.667 0.27 . . . . 1.0 110.67 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.7 mp 59.41 8.97 1.29 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.07 15.37 76.48 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.101 -1.199 . . . . 1.0 110.101 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.1 m -65.62 -134.95 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.01 -0.367 . . . . 1.0 110.01 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 20.8 p -170.61 105.97 0.28 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.865 0.364 . . . . 1.0 110.054 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.37 33.9 78.61 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.652 -0.979 . . . . 1.0 110.652 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -151.25 137.16 18.14 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 m -142.3 138.33 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.307 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.429 ' N ' ' CD1' ' A' ' 97' ' ' TYR . 21.5 m-85 -116.69 120.39 38.45 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 156.8 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.296 -1.001 . . . . 1.0 108.296 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.43 150.8 30.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.18 -0.918 . . . . 1.0 109.328 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.489 HG23 ' CZ ' ' A' ' 83' ' ' PHE . 2.7 p -123.38 135.66 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 115.115 -0.948 . . . . 1.0 109.568 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 13.4 p90 -149.03 97.33 3.64 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.135 -0.938 . . . . 1.0 108.971 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -51.63 144.84 32.05 Favored 'Trans proline' 0 N--CA 1.507 2.279 0 C-N-CA 121.922 1.748 . . . . 1.0 112.058 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 80.7 p -63.29 134.04 55.17 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.348 -0.387 . . . . 1.0 109.98 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -68.78 -41.1 79.22 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.747 0.308 . . . . 1.0 110.323 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 . . . . . 0 C--O 1.222 -0.389 0 CA-C-O 118.143 -0.932 . . . . 1.0 110.115 -179.224 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 mmt . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.1 t -63.29 -19.81 64.92 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.391 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -63.71 -37.08 86.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.025 -0.534 . . . . 1.0 109.61 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 m -57.55 102.16 0.09 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.411 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.9 p -133.89 125.82 29.11 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -96.1 163.69 13.01 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.88 160.21 22.72 Favored Glycine 0 N--CA 1.471 0.991 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.2 mt -69.84 153.99 42.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.185 -0.507 . . . . 1.0 109.992 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -102.51 118.15 36.23 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.897 0.479 . . . . 1.0 109.785 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.408 ' C ' ' H ' ' A' ' 12' ' ' ILE . 79.8 mtp180 -143.15 -168.17 2.73 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.744 -0.836 . . . . 1.0 108.744 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -57.83 -5.26 0.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.651 -0.249 . . . . 1.0 111.216 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.408 ' H ' ' C ' ' A' ' 10' ' ' ARG . 79.7 mt -96.79 128.88 47.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.295 -1.002 . . . . 1.0 108.295 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -56.08 0.44 Allowed Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 108.295 -1.002 . . . . 1.0 108.295 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.01 126.38 5.69 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 121.228 1.285 . . . . 1.0 110.743 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -152.18 153.12 33.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.839 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.0 tp -116.39 118.32 32.4 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.388 -1.338 . . . . 1.0 107.388 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.34 161.9 33.02 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 108.73 -1.748 . . . . 1.0 108.73 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.39 67.6 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -73.31 122.17 21.58 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.295 -0.632 . . . . 1.0 109.295 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.6 mt -90.06 144.91 25.47 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.702 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -102.99 136.79 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -75.75 133.61 40.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.942 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -172.25 109.18 0.23 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.016 -0.735 . . . . 1.0 109.016 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.66 -161.48 53.76 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 109.759 -1.337 . . . . 1.0 109.759 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -87.14 5.87 35.7 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.732 0.301 . . . . 1.0 110.389 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -127.79 136.36 51.37 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.09 0.471 . . . . 1.0 110.054 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.2 mp -89.07 127.73 35.71 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.941 -0.762 . . . . 1.0 108.941 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -83.9 116.31 22.71 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.664 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -97.67 103.65 15.6 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.847 -1.168 . . . . 1.0 107.847 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 30' ' ' LEU . 10.5 mp -86.68 134.62 33.59 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.052 -0.722 . . . . 1.0 109.052 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.05 -24.58 30.38 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.883 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -73.93 -10.44 59.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.028 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -108.41 16.64 22.9 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.537 0.335 . . . . 1.0 110.473 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.22 127.67 10.0 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.2 m -86.92 170.27 11.77 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.853 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.4 pt -97.4 155.07 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 82.0 p -134.45 128.64 33.88 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.48 99.16 0.01 OUTLIER Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.102 -0.799 . . . . 1.0 111.102 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -56.07 99.64 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.789 0.328 . . . . 1.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -69.23 140.08 54.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.007 -0.542 . . . . 1.0 109.544 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -69.46 171.07 9.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.276 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -64.28 -21.18 66.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.58 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.32 -22.51 20.5 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 120.825 0.345 . . . . 1.0 110.103 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -96.87 -26.36 15.11 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.904 0.482 . . . . 1.0 110.717 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -60.36 -57.59 25.53 Favored Pre-proline 0 CA--C 1.555 1.135 0 O-C-N 122.089 -0.382 . . . . 1.0 110.127 177.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 45' ' ' CYS . 35.0 Cg_endo -56.22 -41.91 71.69 Favored 'Trans proline' 0 N--CA 1.51 2.478 0 C-N-CA 122.497 2.131 . . . . 1.0 112.688 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -56.74 -37.31 70.84 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.951 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.55 -31.11 47.25 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.047 0.451 . . . . 1.0 110.091 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.13 -40.82 86.84 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.629 -0.669 . . . . 1.0 110.685 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.2 m -75.12 -20.56 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -86.01 -20.54 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.184 0.516 . . . . 1.0 110.045 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.79 -57.06 26.53 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.063 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -56.6 -26.92 67.14 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.161 1.241 . . . . 1.0 111.72 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -77.35 16.08 0.66 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.749 0.309 . . . . 1.0 110.97 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -131.32 -37.33 1.24 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.12 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.7 mm -74.74 -30.78 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.8 m -60.82 -43.92 97.6 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.844 0.354 . . . . 1.0 111.132 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -65.42 -42.5 92.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.91 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.14 -46.94 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.37 -45.9 90.15 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.5 t -65.81 -40.67 92.09 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.495 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.428 ' O ' ' N ' ' A' ' 66' ' ' GLY . 45.6 ttm -50.67 -44.05 57.58 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.863 0.363 . . . . 1.0 110.925 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.37 -37.33 86.86 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.283 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -68.77 -61.72 1.69 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.756 0.312 . . . . 1.0 111.616 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.4 t -72.4 -39.47 67.92 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.067 0.46 . . . . 1.0 110.781 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' MET . . . -98.51 73.4 0.57 Allowed Glycine 0 N--CA 1.462 0.396 0 N-CA-C 109.073 -1.611 . . . . 1.0 109.073 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.25 88.82 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -82.72 123.67 29.51 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.774 -1.195 . . . . 1.0 107.774 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.418 ' N ' HD13 ' A' ' 68' ' ' LEU . 24.1 m120 -122.68 147.03 49.51 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-O 119.286 -0.388 . . . . 1.0 110.727 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.28 88.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.506 2.233 0 C-N-CA 121.419 1.412 . . . . 1.0 112.159 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -131.67 -50.83 0.98 Allowed 'General case' 0 N--CA 1.48 1.065 0 O-C-N 121.999 -0.438 . . . . 1.0 109.9 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -163.36 151.72 13.78 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.767 -178.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.85 150.31 20.5 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.717 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -155.4 139.64 16.61 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.2 t -130.55 143.63 50.88 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.628 -0.508 . . . . 1.0 109.628 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.86 144.88 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.597 -0.52 . . . . 1.0 109.597 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.6 p -115.36 116.36 28.14 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 67.4 mt -99.79 134.76 42.22 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.52 -0.919 . . . . 1.0 108.52 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.414 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 47.2 p90 -115.03 127.58 55.73 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -156.72 141.2 16.72 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.456 ' ND2' ' CD1' ' A' ' 83' ' ' PHE . 5.7 p-10 43.91 29.5 0.32 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.237 0.458 . . . . 1.0 112.237 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.21 -27.25 4.61 Favored Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.876 -0.89 . . . . 1.0 110.876 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.456 ' CD1' ' ND2' ' A' ' 81' ' ' ASN . 6.5 m-85 -68.78 150.02 48.34 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.0 m -142.29 108.11 5.14 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.139 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.5 m -93.63 143.04 26.68 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -99.36 140.75 33.08 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.61 150.27 37.15 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 110.288 -0.264 . . . . 1.0 110.288 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -164.54 134.18 3.82 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.8 m -77.21 -42.59 36.84 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.991 0.424 . . . . 1.0 110.729 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' A' ' 92' ' ' SER . 57.5 mt 58.01 37.09 26.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.118 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.41 5.93 1.99 Allowed Glycine 0 CA--C 1.533 1.209 0 N-CA-C 111.386 -0.686 . . . . 1.0 111.386 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 90' ' ' LEU . 28.7 t -104.36 57.47 0.71 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.7 p -58.41 -23.41 57.18 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 119.954 -0.698 . . . . 1.0 110.386 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.66 -12.82 48.77 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.907 -0.877 . . . . 1.0 110.907 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -155.18 119.57 4.7 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 t -101.59 113.68 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -90.49 131.01 36.48 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.163 -0.68 . . . . 1.0 109.163 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.9 pt -139.03 161.55 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.1 111.57 3.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.402 0.62 . . . . 1.0 109.397 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.1 t -91.49 136.07 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 114.845 -1.071 . . . . 1.0 108.658 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -145.38 128.19 8.21 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 119.029 -0.51 . . . . 1.0 109.761 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.27 145.74 39.22 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.374 1.383 . . . . 1.0 111.243 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.2 p -83.58 138.67 33.27 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -64.87 -47.08 79.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.783 0.325 . . . . 1.0 110.343 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.067 -0.968 . . . . 1.0 110.397 -179.303 . . . . . . . . 0 0 . 1 stop_ save_